1	Persistent	persistent	JJ	JJ	_	2	amod	_	_
2	Amyloidosis	amyloidosis	NN	NN	_	0	root	_	_
3	following	follow	VBG	VBG	sem=TMP	2	prep	_	_
4	Suppression	suppression	NN	NN	_	3	pobj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	Aβ	aβ	NN	NN	_	7	compound	_	_
7	Production	production	NN	NN	_	5	pobj	_	_
8	in	in	IN	IN	sem=LOC	4	prep	_	_
9	a	a	DT	DT	_	11	det	_	_
10	Transgenic	transgenic	JJ	JJ	_	11	amod	_	_
11	Model	model	NN	NN	_	8	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	Alzheimer	alzheimer	NNP	NNP	_	14	compound	_	_
14	Disease	disease	NN	NN	_	12	pobj	_	_

1	Abstract	abstract	NN	NN	_	0	root	_	_

1	Background	background	NN	NN	_	0	root	_	_

1	The	the	DT	DT	_	4	det	_	_
2	proteases	protease	NNS	NNS	_	4	nmod	_	_
3	(	(	-LRB-	-LRB-	_	4	punct	_	_
4	secretases	secretase	NNS	NNS	_	24	nsubj	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	that	that	WDT	WDT	_	7	dep	_	4:ref
7	cleave	cleave	VBP	VBP	_	4	relcl	_	_
8	amyloid	amyloid	NN	NN	_	10	nmod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	β	β	NN	NN	_	14	nmod	_	_
11	(	(	-LRB-	-LRB-	_	10	punct	_	_
12	Aβ	aβ	NN	NN	_	10	appos	_	_
13	)	)	-RRB-	-RRB-	_	14	punct	_	_
14	peptide	peptide	NN	NN	_	7	dobj	_	_
15	from	from	IN	IN	_	7	prep	_	_
16	the	the	DT	DT	_	19	det	_	_
17	amyloid	amyloid	NN	NN	_	19	compound	_	_
18	precursor	precursor	NN	NN	_	19	compound	_	_
19	protein	protein	NN	NN	_	15	pobj	_	_
20	(	(	-LRB-	-LRB-	_	19	punct	_	_
21	APP	app	NN	NN	_	19	appos	_	_
22	)	)	-RRB-	-RRB-	_	24	punct	_	_
23	have	have	VBP	VBP	_	24	aux	_	_
24	been	be	VBN	VBN	_	0	root	_	_
25	the	the	DT	DT	_	26	det	_	_
26	focus	focus	NN	NN	syn=PRD	24	attr	_	_
27	of	of	IN	IN	_	26	prep	_	_
28	considerable	considerable	JJ	JJ	_	29	amod	_	_
29	investigation	investigation	NN	NN	_	27	pobj	_	_
30	in	in	IN	IN	_	29	prep	_	_
31	the	the	DT	DT	_	32	det	_	_
32	development	development	NN	NN	_	30	pobj	_	_
33	of	of	IN	IN	_	32	prep	_	_
34	treatments	treatment	NNS	NNS	_	33	pobj	_	_
35	for	for	IN	IN	_	34	prep	_	_
36	Alzheimer	alzheimer	NNP	NNP	_	37	compound	_	_
37	disease	disease	NN	NN	_	35	pobj	_	_
38	.	.	.	.	_	24	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	prediction	prediction	NN	NN	_	4	nsubj	_	_
3	has	have	VBZ	VBZ	_	4	aux	_	_
4	been	be	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	28	mark	_	_
6	reducing	reduce	VBG	VBG	syn=NOM	28	csubj	_	_
7	Aβ	aβ	NN	NN	_	8	compound	_	_
8	production	production	NN	NN	_	6	dobj	_	_
9	in	in	IN	IN	sem=LOC	6	prep	_	_
10	the	the	DT	DT	_	11	det	_	_
11	brain	brain	NN	NN	_	9	pobj	_	_
12	,	,	,	,	_	28	punct	_	_
13	even	even	RB	RB	_	14	advmod	_	_
14	after	after	IN	IN	sem=TMP	28	prep	_	_
15	the	the	DT	DT	_	16	det	_	_
16	onset	onset	NN	NN	_	14	pobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	clinical	clinical	JJ	JJ	_	19	amod	_	_
19	symptoms	symptom	NNS	NNS	_	17	pobj	_	_
20	and	and	CC	CC	_	16	cc	_	_
21	the	the	DT	DT	_	22	det	_	_
22	development	development	NN	NN	_	16	conj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	associated	associate	VBN	VBN	_	25	amod	_	_
25	pathology	pathology	NN	NN	_	23	pobj	_	_
26	,	,	,	,	_	28	punct	_	_
27	will	will	MD	MD	_	28	aux	_	_
28	facilitate	facilitate	VB	VB	syn=PRD	4	ccomp	_	_
29	the	the	DT	DT	_	30	det	_	_
30	repair	repair	NN	NN	_	28	dobj	_	_
31	of	of	IN	IN	_	30	prep	_	_
32	damaged	damage	VBN	VBN	_	33	amod	_	_
33	tissue	tissue	NN	NN	_	31	pobj	_	_
34	and	and	CC	CC	_	30	cc	_	_
35	removal	removal	NN	NN	_	30	conj	_	_
36	of	of	IN	IN	_	35	prep	_	_
37	amyloid	amyloid	NN	NN	_	38	compound	_	_
38	lesions	lesion	NNS	NNS	_	36	pobj	_	_
39	.	.	.	.	_	4	punct	_	_

1	However	however	RB	RB	_	17	advmod	_	_
2	,	,	,	,	_	17	punct	_	_
3	no	no	DT	DT	_	7	det	_	_
4	long	long	JJ	JJ	_	6	amod	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	term	term	NN	NN	_	7	compound	_	_
7	studies	study	NNS	NNS	_	17	nsubjpass	_	_
8	using	use	VBG	VBG	_	7	acl	_	_
9	animal	animal	NN	NN	_	10	compound	_	_
10	models	model	NNS	NNS	_	8	dobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	amyloid	amyloid	NN	NN	_	13	compound	_	_
13	pathology	pathology	NN	NN	_	11	pobj	_	_
14	have	have	VBP	VBP	_	17	aux	_	_
15	yet	yet	RB	RB	_	17	advmod	_	_
16	been	be	VBN	VBN	_	17	auxpass	_	_
17	performed	performed	VBN	VBN	_	0	root	_	_
18	to	to	TO	TO	_	19	aux	_	_
19	test	test	VB	VB	sem=PRP	17	advcl	_	_
20	this	this	DT	DT	_	21	det	_	_
21	hypothesis	hypothesis	NN	NN	_	19	dobj	_	_
22	.	.	.	.	_	17	punct	_	_

1	Methods	method	NNS	NNS	_	0	root	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	Findings	finding	NNS	NNS	_	1	conj	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	generated	generate	VBN	VBN	_	0	root	_	_
4	a	a	DT	DT	_	7	det	_	_
5	transgenic	transgenic	JJ	JJ	_	7	amod	_	_
6	mouse	mouse	NN	NN	_	7	compound	_	_
7	model	model	NN	NN	_	3	dobj	_	_
8	that	that	WDT	WDT	_	10	dep	_	7:ref
9	genetically	genetically	RB	RB	_	10	advmod	_	_
10	mimics	mimic	VBZ	VBZ	_	7	relcl	_	_
11	the	the	DT	DT	_	12	det	_	_
12	arrest	arrest	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	Aβ	aβ	NN	NN	_	15	compound	_	_
15	production	production	NN	NN	_	13	pobj	_	_
16	expected	expect	VBN	VBN	_	15	acl	_	_
17	from	from	IN	IN	_	16	prep	_	_
18	treatment	treatment	NN	NN	_	17	pobj	_	_
19	with	with	IN	IN	_	18	prep	_	_
20	secretase	secretase	NN	NN	_	21	compound	_	_
21	inhibitors	inhibitor	NNS	NNS	_	19	pobj	_	_
22	.	.	.	.	_	3	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	mice	mouse	NNS	NNS	_	3	nsubj	_	_
3	overexpress	overexpress	VBP	VBP	_	0	root	_	_
4	mutant	mutant	NN	NN	_	5	compound	_	_
5	APP	app	NN	NN	_	3	dobj	_	_
6	from	from	IN	IN	_	3	prep	_	_
7	a	a	DT	DT	_	8	det	_	_
8	vector	vector	NN	NN	_	6	pobj	_	_
9	that	that	WDT	WDT	_	12	dep	_	8:ref
10	can	can	MD	MD	_	12	aux	_	_
11	be	be	VB	VB	_	12	auxpass	_	_
12	regulated	regulate	VBN	VBN	_	8	relcl	_	_
13	by	by	IN	IN	_	12	agent	_	_
14	doxycycline	doxycycline	NN	NN	_	13	pobj	_	_
15	.	.	.	.	_	3	punct	_	_

1	Under	under	IN	IN	_	12	prep	_	_
2	normal	normal	JJ	JJ	_	3	amod	_	_
3	conditions	condition	NNS	NNS	_	1	pobj	_	_
4	,	,	,	,	_	12	punct	_	_
5	high	high	JJ	JJ	_	7	amod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	level	level	NN	NN	_	8	compound	_	_
8	expression	expression	NN	NN	_	12	nsubj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	APP	app	NN	NN	_	9	pobj	_	_
11	quickly	quickly	RB	RB	_	12	advmod	_	_
12	induces	induce	VBZ	VBZ	_	0	root	_	_
13	fulminant	fulminant	JJ	JJ	_	15	amod	_	_
14	amyloid	amyloid	NN	NN	_	15	compound	_	_
15	pathology	pathology	NN	NN	_	12	dobj	_	_
16	.	.	.	.	_	12	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	show	show	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	6	mark	_	_
4	doxycycline	doxycycline	NN	NN	_	5	compound	_	_
5	administration	administration	NN	NN	_	6	nsubj	_	_
6	inhibits	inhibit	VBZ	VBZ	_	2	ccomp	_	_
7	transgenic	transgenic	JJ	JJ	_	9	amod	_	_
8	APP	app	NN	NN	_	9	compound	_	_
9	expression	expression	NN	NN	_	6	dobj	_	_
10	by	by	IN	IN	_	6	prep	_	_
11	greater	great	JJR	JJR	_	13	amod	_	_
12	than	than	IN	IN	_	13	quantmod	_	_
13	95	0	CD	CD	_	14	nummod	_	_
14	%	%	NN	NN	_	10	pobj	_	_
15	and	and	CC	CC	_	6	cc	_	_
16	reduces	reduce	VBZ	VBZ	_	6	conj	_	_
17	Aβ	aβ	NN	NN	_	18	compound	_	_
18	production	production	NN	NN	_	16	dobj	_	_
19	to	to	IN	IN	_	16	prep	_	_
20	levels	level	NNS	NNS	_	19	pobj	_	_
21	found	find	VBN	VBN	_	20	acl	_	_
22	in	in	IN	IN	sem=LOC	21	prep	_	_
23	nontransgenic	nontransgenic	JJ	JJ	_	24	amod	_	_
24	mice	mouse	NNS	NNS	_	22	pobj	_	_
25	.	.	.	.	_	2	punct	_	_

1	Suppression	suppression	NN	NN	_	10	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	transgenic	transgenic	JJ	JJ	_	5	amod	_	_
4	Aβ	aβ	NN	NN	_	5	compound	_	_
5	synthesis	synthesis	NN	NN	_	2	pobj	_	_
6	in	in	IN	IN	_	1	prep	_	_
7	this	this	DT	DT	_	8	det	_	_
8	model	model	NN	NN	_	6	pobj	_	_
9	abruptly	abruptly	RB	RB	sem=MNR	10	advmod	_	_
10	halts	halt	VBZ	VBZ	_	0	root	_	_
11	the	the	DT	DT	_	12	det	_	_
12	progression	progression	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	amyloid	amyloid	NN	NN	_	15	compound	_	_
15	pathology	pathology	NN	NN	_	13	pobj	_	_
16	.	.	.	.	_	10	punct	_	_

1	However	however	RB	RB	_	9	advmod	_	_
2	,	,	,	,	_	9	punct	_	_
3	formation	formation	NN	NN	_	9	nsubj	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	disaggregation	disaggregation	NN	NN	_	3	conj	_	_
6	of	of	IN	IN	_	3	prep	_	_
7	amyloid	amyloid	NN	NN	_	8	compound	_	_
8	deposits	deposit	NNS	NNS	_	6	pobj	_	_
9	appear	appear	VBP	VBP	_	0	root	_	_
10	to	to	TO	TO	_	11	aux	_	_
11	be	be	VB	VB	_	9	xcomp	_	_
12	in	in	IN	IN	syn=PRD	11	prep	_	_
13	disequilibrium	disequilibrium	NN	NN	_	12	pobj	_	_
14	as	as	IN	IN	_	17	mark	_	_
15	the	the	DT	DT	_	16	det	_	_
16	plaques	plaque	NNS	NNS	_	17	nsubj	_	_
17	require	require	VBP	VBP	sem=PRP	11	advcl	_	_
18	far	far	RB	RB	_	19	advmod	_	_
19	longer	long	RBR	RBR	sem=TMP	17	advmod	_	_
20	to	to	TO	TO	_	21	aux	_	_
21	disperse	disperse	VB	VB	_	17	xcomp	_	_
22	than	than	IN	IN	_	24	mark	_	_
23	to	to	TO	TO	_	24	aux	_	_
24	assemble	assemble	VB	VB	_	17	advcl	_	_
25	.	.	.	.	_	9	punct	_	_

1	Mice	mouse	NNS	NNS	_	20	nsubj	_	_
2	in	in	IN	IN	_	7	prep	_	_
3	which	which	WDT	WDT	_	2	pobj	_	1:ref
4	APP	app	NN	NN	_	5	compound	_	_
5	synthesis	synthesis	NN	NN	_	7	nsubjpass	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	suppressed	suppress	VBN	VBN	_	1	relcl	_	_
8	for	for	IN	IN	sem=TMP	7	prep	_	_
9	as	as	RB	RB	_	12	advmod	_	_
10	long	long	JJ	JJ	_	12	amod	_	_
11	as	as	IN	IN	_	12	quantmod	_	_
12	6	0	CD	CD	_	13	nummod	_	_
13	mo	mo	NN	NN	_	8	pobj	_	_
14	after	after	IN	IN	sem=TMP	7	prep	_	_
15	the	the	DT	DT	_	16	det	_	_
16	formation	formation	NN	NN	_	14	pobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	Aβ	aβ	NN	NN	_	19	compound	_	_
19	deposits	deposit	NNS	NNS	_	17	pobj	_	_
20	retain	retain	VBP	VBP	_	0	root	_	_
21	a	a	DT	DT	_	24	det	_	_
22	considerable	considerable	JJ	JJ	_	24	amod	_	_
23	amyloid	amyloid	NN	NN	_	24	compound	_	_
24	load	load	NN	NN	_	20	dobj	_	_
25	,	,	,	,	_	20	punct	_	_
26	with	with	IN	IN	_	20	prep	_	_
27	little	little	JJ	JJ	_	28	amod	_	_
28	sign	sign	NN	NN	_	26	pobj	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	active	active	JJ	JJ	_	31	amod	_	_
31	clearance	clearance	NN	NN	_	29	pobj	_	_
32	.	.	.	.	_	20	punct	_	_

1	Conclusion	conclusion	NN	NN	_	0	root	_	_

1	This	this	DT	DT	_	2	det	_	_
2	study	study	NN	NN	_	3	nsubj	_	_
3	demonstrates	demonstrate	VBZ	VBZ	_	0	root	_	_
4	that	that	IN	IN	_	10	mark	_	_
5	amyloid	amyloid	NN	NN	_	6	compound	_	_
6	lesions	lesion	NNS	NNS	_	10	nsubj	_	_
7	in	in	IN	IN	sem=LOC	6	prep	_	_
8	transgenic	transgenic	JJ	JJ	_	9	amod	_	_
9	mice	mouse	NNS	NNS	_	7	pobj	_	_
10	are	be	VBP	VBP	_	3	ccomp	_	_
11	highly	highly	RB	RB	_	12	advmod	_	_
12	stable	stable	JJ	JJ	_	13	amod	_	_
13	structures	structure	NNS	NNS	syn=PRD	10	attr	_	_
14	in	in	FW	FW	_	15	advmod	_	_
15	vivo	vivo	FW	FW	_	13	advmod	_	_
16	that	that	WDT	WDT	_	17	dep	_	13:ref
17	are	be	VBP	VBP	_	13	relcl	_	_
18	slow	slow	JJ	JJ	syn=PRD	17	acomp	_	_
19	to	to	TO	TO	_	20	aux	_	_
20	disaggregate	disaggregate	VB	VB	_	18	xcomp	_	_
21	.	.	.	.	_	3	punct	_	_

1	Our	our	PRP$	PRP$	_	2	poss	_	_
2	findings	finding	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	14	mark	_	_
5	arresting	arrest	VBG	VBG	syn=NOM	14	csubj	_	_
6	Aβ	aβ	NN	NN	_	7	compound	_	_
7	production	production	NN	NN	_	5	dobj	_	_
8	in	in	IN	IN	sem=LOC	5	prep	_	_
9	patients	patient	NNS	NNS	_	8	pobj	_	_
10	with	with	IN	IN	_	9	prep	_	_
11	Alzheimer	alzheimer	NNP	NNP	_	12	compound	_	_
12	disease	disease	NN	NN	_	10	pobj	_	_
13	should	should	MD	MD	_	14	aux	_	_
14	halt	halt	VB	VB	_	3	advcl	_	_
15	the	the	DT	DT	_	16	det	_	_
16	progression	progression	NN	NN	_	14	dobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	pathology	pathology	NN	NN	_	17	pobj	_	_
19	,	,	,	,	_	14	punct	_	_
20	but	but	CC	CC	_	14	cc	_	_
21	that	that	IN	IN	_	25	mark	_	_
22	early	early	JJ	JJ	_	23	amod	_	_
23	treatment	treatment	NN	NN	_	25	nsubj	_	_
24	may	may	MD	MD	_	25	aux	_	_
25	be	be	VB	VB	_	14	conj	_	_
26	imperative	imperative	JJ	JJ	syn=PRD	25	acomp	_	_
27	,	,	,	,	_	25	punct	_	_
28	as	as	IN	IN	_	30	mark	_	_
29	it	it	PRP	PRP	_	30	nsubj	_	_
30	appears	appear	VBZ	VBZ	sem=PRP	25	advcl	_	_
31	that	that	IN	IN	_	39	mark	_	_
32	amyloid	amyloid	NN	NN	_	33	compound	_	_
33	deposits	deposit	NNS	NNS	_	39	nsubj	_	_
34	,	,	,	,	_	39	punct	_	_
35	once	once	IN	IN	_	36	mark	_	_
36	formed	form	VBN	VBN	sem=TMP	39	advcl	_	_
37	,	,	,	,	_	39	punct	_	_
38	will	will	MD	MD	_	39	aux	_	_
39	require	require	VB	VB	_	30	ccomp	_	_
40	additional	additional	JJ	JJ	_	41	amod	_	_
41	intervention	intervention	NN	NN	_	39	dobj	_	_
42	to	to	TO	TO	_	43	aux	_	_
43	clear	clear	VB	VB	_	41	advcl	_	_
44	.	.	.	.	_	3	punct	_	_

1	Introduction	introduction	NN	NN	_	0	root	_	_

1	Over	over	IN	IN	_	2	quantmod	_	_
2	a	a	DT	DT	_	3	nummod	_	_
3	decade	decade	NN	NN	_	4	npadvmod	_	_
4	ago	ago	RB	RB	sem=TMP	9	advmod	_	_
5	the	the	DT	DT	_	8	det	_	_
6	amyloid	amyloid	NN	NN	_	7	compound	_	_
7	cascade	cascade	NN	NN	_	8	compound	_	_
8	hypothesis	hypothesis	NN	NN	_	9	nsubj	_	_
9	predicted	predict	VBD	VBD	_	0	root	_	_
10	that	that	IN	IN	_	21	mark	_	_
11	increased	increase	VBN	VBN	_	12	amod	_	_
12	levels	level	NNS	NNS	_	21	nsubj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	amyloid	amyloid	NN	NN	_	16	nmod	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	β	β	NN	NN	_	20	nmod	_	_
17	(	(	-LRB-	-LRB-	_	16	punct	_	_
18	Aβ	aβ	NN	NN	_	16	appos	_	_
19	)	)	-RRB-	-RRB-	_	20	punct	_	_
20	peptide	peptide	NN	NN	_	13	pobj	_	_
21	lead	lead	VBP	VBP	_	9	ccomp	_	_
22	to	to	IN	IN	_	21	prep	_	_
23	secondary	secondary	JJ	JJ	_	24	amod	_	_
24	pathologies	pathology	NNS	NNS	_	22	pobj	_	_
25	that	that	WDT	WDT	_	27	dep	_	24:ref
26	ultimately	ultimately	RB	RB	_	27	advmod	_	_
27	culminate	culminate	VBP	VBP	_	24	relcl	_	_
28	in	in	IN	IN	_	27	prep	_	_
29	the	the	DT	DT	_	30	det	_	_
30	onset	onset	NN	NN	_	28	pobj	_	_
31	of	of	IN	IN	_	30	prep	_	_
32	Alzheimer	alzheimer	NNP	NNP	_	33	compound	_	_
33	disease	disease	NN	NN	_	31	pobj	_	_
34	(	(	-LRB-	-LRB-	_	33	punct	_	_
35	AD	ad	NN	NN	_	33	appos	_	_
36	)	)	-RRB-	-RRB-	_	21	punct	_	_
37	[	[	-LRB-	-LRB-	_	38	punct	_	_
38	1	0	CD	CD	_	21	parataxis	_	_
39	]	]	-RRB-	-RRB-	_	38	punct	_	_
40	.	.	.	.	_	9	punct	_	_

1	Early	early	JJ	JJ	_	2	amod	_	_
2	support	support	NN	NN	_	6	nsubj	_	_
3	for	for	IN	IN	_	2	prep	_	_
4	this	this	DT	DT	_	5	det	_	_
5	hypothesis	hypothesis	NN	NN	_	3	pobj	_	_
6	came	come	VBD	VBD	_	0	root	_	_
7	from	from	IN	IN	_	6	prep	_	_
8	genetic	genetic	JJ	JJ	_	9	amod	_	_
9	studies	study	NNS	NNS	_	7	pobj	_	_
10	linking	link	VBG	VBG	_	9	acl	_	_
11	early	early	JJ	JJ	_	13	amod	_	_
12	-	-	HYPH	HYPH	_	13	punct	_	_
13	onset	onset	NN	NN	_	14	compound	_	_
14	AD	ad	NN	NN	_	10	dobj	_	_
15	to	to	IN	IN	_	10	prep	_	_
16	mutations	mutation	NNS	NNS	_	15	pobj	_	_
17	in	in	IN	IN	sem=LOC	16	prep	_	_
18	the	the	DT	DT	_	21	det	_	_
19	amyloid	amyloid	NN	NN	_	21	compound	_	_
20	precursor	precursor	NN	NN	_	21	compound	_	_
21	protein	protein	NN	NN	_	17	pobj	_	_
22	(	(	-LRB-	-LRB-	_	21	punct	_	_
23	APP	app	NN	NN	_	21	appos	_	_
24	)	)	-RRB-	-RRB-	_	21	punct	_	_
25	,	,	,	,	_	21	punct	_	_
26	from	from	IN	IN	_	30	prep	_	_
27	which	which	WDT	WDT	_	26	pobj	_	21:ref
28	Aβ	aβ	NN	NN	_	30	nsubjpass	_	_
29	is	be	VBZ	VBZ	_	30	auxpass	_	_
30	derived	derive	VBN	VBN	_	21	relcl	_	_
31	,	,	,	,	_	21	punct	_	_
32	and	and	CC	CC	_	21	cc	_	_
33	presenilins	presenilins	NNS	NNS	_	34	nmod	_	_
34	1	0	CD	CD	_	21	conj	_	_
35	and	and	CC	CC	_	34	cc	_	_
36	2	0	CD	CD	_	34	conj	_	_
37	,	,	,	,	_	34	punct	_	_
38	which	which	WDT	WDT	_	39	dep	_	34:ref
39	are	be	VBP	VBP	_	34	relcl	_	_
40	interchangeable	interchangeable	JJ	JJ	_	41	amod	_	_
41	components	component	NNS	NNS	syn=PRD	39	attr	_	_
42	of	of	IN	IN	_	41	prep	_	_
43	a	a	DT	DT	_	45	det	_	_
44	endoprotease	endoprotease	NN	NN	_	45	compound	_	_
45	complex	complex	NN	NN	_	42	pobj	_	_
46	that	that	WDT	WDT	_	47	dep	_	45:ref
47	releases	release	VBZ	VBZ	_	45	relcl	_	_
48	Aβ	aβ	NN	NN	_	47	dobj	_	_
49	from	from	IN	IN	_	47	prep	_	_
50	APP	app	NN	NN	_	49	pobj	_	_
51	(	(	-LRB-	-LRB-	_	54	punct	_	_
52	for	for	IN	IN	_	54	prep	_	_
53	review	review	NN	NN	_	52	pobj	_	_
54	see	see	VBP	VBP	_	47	parataxis	_	_
55	[	[	-LRB-	-LRB-	_	54	punct	_	_
56	2	0	CD	CD	_	58	nummod	_	_
57	,	,	,	,	_	58	punct	_	_
58	3	0	CD	CD	_	54	dobj	_	_
59	]	]	-RRB-	-RRB-	_	54	punct	_	_
60	)	)	-RRB-	-RRB-	_	54	punct	_	_
61	.	.	.	.	_	6	punct	_	_

1	If	if	IN	IN	_	9	mark	_	_
2	,	,	,	,	_	9	punct	_	_
3	as	as	IN	IN	_	4	mark	_	_
4	predicted	predict	VBN	VBN	syn=ADV	9	advcl	_	_
5	,	,	,	,	_	9	punct	_	_
6	overproduction	overproduction	NN	NN	_	9	nsubj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	Aβ	aβ	NN	NN	_	7	pobj	_	_
9	initiates	initiate	VBZ	VBZ	syn=ADV	27	advcl	_	_
10	the	the	DT	DT	_	11	det	_	_
11	cascade	cascade	NN	NN	_	9	dobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	events	event	NNS	NNS	_	12	pobj	_	_
14	leading	lead	VBG	VBG	_	13	acl	_	_
15	to	to	IN	IN	_	14	prep	_	_
16	disease	disease	NN	NN	_	15	pobj	_	_
17	,	,	,	,	_	27	punct	_	_
18	then	then	RB	RB	sem=TMP	27	advmod	_	_
19	therapeutic	therapeutic	JJ	JJ	_	20	amod	_	_
20	strategies	strategy	NNS	NNS	_	27	nsubj	_	_
21	that	that	WDT	WDT	_	22	dep	_	20:ref
22	lower	lower	VBP	VBP	_	20	relcl	_	_
23	Aβ	aβ	NN	NN	_	24	compound	_	_
24	levels	level	NNS	NNS	_	22	dobj	_	_
25	should	should	MD	MD	_	27	aux	_	_
26	either	either	CC	CC	_	27	preconj	_	_
27	arrest	arrest	VB	VB	_	0	root	_	_
28	or	or	CC	CC	_	27	cc	_	_
29	reverse	reverse	VB	VB	_	27	conj	_	_
30	the	the	DT	DT	_	31	det	_	_
31	progression	progression	NN	NN	_	29	dobj	_	_
32	from	from	IN	IN	_	31	prep	_	_
33	peptide	peptide	NN	NN	_	32	pobj	_	_
34	to	to	IN	IN	_	32	prep	_	_
35	dementia	dementia	NN	NN	_	34	pobj	_	_
36	.	.	.	.	_	27	punct	_	_

1	Early	early	JJ	JJ	_	2	amod	_	_
2	evidence	evidence	NN	NN	_	24	nsubj	_	_
3	from	from	IN	IN	_	2	prep	_	_
4	clinical	clinical	JJ	JJ	_	5	amod	_	_
5	trials	trial	NNS	NNS	_	3	pobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	antibody	antibody	NN	NN	_	9	npadvmod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	mediated	mediate	VBN	VBN	_	10	amod	_	_
10	clearance	clearance	NN	NN	_	6	pobj	_	_
11	,	,	,	,	_	10	punct	_	_
12	one	#crd#	CD	CD	_	10	appos	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	the	the	DT	DT	_	19	det	_	_
15	first	#ord#	JJ	JJ	_	19	amod	_	_
16	Aβ	aβ	NN	NN	_	18	npadvmod	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	lowering	lower	VBG	VBG	_	19	amod	_	_
19	approaches	approach	NNS	NNS	_	13	pobj	_	_
20	tested	test	VBN	VBN	_	19	acl	_	_
21	in	in	IN	IN	sem=LOC	20	prep	_	_
22	humans	human	NNS	NNS	_	21	pobj	_	_
23	,	,	,	,	_	24	punct	_	_
24	suggested	suggest	VBD	VBD	_	0	root	_	_
25	that	that	IN	IN	_	34	mark	_	_
26	treatments	treatment	NNS	NNS	_	34	nsubj	_	_
27	designed	design	VBN	VBN	_	26	acl	_	_
28	to	to	TO	TO	_	29	aux	_	_
29	reduce	reduce	VB	VB	sem=PRP	27	advcl	_	_
30	amyloid	amyloid	NN	NN	_	31	compound	_	_
31	burden	burden	NN	NN	_	29	dobj	_	_
32	may	may	MD	MD	_	34	aux	_	_
33	indeed	indeed	RB	RB	_	34	advmod	_	_
34	be	be	VB	VB	_	24	ccomp	_	_
35	beneficial	beneficial	JJ	JJ	syn=PRD	34	acomp	_	_
36	.	.	.	.	_	24	punct	_	_

1	Although	although	IN	IN	_	5	mark	_	_
2	the	the	DT	DT	_	3	det	_	_
3	trials	trial	NNS	NNS	_	5	nsubjpass	_	_
4	were	be	VBD	VBD	_	5	auxpass	_	_
5	halted	halt	VBN	VBN	syn=ADV	26	advcl	_	_
6	because	because	IN	IN	sem=PRP	5	prep	_	_
7	of	of	IN	IN	_	6	pcomp	_	_
8	adverse	adverse	JJ	JJ	_	9	amod	_	_
9	effects	effect	NNS	NNS	_	6	pobj	_	_
10	in	in	IN	IN	_	9	prep	_	_
11	a	a	DT	DT	_	12	det	_	_
12	subset	subset	NN	NN	_	10	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	volunteers	volunteer	NNS	NNS	_	13	pobj	_	_
15	[	[	-LRB-	-LRB-	_	18	punct	_	_
16	4	0	CD	CD	_	18	nummod	_	_
17	,	,	,	,	_	18	punct	_	_
18	5	0	CD	CD	_	5	parataxis	_	_
19	]	]	-RRB-	-RRB-	_	18	punct	_	_
20	,	,	,	,	_	26	punct	_	_
21	further	far	JJ	JJ	_	22	amod	_	_
22	analysis	analysis	NN	NN	_	26	nsubj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	several	several	JJ	JJ	_	25	amod	_	_
25	patients	patient	NNS	NNS	_	23	pobj	_	_
26	found	find	VBD	VBD	_	0	root	_	_
27	evidence	evidence	NN	NN	_	26	dobj	_	_
28	that	that	IN	IN	_	41	mark	_	_
29	amyloid	amyloid	NN	NN	_	30	compound	_	_
30	pathology	pathology	NN	NN	_	41	nsubjpass	_	_
31	,	,	,	,	_	30	punct	_	_
32	and	and	CC	CC	_	30	cc	_	_
33	to	to	IN	IN	_	38	prep	_	_
34	a	a	DT	DT	_	36	det	_	_
35	lesser	less	JJR	JJR	_	36	amod	_	_
36	degree	degree	NN	NN	_	33	pobj	_	_
37	cognitive	cognitive	JJ	JJ	_	38	amod	_	_
38	function	function	NN	NN	_	30	conj	_	_
39	,	,	,	,	_	41	punct	_	_
40	was	be	VBD	VBD	_	41	auxpass	_	_
41	improved	improve	VBN	VBN	_	27	acl	_	_
42	in	in	IN	IN	_	41	prep	_	_
43	proportion	proportion	NN	NN	_	42	pobj	_	_
44	to	to	IN	IN	_	43	prep	_	_
45	the	the	DT	DT	_	46	det	_	_
46	patient	patient	NN	NN	_	48	poss	_	_
47	's	's	POS	POS	_	46	case	_	_
48	titer	titer	NN	NN	_	44	pobj	_	_
49	of	of	IN	IN	_	48	prep	_	_
50	Aβ	aβ	NN	NN	_	52	npadvmod	_	_
51	-	-	HYPH	HYPH	_	52	punct	_	_
52	specific	specific	JJ	JJ	_	53	amod	_	_
53	antibody	antibody	NN	NN	_	49	pobj	_	_
54	[	[	-LRB-	-LRB-	_	57	punct	_	_
55	6	0	CD	CD	_	57	nummod	_	_
56	,	,	,	,	_	57	punct	_	_
57	7	0	CD	CD	_	41	parataxis	_	_
58	]	]	-RRB-	-RRB-	_	57	punct	_	_
59	.	.	.	.	_	26	punct	_	_

1	While	while	IN	IN	_	4	mark	_	_
2	this	this	DT	DT	_	3	det	_	_
3	approach	approach	NN	NN	_	4	nsubj	_	_
4	is	be	VBZ	VBZ	syn=ADV	21	advcl	_	_
5	promising	promising	JJ	JJ	syn=PRD	4	acomp	_	_
6	,	,	,	,	_	21	punct	_	_
7	constant	constant	JJ	JJ	_	8	amod	_	_
8	exposure	exposure	NN	NN	_	21	nsubj	_	_
9	to	to	IN	IN	_	8	prep	_	_
10	antibodies	antibody	NNS	NNS	_	9	pobj	_	_
11	that	that	WDT	WDT	_	12	dep	_	10:ref
12	recognize	recognize	VBP	VBP	_	10	relcl	_	_
13	an	an	DT	DT	_	14	det	_	_
14	epitope	epitope	NN	NN	_	12	dobj	_	_
15	highly	highly	RB	RB	_	16	advmod	_	_
16	enriched	enrich	VBN	VBN	_	14	amod	_	_
17	in	in	IN	IN	sem=LOC	16	prep	_	_
18	the	the	DT	DT	_	19	det	_	_
19	brain	brain	NN	NN	_	17	pobj	_	_
20	may	may	MD	MD	_	21	aux	_	_
21	have	have	VB	VB	_	0	root	_	_
22	unexpected	unexpected	JJ	JJ	_	24	amod	_	_
23	side	side	NN	NN	_	24	compound	_	_
24	effects	effect	NNS	NNS	_	21	dobj	_	_
25	that	that	WDT	WDT	_	27	dep	_	24:ref
26	will	will	MD	MD	_	27	aux	_	_
27	limit	limit	VB	VB	_	24	relcl	_	_
28	its	its	PRP$	PRP$	_	32	poss	_	_
29	long	long	JJ	JJ	_	31	amod	_	_
30	-	-	HYPH	HYPH	_	31	punct	_	_
31	term	term	NN	NN	_	32	compound	_	_
32	use	use	NN	NN	_	27	dobj	_	_
33	.	.	.	.	_	21	punct	_	_

1	An	an	DT	DT	_	3	det	_	_
2	alternative	alternative	JJ	JJ	_	3	amod	_	_
3	approach	approach	NN	NN	_	14	nsubj	_	_
4	that	that	WDT	WDT	_	8	dep	_	3:ref
5	is	be	VBZ	VBZ	_	8	aux	_	_
6	being	be	VBG	VBG	_	8	auxpass	_	_
7	actively	actively	RB	RB	sem=MNR	8	advmod	_	_
8	pursued	pursue	VBN	VBN	_	3	relcl	_	_
9	for	for	IN	IN	sem=PRP	8	prep	_	_
10	future	future	JJ	JJ	_	11	amod	_	_
11	treatment	treatment	NN	NN	_	9	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	AD	ad	NN	NN	_	12	pobj	_	_
14	seeks	seek	VBZ	VBZ	_	0	root	_	_
15	to	to	TO	TO	_	16	aux	_	_
16	lower	lower	VB	VB	_	14	xcomp	_	_
17	Aβ	aβ	NN	NN	_	18	compound	_	_
18	levels	level	NNS	NNS	_	16	dobj	_	_
19	by	by	IN	IN	sem=MNR	16	prep	_	_
20	limiting	limit	VBG	VBG	syn=NOM	19	pcomp	_	_
21	its	its	PRP$	PRP$	_	22	poss	_	_
22	production	production	NN	NN	_	20	dobj	_	_
23	from	from	IN	IN	_	20	prep	_	_
24	the	the	DT	DT	_	26	det	_	_
25	precursor	precursor	NN	NN	_	26	compound	_	_
26	protein	protein	NN	NN	_	23	pobj	_	_
27	APP	app	NN	NN	_	26	appos	_	_
28	.	.	.	.	_	14	punct	_	_

1	Peptide	peptide	NN	NN	_	2	compound	_	_
2	Aβ	aβ	NN	NN	_	4	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	4	auxpass	_	_
4	released	release	VBN	VBN	_	0	root	_	_
5	from	from	IN	IN	_	4	prep	_	_
6	APP	app	NN	NN	_	5	pobj	_	_
7	by	by	IN	IN	_	4	agent	_	_
8	the	the	DT	DT	_	9	det	_	_
9	action	action	NN	NN	_	7	pobj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	two	#crd#	CD	CD	_	12	nummod	_	_
12	enzymes	enzyme	NNS	NNS	_	10	pobj	_	_
13	,	,	,	,	_	12	punct	_	_
14	the	the	DT	DT	_	19	det	_	_
15	β	β	NN	NN	_	17	compound	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	APP	app	NN	NN	_	18	npadvmod	_	_
18	cleaving	cleave	VBG	VBG	_	19	amod	_	_
19	enzyme	enzyme	NN	NN	_	12	appos	_	_
20	1	0	CD	CD	_	19	nummod	_	_
21	(	(	-LRB-	-LRB-	_	19	punct	_	_
22	BACE1	bace0	NN	NN	_	19	appos	_	_
23	)	)	-RRB-	-RRB-	_	19	punct	_	_
24	and	and	CC	CC	_	19	cc	_	_
25	γ	γ	SYM	SYM	_	27	punct	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	secretase	secretase	NN	NN	_	19	conj	_	_
28	,	,	,	,	_	12	punct	_	_
29	which	which	WDT	WDT	_	30	dep	_	12:ref
30	cleave	cleave	VBP	VBP	_	12	relcl	_	_
31	the	the	DT	DT	_	32	det	_	_
32	holoprotein	holoprotein	NN	NN	_	30	dobj	_	_
33	at	at	IN	IN	sem=LOC	30	prep	_	_
34	the	the	DT	DT	_	40	det	_	_
35	N	n	NN	NN	_	40	nmod	_	_
36	-	-	HYPH	HYPH	_	35	punct	_	_
37	and	and	CC	CC	_	35	cc	_	_
38	C	c	NN	NN	_	35	conj	_	_
39	-	-	HYPH	HYPH	_	40	punct	_	_
40	termini	terminus	NNS	NNS	_	33	pobj	_	_
41	of	of	IN	IN	_	40	prep	_	_
42	Aβ	aβ	NN	NN	_	41	pobj	_	_
43	,	,	,	,	_	4	punct	_	_
44	respectively	respectively	RB	RB	_	4	advmod	_	_
45	.	.	.	.	_	4	punct	_	_

1	Several	several	JJ	JJ	_	2	amod	_	_
2	inhibitors	inhibitor	NNS	NNS	_	10	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	γ	γ	SYM	SYM	_	6	punct	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	secretase	secretase	NN	NN	_	3	pobj	_	_
7	have	have	VBP	VBP	_	10	aux	_	_
8	already	already	RB	RB	_	10	advmod	_	_
9	been	be	VBN	VBN	_	10	auxpass	_	_
10	produced	produce	VBN	VBN	_	0	root	_	_
11	[	[	-LRB-	-LRB-	_	14	punct	_	_
12	8	0	CD	CD	_	14	nummod	_	_
13	,	,	,	,	_	14	punct	_	_
14	9	0	CD	CD	_	10	parataxis	_	_
15	]	]	-RRB-	-RRB-	_	14	punct	_	_
16	,	,	,	,	_	10	punct	_	_
17	and	and	CC	CC	_	10	cc	_	_
18	small	small	JJ	JJ	_	20	amod	_	_
19	molecule	molecule	NN	NN	_	20	compound	_	_
20	inhibitors	inhibitor	NNS	NNS	_	31	nsubjpass	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	β	β	NN	NN	_	24	compound	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	APP	app	NN	NN	_	25	npadvmod	_	_
25	cleaving	cleave	VBG	VBG	_	26	amod	_	_
26	enzyme	enzyme	NN	NN	_	21	pobj	_	_
27	1	0	CD	CD	_	26	nummod	_	_
28	are	be	VBP	VBP	_	31	aux	_	_
29	currently	currently	RB	RB	sem=TMP	31	advmod	_	_
30	being	be	VBG	VBG	_	31	auxpass	_	_
31	developed	develop	VBN	VBN	_	10	conj	_	_
32	[	[	-LRB-	-LRB-	_	35	punct	_	_
33	10	0	CD	CD	_	35	nummod	_	_
34	,	,	,	,	_	35	punct	_	_
35	11	0	CD	CD	_	31	parataxis	_	_
36	]	]	-RRB-	-RRB-	_	35	punct	_	_
37	.	.	.	.	_	31	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	long	long	JJ	JJ	_	4	amod	_	_
3	-	-	HYPH	HYPH	_	4	punct	_	_
4	term	term	NN	NN	_	5	compound	_	_
5	effectiveness	effectiveness	NN	NN	_	21	nsubjpass	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	this	this	DT	DT	_	8	det	_	_
8	approach	approach	NN	NN	_	6	pobj	_	_
9	in	in	IN	IN	sem=LOC	5	prep	_	_
10	either	either	CC	CC	_	11	preconj	_	_
11	humans	human	NNS	NNS	_	9	pobj	_	_
12	or	or	CC	CC	_	11	cc	_	_
13	model	model	NN	NN	_	14	compound	_	_
14	systems	system	NNS	NNS	_	11	conj	_	_
15	,	,	,	,	_	21	punct	_	_
16	however	however	RB	RB	_	21	advmod	_	_
17	,	,	,	,	_	21	punct	_	_
18	has	have	VBZ	VBZ	_	21	aux	_	_
19	not	not	RB	RB	_	21	neg	_	_
20	been	be	VBN	VBN	_	21	auxpass	_	_
21	reported	report	VBN	VBN	_	0	root	_	_
22	.	.	.	.	_	21	punct	_	_

1	Although	although	IN	IN	_	12	mark	_	_
2	loss	loss	NN	NN	_	12	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	β	β	NN	NN	_	6	compound	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	APP	app	NN	NN	_	7	npadvmod	_	_
7	cleaving	cleave	VBG	VBG	_	10	amod	_	_
8	enzyme	enzyme	NN	NN	_	10	nmod	_	_
9	1	0	CD	CD	_	8	nummod	_	_
10	function	function	NN	NN	_	3	pobj	_	_
11	can	can	MD	MD	_	12	aux	_	_
12	prevent	prevent	VB	VB	syn=ADV	41	advcl	_	_
13	the	the	DT	DT	_	14	det	_	_
14	development	development	NN	NN	_	12	dobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	plaques	plaque	NNS	NNS	_	15	pobj	_	_
17	in	in	IN	IN	sem=LOC	12	prep	_	_
18	transgenic	transgenic	JJ	JJ	_	20	amod	_	_
19	mouse	mouse	NN	NN	_	20	compound	_	_
20	models	model	NNS	NNS	_	17	pobj	_	_
21	for	for	IN	IN	_	20	prep	_	_
22	AD	ad	NN	NN	_	21	pobj	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	F.	f.	NNP	NNP	_	12	meta	_	_
25	Laird	laird	NNP	NNP	_	24	nmod	_	_
26	,	,	,	,	_	24	punct	_	_
27	H.	h.	NNP	NNP	_	24	nmod	_	_
28	Cai	cai	NNP	NNP	_	24	nmod	_	_
29	,	,	,	,	_	24	punct	_	_
30	P.	p.	NNP	NNP	_	24	nmod	_	_
31	C.	c.	NNP	NNP	_	24	nmod	_	_
32	Wong	wong	NNP	NNP	_	24	nmod	_	_
33	,	,	,	,	_	24	punct	_	_
34	personal	personal	JJ	JJ	_	24	amod	_	_
35	communication	communication	NN	NN	_	24	nmod	_	_
36	)	)	-RRB-	-RRB-	_	24	punct	_	_
37	,	,	,	,	_	41	punct	_	_
38	it	it	PRP	PRP	_	41	nsubjpass	_	_
39	is	be	VBZ	VBZ	_	41	auxpass	_	_
40	not	not	RB	RB	_	41	neg	_	_
41	known	know	VBN	VBN	_	0	root	_	_
42	whether	whether	IN	IN	_	46	mark	_	_
43	the	the	DT	DT	_	44	det	_	_
44	brain	brain	NN	NN	_	46	nsubj	_	_
45	can	can	MD	MD	_	46	aux	_	_
46	clear	clear	VB	VB	_	41	ccomp	_	_
47	pre-existing	pre-existing	JJ	JJ	_	49	amod	_	_
48	amyloid	amyloid	NN	NN	_	49	compound	_	_
49	deposits	deposit	NNS	NNS	_	46	dobj	_	_
50	once	once	IN	IN	_	56	mark	_	_
51	production	production	NN	NN	_	56	nsubjpass	_	_
52	of	of	IN	IN	_	51	prep	_	_
53	Aβ	aβ	NN	NN	_	52	pobj	_	_
54	has	have	VBZ	VBZ	_	56	aux	_	_
55	been	be	VBN	VBN	_	56	auxpass	_	_
56	suppressed	suppress	VBN	VBN	sem=TMP	46	advcl	_	_
57	.	.	.	.	_	41	punct	_	_

1	Clearly	clearly	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	the	the	DT	DT	_	7	det	_	_
4	amyloid	amyloid	NN	NN	_	6	npadvmod	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	lowering	lower	VBG	VBG	_	7	amod	_	_
7	approach	approach	NN	NN	_	11	nsubjpass	_	_
8	should	should	MD	MD	_	11	aux	_	_
9	be	be	VB	VB	_	11	auxpass	_	_
10	rigorously	rigorously	RB	RB	sem=MNR	11	advmod	_	_
11	examined	examine	VBN	VBN	_	0	root	_	_
12	in	in	IN	IN	sem=LOC	11	prep	_	_
13	animal	animal	NN	NN	_	14	compound	_	_
14	models	model	NNS	NNS	_	12	pobj	_	_
15	before	before	IN	IN	_	19	mark	_	_
16	these	these	DT	DT	_	17	det	_	_
17	reagents	reagent	NNS	NNS	_	19	nsubjpass	_	_
18	are	be	VBP	VBP	_	19	auxpass	_	_
19	tested	test	VBN	VBN	sem=TMP	11	advcl	_	_
20	in	in	IN	IN	sem=LOC	19	prep	_	_
21	patients	patient	NNS	NNS	_	20	pobj	_	_
22	.	.	.	.	_	11	punct	_	_

1	However	however	RB	RB	_	13	advmod	_	_
2	,	,	,	,	_	13	punct	_	_
3	the	the	DT	DT	_	6	det	_	_
4	chemical	chemical	JJ	JJ	_	6	amod	_	_
5	secretase	secretase	NN	NN	_	6	compound	_	_
6	inhibitors	inhibitor	NNS	NNS	_	13	nsubj	_	_
7	most	most	RBS	RBS	_	8	advmod	_	_
8	likely	likely	JJ	JJ	_	6	amod	_	_
9	to	to	TO	TO	_	10	aux	_	_
10	reach	reach	VB	VB	_	8	xcomp	_	_
11	human	human	JJ	JJ	_	12	amod	_	_
12	trials	trial	NNS	NNS	_	10	dobj	_	_
13	are	be	VBP	VBP	_	0	root	_	_
14	still	still	RB	RB	sem=TMP	13	advmod	_	_
15	in	in	IN	IN	syn=PRD	13	prep	_	_
16	development	development	NN	NN	_	15	pobj	_	_
17	.	.	.	.	_	13	punct	_	_

1	Therefore	therefore	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	developed	develop	VBD	VBD	_	0	root	_	_
5	a	a	DT	DT	_	7	det	_	_
6	mouse	mouse	NN	NN	_	7	compound	_	_
7	model	model	NN	NN	_	4	dobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	Alzheimer	alzheimer	NNP	NNP	_	11	compound	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	type	type	NN	NN	_	12	compound	_	_
12	amyloid	amyloid	NN	NN	_	8	pobj	_	_
13	that	that	WDT	WDT	_	14	dep	_	12:ref
14	expresses	express	VBZ	VBZ	_	12	relcl	_	_
15	a	a	DT	DT	_	18	det	_	_
16	controllable	controllable	JJ	JJ	_	18	amod	_	_
17	APP	app	NN	NN	_	18	compound	_	_
18	transgene	transgene	NN	NN	_	14	dobj	_	_
19	.	.	.	.	_	4	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	system	system	NN	NN	_	15	nsubjpass	_	_
3	,	,	,	,	_	2	punct	_	_
4	commonly	commonly	RB	RB	_	5	advmod	_	_
5	known	know	VBN	VBN	_	2	acl	_	_
6	as	as	IN	IN	_	5	prep	_	_
7	the	the	DT	DT	_	11	det	_	_
8	tet	tet	NN	NN	_	10	compound	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	off	off	NN	NN	_	11	compound	_	_
11	system	system	NN	NN	_	6	pobj	_	_
12	,	,	,	,	_	15	punct	_	_
13	can	can	MD	MD	_	15	aux	_	_
14	be	be	VB	VB	_	15	auxpass	_	_
15	regulated	regulate	VBN	VBN	_	0	root	_	_
16	by	by	IN	IN	_	15	agent	_	_
17	analogs	analog	NNS	NNS	_	16	pobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	tetracycline	tetracycline	NN	NN	_	18	pobj	_	_
20	administered	administer	VBN	VBN	_	19	acl	_	_
21	in	in	IN	IN	sem=LOC	20	prep	_	_
22	food	food	NN	NN	_	21	pobj	_	_
23	or	or	CC	CC	_	22	cc	_	_
24	water	water	NN	NN	_	22	conj	_	_
25	[	[	-LRB-	-LRB-	_	28	punct	_	_
26	12	0	CD	CD	_	28	nummod	_	_
27	,	,	,	,	_	28	punct	_	_
28	13	0	CD	CD	_	15	parataxis	_	_
29	]	]	-RRB-	-RRB-	_	28	punct	_	_
30	.	.	.	.	_	15	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	strong	strong	JJ	JJ	_	4	amod	_	_
3	expression	expression	NN	NN	_	4	compound	_	_
4	levels	level	NNS	NNS	_	32	nsubj	_	_
5	produced	produce	VBN	VBN	_	4	acl	_	_
6	with	with	IN	IN	_	5	prep	_	_
7	the	the	DT	DT	_	11	det	_	_
8	tet	tet	NN	NN	_	10	compound	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	off	off	NN	NN	_	11	compound	_	_
11	vectors	vector	NNS	NNS	_	6	pobj	_	_
12	,	,	,	,	_	11	punct	_	_
13	combined	combine	VBN	VBN	_	11	acl	_	_
14	with	with	IN	IN	_	13	prep	_	_
15	the	the	DT	DT	_	16	det	_	_
16	ability	ability	NN	NN	_	14	pobj	_	_
17	to	to	TO	TO	_	18	aux	_	_
18	reduce	reduce	VB	VB	_	16	acl	_	_
19	this	this	DT	DT	_	20	det	_	_
20	expression	expression	NN	NN	_	18	dobj	_	_
21	by	by	IN	IN	sem=EXT	18	prep	_	_
22	several	several	JJ	JJ	_	23	amod	_	_
23	orders	order	NNS	NNS	_	21	pobj	_	_
24	of	of	IN	IN	_	23	prep	_	_
25	magnitude	magnitude	NN	NN	_	24	pobj	_	_
26	with	with	IN	IN	sem=MNR	18	prep	_	_
27	tetracycline	tetracycline	NN	NN	_	26	pobj	_	_
28	[	[	-LRB-	-LRB-	_	29	punct	_	_
29	14	0	CD	CD	_	18	parataxis	_	_
30	]	]	-RRB-	-RRB-	_	29	punct	_	_
31	,	,	,	,	_	32	punct	_	_
32	allowed	allow	VBD	VBD	_	0	root	_	_
33	for	for	IN	IN	_	32	prep	_	_
34	a	a	DT	DT	_	36	det	_	_
35	stringent	stringent	JJ	JJ	_	36	amod	_	_
36	test	test	NN	NN	_	33	pobj	_	_
37	of	of	IN	IN	_	36	prep	_	_
38	how	how	WRB	WRB	_	48	advmod	_	_
39	a	a	DT	DT	_	43	det	_	_
40	highly	highly	RB	RB	_	41	advmod	_	_
41	effective	effective	JJ	JJ	_	43	amod	_	_
42	pharmaceutical	pharmaceutical	JJ	JJ	_	43	amod	_	_
43	inhibitor	inhibitor	NN	NN	_	48	nsubj	_	_
44	of	of	IN	IN	_	43	prep	_	_
45	Aβ	aβ	NN	NN	_	46	compound	_	_
46	production	production	NN	NN	_	44	pobj	_	_
47	would	would	MD	MD	_	48	aux	_	_
48	impact	impact	VB	VB	syn=NOM	37	pobj	_	_
49	the	the	DT	DT	_	50	det	_	_
50	progression	progression	NN	NN	_	48	dobj	_	_
51	of	of	IN	IN	_	50	prep	_	_
52	amyloid	amyloid	NN	NN	_	53	compound	_	_
53	pathology	pathology	NN	NN	_	51	pobj	_	_
54	and	and	CC	CC	_	48	cc	_	_
55	whether	whether	IN	IN	_	61	mark	_	_
56	reversal	reversal	NN	NN	_	61	nsubj	_	_
57	of	of	IN	IN	_	56	prep	_	_
58	these	these	DT	DT	_	59	det	_	_
59	lesions	lesion	NNS	NNS	_	57	pobj	_	_
60	might	might	MD	MD	_	61	aux	_	_
61	be	be	VB	VB	syn=NOM	48	conj	_	_
62	possible	possible	JJ	JJ	syn=PRD	61	acomp	_	_
63	following	follow	VBG	VBG	sem=TMP	61	prep	_	_
64	such	such	JJ	JJ	_	63	prep	_	_
65	treatment	treatment	NN	NN	_	64	pobj	_	_
66	.	.	.	.	_	32	punct	_	_

1	Methods	method	NNS	NNS	_	0	root	_	_

1	Transgene	transgene	NN	NN	_	2	compound	_	_
2	Construction	construction	NN	NN	_	0	root	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	created	create	VBD	VBD	_	0	root	_	_
3	a	a	DT	DT	_	19	det	_	_
4	tetracycline	tetracycline	NN	NN	_	6	npadvmod	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	responsive	responsive	JJ	JJ	_	19	amod	_	_
7	chimeric	chimeric	JJ	JJ	_	19	amod	_	_
8	mouse	mouse	NN	NN	_	19	nmod	_	_
9	/	/	HYPH	HYPH	_	8	punct	_	_
10	human	human	JJ	JJ	_	8	amod	_	_
11	APP695Swedish	app0swedish	NN	NN	_	13	nmod	_	_
12	/	/	HYPH	HYPH	_	13	punct	_	_
13	Indiana	indiana	NNP	NNP	_	19	nmod	_	_
14	(	(	-LRB-	-LRB-	_	13	punct	_	_
15	swe	swe	NN	NN	_	17	compound	_	_
16	/	/	HYPH	HYPH	_	17	punct	_	_
17	ind	ind	NN	NN	_	13	appos	_	_
18	)	)	-RRB-	-RRB-	_	19	punct	_	_
19	vector	vector	NN	NN	_	2	dobj	_	_
20	by	by	IN	IN	sem=MNR	2	prep	_	_
21	replacing	replace	VBG	VBG	syn=NOM	20	pcomp	_	_
22	the	the	DT	DT	_	24	det	_	_
23	promoter	promoter	NN	NN	_	24	compound	_	_
24	region	region	NN	NN	_	21	dobj	_	_
25	of	of	IN	IN	_	24	prep	_	_
26	the	the	DT	DT	_	28	det	_	_
27	moPrP.XhoI	#hlink#	NN	NN	_	28	compound	_	_
28	vector	vector	NN	NN	_	25	pobj	_	_
29	(	(	-LRB-	-LRB-	_	31	punct	_	_
30	also	also	RB	RB	_	31	advmod	_	_
31	known	know	VBN	VBN	_	21	parataxis	_	_
32	as	as	IN	IN	_	31	prep	_	_
33	pPrPpE1	pprppe0	NN	NN	_	37	nmod	_	_
34	/	/	HYPH	HYPH	_	37	punct	_	_
35	E2	e0	NN	NN	_	37	nmod	_	_
36	,	,	,	,	_	37	punct	_	_
37	3sal	0sal	NN	NN	_	32	pobj	_	_
38	[	[	-LRB-	-LRB-	_	39	punct	_	_
39	15	0	CD	CD	_	31	parataxis	_	_
40	]	]	-RRB-	-RRB-	_	39	punct	_	_
41	)	)	-RRB-	-RRB-	_	31	punct	_	_
42	with	with	IN	IN	_	21	prep	_	_
43	the	the	DT	DT	_	47	det	_	_
44	tetracycline	tetracycline	NN	NN	_	46	npadvmod	_	_
45	-	-	HYPH	HYPH	_	46	punct	_	_
46	responsive	responsive	JJ	JJ	_	47	amod	_	_
47	promoter	promoter	NN	NN	_	42	pobj	_	_
48	of	of	IN	IN	_	47	prep	_	_
49	pTetSplice	ptetsplice	NN	NN	_	48	pobj	_	_
50	(	(	-LRB-	-LRB-	_	52	punct	_	_
51	Life	life	NNP	NNP	_	52	compound	_	_
52	Technologies	technologies	NNP	NNP	_	49	parataxis	_	_
53	,	,	,	,	_	52	punct	_	_
54	Rockville	rockville	NNP	NNP	sem=LOC	52	npadvmod	_	_
55	,	,	,	,	_	52	punct	_	_
56	Maryland	maryland	NNP	NNP	sem=LOC	52	npadvmod	_	_
57	,	,	,	,	_	52	punct	_	_
58	United	united	NNP	NNP	_	59	compound	_	_
59	States	state	NNP	NNP	sem=LOC	52	npadvmod	_	_
60	)	)	-RRB-	-RRB-	_	52	punct	_	_
61	,	,	,	,	_	21	punct	_	_
62	and	and	CC	CC	_	21	cc	_	_
63	then	then	RB	RB	sem=TMP	64	advmod	_	_
64	ligating	ligate	VBG	VBG	_	21	conj	_	_
65	mouse	mouse	NN	NN	_	66	compound	_	_
66	APP	app	NN	NN	_	64	dobj	_	_
67	with	with	IN	IN	sem=MNR	64	prep	_	_
68	a	a	DT	DT	_	71	det	_	_
69	humanized	humanized	JJ	JJ	_	71	amod	_	_
70	Aβ	aβ	NN	NN	_	71	nmod	_	_
71	domain	domain	NN	NN	_	77	nmod	_	_
72	(	(	-LRB-	-LRB-	_	71	punct	_	_
73	mo	mo	NN	NN	_	75	compound	_	_
74	/	/	HYPH	HYPH	_	75	punct	_	_
75	huAPP695	huapp0	NN	NN	_	71	appos	_	_
76	)	)	-RRB-	-RRB-	_	77	punct	_	_
77	cDNA	cdna	NN	NN	_	67	pobj	_	_
78	into	into	IN	IN	sem=LOC	64	prep	_	_
79	the	the	DT	DT	_	81	det	_	_
80	new	new	JJ	JJ	_	81	amod	_	_
81	vector	vector	NN	NN	_	78	pobj	_	_
82	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	began	begin	VBD	VBD	_	0	root	_	_
3	by	by	IN	IN	sem=MNR	2	prep	_	_
4	cloning	clone	VBG	VBG	syn=NOM	3	pcomp	_	_
5	the	the	DT	DT	_	9	det	_	_
6	tetracycline	tetracycline	NN	NN	_	8	npadvmod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	responsive	responsive	JJ	JJ	_	9	amod	_	_
9	promoter	promoter	NN	NN	_	4	dobj	_	_
10	(	(	-LRB-	-LRB-	_	12	punct	_	_
11	bp	bp	NN	NN	_	12	nmod	_	_
12	6	0	CD	CD	_	9	parataxis	_	_
13	–	-	SYM	SYM	_	14	punct	_	_
14	481	0	CD	CD	_	12	prep	_	_
15	)	)	-RRB-	-RRB-	_	12	punct	_	_
16	from	from	IN	IN	_	4	prep	_	_
17	pTetSplice	ptetsplice	NN	NN	_	16	pobj	_	_
18	by	by	IN	IN	_	17	prep	_	_
19	PCR	pcr	NN	NN	_	18	pobj	_	_
20	using	use	VBG	VBG	_	19	acl	_	_
21	primers	primer	NNS	NNS	_	20	dobj	_	_
22	that	that	WDT	WDT	_	23	dep	_	21:ref
23	added	add	VBD	VBD	_	21	relcl	_	_
24	external	external	JJ	JJ	_	28	amod	_	_
25	BamHI	bamhi	NN	NN	_	28	nmod	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	NotI	noti	NN	NN	_	25	conj	_	_
28	sites	site	NNS	NNS	_	23	dobj	_	28:gap
29	to	to	IN	IN	_	23	prep	_	29:gap
30	the	the	DT	DT	_	33	det	_	_
31	5	0	CD	CD	_	33	nummod	_	_
32	′	′	SYM	SYM	_	31	punct	_	_
33	end	end	NN	NN	_	29	pobj	_	_
34	and	and	CC	CC	_	23	cc	_	_
35	a	a	DT	DT	_	37	det	_	_
36	BamHI	bamhi	NN	NN	_	37	compound	_	_
37	site	site	NN	NN	_	23	conj	_	28:gap
38	to	to	IN	IN	_	37	prep	_	29:gap
39	the	the	DT	DT	_	42	det	_	_
40	3	0	CD	CD	_	42	nummod	_	_
41	′	′	SYM	SYM	_	40	punct	_	_
42	end	end	NN	NN	_	38	pobj	_	_
43	,	,	,	,	_	2	punct	_	_
44	while	while	IN	IN	_	45	mark	_	_
45	destroying	destroy	VBG	VBG	syn=ADV	2	advcl	_	_
46	XhoI	xhoi	NN	NN	_	49	nmod	_	_
47	and	and	CC	CC	_	46	cc	_	_
48	BamHI	bamhi	NN	NN	_	46	conj	_	_
49	sites	site	NNS	NNS	_	45	dobj	_	_
50	within	within	IN	IN	_	49	prep	_	_
51	the	the	DT	DT	_	52	det	_	_
52	promoter	promoter	NN	NN	_	50	pobj	_	_
53	(	(	-LRB-	-LRB-	_	83	punct	_	_
54	forward	forward	NN	NN	_	69	dep	_	_
55	:	:	:	:	_	69	punct	_	_
56	GCC	gcc	NN	NN	_	69	compound	_	_
57	GGA	gga	NN	NN	_	69	compound	_	_
58	TCC	tcc	NN	NN	_	69	compound	_	_
59	GCG	gcg	NN	NN	_	69	compound	_	_
60	GCC	gcc	NN	NN	_	69	compound	_	_
61	GCC	gcc	NN	NN	_	69	compound	_	_
62	GTC	gtc	NN	NN	_	69	compound	_	_
63	GAG	gag	NN	NN	_	69	compound	_	_
64	TTT	ttt	NN	NN	_	69	compound	_	_
65	ACC	acc	NN	NN	_	69	compound	_	_
66	ACT	act	NN	NN	_	69	compound	_	_
67	CCC	ccc	NN	NN	_	69	compound	_	_
68	TAT	tat	NN	NN	_	69	compound	_	_
69	C	c	NN	NN	_	83	dep	_	_
70	;	;	:	:	_	83	punct	_	_
71	reverse	reverse	NN	NN	_	83	dep	_	_
72	:	:	:	:	_	83	punct	_	_
73	GCC	gcc	NN	NN	_	83	compound	_	_
74	GGA	gga	NN	NN	_	83	compound	_	_
75	TCC	tcc	NN	NN	_	83	compound	_	_
76	ACT	act	NN	NN	_	83	compound	_	_
77	CTA	cta	NN	NN	_	83	compound	_	_
78	GAA	gaa	NN	NN	_	83	compound	_	_
79	GAT	gat	NN	NN	_	83	compound	_	_
80	CCC	ccc	NN	NN	_	83	compound	_	_
81	CGG	cgg	NN	NN	_	83	compound	_	_
82	GTA	gta	NN	NN	_	83	compound	_	_
83	CCG	ccg	NN	NN	_	45	parataxis	_	_
84	)	)	-RRB-	-RRB-	_	83	punct	_	_
85	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	then	then	RB	RB	sem=TMP	3	advmod	_	_
3	isolated	isolate	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	6	det	_	_
5	moPrP.XhoI	#hlink#	NN	NN	_	6	compound	_	_
6	intron	intron	NN	NN	_	3	dobj	_	_
7	by	by	IN	IN	sem=MNR	3	prep	_	_
8	amplification	amplification	NN	NN	_	7	pobj	_	_
9	with	with	IN	IN	_	8	prep	_	_
10	primers	primer	NNS	NNS	_	9	pobj	_	_
11	that	that	WDT	WDT	_	12	dep	_	10:ref
12	added	add	VBD	VBD	_	10	relcl	_	_
13	an	an	DT	DT	_	16	det	_	_
14	external	external	JJ	JJ	_	16	amod	_	_
15	BamHI	bamhi	NN	NN	_	16	compound	_	_
16	site	site	NN	NN	_	12	dobj	_	_
17	to	to	IN	IN	_	12	prep	_	_
18	the	the	DT	DT	_	21	det	_	_
19	5	0	CD	CD	_	21	nummod	_	_
20	′	′	SYM	SYM	_	19	punct	_	_
21	end	end	NN	NN	_	17	pobj	_	_
22	of	of	IN	IN	_	21	prep	_	_
23	exon	exon	NN	NN	_	22	pobj	_	_
24	1	0	CD	CD	_	23	nummod	_	_
25	and	and	CC	CC	_	12	cc	_	_
26	ran	run	VBD	VBD	_	12	conj	_	_
27	through	through	IN	IN	_	26	prep	_	_
28	the	the	DT	DT	_	30	det	_	_
29	Asp718	asp0	NN	NN	_	30	compound	_	_
30	site	site	NN	NN	_	27	pobj	_	_
31	of	of	IN	IN	_	30	prep	_	_
32	exon	exon	NN	NN	_	31	pobj	_	_
33	2	0	CD	CD	_	32	nummod	_	_
34	(	(	-LRB-	-LRB-	_	58	punct	_	_
35	forward	forward	NN	NN	_	46	dep	_	_
36	:	:	:	:	_	46	punct	_	_
37	GCC	gcc	NN	NN	_	46	compound	_	_
38	GGA	gga	NN	NN	_	46	compound	_	_
39	TCC	tcc	NN	NN	_	46	compound	_	_
40	GAT	gat	NN	NN	_	46	compound	_	_
41	CAG	cag	NN	NN	_	46	compound	_	_
42	CAG	cag	NN	NN	_	46	compound	_	_
43	ACC	acc	NN	NN	_	46	compound	_	_
44	GAT	gat	NN	NN	_	46	compound	_	_
45	TCT	tct	NN	NN	_	46	compound	_	_
46	GG	gg	NN	NN	_	58	dep	_	_
47	;	;	:	:	_	58	punct	_	_
48	reverse	reverse	NN	NN	_	58	dep	_	_
49	:	:	:	:	_	58	punct	_	_
50	GCC	gcc	NN	NN	_	58	compound	_	_
51	GGT	ggt	NN	NN	_	58	compound	_	_
52	ACC	acc	NN	NN	_	58	compound	_	_
53	ACT	act	NN	NN	_	58	compound	_	_
54	AGG	agg	NN	NN	_	58	compound	_	_
55	AAG	aag	NN	NN	_	58	compound	_	_
56	GCA	gca	NN	NN	_	58	compound	_	_
57	GAA	gaa	NN	NN	_	58	compound	_	_
58	TGC	tgc	NN	NN	_	30	parataxis	_	_
59	)	)	-RRB-	-RRB-	_	58	punct	_	_
60	.	.	.	.	_	3	punct	_	_

1	This	this	DT	DT	_	6	det	_	_
2	2	0	CD	CD	_	4	nummod	_	_
3	-	-	HYPH	HYPH	_	4	punct	_	_
4	kb	kb	NN	NN	_	6	compound	_	_
5	intron	intron	NN	NN	_	6	compound	_	_
6	fragment	fragment	NN	NN	_	8	nsubj	_	_
7	was	be	VBD	VBD	_	8	aux	_	_
8	cloned	clone	VBN	VBN	_	0	root	_	_
9	into	into	IN	IN	sem=LOC	8	prep	_	_
10	a	a	DT	DT	_	13	det	_	_
11	TA	ta	NN	NN	_	12	compound	_	_
12	cloning	cloning	NN	NN	_	13	compound	_	_
13	vector	vector	NN	NN	_	9	pobj	_	_
14	(	(	-LRB-	-LRB-	_	15	punct	_	_
15	Invitrogen	invitrogen	NNP	NNP	_	13	parataxis	_	_
16	,	,	,	,	_	15	punct	_	_
17	Carlsbad	carlsbad	NNP	NNP	sem=LOC	15	npadvmod	_	_
18	,	,	,	,	_	15	punct	_	_
19	California	california	NNP	NNP	sem=LOC	15	npadvmod	_	_
20	,	,	,	,	_	15	punct	_	_
21	United	united	NNP	NNP	_	22	compound	_	_
22	States	state	NNP	NNP	sem=LOC	15	npadvmod	_	_
23	)	)	-RRB-	-RRB-	_	15	punct	_	_
24	,	,	,	,	_	8	punct	_	_
25	then	then	RB	RB	sem=TMP	26	advmod	_	_
26	excised	excise	VBN	VBN	_	8	conj	_	_
27	by	by	IN	IN	sem=MNR	26	prep	_	_
28	Asp718	asp0	NN	NN	_	29	compound	_	_
29	digestion	digestion	NN	NN	_	27	pobj	_	_
30	and	and	CC	CC	_	26	cc	_	_
31	ligated	ligate	VBN	VBN	_	26	conj	_	_
32	to	to	IN	IN	_	31	prep	_	_
33	the	the	DT	DT	_	38	det	_	_
34	6.8	0	CD	CD	_	36	nummod	_	_
35	-	-	HYPH	HYPH	_	36	punct	_	_
36	kb	kb	NN	NN	_	38	compound	_	_
37	Asp718	asp0	NN	NN	_	38	compound	_	_
38	fragment	fragment	NN	NN	_	32	pobj	_	_
39	of	of	IN	IN	_	38	prep	_	_
40	moPrP.XhoI	#hlink#	NN	NN	_	39	pobj	_	_
41	containing	contain	VBG	VBG	_	38	acl	_	_
42	exon	exon	NN	NN	_	41	dobj	_	_
43	2	0	CD	CD	_	42	nummod	_	_
44	,	,	,	,	_	42	punct	_	_
45	exon	exon	NN	NN	_	42	conj	_	_
46	3	0	CD	CD	_	45	nummod	_	_
47	,	,	,	,	_	45	punct	_	_
48	the	the	DT	DT	_	51	det	_	_
49	3	0	CD	CD	_	51	nummod	_	_
50	′	′	SYM	SYM	_	49	punct	_	_
51	UTR	utr	NN	NN	_	45	conj	_	_
52	,	,	,	,	_	51	punct	_	_
53	and	and	CC	CC	_	51	cc	_	_
54	pBluescript	pbluescript	NN	NN	_	51	conj	_	_
55	to	to	TO	TO	_	56	aux	_	_
56	generate	generate	VB	VB	sem=PRP	8	advcl	_	_
57	an	an	DT	DT	_	59	det	_	_
58	intermediate	intermediate	JJ	JJ	_	59	amod	_	_
59	vector	vector	NN	NN	_	56	dobj	_	_
60	with	with	IN	IN	sem=MNR	56	prep	_	_
61	all	all	DT	DT	_	63	det	_	_
62	three	#crd#	CD	CD	_	63	nummod	_	_
63	exons	exon	NNS	NNS	_	60	pobj	_	_
64	and	and	CC	CC	_	63	cc	_	_
65	a	a	DT	DT	_	67	det	_	_
66	central	central	JJ	JJ	_	67	amod	_	_
67	intron	intron	NN	NN	_	63	conj	_	_
68	but	but	CC	CC	_	63	cc	_	_
69	no	no	DT	DT	_	70	det	_	_
70	promoter	promoter	NN	NN	_	63	conj	_	_
71	.	.	.	.	_	8	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	vector	vector	NN	NN	_	5	nsubjpass	_	_
3	was	be	VBD	VBD	_	5	auxpass	_	_
4	then	then	RB	RB	sem=TMP	5	advmod	_	_
5	opened	open	VBN	VBN	_	0	root	_	_
6	at	at	IN	IN	sem=LOC	5	prep	_	_
7	the	the	DT	DT	_	9	det	_	_
8	BamHI	bamhi	NN	NN	_	9	compound	_	_
9	site	site	NN	NN	_	6	pobj	_	_
10	introduced	introduce	VBN	VBN	_	9	acl	_	_
11	by	by	IN	IN	_	10	agent	_	_
12	the	the	DT	DT	_	15	det	_	_
13	intron	intron	NN	NN	_	15	compound	_	_
14	cloning	cloning	NN	NN	_	15	compound	_	_
15	primer	primer	NN	NN	_	11	pobj	_	_
16	,	,	,	,	_	5	punct	_	_
17	and	and	CC	CC	_	5	cc	_	_
18	ligated	ligate	VBN	VBN	_	5	conj	_	_
19	to	to	IN	IN	_	18	prep	_	_
20	the	the	DT	DT	_	29	det	_	_
21	0.5	0	CD	CD	_	23	nummod	_	_
22	-	-	HYPH	HYPH	_	23	punct	_	_
23	kb	kb	NN	NN	_	29	compound	_	_
24	BamHI	bamhi	NN	NN	_	26	compound	_	_
25	-	-	HYPH	HYPH	_	26	punct	_	_
26	cut	cut	NN	NN	_	29	compound	_	_
27	tetracycline	tetracycline	NN	NN	_	28	compound	_	_
28	promoter	promoter	NN	NN	_	29	compound	_	_
29	fragment	fragment	NN	NN	_	19	pobj	_	_
30	.	.	.	.	_	5	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	ligation	ligation	NN	NN	_	3	nsubj	_	_
3	generated	generate	VBD	VBD	_	0	root	_	_
4	a	a	DT	DT	_	8	det	_	_
5	9.3	0	CD	CD	_	7	nummod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	kb	kb	NN	NN	_	8	compound	_	_
8	vector	vector	NN	NN	_	3	dobj	_	_
9	encoding	encode	VBG	VBG	_	8	acl	_	_
10	the	the	DT	DT	_	12	det	_	_
11	tetracycline	tetracycline	NN	NN	_	12	compound	_	_
12	promoter	promoter	NN	NN	_	9	dobj	_	_
13	from	from	IN	IN	_	12	prep	_	_
14	pTetSplice	ptetsplice	NN	NN	_	13	pobj	_	_
15	with	with	IN	IN	sem=MNR	9	prep	_	_
16	two	#crd#	CD	CD	_	17	nummod	_	_
17	exons	exon	NNS	NNS	_	15	pobj	_	_
18	,	,	,	,	_	17	punct	_	_
19	one	#crd#	CD	CD	_	20	nummod	_	_
20	intron	intron	NN	NN	_	17	conj	_	_
21	,	,	,	,	_	20	punct	_	_
22	and	and	CC	CC	_	20	cc	_	_
23	the	the	DT	DT	_	27	det	_	_
24	original	original	JJ	JJ	_	27	amod	_	_
25	3	0	CD	CD	_	27	nummod	_	_
26	′	′	SYM	SYM	_	25	punct	_	_
27	UTR	utr	NN	NN	_	20	conj	_	_
28	of	of	IN	IN	_	27	prep	_	_
29	the	the	DT	DT	_	31	det	_	_
30	moPrP.XhoI	#hlink#	NN	NN	_	31	compound	_	_
31	vector	vector	NN	NN	_	28	pobj	_	_
32	,	,	,	,	_	17	punct	_	_
33	all	all	RB	RB	_	34	advmod	_	_
34	carried	carry	VBN	VBN	_	17	acl	_	_
35	in	in	IN	IN	sem=LOC	34	prep	_	_
36	the	the	DT	DT	_	39	det	_	_
37	pBluescript	pbluescript	NNP	NNP	_	38	compound	_	_
38	cloning	cloning	NN	NN	_	39	compound	_	_
39	vector	vector	NN	NN	_	35	pobj	_	_
40	.	.	.	.	_	3	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	incorporated	incorporate	VBD	VBD	_	44	ccomp	_	_
3	the	the	DT	DT	_	15	det	_	_
4	Swedish	swedish	NNP	NNP	_	15	amod	_	_
5	(	(	-LRB-	-LRB-	_	8	punct	_	_
6	KM570	km0	NN	NN	_	8	compound	_	_
7	/	/	HYPH	HYPH	_	8	punct	_	_
8	571NL	0nl	NN	NN	_	4	parataxis	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	and	and	CC	CC	_	4	cc	_	_
11	Indiana	indiana	NNP	NNP	_	4	conj	_	_
12	(	(	-LRB-	-LRB-	_	13	punct	_	_
13	V617F	v0f	NN	NN	_	11	parataxis	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	mutations	mutation	NNS	NNS	_	2	dobj	_	_
16	into	into	IN	IN	_	2	prep	_	_
17	the	the	DT	DT	_	21	det	_	_
18	mo	mo	NN	NN	_	20	compound	_	_
19	/	/	HYPH	HYPH	_	20	punct	_	_
20	huAPP695	huapp0	NN	NN	_	21	compound	_	_
21	cDNA	cdna	NN	NN	_	16	pobj	_	_
22	(	(	-LRB-	-LRB-	_	21	punct	_	_
23	in	in	IN	IN	sem=LOC	21	prep	_	_
24	BS	bs	NN	NN	_	26	compound	_	_
25	-	-	HYPH	HYPH	_	26	punct	_	_
26	KS	ks	NN	NN	_	23	pobj	_	_
27	)	)	-RRB-	-RRB-	_	2	punct	_	_
28	by	by	IN	IN	sem=MNR	2	prep	_	_
29	PCR	pcr	NN	NN	_	28	pobj	_	_
30	using	use	VBG	VBG	sem=MNR	2	advcl	_	_
31	a	a	DT	DT	_	35	det	_	_
32	four	#crd#	CD	CD	_	34	nummod	_	_
33	-	-	HYPH	HYPH	_	34	punct	_	_
34	primer	primer	NN	NN	_	35	compound	_	_
35	strategy	strategy	NN	NN	_	30	dobj	_	_
36	:	:	:	:	_	44	punct	_	_
37	first	#ord#	RB	RB	sem=TMP	44	advmod	_	_
38	,	,	,	,	_	44	punct	_	_
39	two	#crd#	CD	CD	_	42	nummod	_	_
40	partially	partially	RB	RB	_	41	advmod	_	_
41	overlapping	overlap	VBG	VBG	_	42	amod	_	_
42	products	product	NNS	NNS	_	44	nsubjpass	_	_
43	were	be	VBD	VBD	_	44	auxpass	_	_
44	generated	generate	VBN	VBN	_	0	root	_	_
45	in	in	IN	IN	_	44	prep	_	_
46	separate	separate	JJ	JJ	_	47	amod	_	_
47	reactions	reaction	NNS	NNS	_	45	pobj	_	_
48	using	use	VBG	VBG	sem=MNR	44	advcl	_	_
49	primers	primer	NNS	NNS	_	48	dobj	_	_
50	that	that	WDT	WDT	_	51	dep	_	49:ref
51	encode	encode	VBP	VBP	_	49	relcl	_	_
52	the	the	DT	DT	_	54	det	_	_
53	desired	desire	VBN	VBN	_	54	amod	_	_
54	mutations	mutation	NNS	NNS	_	51	dobj	_	_
55	(	(	-LRB-	-LRB-	_	96	punct	_	_
56	Swedish	swedish	NNP	NNP	_	57	compound	_	_
57	forward	forward	NN	NN	_	70	dep	_	_
58	:	:	:	:	_	70	punct	_	_
59	GGA	gga	NN	NN	_	70	compound	_	_
60	GAT	gat	NN	NN	_	70	compound	_	_
61	CTC	ctc	NN	NN	_	70	compound	_	_
62	TGA	tga	NN	NN	_	70	compound	_	_
63	AGT	agt	NN	NN	_	70	compound	_	_
64	GAA	gaa	NN	NN	_	70	compound	_	_
65	TCT	tct	NN	NN	_	70	compound	_	_
66	GGA	gga	NNP	NNP	_	70	compound	_	_
67	TGC	tgc	NNP	NNP	_	70	compound	_	_
68	AGA	aga	NNP	NNP	_	70	compound	_	_
69	ATT	att	NNP	NNP	_	70	compound	_	_
70	CCG	ccg	NN	NN	_	82	dep	_	_
71	/	/	HYPH	HYPH	_	82	punct	_	_
72	Indiana	indiana	NNP	NNP	_	73	compound	_	_
73	reverse	reverse	NN	NN	_	82	dep	_	_
74	:	:	:	:	_	82	punct	_	_
75	GGG	ggg	NN	NN	_	82	compound	_	_
76	TGA	tga	NN	NN	_	82	compound	_	_
77	TGA	tga	NN	NN	_	82	compound	_	_
78	AAA	aaa	NN	NN	_	82	compound	_	_
79	TCA	tca	NN	NN	_	82	compound	_	_
80	CGG	cgg	NN	NN	_	82	compound	_	_
81	TTG	ttg	NN	NN	_	82	compound	_	_
82	C	c	NN	NN	_	96	dep	_	_
83	;	;	:	:	_	96	punct	_	_
84	Indiana	indiana	NNP	NNP	_	85	compound	_	_
85	forward	forward	NN	NN	_	96	dep	_	_
86	:	:	:	:	_	96	punct	_	_
87	CAA	caa	NN	NN	_	96	compound	_	_
88	CCG	ccg	NN	NN	_	96	compound	_	_
89	TGA	tga	NN	NN	_	96	compound	_	_
90	TTT	ttt	NN	NN	_	96	compound	_	_
91	TCA	tca	NN	NN	_	96	compound	_	_
92	TCA	tca	NN	NN	_	96	compound	_	_
93	CCC	ccc	NN	NN	_	96	compound	_	_
94	TGG	tgg	NN	NN	_	96	compound	_	_
95	/	/	HYPH	HYPH	_	96	punct	_	_
96	M13	m0	NN	NN	_	51	parataxis	_	_
97	reverse	reverse	RB	RB	_	96	advmod	_	_
98	)	)	-RRB-	-RRB-	_	96	punct	_	_
99	.	.	.	.	_	44	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	two	#crd#	CD	CD	_	4	nummod	_	_
3	PCR	pcr	NN	NN	_	4	compound	_	_
4	products	product	NNS	NNS	_	6	nsubjpass	_	_
5	were	be	VBD	VBD	_	6	auxpass	_	_
6	ligated	ligate	VBN	VBN	_	0	root	_	_
7	,	,	,	,	_	6	punct	_	_
8	digested	digest	VBN	VBN	_	6	dep	_	_
9	with	with	IN	IN	sem=MNR	6	prep	_	_
10	BglII	bglii	NN	NN	_	9	pobj	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	ApaI	apai	NN	NN	_	10	conj	_	_
13	and	and	CC	CC	_	6	cc	_	_
14	cloned	clone	VBN	VBN	_	6	conj	_	_
15	back	back	RB	RB	_	14	advmod	_	_
16	into	into	IN	IN	_	14	prep	_	_
17	the	the	DT	DT	_	26	det	_	_
18	original	original	JJ	JJ	_	26	amod	_	_
19	mo	mo	NN	NN	_	25	compound	_	_
20	/	/	HYPH	HYPH	_	25	punct	_	_
21	huAPP695	huapp0	NN	NN	_	25	compound	_	_
22	-	-	HYPH	HYPH	_	25	punct	_	_
23	BS	bs	NN	NN	_	25	compound	_	_
24	-	-	HYPH	HYPH	_	25	punct	_	_
25	KS	ks	NN	NN	_	26	compound	_	_
26	vector	vector	NN	NN	_	16	pobj	_	_
27	.	.	.	.	_	6	punct	_	_

1	Finally	finally	RB	RB	sem=TMP	9	advmod	_	_
2	,	,	,	,	_	9	punct	_	_
3	the	the	DT	DT	_	7	det	_	_
4	new	new	JJ	JJ	_	7	amod	_	_
5	APP695swe	app0swe	NN	NN	_	7	compound	_	_
6	/	/	HYPH	HYPH	_	7	punct	_	_
7	ind	ind	NN	NN	_	9	nsubjpass	_	_
8	was	be	VBD	VBD	_	9	auxpass	_	_
9	subcloned	subcloned	VBN	VBN	_	0	root	_	_
10	into	into	IN	IN	sem=LOC	9	prep	_	_
11	the	the	DT	DT	_	13	det	_	_
12	XhoI	xhoi	NN	NN	_	13	compound	_	_
13	site	site	NN	NN	_	10	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	the	the	DT	DT	_	19	det	_	_
16	moPrP	moprp	NN	NN	_	18	compound	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	tetP	tetp	NN	NN	_	19	compound	_	_
19	vector	vector	NN	NN	_	14	pobj	_	_
20	from	from	IN	IN	sem=DIR	9	prep	_	_
21	above	above	RB	RB	_	20	pcomp	_	_
22	to	to	TO	TO	_	23	aux	_	_
23	complete	complete	VB	VB	sem=PRP	9	advcl	_	_
24	the	the	DT	DT	_	25	det	_	_
25	construct	construct	NN	NN	_	23	dobj	_	_
26	.	.	.	.	_	9	punct	_	_

1	Pronuclear	pronuclear	JJ	JJ	_	2	amod	_	_
2	Injection	injection	NN	NN	_	0	root	_	_
3	,	,	,	,	_	2	punct	_	_
4	Screening	screening	NN	NN	_	2	conj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	Founders	founder	NNS	NNS	_	5	pobj	_	_
7	,	,	,	,	_	4	punct	_	_
8	and	and	CC	CC	_	4	cc	_	_
9	Maintenance	maintenance	NN	NN	_	4	conj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	the	the	DT	DT	_	12	det	_	_
12	Lines	line	NNS	NNS	_	10	pobj	_	_

1	The	the	DT	DT	_	11	det	_	_
2	moPrP	moprp	NN	NN	_	10	compound	_	_
3	-	-	HYPH	HYPH	_	10	punct	_	_
4	tetP	tetp	NN	NN	_	10	compound	_	_
5	-	-	HYPH	HYPH	_	10	punct	_	_
6	mo	mo	NN	NN	_	10	compound	_	_
7	/	/	HYPH	HYPH	_	10	punct	_	_
8	huAPP695swe	huapp0swe	NN	NN	_	10	compound	_	_
9	/	/	HYPH	HYPH	_	10	punct	_	_
10	ind	ind	NN	NN	_	11	compound	_	_
11	vector	vector	NN	NN	_	13	nsubjpass	_	11:gap
12	was	be	VBD	VBD	_	13	auxpass	_	_
13	linearized	linearize	VBN	VBN	_	0	root	_	13:gap
14	and	and	CC	CC	_	13	cc	_	_
15	the	the	DT	DT	_	17	det	_	_
16	pBluescript	pbluescript	NNP	NNP	_	17	compound	_	_
17	domain	domain	NN	NN	_	18	nsubj	_	11:gap
18	excised	excise	VBN	VBN	_	13	conj	_	13:gap
19	by	by	IN	IN	sem=MNR	18	prep	_	_
20	digestion	digestion	NN	NN	_	19	pobj	_	_
21	with	with	IN	IN	_	20	prep	_	_
22	NotI	noti	NN	NN	_	21	pobj	_	_
23	.	.	.	.	_	18	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	purified	purify	VBN	VBN	_	3	amod	_	_
3	vector	vector	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	injected	inject	VBN	VBN	_	0	root	_	_
6	into	into	IN	IN	sem=DIR	5	prep	_	_
7	the	the	DT	DT	_	8	det	_	_
8	pronucleus	pronucleus	NN	NN	_	6	pobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	fertilized	fertilize	VBN	VBN	_	11	amod	_	_
11	eggs	egg	NNS	NNS	_	9	pobj	_	_
12	from	from	IN	IN	_	11	prep	_	_
13	C57BL	c0bl	NN	NN	_	17	nmod	_	_
14	/	/	HYPH	HYPH	_	17	punct	_	_
15	6J	0j	NN	NN	_	17	nmod	_	_
16	×	×	SYM	SYM	_	17	punct	_	_
17	C3HeJ	c0hej	NN	NN	_	19	compound	_	_
18	F1	f0	NN	NN	_	19	compound	_	_
19	matings	mating	NNS	NNS	_	12	pobj	_	_
20	.	.	.	.	_	5	punct	_	_

1	Founder	founder	NN	NN	_	2	compound	_	_
2	animals	animal	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	screened	screen	VBN	VBN	_	0	root	_	_
5	for	for	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	7	det	_	_
7	presence	presence	NN	NN	_	5	pobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	transgene	transgene	NN	NN	_	8	pobj	_	_
11	by	by	IN	IN	sem=MNR	4	prep	_	_
12	three	#crd#	CD	CD	_	14	nummod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	way	way	NN	NN	_	15	compound	_	_
15	PCR	pcr	NN	NN	_	11	pobj	_	_
16	using	use	VBG	VBG	sem=MNR	4	advcl	_	_
17	the	the	DT	DT	_	27	det	_	_
18	S36	s0	NN	NN	_	27	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	PrP	prp	NN	NN	_	26	compound	_	_
21	-	-	HYPH	HYPH	_	26	punct	_	_
22	S	s	NN	NN	_	26	compound	_	_
23	/	/	HYPH	HYPH	_	26	punct	_	_
24	PrP	prp	NN	NN	_	26	compound	_	_
25	-	-	HYPH	HYPH	_	26	punct	_	_
26	AS	as	NN	NN	_	18	conj	_	_
27	primers	primer	NNS	NNS	_	16	dobj	_	_
28	described	describe	VBN	VBN	_	27	acl	_	_
29	below	below	RB	RB	_	28	advmod	_	_
30	.	.	.	.	_	4	punct	_	_

1	Transgene	transgene	NN	NN	_	3	npadvmod	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	positive	positive	JJ	JJ	_	4	amod	_	_
4	founders	founder	NNS	NNS	_	6	nsubjpass	_	_
5	were	be	VBD	VBD	_	6	auxpass	_	_
6	bred	breed	VBN	VBN	_	0	root	_	_
7	to	to	IN	IN	_	6	prep	_	_
8	animals	animal	NNS	NNS	_	7	pobj	_	_
9	expressing	express	VBG	VBG	_	8	acl	_	_
10	the	the	DT	DT	_	12	det	_	_
11	tetracycline	tetracycline	NN	NN	_	12	compound	_	_
12	transactivator	transactivator	NN	NN	_	9	dobj	_	_
13	(	(	-LRB-	-LRB-	_	12	punct	_	_
14	tTA	tta	NN	NN	_	12	appos	_	_
15	)	)	-RRB-	-RRB-	_	6	punct	_	_
16	under	under	IN	IN	sem=MNR	6	prep	_	_
17	control	control	NN	NN	_	16	pobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	the	the	DT	DT	_	28	det	_	_
20	calcium	calcium	NN	NN	_	22	nmod	_	_
21	-	-	HYPH	HYPH	_	22	punct	_	_
22	calmodulin	calmodulin	NN	NN	_	24	nmod	_	_
23	kinase	kinase	NN	NN	_	24	nmod	_	_
24	IIα	iiα	NN	NN	_	28	nmod	_	_
25	(	(	-LRB-	-LRB-	_	28	punct	_	_
26	CaMKIIα	camkiiα	NN	NN	_	28	nmod	_	_
27	)	)	-RRB-	-RRB-	_	28	punct	_	_
28	promoter	promoter	NN	NN	_	18	pobj	_	_
29	obtained	obtain	VBN	VBN	_	28	acl	_	_
30	from	from	IN	IN	_	29	prep	_	_
31	Jackson	jackson	NNP	NNP	_	32	compound	_	_
32	Laboratory	laboratory	NNP	NNP	_	30	pobj	_	_
33	[	[	-LRB-	-LRB-	_	34	punct	_	_
34	16	0	CD	CD	_	32	parataxis	_	_
35	]	]	-RRB-	-RRB-	_	34	punct	_	_
36	(	(	-LRB-	-LRB-	_	38	punct	_	_
37	Bar	bar	NNP	NNP	_	38	compound	_	_
38	Harbor	harbor	NNP	NNP	_	29	parataxis	_	_
39	,	,	,	,	_	38	punct	_	_
40	Maine	maine	NNP	NNP	sem=LOC	38	npadvmod	_	_
41	,	,	,	,	_	38	punct	_	_
42	United	united	NNP	NNP	_	43	compound	_	_
43	States	state	NNP	NNP	sem=LOC	38	npadvmod	_	_
44	;	;	:	:	_	38	punct	_	_
45	stock	stock	NN	NN	_	59	dep	_	_
46	#	#	SYM	SYM	_	45	punct	_	_
47	3010	0	CD	CD	_	45	nummod	_	_
48	;	;	:	:	_	59	punct	_	_
49	B6	b0	NN	NN	_	59	dep	_	_
50	;	;	:	:	_	59	punct	_	_
51	CBA	cba	NN	NN	_	59	nmod	_	_
52	-	-	HYPH	HYPH	_	59	punct	_	_
53	TgN	tgn	NN	NN	_	59	nmod	_	_
54	[	[	-LRB-	-LRB-	_	59	punct	_	_
55	Camk2a	camk0a	NN	NN	_	59	nmod	_	_
56	-	-	HYPH	HYPH	_	59	punct	_	_
57	tTA	tta	NN	NN	_	59	nmod	_	_
58	]	]	-RRB-	-RRB-	_	59	punct	_	_
59	1Mmay	0mmay	NN	NN	_	38	dep	_	_
60	)	)	-RRB-	-RRB-	_	38	punct	_	_
61	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	colony	colony	NN	NN	_	5	nsubjpass	_	_
3	was	be	VBD	VBD	_	5	auxpass	_	_
4	thereafter	thereafter	RB	RB	sem=TMP	5	advmod	_	_
5	maintained	maintain	VBN	VBN	_	0	root	_	_
6	by	by	IN	IN	sem=MNR	5	prep	_	_
7	crossing	cross	VBG	VBG	syn=NOM	6	pcomp	_	_
8	single	single	JJ	JJ	_	13	amod	_	_
9	transgenic	transgenic	JJ	JJ	_	13	amod	_	_
10	tTA	tta	NN	NN	_	13	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	APP	app	NN	NN	_	10	conj	_	_
13	offspring	offspring	NN	NN	_	7	dobj	_	_
14	for	for	IN	IN	_	7	prep	_	_
15	each	each	DT	DT	_	14	pobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	the	the	DT	DT	_	20	det	_	_
18	four	#crd#	CD	CD	_	20	nummod	_	_
19	APP	app	NN	NN	_	20	compound	_	_
20	lines	line	NNS	NNS	_	16	pobj	_	_
21	.	.	.	.	_	5	punct	_	_

1	All	all	DT	DT	_	2	det	_	_
2	mice	mouse	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	provided	provided	VBN	VBN	_	0	root	_	_
5	fresh	fresh	JJ	JJ	_	6	amod	_	_
6	food	food	NN	NN	_	4	dobj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	water	water	NN	NN	_	6	conj	_	_
9	ad	ad	FW	FW	_	10	advmod	_	_
10	libitum	libitum	FW	FW	sem=MNR	4	advmod	_	_
11	.	.	.	.	_	4	punct	_	_

1	Animal	animal	NN	NN	_	2	compound	_	_
2	protocols	protocol	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	approved	approve	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	_	4	agent	_	_
6	both	both	DT	DT	_	10	det	_	_
7	the	the	DT	DT	_	10	det	_	_
8	Johns	johns	NNP	NNP	_	10	nmod	_	_
9	Hopkins	hopkins	NNP	NNP	_	10	nmod	_	_
10	University	university	NNP	NNP	_	22	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	the	the	DT	DT	_	14	det	_	_
13	California	california	NNP	NNP	_	14	compound	_	_
14	Institute	institute	NNP	NNP	_	10	conj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	Technology	technology	NNP	NNP	_	15	pobj	_	_
17	Institutional	institutional	NNP	NNP	_	18	nmod	_	_
18	Animal	animal	NNP	NNP	_	22	nmod	_	_
19	Care	care	NNP	NNP	_	18	appos	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	Use	use	NNP	NNP	_	19	conj	_	_
22	Committees	committee	NNPS	NNPS	_	5	pobj	_	_
23	.	.	.	.	_	4	punct	_	_

1	Doxycycline	doxycycline	NN	NN	_	2	compound	_	_
2	Administration	administration	NN	NN	_	0	root	_	_

1	Doxycycline	doxycycline	NN	NN	_	6	nsubjpass	_	_
2	(	(	-LRB-	-LRB-	_	1	punct	_	_
3	dox	dox	NN	NN	_	1	appos	_	_
4	)	)	-RRB-	-RRB-	_	1	punct	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	administered	administer	VBN	VBN	_	0	root	_	_
7	through	through	IN	IN	sem=MNR	6	prep	_	_
8	commercially	commercially	RB	RB	_	9	advmod	_	_
9	available	available	JJ	JJ	_	13	amod	_	_
10	dox	dox	NN	NN	_	12	npadvmod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	containing	contain	VBG	VBG	_	13	amod	_	_
13	chow	chow	NN	NN	_	7	pobj	_	_
14	(	(	-LRB-	-LRB-	_	15	punct	_	_
15	BioServ	bioserv	NNP	NNP	_	6	parataxis	_	_
16	,	,	,	,	_	15	punct	_	_
17	Frenchtown	frenchtown	NNP	NNP	sem=LOC	15	npadvmod	_	_
18	,	,	,	,	_	15	punct	_	_
19	New	new	NNP	NNP	_	20	compound	_	_
20	Jersey	jersey	NNP	NNP	sem=LOC	15	npadvmod	_	_
21	,	,	,	,	_	15	punct	_	_
22	United	united	NNP	NNP	_	23	compound	_	_
23	States	state	NNP	NNP	sem=LOC	15	npadvmod	_	_
24	)	)	-RRB-	-RRB-	_	15	punct	_	_
25	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	chow	chow	NN	NN	_	3	nsubj	_	_
3	contained	contain	VBD	VBD	_	29	ccomp	_	_
4	200	0	CD	CD	_	5	nummod	_	_
5	mg	mg	NN	NN	_	3	dobj	_	_
6	/	/	SYM	SYM	_	7	punct	_	_
7	kg	kg	NN	NN	_	5	prep	_	_
8	of	of	IN	IN	_	5	prep	_	_
9	antibiotic	antibiotic	JJ	JJ	_	8	pobj	_	_
10	;	;	:	:	_	29	punct	_	_
11	based	base	VBN	VBN	_	29	prep	_	_
12	on	on	IN	IN	_	11	prep	_	_
13	estimated	estimate	VBN	VBN	_	14	amod	_	_
14	consumption	consumption	NN	NN	_	12	pobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	5	0	CD	CD	_	17	nummod	_	_
17	g	g	NN	NN	_	15	pobj	_	_
18	per	per	IN	IN	_	17	prep	_	_
19	mouse	mouse	NN	NN	_	18	pobj	_	_
20	per	per	IN	IN	sem=TMP	17	prep	_	_
21	day	day	NN	NN	_	20	pobj	_	_
22	,	,	,	,	_	29	punct	_	_
23	the	the	DT	DT	_	25	det	_	_
24	expected	expect	VBN	VBN	_	25	amod	_	_
25	dose	dose	NN	NN	_	29	nsubj	_	_
26	to	to	IN	IN	_	25	prep	_	_
27	each	each	DT	DT	_	28	det	_	_
28	animal	animal	NN	NN	_	26	pobj	_	_
29	was	be	VBD	VBD	_	0	root	_	_
30	1	0	CD	CD	_	31	nummod	_	_
31	mg	mg	NN	NN	_	32	compound	_	_
32	dox	dox	NN	NN	syn=PRD	29	attr	_	_
33	per	per	IN	IN	sem=TMP	32	prep	_	_
34	day	day	NN	NN	_	33	pobj	_	_
35	.	.	.	.	_	29	punct	_	_

1	The	the	DT	DT	_	6	det	_	_
2	average	average	JJ	JJ	_	6	amod	_	_
3	25	0	CD	CD	_	5	nummod	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	g	g	NN	NN	_	6	compound	_	_
6	animal	animal	NN	NN	_	8	nsubj	_	_
7	therefore	therefore	RB	RB	_	8	advmod	_	_
8	received	receive	VBD	VBD	_	0	root	_	_
9	40	0	CD	CD	_	10	nummod	_	_
10	μg	μg	NN	NN	_	8	dobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	dox	dox	NN	NN	_	11	pobj	_	_
13	per	per	IN	IN	_	10	prep	_	_
14	gram	gram	NN	NN	_	16	compound	_	_
15	body	body	NN	NN	_	16	compound	_	_
16	weight	weight	NN	NN	_	13	pobj	_	_
17	per	per	IN	IN	sem=TMP	10	prep	_	_
18	day	day	NN	NN	_	17	pobj	_	_
19	.	.	.	.	_	8	punct	_	_

1	Chow	chow	NN	NN	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	changed	change	VBN	VBN	_	0	root	_	_
4	1	0	CD	CD	_	6	quantmod	_	_
5	–	-	SYM	SYM	_	6	punct	_	_
6	2	0	CD	CD	_	7	nummod	_	_
7	times	time	NNS	NNS	sem=TMP	3	npadvmod	_	_
8	per	per	IN	IN	sem=TMP	7	prep	_	_
9	week	week	NN	NN	_	8	pobj	_	_
10	to	to	TO	TO	_	11	aux	_	_
11	prevent	prevent	VB	VB	sem=PRP	3	advcl	_	_
12	breakdown	breakdown	NN	NN	_	11	dobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	the	the	DT	DT	_	15	det	_	_
15	antibiotic	antibiotic	NN	NN	_	13	pobj	_	_
16	.	.	.	.	_	3	punct	_	_

1	Genotyping	genotyping	NN	NN	_	0	root	_	_

1	Offspring	offspring	NN	NN	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	genotyped	genotyped	VBN	VBN	_	0	root	_	_
4	for	for	IN	IN	_	3	prep	_	_
5	the	the	DT	DT	_	6	det	_	_
6	presence	presence	NN	NN	_	4	pobj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	each	each	DT	DT	_	9	det	_	_
9	transgene	transgene	NN	NN	_	7	pobj	_	_
10	by	by	IN	IN	sem=MNR	3	prep	_	_
11	PCR	pcr	NN	NN	_	12	compound	_	_
12	amplification	amplification	NN	NN	_	10	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	genomic	genomic	JJ	JJ	_	15	amod	_	_
15	DNA	dna	NN	NN	_	13	pobj	_	_
16	extracted	extract	VBN	VBN	_	15	acl	_	_
17	from	from	IN	IN	_	16	prep	_	_
18	a	a	DT	DT	_	23	det	_	_
19	5	0	CD	CD	_	21	nummod	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	mm	mm	NN	NN	_	23	compound	_	_
22	tail	tail	NN	NN	_	23	compound	_	_
23	biopsy	biopsy	NN	NN	_	17	pobj	_	_
24	.	.	.	.	_	3	punct	_	_

1	Tails	tail	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	heated	heat	VBN	VBN	_	0	root	_	_
4	to	to	IN	IN	_	3	prep	_	_
5	95	0	CD	CD	_	6	nummod	_	_
6	°C	°c	NN	NN	_	4	pobj	_	_
7	for	for	IN	IN	sem=TMP	3	prep	_	_
8	45	0	CD	CD	_	9	nummod	_	_
9	min	min	NN	NN	_	7	pobj	_	_
10	in	in	IN	IN	sem=LOC	3	prep	_	_
11	250	0	CD	CD	_	12	nummod	_	_
12	μl	μl	NN	NN	_	10	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	50	0	CD	CD	_	15	nummod	_	_
15	mM	mm	NN	NN	_	16	compound	_	_
16	NaOH	naoh	NN	NN	_	13	pobj	_	_
17	,	,	,	,	_	3	punct	_	_
18	vortexed	vortexed	VBN	VBN	_	3	dep	_	_
19	,	,	,	,	_	3	punct	_	_
20	then	then	RB	RB	sem=TMP	21	advmod	_	_
21	neutralized	neutralize	VBN	VBN	_	3	dep	_	_
22	with	with	IN	IN	sem=MNR	21	prep	_	_
23	an	an	DT	DT	_	25	det	_	_
24	equal	equal	JJ	JJ	_	25	amod	_	_
25	volume	volume	NN	NN	_	22	pobj	_	_
26	of	of	IN	IN	_	25	prep	_	_
27	0.5	0	CD	CD	_	28	nummod	_	_
28	M	m	NN	NN	_	31	compound	_	_
29	Tris	tris	NN	NN	_	31	compound	_	_
30	-	-	HYPH	HYPH	_	31	punct	_	_
31	HCl	hcl	NN	NN	_	26	pobj	_	_
32	(	(	-LRB-	-LRB-	_	33	punct	_	_
33	pH	ph	NN	NN	_	31	parataxis	_	_
34	5.5	0	CD	CD	_	33	nummod	_	_
35	)	)	-RRB-	-RRB-	_	33	punct	_	_
36	.	.	.	.	_	3	punct	_	_

1	Debris	debris	NN	NN	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	sedimented	sediment	VBN	VBN	_	0	root	_	_
4	by	by	IN	IN	sem=MNR	3	prep	_	_
5	centrifugation	centrifugation	NN	NN	_	4	pobj	_	_
6	,	,	,	,	_	3	punct	_	_
7	and	and	CC	CC	_	3	cc	_	_
8	3	0	CD	CD	_	9	nummod	_	_
9	μl	μl	NN	NN	_	13	nsubjpass	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	supernatant	supernatant	NN	NN	_	10	pobj	_	_
12	was	be	VBD	VBD	_	13	auxpass	_	_
13	used	use	VBN	VBN	_	3	conj	_	_
14	for	for	IN	IN	sem=PRP	13	prep	_	_
15	amplification	amplification	NN	NN	_	14	pobj	_	_
16	.	.	.	.	_	13	punct	_	_

1	Genotyping	genotyping	VBG	VBG	_	8	nsubjpass	_	_
2	for	for	IN	IN	_	1	prep	_	_
3	APP	app	NN	NN	_	6	nmod	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	tTA	tta	NN	NN	_	3	conj	_	_
6	transgenes	transgene	NNS	NNS	_	2	pobj	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	performed	performed	VBN	VBN	_	0	root	_	_
9	in	in	IN	IN	_	8	prep	_	_
10	the	the	DT	DT	_	13	det	_	_
11	same	same	JJ	JJ	_	13	amod	_	_
12	PCR	pcr	NN	NN	_	13	compound	_	_
13	reaction	reaction	NN	NN	_	9	pobj	_	_
14	,	,	,	,	_	8	punct	_	_
15	using	use	VBG	VBG	sem=MNR	8	advcl	_	_
16	five	#crd#	CD	CD	_	18	nummod	_	_
17	separate	separate	JJ	JJ	_	18	amod	_	_
18	primers	primer	NNS	NNS	_	15	dobj	_	_
19	.	.	.	.	_	8	punct	_	_

1	APP	app	NN	NN	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	amplified	amplify	VBN	VBN	_	0	root	_	_
4	using	use	VBG	VBG	sem=MNR	3	advcl	_	_
5	forward	forward	RB	RB	_	7	advmod	_	_
6	primer	primer	NN	NN	_	7	compound	_	_
7	S36	s0	NN	NN	_	4	dobj	_	_
8	located	locate	VBN	VBN	_	7	acl	_	_
9	in	in	IN	IN	sem=LOC	8	prep	_	_
10	the	the	DT	DT	_	13	det	_	_
11	3	0	CD	CD	_	13	nummod	_	_
12	′	′	SYM	SYM	_	11	punct	_	_
13	end	end	NN	NN	_	9	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	the	the	DT	DT	_	17	det	_	_
16	APP	app	NN	NN	_	17	compound	_	_
17	cDNA	cdna	NN	NN	_	14	pobj	_	_
18	(	(	-LRB-	-LRB-	_	27	punct	_	_
19	CCG	ccg	NN	NN	_	27	compound	_	_
20	AGA	aga	NN	NN	_	27	compound	_	_
21	TCT	tct	NN	NN	_	27	compound	_	_
22	CTG	ctg	NN	NN	_	27	compound	_	_
23	AAG	aag	NN	NN	_	27	compound	_	_
24	TGA	tga	NN	NN	_	27	compound	_	_
25	AGA	aga	NN	NN	_	27	compound	_	_
26	TGG	tgg	NN	NN	_	27	compound	_	_
27	ATG	atg	NN	NN	_	17	parataxis	_	_
28	)	)	-RRB-	-RRB-	_	27	punct	_	_
29	and	and	CC	CC	_	7	cc	_	_
30	reverse	reverse	JJ	JJ	_	36	amod	_	_
31	primer	primer	NN	NN	_	36	compound	_	_
32	PrP	prp	NN	NN	_	36	compound	_	_
33	-	-	HYPH	HYPH	_	36	punct	_	_
34	AS	as	NN	NN	_	36	compound	_	_
35	-	-	HYPH	HYPH	_	36	punct	_	_
36	J	j	NN	NN	_	7	conj	_	_
37	located	locate	VBN	VBN	_	36	acl	_	_
38	in	in	IN	IN	sem=LOC	37	prep	_	_
39	the	the	DT	DT	_	42	det	_	_
40	3	0	CD	CD	_	42	nummod	_	_
41	′	′	SYM	SYM	_	40	punct	_	_
42	UTR	utr	NN	NN	_	38	pobj	_	_
43	of	of	IN	IN	_	42	prep	_	_
44	the	the	DT	DT	_	45	det	_	_
45	vector	vector	NN	NN	_	43	pobj	_	_
46	(	(	-LRB-	-LRB-	_	54	punct	_	_
47	CCA	cca	NN	NN	_	54	compound	_	_
48	AGC	agc	NN	NN	_	54	compound	_	_
49	CTA	cta	NN	NN	_	54	compound	_	_
50	GAC	gac	NN	NN	_	54	compound	_	_
51	CAC	cac	NN	NN	_	54	compound	_	_
52	GAG	gag	NN	NN	_	54	compound	_	_
53	AAT	aat	NN	NN	_	54	compound	_	_
54	GC	gc	NN	NN	_	42	parataxis	_	_
55	)	)	-RRB-	-RRB-	_	54	punct	_	_
56	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	tTA	tta	NN	NN	_	3	compound	_	_
3	transgene	transgene	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	detected	detect	VBN	VBN	_	0	root	_	_
6	using	use	VBG	VBG	sem=MNR	5	advcl	_	_
7	a	a	DT	DT	_	9	det	_	_
8	primer	primer	NN	NN	_	9	compound	_	_
9	set	set	NN	NN	_	6	dobj	_	_
10	that	that	WDT	WDT	_	11	dep	_	9:ref
11	amplified	amplify	VBD	VBD	_	9	relcl	_	_
12	across	across	IN	IN	sem=LOC	11	prep	_	_
13	its	its	PRP$	PRP$	_	15	poss	_	_
14	two	#crd#	CD	CD	_	15	nummod	_	_
15	subdomains	subdomain	NNS	NNS	_	12	pobj	_	_
16	with	with	IN	IN	sem=MNR	11	prep	_	_
17	tet	tet	NN	NN	_	16	pobj	_	17:gap
18	forward	forward	RB	RB	_	17	advmod	_	_
19	located	locate	VBN	VBN	_	17	acl	_	_
20	within	within	IN	IN	sem=LOC	19	prep	_	20:gap
21	the	the	DT	DT	_	24	det	_	_
22	Tn10	tn0	NN	NN	_	23	compound	_	_
23	tetracycline	tetracycline	NN	NN	_	24	compound	_	_
24	repressor	repressor	NN	NN	_	20	pobj	_	_
25	(	(	-LRB-	-LRB-	_	33	punct	_	_
26	CGC	cgc	NN	NN	_	33	compound	_	_
27	TGT	tgt	NN	NN	_	33	compound	_	_
28	GGG	ggg	NN	NN	_	33	compound	_	_
29	GCA	gca	NN	NN	_	33	compound	_	_
30	TTT	ttt	NN	NN	_	33	compound	_	_
31	TAC	tac	NN	NN	_	33	compound	_	_
32	TTT	ttt	NN	NN	_	33	compound	_	_
33	AG	ag	NN	NN	_	24	parataxis	_	_
34	)	)	-RRB-	-RRB-	_	33	punct	_	_
35	and	and	CC	CC	_	17	cc	_	_
36	tet	tet	NN	NN	_	17	conj	_	17:gap
37	reverse	reverse	JJ	JJ	_	36	amod	_	_
38	within	within	IN	IN	sem=LOC	36	prep	_	20:gap
39	the	the	DT	DT	_	41	det	_	_
40	HSV1	hsv0	NN	NN	_	41	compound	_	_
41	VP16	vp0	NN	NN	_	38	pobj	_	_
42	(	(	-LRB-	-LRB-	_	49	punct	_	_
43	CAT	cat	NN	NN	_	49	compound	_	_
44	GTC	gtc	NN	NN	_	49	compound	_	_
45	CAG	cag	NN	NN	_	49	compound	_	_
46	ATC	atc	NN	NN	_	49	compound	_	_
47	GAA	gaa	NN	NN	_	49	compound	_	_
48	ATC	atc	NN	NN	_	49	compound	_	_
49	GTC	gtc	NN	NN	_	41	parataxis	_	_
50	)	)	-RRB-	-RRB-	_	49	punct	_	_
51	.	.	.	.	_	5	punct	_	_

1	All	all	DT	DT	_	2	det	_	_
2	reactions	reaction	NNS	NNS	_	11	nsubj	_	_
3	,	,	,	,	_	11	punct	_	_
4	whether	whether	IN	IN	_	7	mark	_	_
5	transgene	transgene	NN	NN	_	7	npadvmod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	positive	positive	JJ	JJ	syn=ADV	11	advcl	_	_
8	or	or	CC	CC	_	7	cc	_	_
9	not	not	RB	RB	_	7	conj	_	_
10	,	,	,	,	_	11	punct	_	_
11	amplified	amplify	VBD	VBD	_	0	root	_	_
12	a	a	DT	DT	_	13	det	_	_
13	segment	segment	NN	NN	_	11	dobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	the	the	DT	DT	_	19	det	_	_
16	endogenous	endogenous	JJ	JJ	_	19	amod	_	_
17	prion	prion	NN	NN	_	19	compound	_	_
18	protein	protein	NN	NN	_	19	compound	_	_
19	gene	gene	NN	NN	_	14	pobj	_	_
20	as	as	IN	IN	_	11	prep	_	_
21	a	a	DT	DT	_	22	det	_	_
22	control	control	NN	NN	_	20	pobj	_	_
23	for	for	IN	IN	_	22	prep	_	_
24	DNA	dna	NN	NN	_	25	compound	_	_
25	quality	quality	NN	NN	_	23	pobj	_	_
26	using	use	VBG	VBG	sem=MNR	11	advcl	_	_
27	a	a	DT	DT	_	29	det	_	_
28	forward	forward	JJ	JJ	_	29	amod	_	_
29	primer	primer	NN	NN	_	26	dobj	_	_
30	,	,	,	,	_	29	punct	_	_
31	PrP	prp	NN	NN	_	35	compound	_	_
32	-	-	HYPH	HYPH	_	35	punct	_	_
33	S	s	NN	NN	_	35	compound	_	_
34	-	-	HYPH	HYPH	_	35	punct	_	_
35	J	j	NN	NN	_	29	appos	_	_
36	,	,	,	,	_	29	punct	_	_
37	specific	specific	JJ	JJ	_	29	amod	_	_
38	to	to	IN	IN	_	37	prep	_	_
39	the	the	DT	DT	_	44	det	_	_
40	mouse	mouse	NN	NN	_	44	nmod	_	_
41	PrP	prp	NN	NN	_	44	nmod	_	_
42	open	open	JJ	JJ	_	43	amod	_	_
43	reading	reading	NN	NN	_	44	compound	_	_
44	frame	frame	NN	NN	_	38	pobj	_	_
45	(	(	-LRB-	-LRB-	_	53	punct	_	_
46	GGG	ggg	NN	NN	_	53	compound	_	_
47	ACT	act	NN	NN	_	53	compound	_	_
48	ATG	atg	NN	NN	_	53	compound	_	_
49	TGG	tgg	NN	NN	_	53	compound	_	_
50	ACT	act	NN	NN	_	53	compound	_	_
51	GAT	gat	NN	NN	_	53	compound	_	_
52	GTC	gtc	NN	NN	_	53	compound	_	_
53	GG	gg	NN	NN	_	44	parataxis	_	_
54	)	)	-RRB-	-RRB-	_	53	punct	_	_
55	and	and	CC	CC	_	29	cc	_	_
56	a	a	DT	DT	_	58	det	_	_
57	reverse	reverse	JJ	JJ	_	58	amod	_	_
58	primer	primer	NN	NN	_	29	conj	_	_
59	,	,	,	,	_	58	punct	_	_
60	PrP	prp	NN	NN	_	64	compound	_	_
61	-	-	HYPH	HYPH	_	64	punct	_	_
62	AS	as	NN	NN	_	64	compound	_	_
63	-	-	HYPH	HYPH	_	64	punct	_	_
64	J	j	NN	NN	_	58	appos	_	_
65	,	,	,	,	_	58	punct	_	_
66	shared	share	VBN	VBN	_	58	acl	_	_
67	by	by	IN	IN	_	66	agent	_	_
68	the	the	DT	DT	_	71	det	_	_
69	3	0	CD	CD	_	71	nummod	_	_
70	′	′	SYM	SYM	_	69	punct	_	_
71	UTR	utr	NN	NN	_	67	pobj	_	_
72	of	of	IN	IN	_	71	prep	_	_
73	the	the	DT	DT	_	76	det	_	_
74	endogenous	endogenous	JJ	JJ	_	76	amod	_	_
75	PrP	prp	NN	NN	_	76	compound	_	_
76	gene	gene	NN	NN	_	72	pobj	_	_
77	and	and	CC	CC	_	76	cc	_	_
78	the	the	DT	DT	_	80	det	_	_
79	transgene	transgene	NN	NN	_	80	compound	_	_
80	vector	vector	NN	NN	_	76	conj	_	_
81	.	.	.	.	_	11	punct	_	_

1	Amplification	amplification	NN	NN	_	2	compound	_	_
2	reactions	reaction	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	run	run	VBN	VBN	_	0	root	_	_
5	for	for	IN	IN	_	4	prep	_	_
6	37	0	CD	CD	_	7	nummod	_	_
7	cycles	cycle	NNS	NNS	_	5	pobj	_	_
8	at	at	IN	IN	_	4	prep	_	_
9	94	0	CD	CD	_	10	nummod	_	_
10	°C	°c	NN	NN	_	8	pobj	_	10:gap
11	for	for	IN	IN	sem=TMP	4	prep	_	11:gap
12	30	0	CD	CD	_	13	nummod	_	_
13	s	s	NN	NN	_	11	pobj	_	_
14	,	,	,	,	_	4	punct	_	_
15	64	0	CD	CD	_	16	nummod	_	_
16	°C	°c	NN	NN	_	4	conj	_	10:gap
17	for	for	IN	IN	sem=TMP	16	prep	_	11:gap
18	1	0	CD	CD	_	19	nummod	_	_
19	min	min	NN	NN	_	17	pobj	_	_
20	,	,	,	,	_	16	punct	_	_
21	and	and	CC	CC	_	16	cc	_	_
22	72	0	CD	CD	_	23	nummod	_	_
23	°C	°c	NN	NN	_	16	conj	_	10:gap
24	for	for	IN	IN	sem=TMP	23	prep	_	11:gap
25	1	0	CD	CD	_	26	nummod	_	_
26	min	min	NN	NN	_	24	pobj	_	_
27	.	.	.	.	_	4	punct	_	_

1	All	all	DT	DT	_	2	det	_	_
2	samples	sample	NNS	NNS	_	10	nsubj	_	_
3	,	,	,	,	_	2	punct	_	_
4	transgenic	transgenic	JJ	JJ	_	2	amod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	wild	wild	JJ	JJ	_	8	amod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	type	type	NN	NN	_	4	conj	_	_
9	,	,	,	,	_	10	punct	_	_
10	gave	give	VBD	VBD	_	0	root	_	_
11	a	a	DT	DT	_	15	det	_	_
12	750	0	CD	CD	_	14	nummod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	bp	bp	NN	NN	_	15	compound	_	_
15	product	product	NN	NN	_	10	dobj	_	_
16	from	from	IN	IN	_	15	prep	_	_
17	the	the	DT	DT	_	20	det	_	_
18	endogenous	endogenous	JJ	JJ	_	20	amod	_	_
19	PrP	prp	NN	NN	_	20	compound	_	_
20	gene	gene	NN	NN	_	16	pobj	_	_
21	.	.	.	.	_	10	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	APP	app	NN	NN	_	3	compound	_	_
3	transgene	transgene	NN	NN	_	4	nsubj	_	_
4	yielded	yield	VBD	VBD	_	15	ccomp	_	_
5	an	an	DT	DT	_	7	det	_	_
6	additional	additional	JJ	JJ	_	7	amod	_	_
7	band	band	NN	NN	_	4	dobj	_	_
8	at	at	IN	IN	_	7	prep	_	_
9	400	0	CD	CD	_	10	nummod	_	_
10	bp	bp	NN	NN	_	8	pobj	_	_
11	;	;	:	:	_	15	punct	_	_
12	the	the	DT	DT	_	14	det	_	_
13	tTA	tta	NN	NN	_	14	compound	_	_
14	product	product	NN	NN	_	15	nsubj	_	_
15	fell	fall	VBD	VBD	_	0	root	_	_
16	in	in	RB	RB	_	17	advmod	_	_
17	between	between	RB	RB	_	15	advmod	_	_
18	at	at	IN	IN	sem=LOC	15	prep	_	_
19	480	0	CD	CD	_	20	nummod	_	_
20	bp	bp	NN	NN	_	18	pobj	_	_
21	.	.	.	.	_	15	punct	_	_

1	Immunoblotting	immunoblotting	NN	NN	_	3	compound	_	_
2	/	/	HYPH	HYPH	_	3	punct	_	_
3	Quantitation	quantitation	NN	NN	_	0	root	_	_

1	Frozen	freeze	VBN	VBN	_	6	amod	_	_
2	cortical	cortical	JJ	JJ	_	6	amod	_	_
3	or	or	CC	CC	_	2	cc	_	_
4	whole	whole	JJ	JJ	_	5	amod	_	_
5	forebrain	forebrain	NN	NN	_	2	conj	_	_
6	tissue	tissue	NN	NN	_	8	nsubjpass	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	homogenized	homogenize	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	sem=MNR	8	prep	_	_
10	sonication	sonication	NN	NN	_	9	pobj	_	_
11	in	in	IN	IN	sem=LOC	8	prep	_	_
12	five	#crd#	CD	CD	_	13	nummod	_	_
13	volumes	volume	NNS	NNS	_	11	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	phosphate	phosphate	NN	NN	_	17	npadvmod	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	buffered	buffer	VBN	VBN	_	18	amod	_	_
18	saline	saline	NN	NN	_	14	pobj	_	_
19	(	(	-LRB-	-LRB-	_	18	punct	_	_
20	PBS	pbs	NN	NN	_	18	appos	_	_
21	)	)	-RRB-	-RRB-	_	8	punct	_	_
22	with	with	IN	IN	sem=MNR	8	prep	_	_
23	5	0	CD	CD	_	24	nummod	_	_
24	mM	mm	NN	NN	_	28	nmod	_	_
25	EDTA	edta	NN	NN	_	28	nmod	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	protease	protease	NN	NN	_	25	conj	_	_
28	inhibitors	inhibitor	NNS	NNS	_	22	pobj	_	_
29	(	(	-LRB-	-LRB-	_	32	punct	_	_
30	Mammalian	mammalian	JJ	JJ	_	32	amod	_	_
31	cell	cell	NN	NN	_	32	compound	_	_
32	cocktail	cocktail	NN	NN	_	28	parataxis	_	_
33	,	,	,	,	_	32	punct	_	_
34	Sigma	sigma	NNP	NNP	syn=ADV	32	npadvmod	_	_
35	,	,	,	,	_	32	punct	_	_
36	St.	st.	NNP	NNP	_	37	compound	_	_
37	Louis	louis	NNP	NNP	sem=LOC	32	npadvmod	_	_
38	,	,	,	,	_	32	punct	_	_
39	Missouri	missouri	NNP	NNP	sem=LOC	32	npadvmod	_	_
40	,	,	,	,	_	32	punct	_	_
41	United	united	NNP	NNP	_	42	compound	_	_
42	States	state	NNP	NNP	sem=LOC	32	npadvmod	_	_
43	)	)	-RRB-	-RRB-	_	32	punct	_	_
44	,	,	,	,	_	8	punct	_	_
45	using	use	VBG	VBG	sem=MNR	8	advcl	_	_
46	a	a	DT	DT	_	48	det	_	_
47	probe	probe	NN	NN	_	48	compound	_	_
48	sonicator	sonicator	NN	NN	_	45	dobj	_	_
49	set	set	VBN	VBN	_	48	acl	_	_
50	to	to	IN	IN	_	49	prep	_	_
51	50	0	CD	CD	_	52	nummod	_	_
52	%	%	NN	NN	_	53	compound	_	_
53	output	output	NN	NN	_	50	pobj	_	_
54	(	(	-LRB-	-LRB-	_	55	punct	_	_
55	TEKMAR	tekmar	NNP	NNP	_	48	parataxis	_	_
56	,	,	,	,	_	55	punct	_	_
57	Cincinnati	cincinnati	NNP	NNP	sem=LOC	55	npadvmod	_	_
58	,	,	,	,	_	55	punct	_	_
59	Ohio	ohio	NNP	NNP	sem=LOC	55	npadvmod	_	_
60	,	,	,	,	_	55	punct	_	_
61	United	united	NNP	NNP	_	62	compound	_	_
62	States	state	NNP	NNP	sem=LOC	55	npadvmod	_	_
63	)	)	-RRB-	-RRB-	_	55	punct	_	_
64	.	.	.	.	_	8	punct	_	_

1	After	after	IN	IN	sem=TMP	18	prep	_	_
2	dilution	dilution	NN	NN	_	1	pobj	_	_
3	with	with	IN	IN	_	2	prep	_	_
4	an	an	DT	DT	_	6	det	_	_
5	equal	equal	JJ	JJ	_	6	amod	_	_
6	volume	volume	NN	NN	_	3	pobj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	PBS	pbs	NN	NN	_	12	compound	_	_
9	/	/	HYPH	HYPH	_	12	punct	_	_
10	EDTA	edta	NN	NN	_	12	compound	_	_
11	/	/	HYPH	HYPH	_	12	punct	_	_
12	protease	protease	NN	NN	_	13	compound	_	_
13	inhibitor	inhibitor	NN	NN	_	7	pobj	_	_
14	,	,	,	,	_	18	punct	_	_
15	the	the	DT	DT	_	16	det	_	_
16	samples	sample	NNS	NNS	_	18	nsubjpass	_	16:gap
17	were	be	VBD	VBD	_	18	auxpass	_	_
18	centrifuged	centrifuge	VBN	VBN	_	0	root	_	18:gap
19	briefly	briefly	RB	RB	sem=TMP	18	advmod	_	_
20	and	and	CC	CC	_	18	cc	_	_
21	the	the	DT	DT	_	22	det	_	_
22	supernatant	supernatant	NN	NN	_	23	nsubj	_	16:gap
23	used	use	VBN	VBN	_	18	conj	_	18:gap
24	for	for	IN	IN	sem=PRP	23	prep	_	_
25	analysis	analysis	NN	NN	_	24	pobj	_	_
26	.	.	.	.	_	18	punct	_	_

1	Fifty	#crd#	CD	CD	_	2	nummod	_	_
2	micrograms	microgram	NNS	NNS	_	4	nmod	_	_
3	(	(	-LRB-	-LRB-	_	4	punct	_	_
4	6E10	0e0	NN	NN	_	18	nsubjpass	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	CT15	ct0	NN	NN	_	4	conj	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	or	or	CC	CC	_	4	cc	_	_
9	5	0	CD	CD	_	10	nummod	_	_
10	μg	μg	NN	NN	_	12	nmod	_	_
11	(	(	-LRB-	-LRB-	_	12	punct	_	_
12	22C11	0c0	NN	NN	_	4	conj	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	of	of	IN	IN	_	4	prep	_	_
15	brain	brain	NN	NN	_	16	compound	_	_
16	homogenate	homogenate	NN	NN	_	14	pobj	_	_
17	was	be	VBD	VBD	_	18	auxpass	_	_
18	loaded	load	VBN	VBN	_	0	root	_	_
19	per	per	IN	IN	_	18	prep	_	_
20	lane	lane	NN	NN	_	19	pobj	_	_
21	onto	onto	IN	IN	_	18	prep	_	_
22	7.5	0	CD	CD	_	23	nummod	_	_
23	%	%	NN	NN	_	40	nmod	_	_
24	,	,	,	,	_	23	punct	_	_
25	10	0	CD	CD	_	26	nummod	_	_
26	%	%	NN	NN	_	23	conj	_	_
27	–	-	SYM	SYM	_	29	punct	_	_
28	20	0	CD	CD	_	29	nummod	_	_
29	%	%	NN	NN	_	26	prep	_	_
30	,	,	,	,	_	26	punct	_	_
31	or	or	CC	CC	_	26	cc	_	_
32	4	0	CD	CD	_	33	nummod	_	_
33	%	%	NN	NN	_	26	conj	_	_
34	–	-	SYM	SYM	_	36	punct	_	_
35	20	0	CD	CD	_	36	nummod	_	_
36	%	%	NN	NN	_	33	prep	_	_
37	Tris	tris	NN	NN	_	40	compound	_	_
38	-	-	HYPH	HYPH	_	40	punct	_	_
39	HCl	hcl	NN	NN	_	40	compound	_	_
40	PAGE	page	NN	NN	_	41	compound	_	_
41	gels	gel	NNS	NNS	_	21	pobj	_	_
42	(	(	-LRB-	-LRB-	_	46	punct	_	_
43	Bio	bio	NNP	NNP	_	45	compound	_	_
44	-	-	HYPH	HYPH	_	45	punct	_	_
45	Rad	rad	NNP	NNP	_	46	compound	_	_
46	Laboratories	laboratories	NNP	NNP	_	41	parataxis	_	_
47	,	,	,	,	_	46	punct	_	_
48	Hercules	hercules	NNP	NNP	sem=LOC	46	npadvmod	_	_
49	,	,	,	,	_	46	punct	_	_
50	California	california	NNP	NNP	sem=LOC	46	npadvmod	_	_
51	,	,	,	,	_	46	punct	_	_
52	United	united	NNP	NNP	_	53	compound	_	_
53	States	state	NNP	NNP	sem=LOC	46	npadvmod	_	_
54	)	)	-RRB-	-RRB-	_	46	punct	_	_
55	and	and	CC	CC	_	18	cc	_	_
56	electrophoresed	electrophoresed	VBN	VBN	_	18	conj	_	_
57	for	for	IN	IN	sem=TMP	56	prep	_	_
58	several	several	JJ	JJ	_	59	amod	_	_
59	hours	hour	NNS	NNS	_	57	pobj	_	_
60	in	in	IN	IN	sem=LOC	56	prep	_	_
61	1	0	CD	CD	_	69	nummod	_	_
62	×	×	SYM	SYM	_	61	punct	_	_
63	Tris	tris	NN	NN	_	69	nmod	_	_
64	-	-	HYPH	HYPH	_	69	punct	_	_
65	glycine	glycine	NN	NN	_	69	nmod	_	_
66	–	-	HYPH	HYPH	_	69	punct	_	_
67	sodium	sodium	NN	NN	_	69	nmod	_	_
68	dodecyl	dodecyl	NN	NN	_	69	nmod	_	_
69	sulfate	sulfate	NN	NN	_	77	nmod	_	_
70	(	(	-LRB-	-LRB-	_	69	punct	_	_
71	1	0	CD	CD	_	75	nummod	_	_
72	×	×	SYM	SYM	_	71	punct	_	_
73	TG	tg	NN	NN	_	75	compound	_	_
74	-	-	HYPH	HYPH	_	75	punct	_	_
75	SDS	sds	NN	NN	_	69	appos	_	_
76	)	)	-RRB-	-RRB-	_	77	punct	_	_
77	buffer	buffer	NN	NN	_	60	pobj	_	_
78	(	(	-LRB-	-LRB-	_	83	punct	_	_
79	6E10	0e0	NN	NN	_	83	dep	_	_
80	and	and	CC	CC	_	79	cc	_	_
81	22C11	0c0	NN	NN	_	79	conj	_	_
82	;	;	:	:	_	83	punct	_	_
83	Amresco	amresco	NNP	NNP	_	77	parataxis	_	_
84	,	,	,	,	_	83	punct	_	_
85	Solon	solon	NNP	NNP	sem=LOC	83	npadvmod	_	_
86	,	,	,	,	_	83	punct	_	_
87	Ohio	ohio	NNP	NNP	sem=LOC	83	npadvmod	_	_
88	,	,	,	,	_	83	punct	_	_
89	United	united	NNP	NNP	_	90	compound	_	_
90	States	state	NNP	NNP	sem=LOC	83	npadvmod	_	_
91	)	)	-RRB-	-RRB-	_	83	punct	_	_
92	or	or	CC	CC	_	77	cc	_	_
93	1	0	CD	CD	_	100	nummod	_	_
94	×	×	SYM	SYM	_	93	punct	_	_
95	Tris	tris	NN	NN	_	99	compound	_	_
96	-	-	HYPH	HYPH	_	99	punct	_	_
97	tricine	tricine	NN	NN	_	99	compound	_	_
98	-	-	HYPH	HYPH	_	99	punct	_	_
99	SDS	sds	NN	NN	_	100	compound	_	_
100	buffer	buffer	NN	NN	_	77	conj	_	_
101	(	(	-LRB-	-LRB-	_	104	punct	_	_
102	CT15	ct0	NN	NN	_	104	dep	_	_
103	;	;	:	:	_	104	punct	_	_
104	Invitrogen	invitrogen	NNP	NNP	_	100	parataxis	_	_
105	,	,	,	,	_	104	punct	_	_
106	Carlsbad	carlsbad	NNP	NNP	sem=LOC	104	npadvmod	_	_
107	,	,	,	,	_	104	punct	_	_
108	California	california	NNP	NNP	sem=LOC	104	npadvmod	_	_
109	,	,	,	,	_	104	punct	_	_
110	United	united	NNP	NNP	_	111	compound	_	_
111	States	state	NNP	NNP	sem=LOC	104	npadvmod	_	_
112	)	)	-RRB-	-RRB-	_	104	punct	_	_
113	.	.	.	.	_	18	punct	_	_

1	Proteins	protein	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	transferred	transfer	VBN	VBN	_	0	root	_	_
4	overnight	overnight	RB	RB	sem=TMP	3	advmod	_	_
5	to	to	IN	IN	_	3	prep	_	_
6	0.45	0	CD	CD	_	8	nummod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	μm	μm	NN	NN	_	10	compound	_	_
9	Optitran	optitran	NNP	NNP	_	10	compound	_	_
10	nitrocellulose	nitrocellulose	NN	NN	_	5	pobj	_	_
11	(	(	-LRB-	-LRB-	_	12	punct	_	_
12	Schleicher	schleicher	NNP	NNP	_	10	parataxis	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	Schuell	schuell	NNP	NNP	_	12	conj	_	_
15	,	,	,	,	_	12	punct	_	_
16	Keene	keene	NNP	NNP	sem=LOC	12	npadvmod	_	_
17	,	,	,	,	_	12	punct	_	_
18	New	new	NNP	NNP	_	19	compound	_	_
19	Hampshire	hampshire	NNP	NNP	sem=LOC	12	npadvmod	_	_
20	,	,	,	,	_	12	punct	_	_
21	United	united	NNP	NNP	_	22	compound	_	_
22	States	state	NNP	NNP	sem=LOC	12	npadvmod	_	_
23	)	)	-RRB-	-RRB-	_	12	punct	_	_
24	in	in	IN	IN	sem=LOC	3	prep	_	_
25	1	0	CD	CD	_	28	nummod	_	_
26	×	×	SYM	SYM	_	25	punct	_	_
27	TG	tg	NN	NN	_	28	compound	_	_
28	buffer	buffer	NN	NN	_	24	pobj	_	_
29	(	(	-LRB-	-LRB-	_	30	punct	_	_
30	Amresco	amresco	NNP	NNP	_	28	parataxis	_	_
31	)	)	-RRB-	-RRB-	_	30	punct	_	_
32	.	.	.	.	_	3	punct	_	_

1	Blots	blot	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	blocked	block	VBN	VBN	_	0	root	_	_
4	in	in	IN	IN	sem=LOC	3	prep	_	_
5	PBS	pbs	NN	NN	_	4	pobj	_	_
6	containing	contain	VBG	VBG	_	5	acl	_	_
7	5	0	CD	CD	_	8	nummod	_	_
8	%	%	NN	NN	_	12	nmod	_	_
9	nonfat	nonfat	JJ	JJ	_	11	amod	_	_
10	dry	dry	JJ	JJ	_	11	amod	_	_
11	milk	milk	NN	NN	_	12	compound	_	_
12	powder	powder	NN	NN	_	6	dobj	_	_
13	,	,	,	,	_	3	punct	_	_
14	and	and	CC	CC	_	3	cc	_	_
15	incubated	incubate	VBN	VBN	_	3	conj	_	_
16	for	for	IN	IN	sem=TMP	15	prep	_	_
17	3	0	CD	CD	_	18	nummod	_	_
18	h	h	NN	NN	_	16	pobj	_	_
19	at	at	IN	IN	_	15	prep	_	_
20	room	room	NN	NN	_	21	compound	_	_
21	temperature	temperature	NN	NN	_	19	pobj	_	_
22	in	in	IN	IN	sem=LOC	15	prep	_	_
23	blocking	blocking	NN	NN	_	24	compound	_	_
24	solution	solution	NN	NN	_	22	pobj	_	_
25	with	with	IN	IN	_	24	prep	_	_
26	one	#crd#	CD	CD	_	25	pobj	_	_
27	of	of	IN	IN	_	26	prep	_	_
28	the	the	DT	DT	_	30	det	_	_
29	following	follow	VBG	VBG	_	30	amod	_	_
30	antibodies	antibody	NNS	NNS	_	27	pobj	_	_
31	:	:	:	:	_	30	punct	_	_
32	mouse	mouse	NN	NN	_	34	nmod	_	_
33	monoclonal	monoclonal	JJ	JJ	_	34	amod	_	_
34	22C11	0c0	NN	NN	_	30	appos	_	_
35	(	(	-LRB-	-LRB-	_	46	punct	_	_
36	kind	kind	JJ	JJ	_	37	amod	_	_
37	gift	gift	NN	NN	_	46	dep	_	_
38	of	of	IN	IN	_	37	prep	_	_
39	Konrad	konrad	NNP	NNP	_	40	compound	_	_
40	Beyreuther	beyreuther	NNP	NNP	_	38	pobj	_	_
41	and	and	CC	CC	_	40	cc	_	_
42	Andreas	andreas	NNP	NNP	_	43	compound	_	_
43	Weidemann	weidemann	NNP	NNP	_	40	conj	_	_
44	;	;	:	:	_	46	punct	_	_
45	[	[	-LRB-	-LRB-	_	46	punct	_	_
46	17	0	CD	CD	_	34	parataxis	_	_
47	]	]	-RRB-	-RRB-	_	46	punct	_	_
48	)	)	-RRB-	-RRB-	_	46	punct	_	_
49	diluted	dilute	VBN	VBN	_	34	acl	_	_
50	1	0	CD	CD	sem=EXT	49	npadvmod	_	_
51	:	:	SYM	SYM	_	52	punct	_	_
52	1,000	0	CD	CD	_	50	prep	_	_
53	,	,	,	,	_	34	punct	_	_
54	mouse	mouse	NN	NN	_	56	nmod	_	_
55	monoclonal	monoclonal	JJ	JJ	_	56	amod	_	_
56	6E10	0e0	NN	NN	_	34	conj	_	_
57	(	(	-LRB-	-LRB-	_	59	punct	_	_
58	Signet	signet	NNP	NNP	_	59	compound	_	_
59	Laboratories	laboratories	NNP	NNP	_	56	parataxis	_	_
60	,	,	,	,	_	59	punct	_	_
61	Dedham	dedham	NNP	NNP	sem=LOC	59	npadvmod	_	_
62	,	,	,	,	_	59	punct	_	_
63	Massachusetts	massachusetts	NNP	NNP	sem=LOC	59	npadvmod	_	_
64	,	,	,	,	_	59	punct	_	_
65	United	united	NNP	NNP	_	66	compound	_	_
66	States	state	NNP	NNP	sem=LOC	59	npadvmod	_	_
67	)	)	-RRB-	-RRB-	_	59	punct	_	_
68	diluted	dilute	VBN	VBN	_	56	acl	_	_
69	1	0	CD	CD	sem=EXT	68	npadvmod	_	_
70	:	:	SYM	SYM	_	71	punct	_	_
71	2,500	0	CD	CD	_	69	prep	_	_
72	,	,	,	,	_	56	punct	_	_
73	rabbit	rabbit	NN	NN	_	81	nmod	_	_
74	polyclonal	polyclonal	JJ	JJ	_	81	amod	_	_
75	anti-superoxide	anti-superoxide	JJ	JJ	_	81	amod	_	_
76	dismutase	dismutase	NN	NN	_	81	nmod	_	_
77	1	0	CD	CD	_	81	nummod	_	_
78	(	(	-LRB-	-LRB-	_	81	punct	_	_
79	m	m	NN	NN	_	81	compound	_	_
80	/	/	HYPH	HYPH	_	81	punct	_	_
81	hSOD1	hsod0	NN	NN	_	56	conj	_	_
82	)	)	-RRB-	-RRB-	_	81	punct	_	_
83	[	[	-LRB-	-LRB-	_	84	punct	_	_
84	18	0	CD	CD	_	81	parataxis	_	_
85	]	]	-RRB-	-RRB-	_	84	punct	_	_
86	diluted	dilute	VBN	VBN	_	81	acl	_	_
87	1	0	CD	CD	sem=EXT	86	npadvmod	_	_
88	:	:	SYM	SYM	_	89	punct	_	_
89	2,500	0	CD	CD	_	87	prep	_	_
90	to	to	IN	IN	_	87	prep	_	_
91	1	0	CD	CD	_	90	pobj	_	_
92	:	:	SYM	SYM	_	93	punct	_	_
93	4,000	0	CD	CD	_	91	prep	_	_
94	,	,	,	,	_	81	punct	_	_
95	or	or	CC	CC	_	81	cc	_	_
96	rabbit	rabbit	NN	NN	_	98	nmod	_	_
97	polyclonal	polyclonal	JJ	JJ	_	98	amod	_	_
98	CT15	ct0	NN	NN	_	81	conj	_	_
99	(	(	-LRB-	-LRB-	_	101	punct	_	_
100	kind	kind	JJ	JJ	_	101	amod	_	_
101	gift	gift	NN	NN	_	98	parataxis	_	_
102	of	of	IN	IN	_	101	prep	_	_
103	Ed	ed	NNP	NNP	_	104	compound	_	_
104	Koo	koo	NNP	NNP	_	102	pobj	_	_
105	;	;	:	:	_	101	punct	_	_
106	[	[	-LRB-	-LRB-	_	107	punct	_	_
107	19	0	CD	CD	_	101	parataxis	_	_
108	]	]	-RRB-	-RRB-	_	107	punct	_	_
109	)	)	-RRB-	-RRB-	_	101	punct	_	_
110	diluted	dilute	VBN	VBN	_	98	acl	_	_
111	1	0	CD	CD	sem=EXT	110	npadvmod	_	_
112	:	:	SYM	SYM	_	113	punct	_	_
113	1,000	0	CD	CD	_	111	prep	_	_
114	.	.	.	.	_	3	punct	_	_

1	Subsequently	subsequently	RB	RB	sem=TMP	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	blots	blot	NNS	NNS	_	6	nsubjpass	_	_
5	were	be	VBD	VBD	_	6	auxpass	_	_
6	washed	wash	VBN	VBN	_	0	root	_	_
7	with	with	IN	IN	sem=MNR	6	prep	_	_
8	PBS	pbs	NN	NN	_	7	pobj	_	_
9	containing	contain	VBG	VBG	_	8	acl	_	_
10	0.1	0	CD	CD	_	11	nummod	_	_
11	%	%	NN	NN	_	12	compound	_	_
12	Tween	tween	NN	NN	_	9	dobj	_	_
13	-	-	HYPH	HYPH	_	12	punct	_	_
14	20	0	CD	CD	_	12	nummod	_	_
15	,	,	,	,	_	6	punct	_	_
16	and	and	CC	CC	_	6	cc	_	_
17	then	then	RB	RB	sem=TMP	18	advmod	_	_
18	incubated	incubate	VBN	VBN	_	6	conj	_	_
19	with	with	IN	IN	sem=MNR	18	prep	_	_
20	either	either	CC	CC	_	21	preconj	_	_
21	goat	goat	NN	NN	_	31	nmod	_	_
22	anti-mouse	anti-mouse	JJ	JJ	_	21	amod	_	_
23	–	-	HYPH	HYPH	_	21	punct	_	_
24	or	or	CC	CC	_	21	cc	_	_
25	goat	goat	NN	NN	_	21	conj	_	_
26	anti-rabbit	anti-rabbit	JJ	JJ	_	25	amod	_	_
27	–	-	HYPH	HYPH	_	31	punct	_	_
28	HRP	hrp	NN	NN	_	29	npadvmod	_	_
29	conjugated	conjugate	VBN	VBN	_	31	amod	_	_
30	secondary	secondary	JJ	JJ	_	31	amod	_	_
31	antibody	antibody	NN	NN	_	19	pobj	_	_
32	diluted	dilute	VBN	VBN	_	31	acl	_	_
33	1	0	CD	CD	sem=EXT	32	npadvmod	_	_
34	:	:	SYM	SYM	_	35	punct	_	_
35	1,000	0	CD	CD	_	33	prep	_	_
36	in	in	IN	IN	sem=LOC	32	prep	_	_
37	blocking	blocking	NN	NN	_	38	compound	_	_
38	solution	solution	NN	NN	_	36	pobj	_	_
39	.	.	.	.	_	6	punct	_	_

1	After	after	IN	IN	sem=TMP	16	prep	_	_
2	several	several	JJ	JJ	_	4	amod	_	_
3	additional	additional	JJ	JJ	_	4	amod	_	_
4	rinses	rinse	NNS	NNS	_	1	pobj	_	_
5	in	in	IN	IN	sem=LOC	4	prep	_	_
6	PBS	pbs	NN	NN	_	5	pobj	_	_
7	with	with	IN	IN	_	4	prep	_	_
8	0.1	0	CD	CD	_	10	nummod	_	_
9	%	%	NN	NN	_	8	quantmod	_	_
10	Tween	tween	NN	NN	_	7	pobj	_	_
11	-	-	HYPH	HYPH	_	10	punct	_	_
12	20	0	CD	CD	_	10	nummod	_	_
13	,	,	,	,	_	16	punct	_	_
14	blots	blot	NNS	NNS	_	16	nsubjpass	_	_
15	were	be	VBD	VBD	_	16	auxpass	_	_
16	developed	develop	VBN	VBN	_	0	root	_	_
17	with	with	IN	IN	sem=MNR	16	prep	_	_
18	enhanced	enhance	VBN	VBN	_	20	amod	_	_
19	chemiluminescence	chemiluminescence	NN	NN	_	20	compound	_	_
20	reagent	reagent	NN	NN	_	17	pobj	_	_
21	and	and	CC	CC	_	16	cc	_	_
22	imaged	image	VBN	VBN	_	16	conj	_	_
23	with	with	IN	IN	sem=MNR	22	prep	_	_
24	the	the	DT	DT	_	31	det	_	_
25	Bio	bio	NNP	NNP	_	27	compound	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	Rad	rad	NNP	NNP	_	30	compound	_	_
28	Molecular	molecular	NNP	NNP	_	30	compound	_	_
29	Imager	imager	NNP	NNP	_	30	compound	_	_
30	FX	fx	NNP	NNP	_	31	compound	_	_
31	system	system	NN	NN	_	23	pobj	_	_
32	.	.	.	.	_	16	punct	_	_

1	Staining	staining	NN	NN	_	2	compound	_	_
2	intensity	intensity	NN	NN	_	7	nsubjpass	_	_
3	within	within	IN	IN	_	2	prep	_	_
4	each	each	DT	DT	_	5	det	_	_
5	lane	lane	NN	NN	_	3	pobj	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	quantified	quantify	VBN	VBN	_	0	root	_	_
8	using	use	VBG	VBG	sem=MNR	7	advcl	_	_
9	the	the	DT	DT	_	14	det	_	_
10	Quantity	quantity	NNP	NNP	_	14	nmod	_	_
11	One	#crd#	CD	CD	_	10	nummod	_	_
12	image	image	NN	NN	_	13	compound	_	_
13	analysis	analysis	NN	NN	_	14	compound	_	_
14	software	software	NN	NN	_	8	dobj	_	_
15	(	(	-LRB-	-LRB-	_	18	punct	_	_
16	Molecular	molecular	NNP	NNP	_	17	compound	_	_
17	Imager	imager	NNP	NNP	_	18	compound	_	_
18	FX	fx	NNP	NNP	_	14	parataxis	_	_
19	,	,	,	,	_	18	punct	_	_
20	Bio	bio	NNP	NNP	_	22	compound	_	_
21	-	-	HYPH	HYPH	_	22	punct	_	_
22	Rad	rad	NNP	NNP	_	23	compound	_	_
23	Laboratories	laboratories	NNP	NNP	syn=ADV	18	npadvmod	_	_
24	)	)	-RRB-	-RRB-	_	18	punct	_	_
25	.	.	.	.	_	7	punct	_	_

1	Background	background	NN	NN	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	calculated	calculate	VBN	VBN	_	0	root	_	_
4	from	from	IN	IN	_	3	prep	_	_
5	across	across	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	7	det	_	_
7	image	image	NN	NN	_	5	pobj	_	_
8	and	and	CC	CC	_	3	cc	_	_
9	subtracted	subtract	VBN	VBN	_	3	conj	_	_
10	from	from	IN	IN	_	9	prep	_	_
11	the	the	DT	DT	_	13	det	_	_
12	entire	entire	JJ	JJ	_	13	amod	_	_
13	file	file	NN	NN	_	10	pobj	_	_
14	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	signal	signal	NN	NN	_	3	compound	_	_
3	intensity	intensity	NN	NN	_	17	nsubjpass	_	_
4	for	for	IN	IN	_	3	prep	_	_
5	each	each	DT	DT	_	6	det	_	_
6	band	band	NN	NN	_	4	pobj	_	_
7	(	(	-LRB-	-LRB-	_	10	punct	_	_
8	corrected	correct	VBN	VBN	_	10	amod	_	_
9	signal	signal	NN	NN	_	10	compound	_	_
10	intensity	intensity	NN	NN	_	3	parataxis	_	_
11	×	×	SYM	SYM	_	10	punct	_	_
12	pixel	pixel	NN	NN	_	13	compound	_	_
13	number	number	NN	NN	_	10	appos	_	_
14	)	)	-RRB-	-RRB-	_	10	punct	_	_
15	was	be	VBD	VBD	_	17	auxpass	_	_
16	then	then	RB	RB	sem=TMP	17	advmod	_	_
17	calculated	calculate	VBN	VBN	_	0	root	_	_
18	using	use	VBG	VBG	sem=MNR	17	advcl	_	_
19	the	the	DT	DT	_	22	det	_	_
20	Volume	volume	NN	NN	_	21	compound	_	_
21	report	report	NN	NN	_	22	compound	_	_
22	tool	tool	NN	NN	_	18	dobj	_	_
23	.	.	.	.	_	17	punct	_	_

1	Slot	slot	NN	NN	_	2	compound	_	_
2	Blot	blot	NN	NN	_	4	compound	_	_
3	mRNA	mrna	NN	NN	_	4	compound	_	_
4	Analysis	analysis	NN	NN	_	0	root	_	_

1	Five	#crd#	CD	CD	_	2	nummod	_	_
2	micrograms	microgram	NNS	NNS	_	31	nsubjpass	_	_
3	per	per	IN	IN	_	2	prep	_	_
4	sample	sample	NN	NN	_	3	pobj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	total	total	JJ	JJ	_	7	amod	_	_
7	RNA	rna	NN	NN	_	5	pobj	_	_
8	extracted	extract	VBN	VBN	_	7	acl	_	_
9	from	from	IN	IN	_	8	prep	_	_
10	fresh	fresh	JJ	JJ	_	12	amod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	frozen	freeze	VBN	VBN	_	13	amod	_	_
13	brain	brain	NN	NN	_	9	pobj	_	_
14	,	,	,	,	_	13	punct	_	_
15	liver	liver	NN	NN	_	13	conj	_	_
16	,	,	,	,	_	15	punct	_	_
17	kidney	kidney	NN	NN	_	15	conj	_	_
18	,	,	,	,	_	17	punct	_	_
19	heart	heart	NN	NN	_	17	conj	_	_
20	,	,	,	,	_	19	punct	_	_
21	lung	lung	NN	NN	_	19	conj	_	_
22	,	,	,	,	_	21	punct	_	_
23	spleen	spleen	NN	NN	_	21	conj	_	_
24	,	,	,	,	_	23	punct	_	_
25	and	and	CC	CC	_	23	cc	_	_
26	skeletal	skeletal	JJ	JJ	_	27	amod	_	_
27	muscle	muscle	NN	NN	_	23	conj	_	_
28	was	be	VBD	VBD	_	31	auxpass	_	_
29	vacuum	vacuum	NN	NN	_	31	dep	_	_
30	-	-	HYPH	HYPH	_	31	punct	_	_
31	filtered	filter	VBN	VBN	_	0	root	_	_
32	through	through	IN	IN	sem=MNR	31	prep	_	_
33	0.45	0	CD	CD	_	35	nummod	_	_
34	-	-	HYPH	HYPH	_	35	punct	_	_
35	μm	μm	NN	NN	_	37	compound	_	_
36	Optitran	optitran	NNP	NNP	_	37	compound	_	_
37	nitrocellulose	nitrocellulose	NN	NN	_	32	pobj	_	_
38	.	.	.	.	_	31	punct	_	_

1	After	after	IN	IN	sem=TMP	16	prep	_	_
2	several	several	JJ	JJ	_	3	amod	_	_
3	washes	wash	NNS	NNS	_	1	pobj	_	_
4	through	through	IN	IN	_	3	prep	_	_
5	the	the	DT	DT	_	6	det	_	_
6	manifold	manifold	NN	NN	_	4	pobj	_	_
7	with	with	IN	IN	_	3	prep	_	_
8	10	0	CD	CD	_	10	nummod	_	_
9	×	×	SYM	SYM	_	8	punct	_	_
10	SSC	ssc	NN	NN	_	7	pobj	_	_
11	,	,	,	,	_	16	punct	_	_
12	blots	blot	NNS	NNS	_	16	nsubjpass	_	_
13	were	be	VBD	VBD	_	16	auxpass	_	_
14	UV	uv	NN	NN	_	16	dep	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	cross-linked	cross-linked	VBN	VBN	_	0	root	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	probed	probe	VBN	VBN	_	16	conj	_	_
19	with	with	IN	IN	sem=MNR	18	prep	_	_
20	a	a	DT	DT	_	30	det	_	_
21	radiolabeled	radiolabeled	VBN	VBN	_	30	amod	_	_
22	∼	∼	SYM	SYM	_	23	punct	_	_
23	350	0	CD	CD	_	25	nummod	_	_
24	-	-	HYPH	HYPH	_	25	punct	_	_
25	bp	bp	NN	NN	_	30	compound	_	_
26	BglII	bglii	NN	NN	_	28	compound	_	_
27	–	-	HYPH	HYPH	_	28	punct	_	_
28	XhoI	xhoi	NN	NN	_	30	compound	_	_
29	cDNA	cdna	NN	NN	_	30	compound	_	_
30	fragment	fragment	NN	NN	_	19	pobj	_	_
31	of	of	IN	IN	_	30	prep	_	_
32	mo	mo	NN	NN	_	34	compound	_	_
33	/	/	HYPH	HYPH	_	34	punct	_	_
34	huAPP695	huapp0	NN	NN	_	35	compound	_	_
35	cDNA	cdna	NN	NN	_	31	pobj	_	_
36	.	.	.	.	_	16	punct	_	_

1	After	after	IN	IN	sem=TMP	36	prep	_	_
2	hybridizing	hybridize	VBG	VBG	syn=NOM	1	pcomp	_	_
3	overnight	overnight	RB	RB	sem=TMP	2	advmod	_	_
4	at	at	IN	IN	_	2	prep	_	_
5	65	0	CD	CD	_	6	nummod	_	_
6	°C	°c	NN	NN	_	4	pobj	_	_
7	in	in	IN	IN	sem=LOC	2	prep	_	_
8	1	0	CD	CD	_	9	nummod	_	_
9	%	%	NN	NN	_	10	compound	_	_
10	BSA	bsa	NN	NN	_	7	pobj	_	_
11	/	/	HYPH	HYPH	_	10	punct	_	_
12	1	0	CD	CD	_	13	nummod	_	_
13	mM	mm	NN	NN	_	14	compound	_	_
14	EDTA	edta	NN	NN	_	10	appos	_	_
15	/	/	HYPH	HYPH	_	10	punct	_	_
16	0.5	0	CD	CD	_	17	nummod	_	_
17	M	m	NN	NN	_	20	compound	_	_
18	sodium	sodium	NN	NN	_	20	compound	_	_
19	phosphate	phosphate	NN	NN	_	20	compound	_	_
20	buffer	buffer	NN	NN	_	10	appos	_	_
21	(	(	-LRB-	-LRB-	_	22	punct	_	_
22	pH	ph	NN	NN	_	20	parataxis	_	_
23	7.2	0	CD	CD	_	22	nummod	_	_
24	)	)	-RRB-	-RRB-	_	22	punct	_	_
25	/	/	HYPH	HYPH	_	10	punct	_	_
26	7	0	CD	CD	_	27	nummod	_	_
27	%	%	NN	NN	_	28	compound	_	_
28	SDS	sds	NN	NN	_	10	appos	_	_
29	[	[	-LRB-	-LRB-	_	30	punct	_	_
30	20	0	CD	CD	_	28	parataxis	_	_
31	]	]	-RRB-	-RRB-	_	30	punct	_	_
32	,	,	,	,	_	36	punct	_	_
33	the	the	DT	DT	_	34	det	_	_
34	blots	blot	NNS	NNS	_	36	nsubjpass	_	_
35	were	be	VBD	VBD	_	36	auxpass	_	_
36	washed	wash	VBN	VBN	_	0	root	_	_
37	twice	twice	RB	RB	sem=TMP	36	advmod	_	_
38	at	at	IN	IN	_	36	prep	_	_
39	65	0	CD	CD	_	40	nummod	_	_
40	°C	°c	NN	NN	_	38	pobj	_	_
41	for	for	IN	IN	sem=TMP	36	prep	_	_
42	30	0	CD	CD	_	43	nummod	_	_
43	min	min	NN	NN	_	41	pobj	_	_
44	each	each	DT	DT	_	43	appos	_	_
45	in	in	IN	IN	sem=LOC	36	prep	_	_
46	0.1	0	CD	CD	_	47	nummod	_	_
47	%	%	NN	NN	_	48	compound	_	_
48	BSA	bsa	NN	NN	_	45	pobj	_	_
49	/	/	HYPH	HYPH	_	48	punct	_	_
50	1	0	CD	CD	_	51	nummod	_	_
51	mM	mm	NN	NN	_	52	compound	_	_
52	EDTA	edta	NN	NN	_	48	appos	_	_
53	/	/	HYPH	HYPH	_	48	punct	_	_
54	40	0	CD	CD	_	55	nummod	_	_
55	mM	mm	NN	NN	_	58	compound	_	_
56	sodium	sodium	NN	NN	_	58	compound	_	_
57	phosphate	phosphate	NN	NN	_	58	compound	_	_
58	buffer	buffer	NN	NN	_	48	appos	_	_
59	(	(	-LRB-	-LRB-	_	60	punct	_	_
60	pH	ph	NN	NN	_	58	parataxis	_	_
61	7.2	0	CD	CD	_	60	nummod	_	_
62	)	)	-RRB-	-RRB-	_	60	punct	_	_
63	/	/	HYPH	HYPH	_	48	punct	_	_
64	5	0	CD	CD	_	65	nummod	_	_
65	%	%	NN	NN	_	66	compound	_	_
66	SDS	sds	NN	NN	_	48	appos	_	_
67	before	before	IN	IN	sem=TMP	36	prep	_	_
68	two	#crd#	CD	CD	_	73	nummod	_	_
69	final	final	JJ	JJ	_	73	amod	_	_
70	30	0	CD	CD	_	72	nummod	_	_
71	-	-	HYPH	HYPH	_	72	punct	_	_
72	min	min	NN	NN	_	73	compound	_	_
73	washes	wash	NNS	NNS	_	67	pobj	_	_
74	at	at	IN	IN	_	73	prep	_	_
75	65	0	CD	CD	_	76	nummod	_	_
76	°C	°c	NN	NN	_	74	pobj	_	_
77	with	with	IN	IN	_	73	prep	_	_
78	1	0	CD	CD	_	79	nummod	_	_
79	mM	mm	NN	NN	_	80	compound	_	_
80	EDTA	edta	NN	NN	_	77	pobj	_	_
81	/	/	HYPH	HYPH	_	80	punct	_	_
82	40	0	CD	CD	_	83	nummod	_	_
83	mM	mm	NN	NN	_	86	compound	_	_
84	sodium	sodium	NN	NN	_	86	compound	_	_
85	phosphate	phosphate	NN	NN	_	86	compound	_	_
86	buffer	buffer	NN	NN	_	80	appos	_	_
87	(	(	-LRB-	-LRB-	_	88	punct	_	_
88	pH	ph	NN	NN	_	86	parataxis	_	_
89	7.2	0	CD	CD	_	88	nummod	_	_
90	)	)	-RRB-	-RRB-	_	88	punct	_	_
91	/	/	HYPH	HYPH	_	80	punct	_	_
92	1	0	CD	CD	_	93	nummod	_	_
93	%	%	NN	NN	_	94	compound	_	_
94	SDS	sds	NN	NN	_	80	appos	_	_
95	.	.	.	.	_	36	punct	_	_

1	Blots	blot	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	wrapped	wrap	VBN	VBN	_	0	root	_	_
4	wet	wet	JJ	JJ	syn=PRD	3	advcl	_	_
5	and	and	CC	CC	_	3	cc	_	_
6	exposed	expose	VBN	VBN	_	3	conj	_	_
7	to	to	IN	IN	_	6	prep	_	_
8	phosphorscreens	phosphorscreens	NNS	NNS	_	7	pobj	_	_
9	overnight	overnight	RB	RB	sem=TMP	6	advmod	_	_
10	at	at	IN	IN	_	6	prep	_	_
11	room	room	NN	NN	_	12	compound	_	_
12	temperature	temperature	NN	NN	_	10	pobj	_	_
13	.	.	.	.	_	3	punct	_	_

1	Amyloid	amyloid	NN	NN	_	2	compound	_	_
2	Histology	histology	NN	NN	_	0	root	_	_

1	Mice	mouse	NNS	NNS	_	3	nsubjpass	_	1:gap
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	euthanized	euthanize	VBN	VBN	_	0	root	_	3:gap
4	by	by	IN	IN	sem=MNR	3	prep	_	_
5	ether	ether	NN	NN	_	6	compound	_	_
6	inhalation	inhalation	NN	NN	_	4	pobj	_	_
7	and	and	CC	CC	_	3	cc	_	_
8	brains	brain	NNS	NNS	_	9	nsubj	_	1:gap
9	removed	remove	VBN	VBN	_	3	conj	_	3:gap
10	for	for	IN	IN	sem=PRP	9	prep	_	_
11	immersion	immersion	NN	NN	_	12	compound	_	_
12	fixation	fixation	NN	NN	_	10	pobj	_	_
13	in	in	IN	IN	sem=LOC	12	prep	_	_
14	4	0	CD	CD	_	15	nummod	_	_
15	%	%	NN	NN	_	16	compound	_	_
16	paraformaldehyde	paraformaldehyde	NN	NN	_	13	pobj	_	_
17	/	/	HYPH	HYPH	_	16	punct	_	_
18	1	0	CD	CD	_	20	nummod	_	_
19	×	×	SYM	SYM	_	18	punct	_	_
20	PBS	pbs	NN	NN	_	16	appos	_	_
21	.	.	.	.	_	9	punct	_	_

1	After	after	IN	IN	sem=TMP	12	prep	_	_
2	48	0	CD	CD	_	3	nummod	_	_
3	h	h	NN	NN	_	1	pobj	_	_
4	in	in	IN	IN	_	3	prep	_	_
5	fixative	fixative	JJ	JJ	_	4	pobj	_	_
6	at	at	IN	IN	_	3	prep	_	_
7	4	0	CD	CD	_	8	nummod	_	_
8	°C	°c	NN	NN	_	6	pobj	_	_
9	,	,	,	,	_	12	punct	_	_
10	brains	brain	NNS	NNS	_	12	nsubjpass	_	_
11	were	be	VBD	VBD	_	12	auxpass	_	_
12	transferred	transfer	VBN	VBN	_	0	root	_	_
13	to	to	IN	IN	_	12	prep	_	_
14	PBS	pbs	NN	NN	_	13	pobj	_	_
15	,	,	,	,	_	12	punct	_	_
16	dehydrated	dehydrate	VBN	VBN	_	12	conj	_	_
17	in	in	IN	IN	sem=LOC	16	prep	_	_
18	alcohols	alcohol	NNS	NNS	_	17	pobj	_	_
19	,	,	,	,	_	16	punct	_	_
20	treated	treat	VBN	VBN	_	16	conj	_	_
21	with	with	IN	IN	sem=MNR	20	prep	_	_
22	cedarwood	cedarwood	NN	NN	_	23	compound	_	_
23	oil	oil	NN	NN	_	21	pobj	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	methylsalicylate	methylsalicylate	NN	NN	_	23	conj	_	_
26	,	,	,	,	_	20	punct	_	_
27	and	and	CC	CC	_	20	cc	_	_
28	embedded	embed	VBN	VBN	_	20	conj	_	_
29	in	in	IN	IN	sem=LOC	28	prep	_	_
30	paraffin	paraffin	NN	NN	_	29	pobj	_	_
31	for	for	IN	IN	sem=PRP	28	prep	_	_
32	sectioning	section	VBG	VBG	_	31	pobj	_	_
33	.	.	.	.	_	12	punct	_	_

1	Hirano	hirano	NN	NN	_	3	compound	_	_
2	silver	silver	NN	NN	_	3	compound	_	_
3	stain	stain	NN	NN	_	0	root	_	_

1	Silver	silver	NN	NN	_	3	compound	_	_
2	impregnation	impregnation	NN	NN	_	3	compound	_	_
3	histology	histology	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	performed	performed	VBN	VBN	_	0	root	_	_
6	on	on	IN	IN	_	5	prep	_	_
7	10	0	CD	CD	_	9	nummod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	μm	μm	NN	NN	_	13	nmod	_	_
10	paraffin	paraffin	NN	NN	_	12	npadvmod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	embedded	embed	VBN	VBN	_	13	amod	_	_
13	sections	section	NNS	NNS	_	6	pobj	_	_
14	by	by	IN	IN	sem=MNR	5	prep	_	_
15	Hirano	hirano	NNP	NNP	_	17	poss	_	_
16	's	's	POS	POS	_	15	case	_	_
17	modification	modification	NN	NN	_	14	pobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	the	the	DT	DT	_	21	det	_	_
20	Bielschowsky	bielschowsky	NNP	NNP	_	21	compound	_	_
21	method	method	NN	NN	_	18	pobj	_	_
22	[	[	-LRB-	-LRB-	_	23	punct	_	_
23	21	0	CD	CD	_	5	parataxis	_	_
24	]	]	-RRB-	-RRB-	_	23	punct	_	_
25	.	.	.	.	_	5	punct	_	_

1	Briefly	briefly	RB	RB	sem=TMP	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	sections	section	NNS	NNS	_	5	nsubjpass	_	_
4	were	be	VBD	VBD	_	5	auxpass	_	_
5	deparaffinized	deparaffinized	VBN	VBN	_	0	root	_	_
6	through	through	IN	IN	sem=MNR	5	prep	_	_
7	xylene	xylene	NN	NN	_	6	pobj	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	alcohols	alcohol	NNS	NNS	_	7	conj	_	_
10	into	into	IN	IN	sem=LOC	5	prep	_	_
11	tap	tap	NN	NN	_	12	compound	_	_
12	water	water	NN	NN	_	10	pobj	_	_
13	before	before	IN	IN	sem=TMP	5	prep	_	_
14	being	be	VBG	VBG	_	15	auxpass	_	_
15	placed	place	VBN	VBN	syn=NOM	13	pcomp	_	_
16	into	into	IN	IN	sem=LOC	15	prep	_	_
17	fresh	fresh	JJ	JJ	_	22	amod	_	_
18	20	0	CD	CD	_	19	nummod	_	_
19	%	%	NN	NN	_	22	compound	_	_
20	silver	silver	NN	NN	_	22	compound	_	_
21	nitrate	nitrate	NN	NN	_	22	compound	_	_
22	solution	solution	NN	NN	_	16	pobj	_	_
23	for	for	IN	IN	sem=TMP	15	prep	_	_
24	20	0	CD	CD	_	25	nummod	_	_
25	min	min	NN	NN	_	23	pobj	_	_
26	.	.	.	.	_	5	punct	_	_

1	After	after	IN	IN	sem=TMP	11	prep	_	_
2	being	be	VBG	VBG	_	3	auxpass	_	_
3	washed	wash	VBN	VBN	syn=NOM	1	pcomp	_	_
4	thoroughly	thoroughly	RB	RB	sem=MNR	3	advmod	_	_
5	with	with	IN	IN	_	3	prep	_	_
6	distilled	distilled	JJ	JJ	_	7	amod	_	_
7	water	water	NN	NN	_	5	pobj	_	_
8	,	,	,	,	_	11	punct	_	_
9	slides	slide	NNS	NNS	_	11	nsubjpass	_	_
10	were	be	VBD	VBD	_	11	auxpass	_	_
11	immersed	immerse	VBN	VBN	_	0	root	_	_
12	in	in	IN	IN	sem=LOC	11	prep	_	_
13	20	0	CD	CD	_	14	nummod	_	_
14	%	%	NN	NN	_	17	compound	_	_
15	silver	silver	NN	NN	_	16	compound	_	_
16	nitrate	nitrate	NN	NN	_	17	compound	_	_
17	solution	solution	NN	NN	_	12	pobj	_	_
18	titrated	titrate	VBN	VBN	_	17	acl	_	_
19	with	with	IN	IN	sem=MNR	18	prep	_	_
20	fresh	fresh	JJ	JJ	_	22	amod	_	_
21	ammonium	ammonium	NN	NN	_	22	compound	_	_
22	hydroxide	hydroxide	NN	NN	_	19	pobj	_	_
23	.	.	.	.	_	11	punct	_	_

1	After	after	IN	IN	sem=TMP	7	prep	_	_
2	20	0	CD	CD	_	3	nummod	_	_
3	min	min	NN	NN	_	1	pobj	_	_
4	,	,	,	,	_	7	punct	_	_
5	slides	slide	NNS	NNS	_	7	nsubjpass	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	washed	wash	VBN	VBN	_	0	root	_	_
8	with	with	IN	IN	sem=MNR	7	prep	_	_
9	ammonia	ammonia	NN	NN	_	10	compound	_	_
10	water	water	NN	NN	_	8	pobj	_	_
11	before	before	IN	IN	sem=TMP	7	prep	_	_
12	being	be	VBG	VBG	_	14	auxpass	_	_
13	individually	individually	RB	RB	sem=MNR	14	advmod	_	_
14	developed	develop	VBN	VBN	syn=NOM	11	pcomp	_	_
15	with	with	IN	IN	sem=MNR	14	prep	_	_
16	100	0	CD	CD	_	17	nummod	_	_
17	μl	μl	NN	NN	_	15	pobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	developer	developer	NN	NN	_	18	pobj	_	_
20	(	(	-LRB-	-LRB-	_	22	punct	_	_
21	20	0	CD	CD	_	22	nummod	_	_
22	ml	ml	NN	NN	_	19	parataxis	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	37	0	CD	CD	_	25	nummod	_	_
25	%	%	NN	NN	_	26	compound	_	_
26	formaldehyde	formaldehyde	NN	NN	_	23	pobj	_	_
27	,	,	,	,	_	22	punct	_	_
28	100	0	CD	CD	_	29	nummod	_	_
29	ml	ml	NN	NN	_	22	conj	_	_
30	of	of	IN	IN	_	29	prep	_	_
31	distilled	distilled	JJ	JJ	_	32	amod	_	_
32	water	water	NN	NN	_	30	pobj	_	_
33	,	,	,	,	_	29	punct	_	_
34	50	0	CD	CD	_	35	nummod	_	_
35	μl	μl	NN	NN	_	29	conj	_	_
36	of	of	IN	IN	_	35	prep	_	_
37	concentrated	concentrate	VBN	VBN	_	39	amod	_	_
38	nitric	nitric	JJ	JJ	_	39	amod	_	_
39	acid	acid	NN	NN	_	36	pobj	_	_
40	,	,	,	,	_	35	punct	_	_
41	and	and	CC	CC	_	35	cc	_	_
42	0.5	0	CD	CD	_	43	nummod	_	_
43	g	g	NN	NN	_	35	conj	_	_
44	of	of	IN	IN	_	43	prep	_	_
45	citric	citric	JJ	JJ	_	46	amod	_	_
46	acid	acid	NN	NN	_	44	pobj	_	_
47	)	)	-RRB-	-RRB-	_	22	punct	_	_
48	added	add	VBN	VBN	_	17	acl	_	_
49	to	to	IN	IN	_	48	prep	_	_
50	50	0	CD	CD	_	51	nummod	_	_
51	ml	ml	NN	NN	_	49	pobj	_	_
52	of	of	IN	IN	_	51	prep	_	_
53	titrated	titrate	VBN	VBN	_	56	amod	_	_
54	silver	silver	NN	NN	_	55	compound	_	_
55	nitrate	nitrate	NN	NN	_	56	compound	_	_
56	solution	solution	NN	NN	_	52	pobj	_	_
57	.	.	.	.	_	7	punct	_	_

1	Slides	slide	NNS	NNS	_	4	nsubjpass	_	_
2	were	be	VBD	VBD	_	4	auxpass	_	_
3	then	then	RB	RB	sem=TMP	4	advmod	_	_
4	rinsed	rinse	VBN	VBN	_	0	root	_	_
5	in	in	IN	IN	sem=LOC	4	prep	_	_
6	tap	tap	NN	NN	_	7	compound	_	_
7	water	water	NN	NN	_	5	pobj	_	_
8	,	,	,	,	_	4	punct	_	_
9	fixed	fix	VBN	VBN	_	4	conj	_	_
10	in	in	IN	IN	sem=LOC	9	prep	_	_
11	5	0	CD	CD	_	12	nummod	_	_
12	%	%	NN	NN	_	14	compound	_	_
13	sodium	sodium	NN	NN	_	14	compound	_	_
14	thiosulfate	thiosulfate	NN	NN	_	10	pobj	_	_
15	,	,	,	,	_	9	punct	_	_
16	and	and	CC	CC	_	9	cc	_	_
17	dehydrated	dehydrate	VBN	VBN	_	9	conj	_	_
18	through	through	IN	IN	sem=MNR	17	prep	_	_
19	alcohols	alcohol	NNS	NNS	_	18	pobj	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	xylene	xylene	NN	NN	_	19	conj	_	_
22	.	.	.	.	_	4	punct	_	_

1	Thioflavin	thioflavin	NN	NN	_	3	compound	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	S	s	NN	NN	_	4	compound	_	_
4	staining	staining	NN	NN	_	0	root	_	_

1	Following	follow	VBG	VBG	sem=TMP	17	prep	_	_
2	deparaffinization	deparaffinization	NN	NN	_	1	pobj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	sections	section	NNS	NNS	_	3	pobj	_	_
5	through	through	IN	IN	_	2	prep	_	_
6	xylene	xylene	NN	NN	_	5	pobj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	alcohols	alcohol	NNS	NNS	_	6	conj	_	_
9	,	,	,	,	_	17	punct	_	_
10	amyloid	amyloid	NN	NN	_	11	compound	_	_
11	impregnation	impregnation	NN	NN	_	17	nsubjpass	_	_
12	with	with	IN	IN	_	11	prep	_	_
13	thioflavin	thioflavin	NN	NN	_	15	compound	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	S	s	NN	NN	_	12	pobj	_	_
16	was	be	VBD	VBD	_	17	auxpass	_	_
17	performed	performed	VBN	VBN	_	0	root	_	_
18	according	accord	VBG	VBG	_	17	prep	_	_
19	to	to	IN	IN	_	18	prep	_	_
20	the	the	DT	DT	_	22	det	_	_
21	Guntern	guntern	NN	NN	_	22	compound	_	_
22	modification	modification	NN	NN	_	19	pobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	the	the	DT	DT	_	26	det	_	_
25	standard	standard	JJ	JJ	_	26	amod	_	_
26	protocol	protocol	NN	NN	_	23	pobj	_	_
27	.	.	.	.	_	17	punct	_	_

1	Slides	slide	NNS	NNS	_	9	nsubjpass	_	_
2	holding	hold	VBG	VBG	_	1	acl	_	_
3	10	0	CD	CD	_	5	nummod	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	μm	μm	NN	NN	_	7	compound	_	_
6	paraffin	paraffin	NN	NN	_	7	compound	_	_
7	sections	section	NNS	NNS	_	2	dobj	_	_
8	were	be	VBD	VBD	_	9	auxpass	_	_
9	washed	wash	VBN	VBN	_	0	root	_	_
10	twice	twice	RB	RB	sem=TMP	9	advmod	_	_
11	in	in	IN	IN	sem=LOC	9	prep	_	_
12	distilled	distilled	JJ	JJ	_	13	amod	_	_
13	water	water	NN	NN	_	11	pobj	_	_
14	,	,	,	,	_	9	punct	_	_
15	then	then	RB	RB	sem=TMP	16	advmod	_	_
16	immersed	immerse	VBN	VBN	_	9	dep	_	_
17	for	for	IN	IN	sem=TMP	16	prep	_	_
18	5	0	CD	CD	_	19	nummod	_	_
19	min	min	NN	NN	_	17	pobj	_	_
20	in	in	IN	IN	sem=LOC	16	prep	_	_
21	a	a	DT	DT	_	26	det	_	_
22	0.25	0	CD	CD	_	23	nummod	_	_
23	%	%	NN	NN	_	26	compound	_	_
24	potassium	potassium	NN	NN	_	26	compound	_	_
25	permanganate	permanganate	NN	NN	_	26	compound	_	_
26	solution	solution	NN	NN	_	20	pobj	_	_
27	,	,	,	,	_	16	punct	_	_
28	followed	followed	VBN	VBN	syn=ADV	16	advcl	_	_
29	by	by	IN	IN	_	28	agent	_	_
30	5	0	CD	CD	_	31	nummod	_	_
31	min	min	NN	NN	_	29	pobj	_	_
32	in	in	IN	IN	sem=LOC	31	prep	_	_
33	a	a	DT	DT	_	43	det	_	_
34	1	0	CD	CD	_	35	nummod	_	_
35	%	%	NN	NN	_	37	nmod	_	_
36	potassium	potassium	NN	NN	_	37	nmod	_	_
37	metabisulfate	metabisulfate	NN	NN	_	43	nmod	_	_
38	/	/	HYPH	HYPH	_	37	punct	_	_
39	1	0	CD	CD	_	40	nummod	_	_
40	%	%	NN	NN	_	42	nmod	_	_
41	oxalic	oxalic	JJ	JJ	_	42	amod	_	_
42	acid	acid	NN	NN	_	37	appos	_	_
43	solution	solution	NN	NN	_	32	pobj	_	_
44	.	.	.	.	_	9	punct	_	_

1	After	after	IN	IN	sem=TMP	7	prep	_	_
2	this	this	DT	DT	_	3	det	_	_
3	preparation	preparation	NN	NN	_	1	pobj	_	_
4	,	,	,	,	_	7	punct	_	_
5	slides	slide	NNS	NNS	_	7	nsubjpass	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	placed	place	VBN	VBN	_	0	root	_	_
8	into	into	IN	IN	sem=LOC	7	prep	_	_
9	a	a	DT	DT	_	17	det	_	_
10	filtered	filter	VBN	VBN	_	17	amod	_	_
11	aqueous	aqueous	JJ	JJ	_	17	amod	_	_
12	0.02	0	CD	CD	_	13	nummod	_	_
13	%	%	NN	NN	_	17	compound	_	_
14	thioflavin	thioflavin	NN	NN	_	16	compound	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	S	s	NN	NN	_	17	compound	_	_
17	solution	solution	NN	NN	_	8	pobj	_	_
18	(	(	-LRB-	-LRB-	_	22	punct	_	_
19	Chroma	chroma	NNP	NNP	_	21	compound	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	Gesellschaft	gesellschaft	NNP	NNP	_	22	compound	_	_
22	Schmid	schmid	NNP	NNP	_	17	parataxis	_	_
23	,	,	,	,	_	22	punct	_	_
24	Kongen	kongen	NNP	NNP	sem=LOC	22	npadvmod	_	_
25	,	,	,	,	_	22	punct	_	_
26	Germany	germany	NNP	NNP	sem=LOC	22	npadvmod	_	_
27	)	)	-RRB-	-RRB-	_	22	punct	_	_
28	for	for	IN	IN	sem=TMP	7	prep	_	_
29	8	0	CD	CD	_	30	nummod	_	_
30	min	min	NN	NN	_	28	pobj	_	_
31	.	.	.	.	_	7	punct	_	_

1	Excess	excess	JJ	JJ	_	2	amod	_	_
2	stain	stain	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	removed	remove	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	_	4	agent	_	_
6	two	#crd#	CD	CD	_	8	nummod	_	_
7	brief	brief	JJ	JJ	_	8	amod	_	_
8	rinses	rinse	NNS	NNS	_	5	pobj	_	_
9	in	in	IN	IN	_	8	prep	_	_
10	80	0	CD	CD	_	11	nummod	_	_
11	%	%	NN	NN	_	12	compound	_	_
12	ethanol	ethanol	NN	NN	_	9	pobj	_	_
13	,	,	,	,	_	8	punct	_	_
14	then	then	RB	RB	sem=TMP	15	advmod	_	_
15	two	#crd#	CD	CD	_	8	appos	_	_
16	in	in	IN	IN	sem=LOC	15	prep	_	_
17	distilled	distilled	JJ	JJ	_	18	amod	_	_
18	water	water	NN	NN	_	16	pobj	_	_
19	,	,	,	,	_	8	punct	_	_
20	after	after	IN	IN	_	24	prep	_	_
21	which	which	WDT	WDT	_	20	pobj	_	8:ref
22	slides	slide	NNS	NNS	_	24	nsubjpass	_	_
23	were	be	VBD	VBD	_	24	auxpass	_	_
24	finished	finish	VBN	VBN	_	8	relcl	_	_
25	in	in	IN	IN	sem=LOC	24	prep	_	_
26	aqueous	aqueous	JJ	JJ	_	28	amod	_	_
27	mounting	mounting	NN	NN	_	28	compound	_	_
28	medium	medium	NN	NN	_	25	pobj	_	_
29	for	for	IN	IN	sem=PRP	24	prep	_	_
30	florescence	florescence	NN	NN	_	31	compound	_	_
31	photomicrography	photomicrography	NN	NN	_	29	pobj	_	_
32	.	.	.	.	_	4	punct	_	_

1	Ubiquitin	ubiquitin	NN	NN	_	0	root	_	_
2	,	,	,	,	_	1	punct	_	_
3	glial	glial	JJ	JJ	_	6	amod	_	_
4	fibrillary	fibrillary	JJ	JJ	_	6	amod	_	_
5	acidic	acidic	JJ	JJ	_	6	amod	_	_
6	protein	protein	NN	NN	_	1	conj	_	_
7	,	,	,	,	_	6	punct	_	_
8	and	and	CC	CC	_	6	cc	_	_
9	Aβ	aβ	NN	NN	_	10	compound	_	_
10	immunohistochemistry	immunohistochemistry	NN	NN	_	6	conj	_	_

1	Prior	prior	JJ	JJ	_	2	amod	_	_
2	to	to	IN	IN	sem=TMP	7	prep	_	_
3	immunostaining	immunostaining	NN	NN	_	2	pobj	_	_
4	,	,	,	,	_	7	punct	_	_
5	slides	slide	NNS	NNS	_	7	nsubjpass	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	deparaffinized	deparaffinized	VBN	VBN	_	0	root	_	_
8	by	by	IN	IN	sem=MNR	7	prep	_	_
9	oven	oven	NN	NN	_	10	compound	_	_
10	heating	heating	NN	NN	_	8	pobj	_	_
11	followed	followed	VBN	VBN	sem=TMP	7	advcl	_	_
12	by	by	IN	IN	_	11	agent	_	_
13	immersion	immersion	NN	NN	_	12	pobj	_	_
14	in	in	IN	IN	sem=LOC	13	prep	_	_
15	xylene	xylene	NN	NN	_	14	pobj	_	_
16	.	.	.	.	_	7	punct	_	_

1	After	after	IN	IN	sem=TMP	14	prep	_	_
2	rehydration	rehydration	NN	NN	_	1	pobj	_	_
3	through	through	IN	IN	_	2	prep	_	_
4	graded	grade	VBN	VBN	_	5	amod	_	_
5	alcohols	alcohol	NNS	NNS	_	3	pobj	_	_
6	into	into	IN	IN	sem=LOC	2	prep	_	_
7	tap	tap	NN	NN	_	8	compound	_	_
8	water	water	NN	NN	_	6	pobj	_	_
9	,	,	,	,	_	14	punct	_	_
10	endogenous	endogenous	JJ	JJ	_	12	amod	_	_
11	peroxidase	peroxidase	NN	NN	_	12	compound	_	_
12	activity	activity	NN	NN	_	14	nsubjpass	_	_
13	was	be	VBD	VBD	_	14	auxpass	_	_
14	quenched	quench	VBN	VBN	_	0	root	_	_
15	by	by	IN	IN	_	14	agent	_	_
16	incubation	incubation	NN	NN	_	15	pobj	_	_
17	with	with	IN	IN	_	16	prep	_	_
18	3	0	CD	CD	_	19	nummod	_	_
19	%	%	NN	NN	_	21	compound	_	_
20	hydrogen	hydrogen	NN	NN	_	21	compound	_	_
21	peroxide	peroxide	NN	NN	_	17	pobj	_	_
22	in	in	IN	IN	sem=LOC	16	prep	_	_
23	methanol	methanol	NN	NN	_	22	pobj	_	_
24	.	.	.	.	_	14	punct	_	_

1	Slides	slide	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	microwaved	microwave	VBN	VBN	_	0	root	_	_
4	for	for	IN	IN	sem=TMP	3	prep	_	_
5	5	0	CD	CD	_	7	quantmod	_	_
6	–	-	SYM	SYM	_	7	punct	_	_
7	7	0	CD	CD	_	8	nummod	_	_
8	min	min	NN	NN	_	4	pobj	_	_
9	in	in	IN	IN	sem=LOC	3	prep	_	_
10	water	water	NN	NN	_	9	pobj	_	_
11	,	,	,	,	_	3	punct	_	_
12	cooled	cool	VBN	VBN	_	3	dep	_	_
13	for	for	IN	IN	sem=TMP	12	prep	_	_
14	5	0	CD	CD	_	15	nummod	_	_
15	min	min	NN	NN	_	13	pobj	_	_
16	,	,	,	,	_	3	punct	_	_
17	then	then	RB	RB	sem=TMP	18	advmod	_	_
18	washed	wash	VBN	VBN	_	3	dep	_	_
19	in	in	IN	IN	sem=LOC	18	prep	_	_
20	TBS	tbs	NN	NN	_	19	pobj	_	_
21	.	.	.	.	_	3	punct	_	_

1	Nonspecific	nonspecific	JJ	JJ	_	2	amod	_	_
2	staining	staining	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	blocked	block	VBN	VBN	_	0	root	_	_
5	for	for	IN	IN	sem=TMP	4	prep	_	_
6	1	0	CD	CD	_	7	nummod	_	_
7	h	h	NN	NN	_	5	pobj	_	_
8	with	with	IN	IN	sem=MNR	4	prep	_	_
9	3	0	CD	CD	_	10	nummod	_	_
10	%	%	NN	NN	_	13	nmod	_	_
11	normal	normal	JJ	JJ	_	13	amod	_	_
12	goat	goat	NN	NN	_	13	compound	_	_
13	serum	serum	NN	NN	_	8	pobj	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	0.1	0	CD	CD	_	16	nummod	_	_
16	%	%	NN	NN	_	19	compound	_	_
17	Triton	triton	NN	NN	_	19	compound	_	_
18	-	-	HYPH	HYPH	_	19	punct	_	_
19	X	x	NN	NN	_	13	conj	_	_
20	100	0	CD	CD	_	19	nummod	_	_
21	in	in	IN	IN	sem=LOC	13	prep	_	_
22	TBS	tbs	NN	NN	_	21	pobj	_	_
23	.	.	.	.	_	4	punct	_	_

1	Slides	slide	NNS	NNS	_	4	nsubjpass	_	_
2	were	be	VBD	VBD	_	4	auxpass	_	_
3	then	then	RB	RB	sem=TMP	4	advmod	_	_
4	placed	place	VBN	VBN	_	0	root	_	_
5	into	into	IN	IN	sem=LOC	4	prep	_	_
6	primary	primary	JJ	JJ	_	7	amod	_	_
7	antibody	antibody	NN	NN	_	5	pobj	_	_
8	(	(	-LRB-	-LRB-	_	39	punct	_	_
9	rabbit	rabbit	NN	NN	_	13	nmod	_	_
10	anti-Aβ	anti-aβ	JJ	JJ	_	13	amod	_	_
11	peptide	peptide	NN	NN	_	13	nmod	_	_
12	polyclonal	polyclonal	JJ	JJ	_	13	amod	_	_
13	antibody	antibody	NN	NN	_	39	dep	_	_
14	,	,	,	,	_	13	punct	_	_
15	Zymed	zymed	NNP	NNP	_	16	compound	_	_
16	Laboratories	laboratories	NNP	NNP	syn=ADV	13	npadvmod	_	_
17	,	,	,	,	_	13	punct	_	_
18	South	south	NNP	NNP	_	20	compound	_	_
19	San	san	NNP	NNP	_	20	compound	_	_
20	Francisco	francisco	NNP	NNP	sem=LOC	13	npadvmod	_	_
21	,	,	,	,	_	13	punct	_	_
22	California	california	NNP	NNP	sem=LOC	13	npadvmod	_	_
23	,	,	,	,	_	13	punct	_	_
24	United	united	NNP	NNP	_	25	compound	_	_
25	States	state	NNP	NNP	sem=LOC	13	npadvmod	_	_
26	;	;	:	:	_	39	punct	_	_
27	rabbit	rabbit	NN	NN	_	39	nmod	_	_
28	anti-ubiquitin	anti-ubiquitin	JJ	JJ	_	27	amod	_	_
29	and	and	CC	CC	_	27	cc	_	_
30	rabbit	rabbit	NN	NN	_	27	conj	_	_
31	anti–glial	anti–glial	JJ	JJ	_	30	amod	_	_
32	fibrillary	fibrillary	JJ	JJ	_	34	amod	_	_
33	acidic	acidic	JJ	JJ	_	34	amod	_	_
34	protein	protein	NN	NN	_	39	nmod	_	_
35	(	(	-LRB-	-LRB-	_	34	punct	_	_
36	GFAP	gfap	NN	NN	_	34	appos	_	_
37	)	)	-RRB-	-RRB-	_	39	punct	_	_
38	polyclonal	polyclonal	JJ	JJ	_	39	amod	_	_
39	antibodies	antibody	NNS	NNS	_	7	parataxis	_	_
40	,	,	,	,	_	39	punct	_	_
41	Dako	dako	NNP	NNP	sem=LOC	39	npadvmod	_	_
42	,	,	,	,	_	39	punct	_	_
43	Carpinteria	carpinteria	NNP	NNP	sem=LOC	39	npadvmod	_	_
44	,	,	,	,	_	39	punct	_	_
45	California	california	NNP	NNP	sem=LOC	39	npadvmod	_	_
46	,	,	,	,	_	39	punct	_	_
47	United	united	NNP	NNP	_	48	compound	_	_
48	States	state	NNP	NNP	sem=LOC	39	npadvmod	_	_
49	)	)	-RRB-	-RRB-	_	39	punct	_	_
50	diluted	dilute	VBN	VBN	_	7	acl	_	_
51	1	0	CD	CD	syn=ADV	50	npadvmod	_	_
52	:	:	SYM	SYM	_	53	punct	_	_
53	500	0	CD	CD	_	51	prep	_	_
54	in	in	IN	IN	sem=LOC	50	prep	_	_
55	TBS	tbs	NN	NN	_	54	pobj	_	_
56	with	with	IN	IN	sem=MNR	50	prep	_	_
57	2	0	CD	CD	_	58	nummod	_	_
58	%	%	NN	NN	_	61	nmod	_	_
59	normal	normal	JJ	JJ	_	61	amod	_	_
60	goat	goat	NN	NN	_	61	compound	_	_
61	serum	serum	NN	NN	_	56	pobj	_	_
62	and	and	CC	CC	_	4	cc	_	_
63	incubated	incubate	VBN	VBN	_	4	conj	_	_
64	overnight	overnight	RB	RB	sem=TMP	63	advmod	_	_
65	at	at	IN	IN	_	63	prep	_	_
66	room	room	NN	NN	_	67	compound	_	_
67	temperature	temperature	NN	NN	_	65	pobj	_	_
68	.	.	.	.	_	4	punct	_	_

1	After	after	IN	IN	sem=TMP	16	prep	_	_
2	being	be	VBG	VBG	_	3	auxpass	_	_
3	washed	wash	VBN	VBN	syn=NOM	1	pcomp	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	excess	excess	JJ	JJ	_	7	amod	_	_
6	primary	primary	JJ	JJ	_	7	amod	_	_
7	antibody	antibody	NN	NN	_	4	pobj	_	_
8	with	with	IN	IN	sem=MNR	3	prep	_	_
9	several	several	JJ	JJ	_	10	amod	_	_
10	changes	change	NNS	NNS	_	8	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	TBS	tbs	NN	NN	_	11	pobj	_	_
13	,	,	,	,	_	16	punct	_	_
14	slides	slide	NNS	NNS	_	16	nsubjpass	_	_
15	were	be	VBD	VBD	_	16	auxpass	_	_
16	incubated	incubate	VBN	VBN	_	0	root	_	_
17	with	with	IN	IN	sem=MNR	16	prep	_	_
18	either	either	CC	CC	_	24	preconj	_	_
19	the	the	DT	DT	_	24	det	_	_
20	Vectastain	vectastain	NNP	NNP	_	21	nmod	_	_
21	Elite	elite	NNP	NNP	_	24	nmod	_	_
22	anti-rabbit	anti-rabbit	JJ	JJ	_	24	amod	_	_
23	secondary	secondary	JJ	JJ	_	24	amod	_	_
24	system	system	NN	NN	_	17	pobj	_	_
25	(	(	-LRB-	-LRB-	_	29	punct	_	_
26	anti-Aβ	anti-aβ	JJ	JJ	_	29	amod	_	_
27	;	;	:	:	_	29	punct	_	_
28	Vector	vector	NNP	NNP	_	29	compound	_	_
29	Laboratories	laboratories	NNP	NNP	_	24	parataxis	_	_
30	,	,	,	,	_	29	punct	_	_
31	Burlingame	burlingame	NNP	NNP	sem=LOC	29	npadvmod	_	_
32	,	,	,	,	_	29	punct	_	_
33	California	california	NNP	NNP	sem=LOC	29	npadvmod	_	_
34	,	,	,	,	_	29	punct	_	_
35	United	united	NNP	NNP	_	36	compound	_	_
36	States	state	NNP	NNP	sem=LOC	29	npadvmod	_	_
37	)	)	-RRB-	-RRB-	_	29	punct	_	_
38	or	or	CC	CC	_	24	cc	_	_
39	peroxidase	peroxidase	NN	NN	_	42	nmod	_	_
40	/	/	HYPH	HYPH	_	39	punct	_	_
41	anti-peroxidase	anti-peroxidase	JJ	JJ	_	39	amod	_	_
42	reagents	reagent	NNS	NNS	_	24	conj	_	_
43	(	(	-LRB-	-LRB-	_	49	punct	_	_
44	anti-ubitquitin	anti-ubitquitin	JJ	JJ	_	49	amod	_	_
45	and	and	CC	CC	_	44	cc	_	_
46	anti-GFAP	anti-gfap	JJ	JJ	_	44	conj	_	_
47	;	;	:	:	_	49	punct	_	_
48	Sternberger	sternberger	NNP	NNP	_	49	compound	_	_
49	Monoclonals	monoclonal	NNPS	NNPS	_	42	parataxis	_	_
50	,	,	,	,	_	49	punct	_	_
51	Lutherville	lutherville	NNP	NNP	sem=LOC	49	npadvmod	_	_
52	,	,	,	,	_	49	punct	_	_
53	Maryland	maryland	NNP	NNP	sem=LOC	49	npadvmod	_	_
54	,	,	,	,	_	49	punct	_	_
55	United	united	NNP	NNP	_	56	compound	_	_
56	States	state	NNP	NNP	sem=LOC	49	npadvmod	_	_
57	)	)	-RRB-	-RRB-	_	49	punct	_	_
58	according	accord	VBG	VBG	sem=MNR	16	prep	_	_
59	to	to	IN	IN	_	58	prep	_	_
60	the	the	DT	DT	_	61	det	_	_
61	manufacturers	manufacturer	NNS	NNS	_	63	poss	_	_
62	'	'	POS	POS	_	61	case	_	_
63	directions	direction	NNS	NNS	_	59	pobj	_	_
64	.	.	.	.	_	16	punct	_	_

1	Antibody	antibody	NN	NN	_	2	compound	_	_
2	binding	binding	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	visualized	visualize	VBN	VBN	_	0	root	_	_
5	with	with	IN	IN	sem=MNR	4	prep	_	_
6	diaminobenzidene	diaminobenzidene	NN	NN	_	5	pobj	_	_
7	,	,	,	,	_	4	punct	_	_
8	and	and	CC	CC	_	4	cc	_	_
9	sections	section	NNS	NNS	_	11	nsubjpass	_	_
10	were	be	VBD	VBD	_	11	auxpass	_	_
11	counterstained	counterstained	VBN	VBN	_	4	conj	_	_
12	with	with	IN	IN	sem=MNR	11	prep	_	_
13	hematoxylin	hematoxylin	NN	NN	_	12	pobj	_	_
14	.	.	.	.	_	11	punct	_	_

1	Filter	filter	NN	NN	_	3	compound	_	_
2	Trap	trap	NN	NN	_	3	compound	_	_
3	Assay	assay	NN	NN	_	0	root	_	_

1	An	an	DT	DT	_	2	det	_	_
2	aliquot	aliquot	NN	NN	_	14	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	each	each	DT	DT	_	6	det	_	_
5	cortical	cortical	JJ	JJ	_	6	amod	_	_
6	homogenate	homogenate	NN	NN	_	3	pobj	_	_
7	used	use	VBN	VBN	_	6	acl	_	_
8	for	for	IN	IN	sem=PRP	7	prep	_	_
9	Western	western	NNP	NNP	_	10	compound	_	_
10	blotting	blotting	NN	NN	_	8	pobj	_	_
11	above	above	RB	RB	_	7	advmod	_	_
12	was	be	VBD	VBD	_	14	auxpass	_	_
13	partially	partially	RB	RB	_	14	advmod	_	_
14	solubilized	solubilized	VBN	VBN	_	0	root	_	_
15	by	by	IN	IN	sem=MNR	14	prep	_	_
16	the	the	DT	DT	_	17	det	_	_
17	addition	addition	NN	NN	_	15	pobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	SDS	sds	NN	NN	_	18	pobj	_	_
20	to	to	IN	IN	_	14	prep	_	_
21	a	a	DT	DT	_	23	det	_	_
22	final	final	JJ	JJ	_	23	amod	_	_
23	concentration	concentration	NN	NN	_	20	pobj	_	_
24	of	of	IN	IN	_	23	prep	_	_
25	1	0	CD	CD	_	26	nummod	_	_
26	%	%	NN	NN	_	24	pobj	_	_
27	.	.	.	.	_	14	punct	_	_

1	Serial	serial	JJ	JJ	_	5	amod	_	_
2	1	0	CD	CD	_	5	nummod	_	_
3	:	:	SYM	SYM	_	4	punct	_	_
4	2	0	CD	CD	_	2	prep	_	_
5	dilutions	dilution	NNS	NNS	_	7	nsubjpass	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	made	make	VBN	VBN	_	0	root	_	_
8	with	with	IN	IN	sem=MNR	7	prep	_	_
9	1	0	CD	CD	_	11	nummod	_	_
10	×	×	SYM	SYM	_	9	punct	_	_
11	PBS	pbs	NN	NN	_	8	pobj	_	_
12	/	/	HYPH	HYPH	_	11	punct	_	_
13	1	0	CD	CD	_	14	nummod	_	_
14	%	%	NN	NN	_	15	compound	_	_
15	SDS	sds	NN	NN	_	11	appos	_	_
16	,	,	,	,	_	7	punct	_	_
17	and	and	CC	CC	_	7	cc	_	_
18	100	0	CD	CD	_	19	nummod	_	_
19	μl	μl	NN	NN	_	27	nsubjpass	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	each	each	DT	DT	_	22	det	_	_
22	dilution	dilution	NN	NN	_	20	pobj	_	_
23	was	be	VBD	VBD	_	27	auxpass	_	_
24	then	then	RB	RB	sem=TMP	27	advmod	_	_
25	vacuum	vacuum	NN	NN	_	27	dep	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	filtered	filter	VBN	VBN	_	7	conj	_	_
28	through	through	IN	IN	sem=DIR	27	prep	_	_
29	a	a	DT	DT	_	36	det	_	_
30	pre-wet	pre-wet	JJ	JJ	_	36	amod	_	_
31	0.22	0	CD	CD	_	33	nummod	_	_
32	-	-	HYPH	HYPH	_	33	punct	_	_
33	μm	μm	NN	NN	_	36	compound	_	_
34	cellulose	cellulose	NN	NN	_	36	compound	_	_
35	acetate	acetate	NN	NN	_	36	compound	_	_
36	membrane	membrane	NN	NN	_	28	pobj	_	_
37	(	(	-LRB-	-LRB-	_	38	punct	_	_
38	Schleicher	schleicher	NNP	NNP	_	36	parataxis	_	_
39	and	and	CC	CC	_	38	cc	_	_
40	Schuell	schuell	NNP	NNP	_	38	conj	_	_
41	)	)	-RRB-	-RRB-	_	38	punct	_	_
42	[	[	-LRB-	-LRB-	_	43	punct	_	_
43	22	0	CD	CD	_	27	parataxis	_	_
44	]	]	-RRB-	-RRB-	_	43	punct	_	_
45	.	.	.	.	_	27	punct	_	_

1	Each	each	DT	DT	_	2	det	_	_
2	well	well	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	washed	wash	VBN	VBN	_	0	root	_	_
5	several	several	JJ	JJ	_	6	amod	_	_
6	times	time	NNS	NNS	_	4	dobj	_	_
7	with	with	IN	IN	sem=MNR	4	prep	_	_
8	PBS	pbs	NN	NN	_	7	pobj	_	_
9	,	,	,	,	_	4	punct	_	_
10	after	after	IN	IN	_	14	prep	_	_
11	which	which	WDT	WDT	_	10	pobj	_	_
12	blots	blot	NNS	NNS	_	14	nsubjpass	_	_
13	were	be	VBD	VBD	_	14	auxpass	_	_
14	incubated	incubate	VBN	VBN	sem=TMP	4	advcl	_	_
15	overnight	overnight	RB	RB	sem=TMP	14	advmod	_	_
16	with	with	IN	IN	sem=MNR	14	prep	_	_
17	polyclonal	polyclonal	JJ	JJ	_	19	amod	_	_
18	anti-Aβ	anti-aβ	JJ	JJ	_	19	amod	_	_
19	antibody	antibody	NN	NN	_	16	pobj	_	_
20	(	(	-LRB-	-LRB-	_	22	punct	_	_
21	Zymed	zymed	NNP	NNP	_	22	compound	_	_
22	Laboratories	laboratories	NNP	NNP	_	19	parataxis	_	_
23	)	)	-RRB-	-RRB-	_	22	punct	_	_
24	diluted	dilute	VBN	VBN	_	19	acl	_	_
25	1	0	CD	CD	sem=EXT	24	npadvmod	_	_
26	:	:	SYM	SYM	_	27	punct	_	_
27	600	0	CD	CD	_	25	prep	_	_
28	in	in	IN	IN	sem=LOC	24	prep	_	_
29	a	a	DT	DT	_	31	det	_	_
30	blocking	blocking	NN	NN	_	31	compound	_	_
31	solution	solution	NN	NN	_	28	pobj	_	_
32	of	of	IN	IN	_	31	prep	_	_
33	1	0	CD	CD	_	35	nummod	_	_
34	×	×	SYM	SYM	_	33	punct	_	_
35	TBS	tbs	NN	NN	_	42	nmod	_	_
36	/	/	HYPH	HYPH	_	35	punct	_	_
37	5	0	CD	CD	_	38	nummod	_	_
38	%	%	NN	NN	_	41	nmod	_	_
39	nonfat	nonfat	JJ	JJ	_	41	amod	_	_
40	dry	dry	JJ	JJ	_	41	amod	_	_
41	milk	milk	NN	NN	_	35	appos	_	_
42	powder	powder	NN	NN	_	32	pobj	_	_
43	.	.	.	.	_	4	punct	_	_

1	After	after	IN	IN	sem=TMP	25	prep	_	_
2	washing	wash	VBG	VBG	syn=NOM	1	pcomp	_	_
3	the	the	DT	DT	_	4	det	_	_
4	blots	blot	NNS	NNS	_	2	dobj	_	_
5	three	#crd#	CD	CD	_	6	nummod	_	_
6	times	time	NNS	NNS	sem=TMP	2	npadvmod	_	_
7	for	for	IN	IN	_	2	prep	_	_
8	10	0	CD	CD	_	9	nummod	_	_
9	min	min	NN	NN	_	7	pobj	_	_
10	each	each	DT	DT	_	9	appos	_	_
11	in	in	IN	IN	sem=LOC	2	prep	_	_
12	1	0	CD	CD	_	14	nummod	_	_
13	×	×	SYM	SYM	_	12	punct	_	_
14	TBS	tbs	NN	NN	_	11	pobj	_	_
15	/	/	HYPH	HYPH	_	14	punct	_	_
16	0.1	0	CD	CD	_	17	nummod	_	_
17	%	%	NN	NN	_	18	compound	_	_
18	Tween	tween	NN	NN	_	14	appos	_	_
19	-	-	HYPH	HYPH	_	18	punct	_	_
20	20	0	CD	CD	_	18	nummod	_	_
21	,	,	,	,	_	25	punct	_	_
22	the	the	DT	DT	_	23	det	_	_
23	membrane	membrane	NN	NN	_	25	nsubjpass	_	_
24	was	be	VBD	VBD	_	25	auxpass	_	_
25	incubated	incubate	VBN	VBN	_	0	root	_	_
26	for	for	IN	IN	sem=TMP	25	prep	_	_
27	1	0	CD	CD	_	28	nummod	_	_
28	h	h	NN	NN	_	26	pobj	_	_
29	with	with	IN	IN	sem=MNR	25	prep	_	_
30	HRP	hrp	NN	NN	_	32	npadvmod	_	_
31	-	-	HYPH	HYPH	_	32	punct	_	_
32	conjugated	conjugate	VBN	VBN	_	34	amod	_	_
33	protein	protein	NN	NN	_	34	compound	_	_
34	A	a	NN	NN	_	29	pobj	_	_
35	(	(	-LRB-	-LRB-	_	36	punct	_	_
36	Sigma	sigma	NNP	NNP	_	34	parataxis	_	_
37	)	)	-RRB-	-RRB-	_	36	punct	_	_
38	diluted	dilute	VBN	VBN	_	34	acl	_	_
39	1	0	CD	CD	_	38	dobj	_	_
40	:	:	SYM	SYM	_	41	punct	_	_
41	5,000	0	CD	CD	_	39	prep	_	_
42	in	in	IN	IN	sem=LOC	38	prep	_	_
43	blocking	blocking	NN	NN	_	44	compound	_	_
44	solution	solution	NN	NN	_	42	pobj	_	_
45	.	.	.	.	_	25	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	membranes	membrane	NNS	NNS	_	5	nsubjpass	_	_
3	were	be	VBD	VBD	_	5	auxpass	_	_
4	again	again	RB	RB	sem=TMP	5	advmod	_	_
5	washed	wash	VBN	VBN	_	0	root	_	_
6	three	#crd#	CD	CD	_	7	nummod	_	_
7	times	time	NNS	NNS	sem=TMP	5	npadvmod	_	_
8	with	with	IN	IN	sem=MNR	5	prep	_	_
9	1	0	CD	CD	_	11	nummod	_	_
10	×	×	SYM	SYM	_	9	punct	_	_
11	TBS	tbs	NN	NN	_	8	pobj	_	_
12	/	/	HYPH	HYPH	_	11	punct	_	_
13	0.1	0	CD	CD	_	14	nummod	_	_
14	%	%	NN	NN	_	15	compound	_	_
15	Tween	tween	NN	NN	_	11	appos	_	_
16	-	-	HYPH	HYPH	_	15	punct	_	_
17	20	0	CD	CD	_	15	nummod	_	_
18	,	,	,	,	_	5	punct	_	_
19	before	before	IN	IN	_	23	mark	_	_
20	antibody	antibody	NN	NN	_	21	compound	_	_
21	binding	binding	NN	NN	_	23	nsubjpass	_	_
22	was	be	VBD	VBD	_	23	auxpass	_	_
23	detected	detect	VBN	VBN	sem=TMP	5	advcl	_	_
24	with	with	IN	IN	sem=MNR	23	prep	_	_
25	enhanced	enhance	VBN	VBN	_	26	amod	_	_
26	chemiluminescence	chemiluminescence	NN	NN	_	24	pobj	_	_
27	(	(	-LRB-	-LRB-	_	28	punct	_	_
28	PerkinElmer	perkinelmer	NNP	NNP	_	23	parataxis	_	_
29	,	,	,	,	_	28	punct	_	_
30	Boston	boston	NNP	NNP	sem=LOC	28	npadvmod	_	_
31	,	,	,	,	_	28	punct	_	_
32	Massachusetts	massachusetts	NNP	NNP	sem=LOC	28	npadvmod	_	_
33	,	,	,	,	_	28	punct	_	_
34	United	united	NNP	NNP	_	35	compound	_	_
35	States	state	NNP	NNP	sem=LOC	28	npadvmod	_	_
36	)	)	-RRB-	-RRB-	_	28	punct	_	_
37	.	.	.	.	_	5	punct	_	_

1	Digital	digital	JJ	JJ	_	2	amod	_	_
2	images	image	NNS	NNS	_	7	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	each	each	DT	DT	_	5	det	_	_
5	blot	blot	NN	NN	_	3	pobj	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	captured	capture	VBN	VBN	_	0	root	_	_
8	with	with	IN	IN	sem=MNR	7	prep	_	_
9	a	a	DT	DT	_	15	det	_	_
10	Molecular	molecular	JJ	JJ	_	11	amod	_	_
11	Imager	imager	NNP	NNP	_	12	compound	_	_
12	FX	fx	NNP	NNP	_	15	compound	_	_
13	gel	gel	NN	NN	_	14	compound	_	_
14	documentation	documentation	NN	NN	_	15	compound	_	_
15	system	system	NN	NN	_	8	pobj	_	_
16	,	,	,	,	_	7	punct	_	_
17	and	and	CC	CC	_	7	cc	_	_
18	the	the	DT	DT	_	19	det	_	_
19	intensity	intensity	NN	NN	_	24	nsubjpass	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	Aβ	aβ	NN	NN	_	22	compound	_	_
22	staining	staining	NN	NN	_	20	pobj	_	_
23	was	be	VBD	VBD	_	24	auxpass	_	_
24	quantified	quantify	VBN	VBN	_	7	conj	_	_
25	using	use	VBG	VBG	sem=MNR	24	advcl	_	_
26	Quantity	quantity	NNP	NNP	_	30	nmod	_	_
27	One	#crd#	CD	CD	_	26	nummod	_	_
28	image	image	NN	NN	_	29	compound	_	_
29	analysis	analysis	NN	NN	_	30	compound	_	_
30	software	software	NN	NN	_	25	dobj	_	_
31	.	.	.	.	_	24	punct	_	_

1	Aβ	aβ	NN	NN	_	2	compound	_	_
2	ELISA	elisa	NN	NN	_	0	root	_	_

1	An	an	DT	DT	_	2	det	_	_
2	aliquot	aliquot	NN	NN	_	13	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	cortical	cortical	JJ	JJ	_	5	amod	_	_
5	homogenate	homogenate	NN	NN	_	3	pobj	_	_
6	generated	generate	VBN	VBN	_	5	acl	_	_
7	for	for	IN	IN	sem=PRP	6	prep	_	_
8	Western	western	NNP	NNP	_	9	compound	_	_
9	analysis	analysis	NN	NN	_	7	pobj	_	_
10	described	describe	VBN	VBN	_	9	acl	_	_
11	above	above	RB	RB	_	10	advmod	_	_
12	was	be	VBD	VBD	_	13	auxpass	_	_
13	subjected	subject	VBN	VBN	_	0	root	_	_
14	to	to	IN	IN	_	13	prep	_	_
15	a	a	DT	DT	_	20	det	_	_
16	three	#crd#	CD	CD	_	18	nummod	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	step	step	NN	NN	_	20	nmod	_	_
19	sequential	sequential	JJ	JJ	_	20	amod	_	_
20	extraction	extraction	NN	NN	_	14	pobj	_	_
21	using	use	VBG	VBG	sem=MNR	13	advcl	_	_
22	PBS	pbs	NN	NN	_	21	dobj	_	_
23	,	,	,	,	_	22	punct	_	_
24	2	0	CD	CD	_	25	nummod	_	_
25	%	%	NN	NN	_	26	compound	_	_
26	SDS	sds	NN	NN	_	22	conj	_	_
27	,	,	,	,	_	26	punct	_	_
28	and	and	CC	CC	_	26	cc	_	_
29	70	0	CD	CD	_	30	nummod	_	_
30	%	%	NN	NN	_	26	conj	_	_
31	formic	formic	JJ	JJ	_	32	amod	_	_
32	acid	acid	NN	NN	_	30	appos	_	_
33	(	(	-LRB-	-LRB-	_	32	punct	_	_
34	FA	fa	NN	NN	_	32	appos	_	_
35	)	)	-RRB-	-RRB-	_	13	punct	_	_
36	.	.	.	.	_	13	punct	_	_

1	At	at	IN	IN	_	8	prep	_	_
2	each	each	DT	DT	_	3	det	_	_
3	step	step	NN	NN	_	1	pobj	_	_
4	,	,	,	,	_	8	punct	_	_
5	the	the	DT	DT	_	6	det	_	_
6	sample	sample	NN	NN	_	8	nsubjpass	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	sonicated	sonicated	VBN	VBN	_	0	root	_	_
9	in	in	IN	IN	sem=LOC	8	prep	_	_
10	appropriate	appropriate	JJ	JJ	_	11	amod	_	_
11	buffer	buffer	NN	NN	_	9	pobj	_	_
12	and	and	CC	CC	_	8	cc	_	_
13	centrifuged	centrifuge	VBN	VBN	_	8	conj	_	_
14	at	at	IN	IN	_	13	prep	_	_
15	100,000g	0g	CD	CD	_	14	pobj	_	_
16	for	for	IN	IN	sem=TMP	13	prep	_	_
17	30	0	CD	CD	_	18	nummod	_	_
18	min	min	NN	NN	_	16	pobj	_	_
19	(	(	-LRB-	-LRB-	_	26	punct	_	_
20	1	0	CD	CD	_	23	quantmod	_	_
21	-	-	HYPH	HYPH	_	23	punct	_	_
22	to	to	IN	IN	_	23	quantmod	_	_
23	1.5	0	CD	CD	_	25	nummod	_	_
24	-	-	HYPH	HYPH	_	25	punct	_	_
25	mo	mo	NN	NN	_	26	compound	_	_
26	samples	sample	NNS	NNS	_	18	parataxis	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	or	or	CC	CC	_	18	cc	_	_
29	60	0	CD	CD	_	30	nummod	_	_
30	min	min	NN	NN	_	18	conj	_	_
31	(	(	-LRB-	-LRB-	_	38	punct	_	_
32	6	0	CD	CD	_	35	quantmod	_	_
33	-	-	HYPH	HYPH	_	35	punct	_	_
34	to	to	IN	IN	_	35	quantmod	_	_
35	12	0	CD	CD	_	37	nummod	_	_
36	-	-	HYPH	HYPH	_	37	punct	_	_
37	mo	mo	NN	NN	_	38	compound	_	_
38	samples	sample	NNS	NNS	_	30	parataxis	_	_
39	)	)	-RRB-	-RRB-	_	38	punct	_	_
40	at	at	IN	IN	_	13	prep	_	_
41	4	0	CD	CD	_	42	nummod	_	_
42	°C	°c	NN	NN	_	40	pobj	_	_
43	as	as	IN	IN	_	45	mark	_	_
44	previously	previously	RB	RB	sem=TMP	45	advmod	_	_
45	described	describe	VBN	VBN	sem=MNR	13	advcl	_	_
46	[	[	-LRB-	-LRB-	_	47	punct	_	_
47	23	0	CD	CD	_	13	parataxis	_	_
48	–	-	SYM	SYM	_	49	punct	_	_
49	25	0	CD	CD	_	47	prep	_	_
50	]	]	-RRB-	-RRB-	_	47	punct	_	_
51	.	.	.	.	_	8	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	supernatant	supernatant	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	removed	remove	VBN	VBN	_	0	root	_	_
5	for	for	IN	IN	sem=PRP	4	prep	_	_
6	analysis	analysis	NN	NN	_	5	pobj	_	_
7	,	,	,	,	_	4	punct	_	_
8	and	and	CC	CC	_	4	cc	_	_
9	the	the	DT	DT	_	10	det	_	_
10	pellet	pellet	NN	NN	_	12	nsubjpass	_	_
11	was	be	VBD	VBD	_	12	auxpass	_	_
12	sonicated	sonicated	VBN	VBN	_	4	conj	_	_
13	in	in	IN	IN	sem=LOC	12	prep	_	_
14	the	the	DT	DT	_	16	det	_	_
15	next	next	JJ	JJ	_	16	amod	_	_
16	solution	solution	NN	NN	_	13	pobj	_	_
17	in	in	IN	IN	sem=MNR	12	prep	_	_
18	sequence	sequence	NN	NN	_	17	pobj	_	_
19	.	.	.	.	_	12	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	2	0	CD	CD	_	3	nummod	_	_
3	%	%	NN	NN	_	5	compound	_	_
4	SDS	sds	NN	NN	_	5	compound	_	_
5	extracts	extract	NNS	NNS	_	7	nsubjpass	_	5:gap
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	diluted	dilute	VBN	VBN	_	0	root	_	7:gap
8	in	in	IN	IN	sem=LOC	7	prep	_	_
9	EC	ec	NN	NN	_	10	compound	_	_
10	buffer	buffer	NN	NN	_	8	pobj	_	_
11	,	,	,	,	_	7	punct	_	_
12	and	and	CC	CC	_	7	cc	_	_
13	the	the	DT	DT	_	15	det	_	_
14	FA	fa	NN	NN	_	15	compound	_	_
15	extracts	extract	NNS	NNS	_	16	nsubj	_	5:gap
16	neutralized	neutralize	VBN	VBN	_	7	conj	_	7:gap
17	with	with	IN	IN	sem=MNR	16	prep	_	_
18	1M	0m	NN	NN	_	22	compound	_	_
19	Tris	tris	NN	NN	_	22	compound	_	_
20	-	-	HYPH	HYPH	_	22	punct	_	_
21	phosphate	phosphate	NN	NN	_	22	compound	_	_
22	buffer	buffer	NN	NN	_	17	pobj	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	pH	ph	NN	NN	_	22	parataxis	_	_
25	11	0	CD	CD	_	24	nummod	_	_
26	)	)	-RRB-	-RRB-	_	24	punct	_	_
27	then	then	RB	RB	sem=TMP	28	advmod	_	_
28	diluted	dilute	VBD	VBD	_	16	dep	_	_
29	with	with	IN	IN	sem=MNR	28	prep	_	_
30	EC	ec	NN	NN	_	31	compound	_	_
31	buffer	buffer	NN	NN	_	29	pobj	_	_
32	prior	prior	JJ	JJ	_	33	amod	_	_
33	to	to	IN	IN	sem=TMP	28	prep	_	_
34	testing	testing	NN	NN	_	33	pobj	_	_
35	.	.	.	.	_	16	punct	_	_

1	Human	human	JJ	JJ	_	2	amod	_	_
2	Aβ	aβ	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	measured	measure	VBN	VBN	_	0	root	_	_
5	in	in	IN	IN	_	4	prep	_	_
6	each	each	DT	DT	_	7	det	_	_
7	fraction	fraction	NN	NN	_	5	pobj	_	_
8	using	use	VBG	VBG	sem=MNR	4	advcl	_	_
9	BAN50	ban0	NN	NN	_	8	dobj	_	9:gap
10	for	for	IN	IN	_	8	prep	_	10:gap
11	capture	capture	NN	NN	_	10	pobj	_	_
12	(	(	-LRB-	-LRB-	_	16	punct	_	_
13	epitope	epitope	NN	NN	_	16	compound	_	_
14	Aβ1	aβ0	NN	NN	_	16	compound	_	_
15	–	-	HYPH	HYPH	_	16	punct	_	_
16	16	0	NN	NN	_	11	parataxis	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	and	and	CC	CC	_	8	cc	_	_
19	BA27	ba0	NN	NN	_	8	conj	_	9:gap
20	and	and	CC	CC	_	19	cc	_	_
21	BC05	bc0	NN	NN	_	19	conj	_	_
22	for	for	IN	IN	_	19	prep	_	10:gap
23	detection	detection	NN	NN	_	22	pobj	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	Aβ40	aβ0	NN	NN	_	23	parataxis	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	Aβ42	aβ0	NN	NN	_	25	conj	_	_
28	,	,	,	,	_	25	punct	_	_
29	respectively	respectively	RB	RB	_	25	advmod	_	_
30	)	)	-RRB-	-RRB-	_	25	punct	_	_
31	(	(	-LRB-	-LRB-	_	34	punct	_	_
32	Takeda	takeda	NNP	NNP	_	34	compound	_	_
33	Chemical	chemical	NNP	NNP	_	34	compound	_	_
34	Industries	industry	NNPS	NNPS	_	23	parataxis	_	_
35	,	,	,	,	_	34	punct	_	_
36	Osaka	osaka	NNP	NNP	sem=LOC	34	npadvmod	_	_
37	,	,	,	,	_	34	punct	_	_
38	Japan	japan	NNP	NNP	sem=LOC	34	npadvmod	_	_
39	)	)	-RRB-	-RRB-	_	34	punct	_	_
40	.	.	.	.	_	4	punct	_	_

1	Total	total	JJ	JJ	_	2	amod	_	_
2	Aβ	aβ	NN	NN	_	18	nsubjpass	_	_
3	(	(	-LRB-	-LRB-	_	14	punct	_	_
4	mouse	mouse	NN	NN	_	14	dep	_	_
5	+	+	SYM	SYM	_	4	punct	_	_
6	human	human	JJ	JJ	_	4	amod	_	_
7	;	;	:	:	_	14	punct	_	_
8	1	0	CD	CD	_	11	quantmod	_	_
9	-	-	HYPH	HYPH	_	11	punct	_	_
10	to	to	IN	IN	_	11	quantmod	_	_
11	1.5	0	CD	CD	_	13	nummod	_	_
12	-	-	HYPH	HYPH	_	13	punct	_	_
13	mo	mo	NN	NN	_	14	compound	_	_
14	samples	sample	NNS	NNS	_	2	parataxis	_	_
15	only	only	RB	RB	_	14	advmod	_	_
16	)	)	-RRB-	-RRB-	_	14	punct	_	_
17	was	be	VBD	VBD	_	18	auxpass	_	_
18	measured	measure	VBN	VBN	_	0	root	_	_
19	in	in	IN	IN	_	18	prep	_	_
20	each	each	DT	DT	_	21	det	_	_
21	fraction	fraction	NN	NN	_	19	pobj	_	_
22	using	use	VBG	VBG	sem=MNR	18	advcl	_	_
23	BNT77	bnt0	NN	NN	_	22	dobj	_	23:gap
24	for	for	IN	IN	_	22	prep	_	24:gap
25	capture	capture	NN	NN	_	24	pobj	_	_
26	(	(	-LRB-	-LRB-	_	28	punct	_	_
27	epitope	epitope	NN	NN	_	28	compound	_	_
28	Aβ11	aβ0	NN	NN	_	25	parataxis	_	_
29	–	-	HYPH	HYPH	_	28	punct	_	_
30	28	0	CD	CD	_	28	nummod	_	_
31	)	)	-RRB-	-RRB-	_	28	punct	_	_
32	and	and	CC	CC	_	22	cc	_	_
33	BA27	ba0	NN	NN	_	22	conj	_	23:gap
34	and	and	CC	CC	_	33	cc	_	_
35	BC05	bc0	NN	NN	_	33	conj	_	_
36	for	for	IN	IN	_	33	prep	_	24:gap
37	detection	detection	NN	NN	_	36	pobj	_	_
38	.	.	.	.	_	18	punct	_	_

1	All	all	DT	DT	_	2	det	_	_
2	values	value	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	calculated	calculate	VBN	VBN	_	0	root	_	_
5	as	as	IN	IN	_	4	prep	_	_
6	picomoles	picomoles	NNS	NNS	_	5	pobj	_	_
7	per	per	IN	IN	_	6	prep	_	_
8	gram	gram	NN	NN	_	7	pobj	_	_
9	based	base	VBN	VBN	sem=PRP	4	prep	_	_
10	on	on	IN	IN	_	9	prep	_	_
11	the	the	DT	DT	_	13	det	_	_
12	initial	initial	JJ	JJ	_	13	amod	_	_
13	weight	weight	NN	NN	_	10	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	cortical	cortical	JJ	JJ	_	16	amod	_	_
16	tissue	tissue	NN	NN	_	14	pobj	_	_
17	.	.	.	.	_	4	punct	_	_

1	Activity	activity	NN	NN	_	2	compound	_	_
2	Monitoring	monitoring	NN	NN	_	0	root	_	_

1	Daily	daily	JJ	JJ	_	3	amod	_	_
2	basal	basal	JJ	JJ	_	3	amod	_	_
3	activity	activity	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	studied	study	VBN	VBN	_	0	root	_	_
6	in	in	IN	IN	sem=LOC	5	prep	_	_
7	28	0	CD	CD	_	19	nummod	_	_
8	CaMKIIα	camkiiα	NN	NN	_	16	nmod	_	_
9	-	-	HYPH	HYPH	_	16	punct	_	_
10	tTA	tta	NN	NN	_	16	nmod	_	_
11	×	×	SYM	SYM	_	16	punct	_	_
12	tet	tet	NN	NN	_	16	nmod	_	_
13	-	-	HYPH	HYPH	_	16	punct	_	_
14	APPswe	appswe	NN	NN	_	16	nmod	_	_
15	/	/	HYPH	HYPH	_	16	punct	_	_
16	ind	ind	NN	NN	_	19	nmod	_	_
17	line	line	NN	NN	_	19	nmod	_	_
18	107	0	CD	CD	_	17	nummod	_	_
19	mice	mouse	NNS	NNS	_	6	pobj	_	_
20	between	between	IN	IN	_	21	quantmod	_	_
21	4	0	CD	CD	_	24	nummod	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	5	0	CD	CD	_	21	conj	_	_
24	mo	mo	NN	NN	sem=TMP	19	npadvmod	_	_
25	of	of	IN	IN	_	24	prep	_	_
26	age	age	NN	NN	_	25	pobj	_	_
27	.	.	.	.	_	5	punct	_	_

1	Animals	animal	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	separated	separate	VBN	VBN	_	0	root	_	_
4	into	into	IN	IN	sem=LOC	3	prep	_	_
5	individual	individual	JJ	JJ	_	6	amod	_	_
6	cages	cage	NNS	NNS	_	4	pobj	_	_
7	immediately	immediately	RB	RB	_	8	advmod	_	_
8	before	before	IN	IN	sem=TMP	3	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	start	start	NN	NN	_	8	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	each	each	DT	DT	_	13	det	_	_
13	experiment	experiment	NN	NN	_	11	pobj	_	_
14	(	(	-LRB-	-LRB-	_	19	punct	_	_
15	n	n	NN	NN	_	19	nsubj	_	_
16	=	=	SYM	SYM	_	19	punct	_	_
17	3	0	CD	CD	_	19	quantmod	_	_
18	–	-	SYM	SYM	_	19	punct	_	_
19	6	0	CD	CD	_	3	parataxis	_	_
20	per	per	IN	IN	_	19	prep	_	_
21	genotype	genotype	NN	NN	_	20	pobj	_	_
22	untreated	untreated	JJ	JJ	_	21	amod	_	_
23	,	,	,	,	_	19	punct	_	_
24	2	0	CD	CD	_	26	quantmod	_	_
25	–	-	SYM	SYM	_	26	punct	_	_
26	5	0	CD	CD	_	19	appos	_	_
27	per	per	IN	IN	_	26	prep	_	_
28	genotype	genotype	NN	NN	_	27	pobj	_	_
29	dox	dox	NN	NN	_	31	dep	_	_
30	-	-	HYPH	HYPH	_	31	punct	_	_
31	reared	rear	VBN	VBN	_	28	acl	_	_
32	)	)	-RRB-	-RRB-	_	19	punct	_	_
33	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	cages	cage	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	placed	place	VBN	VBN	_	0	root	_	_
5	inside	inside	IN	IN	sem=LOC	4	prep	_	_
6	activity	activity	NN	NN	_	8	npadvmod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	monitoring	monitor	VBG	VBG	_	9	amod	_	_
9	frames	frame	NNS	NNS	_	5	pobj	_	_
10	designed	design	VBN	VBN	_	9	acl	_	_
11	to	to	TO	TO	_	12	aux	_	_
12	count	count	VB	VB	sem=PRP	10	advcl	_	_
13	every	every	DT	DT	_	14	det	_	_
14	time	time	NN	NN	_	12	dobj	_	_
15	the	the	DT	DT	_	16	det	_	_
16	animal	animal	NN	NN	_	17	nsubj	_	_
17	passed	pass	VBN	VBN	_	14	advcl	_	_
18	through	through	IN	IN	sem=DIR	17	prep	_	_
19	one	#crd#	CD	CD	_	18	pobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	three	#crd#	CD	CD	_	22	nummod	_	_
22	photobeams	photobeams	NNS	NNS	_	20	pobj	_	_
23	spanning	span	VBG	VBG	_	22	acl	_	_
24	the	the	DT	DT	_	25	det	_	_
25	width	width	NN	NN	_	23	dobj	_	_
26	of	of	IN	IN	_	25	prep	_	_
27	the	the	DT	DT	_	28	det	_	_
28	cage	cage	NN	NN	_	26	pobj	_	_
29	(	(	-LRB-	-LRB-	_	32	punct	_	_
30	San	san	NNP	NNP	_	31	compound	_	_
31	Diego	diego	NNP	NNP	_	32	compound	_	_
32	Instruments	instruments	NNP	NNP	_	17	parataxis	_	_
33	,	,	,	,	_	32	punct	_	_
34	San	san	NNP	NNP	_	35	compound	_	_
35	Diego	diego	NNP	NNP	sem=LOC	32	npadvmod	_	_
36	,	,	,	,	_	32	punct	_	_
37	California	california	NNP	NNP	sem=LOC	32	npadvmod	_	_
38	,	,	,	,	_	32	punct	_	_
39	United	united	NNP	NNP	_	40	compound	_	_
40	States	state	NNP	NNP	sem=LOC	32	npadvmod	_	_
41	)	)	-RRB-	-RRB-	_	32	punct	_	_
42	.	.	.	.	_	4	punct	_	_

1	Experiments	experiment	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	started	start	VBN	VBN	_	0	root	_	_
4	midway	midway	RB	RB	_	5	advmod	_	_
5	through	through	IN	IN	sem=TMP	3	prep	_	_
6	the	the	DT	DT	_	8	det	_	_
7	light	light	NN	NN	_	8	compound	_	_
8	phase	phase	NN	NN	_	5	pobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	the	the	DT	DT	_	11	det	_	_
11	day	day	NN	NN	_	9	pobj	_	_
12	,	,	,	,	_	3	punct	_	_
13	and	and	CC	CC	_	3	cc	_	_
14	data	datum	NNS	NNS	_	16	nsubjpass	_	_
15	were	be	VBD	VBD	_	16	auxpass	_	_
16	collected	collect	VBN	VBN	_	3	conj	_	_
17	in	in	IN	IN	sem=LOC	16	prep	_	_
18	1	0	CD	CD	_	20	nummod	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	h	h	NN	NN	_	21	compound	_	_
21	bins	bin	NNS	NNS	_	17	pobj	_	_
22	for	for	IN	IN	sem=TMP	16	prep	_	_
23	the	the	DT	DT	_	26	det	_	_
24	following	following	JJ	JJ	_	26	amod	_	_
25	48	0	CD	CD	_	26	nummod	_	_
26	h	h	NN	NN	_	22	pobj	_	_
27	.	.	.	.	_	16	punct	_	_

1	Testing	testing	NN	NN	_	2	compound	_	_
2	rooms	room	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	maintained	maintain	VBN	VBN	_	0	root	_	_
5	on	on	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	15	det	_	_
7	same	same	JJ	JJ	_	15	amod	_	_
8	13	0	CD	CD	_	11	nummod	_	_
9	:	:	SYM	SYM	_	10	punct	_	_
10	11	0	CD	CD	_	8	prep	_	_
11	h	h	NN	NN	_	15	nmod	_	_
12	day	day	NN	NN	_	15	nmod	_	_
13	:	:	SYM	SYM	_	14	punct	_	_
14	night	night	NN	NN	_	12	prep	_	_
15	cycle	cycle	NN	NN	_	5	pobj	_	_
16	as	as	IN	IN	_	15	prep	_	_
17	the	the	DT	DT	_	21	det	_	_
18	main	main	JJ	JJ	_	21	amod	_	_
19	animal	animal	NN	NN	_	20	compound	_	_
20	housing	housing	NN	NN	_	21	compound	_	_
21	areas	area	NNS	NNS	_	16	pobj	_	_
22	and	and	CC	CC	_	4	cc	_	_
23	were	be	VBD	VBD	_	24	auxpass	_	_
24	closed	close	VBN	VBN	_	4	conj	_	_
25	to	to	IN	IN	_	24	prep	_	_
26	entry	entry	NN	NN	_	25	pobj	_	_
27	during	during	IN	IN	sem=TMP	24	prep	_	_
28	the	the	DT	DT	_	29	det	_	_
29	experiment	experiment	NN	NN	_	27	pobj	_	_
30	.	.	.	.	_	4	punct	_	_

1	Statistical	statistical	JJ	JJ	_	2	amod	_	_
2	Analyses	analysis	NNS	NNS	_	0	root	_	_

1	Statistical	statistical	JJ	JJ	_	2	amod	_	_
2	analyses	analysis	NNS	NNS	_	15	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	protein	protein	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	3	pobj	_	_
6	,	,	,	,	_	5	punct	_	_
7	ELISA	elisa	NN	NN	_	8	compound	_	_
8	data	datum	NNS	NNS	_	5	conj	_	_
9	,	,	,	,	_	8	punct	_	_
10	and	and	CC	CC	_	8	cc	_	_
11	filter	filter	NN	NN	_	12	compound	_	_
12	trap	trap	NN	NN	_	13	compound	_	_
13	assays	assay	NNS	NNS	_	8	conj	_	_
14	were	be	VBD	VBD	_	15	auxpass	_	_
15	performed	performed	VBN	VBN	_	0	root	_	_
16	by	by	IN	IN	sem=MNR	15	prep	_	_
17	ANOVA	anova	NN	NN	_	16	pobj	_	_
18	with	with	IN	IN	sem=MNR	15	prep	_	_
19	Tukey	tukey	NNP	NNP	_	27	poss	_	_
20	's	's	POS	POS	_	19	case	_	_
21	honest	honest	JJ	JJ	_	27	amod	_	_
22	significant	significant	JJ	JJ	_	27	amod	_	_
23	difference	difference	NN	NN	_	27	nmod	_	_
24	post	post	FW	FW	_	26	nmod	_	_
25	-	-	HYPH	HYPH	_	26	punct	_	_
26	hoc	hoc	FW	FW	_	27	nmod	_	_
27	test	test	NN	NN	_	18	pobj	_	_
28	applied	apply	VBN	VBN	_	27	acl	_	_
29	to	to	IN	IN	_	28	prep	_	_
30	significant	significant	JJ	JJ	_	32	amod	_	_
31	main	main	JJ	JJ	_	32	amod	_	_
32	effects	effect	NNS	NNS	_	29	pobj	_	_
33	or	or	CC	CC	_	32	cc	_	_
34	interactions	interaction	NNS	NNS	_	32	conj	_	_
35	(	(	-LRB-	-LRB-	_	36	punct	_	_
36	Statistica	statistica	NNP	NNP	_	15	parataxis	_	_
37	6.0	0	CD	CD	_	36	nummod	_	_
38	,	,	,	,	_	36	punct	_	_
39	StatSoft	statsoft	NNP	NNP	syn=ADV	36	npadvmod	_	_
40	,	,	,	,	_	36	punct	_	_
41	Tulsa	tulsa	NNP	NNP	sem=LOC	36	npadvmod	_	_
42	,	,	,	,	_	36	punct	_	_
43	Oklahoma	oklahoma	NNP	NNP	sem=LOC	36	npadvmod	_	_
44	,	,	,	,	_	36	punct	_	_
45	United	united	NNP	NNP	_	46	compound	_	_
46	States	state	NNP	NNP	sem=LOC	36	npadvmod	_	_
47	)	)	-RRB-	-RRB-	_	36	punct	_	_
48	.	.	.	.	_	15	punct	_	_

1	In	in	IN	IN	_	17	prep	_	_
2	cases	case	NNS	NNS	_	1	pobj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	positively	positively	RB	RB	_	5	advmod	_	_
5	skewed	skew	VBN	VBN	_	7	amod	_	_
6	data	datum	NNS	NNS	_	7	compound	_	_
7	distribution	distribution	NN	NN	_	3	pobj	_	_
8	,	,	,	,	_	17	punct	_	_
9	log10	log0	NN	NN	_	11	nmod	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	x	x	NN	NN	_	15	nmod	_	_
12	+	+	SYM	SYM	_	11	punct	_	_
13	0.5	0	CD	CD	_	11	nummod	_	_
14	)	)	-RRB-	-RRB-	_	11	punct	_	_
15	transformation	transformation	NN	NN	_	17	nsubjpass	_	_
16	was	be	VBD	VBD	_	17	auxpass	_	_
17	applied	apply	VBN	VBN	_	0	root	_	_
18	to	to	IN	IN	_	17	prep	_	_
19	the	the	DT	DT	_	21	det	_	_
20	raw	raw	JJ	JJ	_	21	amod	_	_
21	data	datum	NNS	NNS	_	18	pobj	_	_
22	before	before	IN	IN	sem=TMP	17	prep	_	_
23	submitting	submit	VBG	VBG	syn=NOM	22	pcomp	_	_
24	them	them	PRP	PRP	_	23	dobj	_	_
25	to	to	IN	IN	_	23	prep	_	_
26	ANOVA	anova	NN	NN	_	25	pobj	_	_
27	.	.	.	.	_	17	punct	_	_

1	Results	result	NNS	NNS	_	0	root	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	used	use	VBD	VBD	_	0	root	_	_
3	the	the	DT	DT	_	8	det	_	_
4	tet	tet	NN	NN	_	6	compound	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	off	off	NN	NN	_	8	compound	_	_
7	transgene	transgene	NN	NN	_	8	compound	_	_
8	system	system	NN	NN	_	2	dobj	_	_
9	to	to	TO	TO	_	10	aux	_	_
10	express	express	VB	VB	sem=PRP	2	advcl	_	_
11	a	a	DT	DT	_	14	det	_	_
12	double	double	JJ	JJ	_	14	amod	_	_
13	mutant	mutant	NN	NN	_	14	compound	_	_
14	version	version	NN	NN	_	10	dobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	chimeric	chimeric	JJ	JJ	_	19	amod	_	_
17	mo	mo	NN	NN	_	19	compound	_	_
18	/	/	HYPH	HYPH	_	19	punct	_	_
19	huAPP695	huapp0	NN	NN	_	15	pobj	_	_
20	(	(	-LRB-	-LRB-	_	14	punct	_	_
21	swe	swe	NN	NN	_	24	compound	_	_
22	/	/	HYPH	HYPH	_	24	punct	_	_
23	ind	ind	NN	NN	_	24	compound	_	_
24	KM570	km0	NN	NN	_	14	appos	_	_
25	,	,	,	,	_	24	punct	_	_
26	571NL	0nl	NN	NN	_	24	conj	_	_
27	,	,	,	,	_	26	punct	_	_
28	and	and	CC	CC	_	26	cc	_	_
29	V617F	v0f	NN	NN	_	26	conj	_	_
30	)	)	-RRB-	-RRB-	_	10	punct	_	_
31	from	from	IN	IN	_	10	prep	_	_
32	a	a	DT	DT	_	36	det	_	_
33	tetracycline	tetracycline	NN	NN	_	35	npadvmod	_	_
34	-	-	HYPH	HYPH	_	35	punct	_	_
35	responsive	responsive	JJ	JJ	_	36	amod	_	_
36	promoter	promoter	NN	NN	_	31	pobj	_	_
37	[	[	-LRB-	-LRB-	_	40	punct	_	_
38	12	0	CD	CD	_	40	nummod	_	_
39	,	,	,	,	_	40	punct	_	_
40	13	0	CD	CD	_	10	parataxis	_	_
41	]	]	-RRB-	-RRB-	_	40	punct	_	_
42	.	.	.	.	_	2	punct	_	_

1	Transgenic	transgenic	JJ	JJ	_	2	amod	_	_
2	APP	app	NN	NN	_	3	compound	_	_
3	expression	expression	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	activated	activate	VBN	VBN	_	0	root	_	_
6	by	by	IN	IN	sem=MNR	5	prep	_	_
7	crossing	cross	VBG	VBG	syn=NOM	6	pcomp	_	_
8	the	the	DT	DT	_	12	det	_	_
9	APPswe	appswe	NN	NN	_	11	compound	_	_
10	/	/	HYPH	HYPH	_	11	punct	_	_
11	ind	ind	NN	NN	_	12	compound	_	_
12	mice	mouse	NNS	NNS	_	7	dobj	_	_
13	to	to	IN	IN	_	7	prep	_	_
14	animals	animal	NNS	NNS	_	13	pobj	_	_
15	producing	produce	VBG	VBG	_	14	acl	_	_
16	tTA	tta	NN	NN	_	15	dobj	_	_
17	under	under	IN	IN	_	15	prep	_	_
18	control	control	NN	NN	_	17	pobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	the	the	DT	DT	_	22	det	_	_
21	CaMKIIα	camkiiα	NN	NN	_	22	compound	_	_
22	promoter	promoter	NN	NN	_	19	pobj	_	_
23	[	[	-LRB-	-LRB-	_	24	punct	_	_
24	16	0	CD	CD	_	15	parataxis	_	_
25	]	]	-RRB-	-RRB-	_	24	punct	_	_
26	.	.	.	.	_	5	punct	_	_

1	After	after	IN	IN	sem=TMP	8	prep	_	_
2	initial	initial	JJ	JJ	_	3	amod	_	_
3	screening	screening	NN	NN	_	1	pobj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	founders	founder	NNS	NNS	_	4	pobj	_	_
6	,	,	,	,	_	8	punct	_	_
7	we	we	PRP	PRP	_	8	nsubj	_	_
8	identified	identify	VBD	VBD	_	0	root	_	_
9	four	#crd#	CD	CD	_	10	nummod	_	_
10	lines	line	NNS	NNS	_	8	dobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	tet	tet	NN	NN	_	16	compound	_	_
13	-	-	HYPH	HYPH	_	16	punct	_	_
14	APPswe	appswe	NN	NN	_	16	compound	_	_
15	/	/	HYPH	HYPH	_	16	punct	_	_
16	ind	ind	NN	NN	_	17	compound	_	_
17	mice	mouse	NNS	NNS	_	11	pobj	_	_
18	that	that	WDT	WDT	_	19	dep	_	10:ref
19	produced	produce	VBD	VBD	_	10	relcl	_	_
20	very	very	RB	RB	_	21	advmod	_	_
21	high	high	JJ	JJ	_	22	amod	_	_
22	levels	level	NNS	NNS	_	19	dobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	transgene	transgene	NN	NN	_	25	compound	_	_
25	product	product	NN	NN	_	23	pobj	_	_
26	in	in	IN	IN	sem=LOC	19	prep	_	_
27	offspring	offspring	NN	NN	_	26	pobj	_	_
28	coexpressing	coexpressing	VBG	VBG	_	27	acl	_	_
29	tTA	tta	NN	NN	_	28	dobj	_	_
30	(	(	-LRB-	-LRB-	_	31	punct	_	_
31	Figures	figure	NNS	NNS	_	19	parataxis	_	_
32	1	0	CD	CD	_	31	nummod	_	_
33	and	and	CC	CC	_	31	cc	_	_
34	Figure	figure	NN	NN	_	35	compound	_	_
35	S1	s0	NN	NN	_	31	conj	_	_
36	)	)	-RRB-	-RRB-	_	31	punct	_	_
37	.	.	.	.	_	8	punct	_	_

1	Compared	compare	VBN	VBN	_	32	prep	_	_
2	to	to	IN	IN	_	1	prep	_	_
3	a	a	DT	DT	_	7	det	_	_
4	standard	standard	JJ	JJ	_	7	amod	_	_
5	APP	app	NN	NN	_	7	nmod	_	_
6	transgenic	transgenic	JJ	JJ	_	7	amod	_	_
7	line	line	NN	NN	_	2	pobj	_	_
8	used	use	VBN	VBN	_	7	acl	_	_
9	for	for	IN	IN	sem=PRP	8	prep	_	_
10	previous	previous	JJ	JJ	_	12	amod	_	_
11	amyloid	amyloid	NN	NN	_	12	compound	_	_
12	studies	study	NNS	NNS	_	9	pobj	_	_
13	by	by	IN	IN	_	12	prep	_	_
14	our	our	PRP$	PRP$	_	15	poss	_	_
15	laboratory	laboratory	NN	NN	_	13	pobj	_	_
16	(	(	-LRB-	-LRB-	_	27	punct	_	_
17	line	line	NN	NN	_	18	compound	_	_
18	C3	c0	NN	NN	_	27	dep	_	_
19	–	-	HYPH	HYPH	_	18	punct	_	_
20	3	0	CD	CD	_	18	nummod	_	_
21	;	;	:	:	_	27	punct	_	_
22	[	[	-LRB-	-LRB-	_	27	punct	_	_
23	15	0	CD	CD	_	27	nummod	_	_
24	,	,	,	,	_	27	punct	_	_
25	26	0	CD	CD	_	27	nummod	_	_
26	,	,	,	,	_	27	punct	_	_
27	27	0	CD	CD	_	8	parataxis	_	_
28	]	]	-RRB-	-RRB-	_	27	punct	_	_
29	)	)	-RRB-	-RRB-	_	27	punct	_	_
30	,	,	,	,	_	32	punct	_	_
31	we	we	PRP	PRP	_	32	nsubj	_	_
32	estimated	estimate	VBD	VBD	_	0	root	_	_
33	that	that	IN	IN	_	38	mark	_	_
34	the	the	DT	DT	_	37	det	_	_
35	four	#crd#	CD	CD	_	37	nummod	_	_
36	controllable	controllable	JJ	JJ	_	37	amod	_	_
37	lines	line	NNS	NNS	_	38	nsubj	_	_
38	produce	produce	VBP	VBP	_	32	ccomp	_	_
39	transgenic	transgenic	JJ	JJ	_	41	amod	_	_
40	APP	app	NN	NN	_	41	compound	_	_
41	protein	protein	NN	NN	_	38	dobj	_	_
42	at	at	IN	IN	_	38	prep	_	_
43	10	0	CD	CD	_	42	pcomp	_	_
44	-	-	HYPH	HYPH	_	43	punct	_	_
45	to	to	IN	IN	_	43	quantmod	_	_
46	30-fold	0-fold	RB	RB	_	43	advmod	_	_
47	over	over	IN	IN	_	43	prep	_	_
48	endogenous	endogenous	JJ	JJ	_	49	amod	_	_
49	levels	level	NNS	NNS	_	47	pobj	_	_
50	(	(	-LRB-	-LRB-	_	52	punct	_	_
51	Figure	figure	NN	NN	_	52	compound	_	_
52	S1	s0	NN	NN	_	38	parataxis	_	_
53	)	)	-RRB-	-RRB-	_	52	punct	_	_
54	.	.	.	.	_	32	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	estimate	estimate	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	confirmed	confirm	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	_	4	agent	_	_
6	direct	direct	JJ	JJ	_	7	amod	_	_
7	comparison	comparison	NN	NN	_	5	pobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	APP	app	NN	NN	_	10	compound	_	_
10	levels	level	NNS	NNS	_	8	pobj	_	_
11	in	in	IN	IN	sem=LOC	7	prep	_	_
12	nontransgenic	nontransgenic	JJ	JJ	_	18	amod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	tet	tet	NN	NN	_	16	compound	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	off	off	NN	NN	_	12	conj	_	_
17	APP	app	NN	NN	_	18	compound	_	_
18	mice	mouse	NNS	NNS	_	11	pobj	_	_
19	using	use	VBG	VBG	sem=MNR	4	advcl	_	_
20	an	an	DT	DT	_	21	det	_	_
21	antibody	antibody	NN	NN	_	19	dobj	_	_
22	that	that	WDT	WDT	_	23	dep	_	21:ref
23	recognizes	recognize	VBZ	VBZ	_	21	relcl	_	_
24	both	both	CC	CC	_	26	preconj	_	_
25	endogenous	endogenous	JJ	JJ	_	26	amod	_	_
26	APP	app	NN	NN	_	23	dobj	_	_
27	(	(	-LRB-	-LRB-	_	26	punct	_	_
28	and	and	CC	CC	_	26	cc	_	_
29	amyloid	amyloid	NN	NN	_	33	nmod	_	_
30	precursor	precursor	NN	NN	_	32	npadvmod	_	_
31	-	-	HYPH	HYPH	_	32	punct	_	_
32	like	like	JJ	JJ	_	33	amod	_	_
33	protein	protein	NN	NN	_	26	conj	_	_
34	2	0	CD	CD	_	33	nummod	_	_
35	)	)	-RRB-	-RRB-	_	33	punct	_	_
36	and	and	CC	CC	_	26	cc	_	_
37	the	the	DT	DT	_	39	det	_	_
38	transgenic	transgenic	JJ	JJ	_	39	amod	_	_
39	protein	protein	NN	NN	_	26	conj	_	_
40	(	(	-LRB-	-LRB-	_	46	punct	_	_
41	monoclonal	monoclonal	JJ	JJ	_	43	amod	_	_
42	antibody	antibody	NN	NN	_	43	compound	_	_
43	22C11	0c0	NN	NN	_	46	dep	_	_
44	;	;	:	:	_	46	punct	_	_
45	Figure	figure	NN	NN	_	46	compound	_	_
46	1D	0d	NN	NN	_	39	parataxis	_	_
47	)	)	-RRB-	-RRB-	_	46	punct	_	_
48	.	.	.	.	_	4	punct	_	_

1	Importantly	importantly	RB	RB	_	13	advmod	_	_
2	,	,	,	,	_	13	punct	_	_
3	all	all	DT	DT	_	6	det	_	_
4	four	#crd#	CD	CD	_	6	nummod	_	_
5	new	new	JJ	JJ	_	6	amod	_	_
6	lines	line	NNS	NNS	_	13	nsubj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	tet	tet	NN	NN	_	10	compound	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	off	off	NN	NN	_	12	compound	_	_
11	APP	app	NN	NN	_	12	compound	_	_
12	mice	mouse	NNS	NNS	_	7	pobj	_	_
13	showed	show	VBD	VBD	_	0	root	_	_
14	nearly	nearly	RB	RB	_	15	advmod	_	_
15	complete	complete	JJ	JJ	_	16	amod	_	_
16	suppression	suppression	NN	NN	_	13	dobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	the	the	DT	DT	_	19	det	_	_
19	transgene	transgene	NN	NN	_	17	pobj	_	_
20	following	follow	VBG	VBG	sem=TMP	13	prep	_	_
21	dox	dox	NN	NN	_	22	compound	_	_
22	treatment	treatment	NN	NN	_	20	pobj	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	Figures	figure	NNS	NNS	_	13	parataxis	_	_
25	1	0	CD	CD	_	24	nummod	_	_
26	and	and	CC	CC	_	24	cc	_	_
27	Figure	figure	NN	NN	_	28	compound	_	_
28	S1	s0	NN	NN	_	24	conj	_	_
29	)	)	-RRB-	-RRB-	_	24	punct	_	_
30	.	.	.	.	_	13	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	focused	focus	VBD	VBD	_	0	root	_	_
3	on	on	IN	IN	_	2	prep	_	_
4	one	#crd#	CD	CD	_	3	pobj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	8	det	_	_
7	four	#crd#	CD	CD	_	8	nummod	_	_
8	lines	line	NNS	NNS	_	5	pobj	_	_
9	,	,	,	,	_	4	punct	_	_
10	line	line	NN	NN	_	4	appos	_	_
11	107	0	CD	CD	_	10	nummod	_	_
12	,	,	,	,	_	2	punct	_	_
13	to	to	TO	TO	_	14	aux	_	_
14	examine	examine	VB	VB	sem=PRP	2	advcl	_	_
15	in	in	IN	IN	_	14	prep	_	_
16	more	more	JJR	JJR	_	17	amod	_	_
17	detail	detail	NN	NN	_	15	pobj	_	_
18	the	the	DT	DT	_	20	det	_	_
19	time	time	NN	NN	_	20	compound	_	_
20	dependence	dependence	NN	NN	_	14	dobj	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	extent	extent	NN	NN	_	20	conj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	transgene	transgene	NN	NN	_	25	compound	_	_
25	suppression	suppression	NN	NN	_	23	pobj	_	_
26	following	follow	VBG	VBG	sem=TMP	20	prep	_	_
27	either	either	CC	CC	_	31	preconj	_	_
28	acute	acute	JJ	JJ	_	31	amod	_	_
29	or	or	CC	CC	_	28	cc	_	_
30	chronic	chronic	JJ	JJ	_	28	conj	_	_
31	treatment	treatment	NN	NN	_	26	pobj	_	_
32	with	with	IN	IN	_	31	prep	_	_
33	dox	dox	NN	NN	_	32	pobj	_	_
34	.	.	.	.	_	2	punct	_	_

1	Two	#crd#	CD	CD	_	5	nummod	_	_
2	dox	dox	NN	NN	_	4	npadvmod	_	_
3	-	-	HYPH	HYPH	_	4	punct	_	_
4	treated	treat	VBN	VBN	_	5	amod	_	_
5	groups	group	NNS	NNS	_	7	nsubjpass	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	compared	compare	VBN	VBN	_	57	ccomp	_	_
8	to	to	IN	IN	_	7	prep	_	_
9	two	#crd#	CD	CD	_	11	nummod	_	_
10	untreated	untreated	JJ	JJ	_	11	amod	_	_
11	groups	group	NNS	NNS	_	8	pobj	_	_
12	:	:	:	:	_	57	punct	_	_
13	one	#crd#	CD	CD	_	14	nummod	_	_
14	group	group	NN	NN	_	18	nsubjpass	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	mice	mouse	NNS	NNS	_	15	pobj	_	_
17	was	be	VBD	VBD	_	18	auxpass	_	_
18	born	bear	VBN	VBN	_	57	ccomp	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	raised	raise	VBN	VBN	_	18	conj	_	_
21	on	on	IN	IN	_	20	prep	_	_
22	dox	dox	NN	NN	_	21	pobj	_	_
23	,	,	,	,	_	57	punct	_	_
24	a	a	DT	DT	_	26	det	_	_
25	second	#ord#	JJ	JJ	_	26	amod	_	_
26	group	group	NN	NN	_	28	nsubjpass	_	_
27	was	be	VBD	VBD	_	28	auxpass	_	_
28	treated	treat	VBN	VBN	_	57	ccomp	_	_
29	with	with	IN	IN	sem=MNR	28	prep	_	_
30	dox	dox	NN	NN	_	29	pobj	_	_
31	for	for	IN	IN	sem=TMP	28	prep	_	_
32	2	0	CD	CD	_	33	nummod	_	_
33	wk	wk	NN	NN	_	31	pobj	_	_
34	starting	start	VBG	VBG	sem=TMP	28	advcl	_	_
35	at	at	IN	IN	_	34	prep	_	_
36	1	0	CD	CD	_	37	nummod	_	_
37	mo	mo	NN	NN	_	35	pobj	_	_
38	of	of	IN	IN	_	37	prep	_	_
39	age	age	NN	NN	_	38	pobj	_	_
40	(	(	-LRB-	-LRB-	_	42	punct	_	_
41	4	0	CD	CD	_	42	nummod	_	_
42	wk	wk	NN	NN	_	28	parataxis	_	_
43	+	+	SYM	SYM	_	42	punct	_	_
44	2	0	CD	CD	_	45	nummod	_	_
45	wk	wk	NN	NN	_	46	compound	_	_
46	dox	dox	NN	NN	_	42	appos	_	_
47	)	)	-RRB-	-RRB-	_	42	punct	_	_
48	;	;	:	:	_	57	punct	_	_
49	two	#crd#	CD	CD	_	51	nummod	_	_
50	untreated	untreated	JJ	JJ	_	51	amod	_	_
51	groups	group	NNS	NNS	_	57	nsubjpass	_	_
52	kept	keep	VBN	VBN	_	51	acl	_	_
53	on	on	IN	IN	_	52	prep	_	_
54	normal	normal	JJ	JJ	_	55	amod	_	_
55	chow	chow	NN	NN	_	53	pobj	_	_
56	were	be	VBD	VBD	_	57	auxpass	_	_
57	harvested	harvest	VBN	VBN	_	0	root	_	_
58	at	at	IN	IN	sem=TMP	57	prep	_	_
59	either	either	CC	CC	_	60	preconj	_	_
60	4	0	CD	CD	_	63	nummod	_	_
61	or	or	CC	CC	_	60	cc	_	_
62	6	0	CD	CD	_	60	conj	_	_
63	wk	wk	NN	NN	_	58	pobj	_	_
64	of	of	IN	IN	_	63	prep	_	_
65	age	age	NN	NN	_	64	pobj	_	_
66	.	.	.	.	_	57	punct	_	_

1	Animals	animal	NNS	NNS	_	7	nsubj	_	_
2	born	bear	VBN	VBN	_	1	acl	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	raised	raise	VBN	VBN	_	2	conj	_	_
5	on	on	IN	IN	_	4	prep	_	_
6	dox	dox	NN	NN	_	5	pobj	_	_
7	harbored	harbor	VBD	VBD	_	0	root	_	_
8	no	no	DT	DT	_	10	det	_	_
9	transgenic	transgenic	JJ	JJ	_	10	amod	_	_
10	APP	app	NN	NN	_	7	dobj	_	_
11	(	(	-LRB-	-LRB-	_	13	punct	_	_
12	Figure	figure	NN	NN	_	13	compound	_	_
13	1A	0a	NN	NN	_	7	parataxis	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	.	.	.	.	_	7	punct	_	_

1	Following	follow	VBG	VBG	sem=TMP	15	prep	_	_
2	as	as	RB	RB	_	5	advmod	_	_
3	little	little	JJ	JJ	_	5	amod	_	_
4	as	as	IN	IN	_	5	quantmod	_	_
5	2	0	CD	CD	_	6	nummod	_	_
6	wk	wk	NN	NN	_	1	pobj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	dox	dox	NN	NN	_	9	compound	_	_
9	treatment	treatment	NN	NN	_	7	pobj	_	_
10	,	,	,	,	_	15	punct	_	_
11	transgenic	transgenic	JJ	JJ	_	13	amod	_	_
12	APP	app	NN	NN	_	13	compound	_	_
13	expression	expression	NN	NN	_	15	nsubjpass	_	_
14	was	be	VBD	VBD	_	15	auxpass	_	_
15	reduced	reduce	VBN	VBN	_	0	root	_	_
16	by	by	IN	IN	sem=EXT	15	prep	_	_
17	more	more	JJR	JJR	_	19	amod	_	_
18	than	than	IN	IN	_	19	quantmod	_	_
19	95	0	CD	CD	_	20	nummod	_	_
20	%	%	NN	NN	_	16	pobj	_	_
21	compared	compare	VBN	VBN	_	15	prep	_	_
22	to	to	IN	IN	_	21	prep	_	_
23	pre-dox	pre-dox	JJ	JJ	_	24	amod	_	_
24	levels	level	NNS	NNS	_	22	pobj	_	_
25	.	.	.	.	_	15	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	residual	residual	JJ	JJ	_	3	amod	_	_
3	expression	expression	NN	NN	_	9	nsubj	_	_
4	remaining	remain	VBG	VBG	_	3	acl	_	_
5	in	in	IN	IN	sem=LOC	4	prep	_	_
6	acutely	acutely	RB	RB	_	7	advmod	_	_
7	treated	treat	VBN	VBN	_	8	amod	_	_
8	mice	mouse	NNS	NNS	_	5	pobj	_	_
9	represents	represent	VBZ	VBZ	_	0	root	_	_
10	less	less	JJR	JJR	_	12	amod	_	_
11	than	than	IN	IN	_	12	quantmod	_	_
12	4	0	CD	CD	_	13	nummod	_	_
13	%	%	NN	NN	_	9	dobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	the	the	DT	DT	_	17	det	_	_
16	transgenic	transgenic	JJ	JJ	_	17	amod	_	_
17	protein	protein	NN	NN	_	14	pobj	_	_
18	produced	produce	VBN	VBN	_	17	acl	_	_
19	in	in	IN	IN	_	18	prep	_	_
20	the	the	DT	DT	_	21	det	_	_
21	absence	absence	NN	NN	_	19	pobj	_	_
22	of	of	IN	IN	_	21	prep	_	_
23	dox	dox	NN	NN	_	22	pobj	_	_
24	(	(	-LRB-	-LRB-	_	26	punct	_	_
25	Figure	figure	NN	NN	_	26	compound	_	_
26	1C	0c	NN	NN	_	18	parataxis	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	,	,	,	,	_	9	punct	_	_
29	and	and	CC	CC	_	9	cc	_	_
30	likely	likely	RB	RB	_	31	advmod	_	_
31	results	result	VBZ	VBZ	_	9	conj	_	_
32	from	from	IN	IN	_	31	prep	_	_
33	slight	slight	JJ	JJ	_	34	amod	_	_
34	leakage	leakage	NN	NN	_	32	pobj	_	_
35	at	at	IN	IN	_	34	prep	_	_
36	the	the	DT	DT	_	37	det	_	_
37	level	level	NN	NN	_	35	pobj	_	_
38	of	of	IN	IN	_	37	prep	_	_
39	transcription	transcription	NN	NN	_	38	pobj	_	_
40	(	(	-LRB-	-LRB-	_	43	punct	_	_
41	data	datum	NNS	NNS	_	43	nsubj	_	_
42	not	not	RB	RB	_	43	neg	_	_
43	shown	show	VBN	VBN	_	31	parataxis	_	_
44	)	)	-RRB-	-RRB-	_	43	punct	_	_
45	.	.	.	.	_	9	punct	_	_

1	Importantly	importantly	RB	RB	_	23	advmod	_	_
2	,	,	,	,	_	23	punct	_	_
3	the	the	DT	DT	_	5	det	_	_
4	total	total	JJ	JJ	_	5	amod	_	_
5	amount	amount	NN	NN	_	23	nsubj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	APP	app	NN	NN	_	6	pobj	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	endogenous	endogenous	JJ	JJ	_	7	parataxis	_	_
10	plus	plus	CC	CC	_	9	cc	_	_
11	transgenic	transgenic	JJ	JJ	_	9	conj	_	_
12	)	)	-RRB-	-RRB-	_	9	punct	_	_
13	and	and	CC	CC	_	7	cc	_	_
14	related	related	JJ	JJ	_	15	amod	_	_
15	APLPs	aplps	NNS	NNS	_	7	conj	_	_
16	in	in	IN	IN	sem=LOC	5	prep	_	_
17	both	both	CC	CC	_	18	preconj	_	_
18	acute	acute	JJ	JJ	_	22	amod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	chronically	chronically	RB	RB	_	21	advmod	_	_
21	treated	treat	VBN	VBN	_	18	conj	_	_
22	animals	animal	NNS	NNS	_	16	pobj	_	_
23	was	be	VBD	VBD	_	0	root	_	_
24	statistically	statistically	RB	RB	_	25	advmod	_	_
25	indistinguishable	indistinguishable	JJ	JJ	syn=PRD	23	acomp	_	_
26	from	from	IN	IN	_	25	prep	_	_
27	that	that	DT	DT	_	26	pobj	_	_
28	in	in	IN	IN	sem=LOC	27	prep	_	_
29	nontransgenic	nontransgenic	JJ	JJ	_	30	amod	_	_
30	mice	mouse	NNS	NNS	_	28	pobj	_	_
31	(	(	-LRB-	-LRB-	_	33	punct	_	_
32	Figure	figure	NN	NN	_	33	compound	_	_
33	1D	0d	NN	NN	_	23	parataxis	_	_
34	;	;	:	:	_	33	punct	_	_
35	statistical	statistical	JJ	JJ	_	36	amod	_	_
36	analyses	analysis	NNS	NNS	_	43	nsubjpass	_	_
37	for	for	IN	IN	_	36	prep	_	_
38	experiments	experiment	NNS	NNS	_	37	pobj	_	_
39	throughout	throughout	IN	IN	_	38	prep	_	_
40	the	the	DT	DT	_	41	det	_	_
41	study	study	NN	NN	_	39	pobj	_	_
42	are	be	VBP	VBP	_	43	auxpass	_	_
43	presented	present	VBN	VBN	_	33	ccomp	_	_
44	in	in	IN	IN	_	43	prep	_	_
45	the	the	DT	DT	_	48	det	_	_
46	accompanying	accompany	VBG	VBG	_	48	amod	_	_
47	figure	figure	NN	NN	_	48	compound	_	_
48	legends	legend	NNS	NNS	_	44	pobj	_	_
49	)	)	-RRB-	-RRB-	_	33	punct	_	_
50	.	.	.	.	_	23	punct	_	_

1	To	to	TO	TO	_	2	aux	_	_
2	ensure	ensure	VB	VB	sem=PRP	24	advcl	_	_
3	that	that	IN	IN	_	7	mark	_	_
4	Aβ	aβ	NN	NN	_	5	compound	_	_
5	production	production	NN	NN	_	7	nsubjpass	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	suppressed	suppress	VBN	VBN	_	2	ccomp	_	_
8	in	in	IN	IN	_	7	prep	_	_
9	concert	concert	NN	NN	_	8	pobj	_	_
10	with	with	IN	IN	_	9	prep	_	_
11	the	the	DT	DT	_	15	det	_	_
12	dox	dox	NN	NN	_	14	npadvmod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	mediated	mediate	VBN	VBN	_	15	amod	_	_
15	inhibition	inhibition	NN	NN	_	10	pobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	its	its	PRP$	PRP$	_	18	poss	_	_
18	precursor	precursor	NN	NN	_	16	pobj	_	_
19	APPswe	appswe	NN	NN	_	21	compound	_	_
20	/	/	HYPH	HYPH	_	21	punct	_	_
21	ind	ind	NN	NN	_	18	appos	_	_
22	,	,	,	,	_	24	punct	_	_
23	we	we	PRP	PRP	_	24	nsubj	_	_
24	measured	measure	VBD	VBD	_	0	root	_	_
25	Aβ40	aβ0	NN	NN	_	28	nmod	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	Aβ42	aβ0	NN	NN	_	25	conj	_	_
28	levels	level	NNS	NNS	_	24	dobj	_	_
29	by	by	IN	IN	sem=MNR	24	prep	_	_
30	ELISA	elisa	NN	NN	_	29	pobj	_	_
31	in	in	IN	IN	sem=LOC	24	prep	_	_
32	forebrain	forebrain	NN	NN	_	33	compound	_	_
33	homogenates	homogenate	NNS	NNS	_	31	pobj	_	_
34	from	from	IN	IN	_	33	prep	_	_
35	young	young	JJ	JJ	_	39	amod	_	_
36	tet	tet	NN	NN	_	38	compound	_	_
37	-	-	HYPH	HYPH	_	38	punct	_	_
38	off	off	NN	NN	_	39	compound	_	_
39	animals	animal	NNS	NNS	_	34	pobj	_	_
40	.	.	.	.	_	24	punct	_	_

1	At	at	IN	IN	sem=TMP	9	prep	_	_
2	1	0	CD	CD	_	3	nummod	_	_
3	mo	mo	NN	NN	_	1	pobj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	age	age	NN	NN	_	4	pobj	_	_
6	,	,	,	,	_	9	punct	_	_
7	the	the	DT	DT	_	8	det	_	_
8	mice	mouse	NNS	NNS	_	9	nsubj	_	_
9	lacked	lack	VBD	VBD	_	0	root	_	_
10	visible	visible	JJ	JJ	_	12	amod	_	_
11	amyloid	amyloid	NN	NN	_	12	compound	_	_
12	aggregates	aggregate	NNS	NNS	_	9	dobj	_	_
13	that	that	WDT	WDT	_	15	dep	_	12:ref
14	might	might	MD	MD	_	15	aux	_	_
15	act	act	VB	VB	_	12	relcl	_	_
16	as	as	IN	IN	_	15	prep	_	_
17	an	an	DT	DT	_	19	det	_	_
18	intractable	intractable	JJ	JJ	_	19	amod	_	_
19	reservoir	reservoir	NN	NN	_	16	pobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	peptide	peptide	NN	NN	_	20	pobj	_	_
22	remaining	remain	VBG	VBG	_	19	acl	_	_
23	in	in	IN	IN	sem=LOC	22	prep	_	_
24	the	the	DT	DT	_	25	det	_	_
25	brain	brain	NN	NN	_	23	pobj	_	_
26	after	after	IN	IN	_	31	prep	_	_
27	the	the	DT	DT	_	28	det	_	_
28	transgene	transgene	NN	NN	_	31	nsubjpass	_	_
29	had	have	VBD	VBD	_	31	aux	_	_
30	been	be	VBN	VBN	_	31	auxpass	_	_
31	suppressed	suppress	VBN	VBN	sem=TMP	22	advcl	_	_
32	.	.	.	.	_	9	punct	_	_

1	To	to	TO	TO	_	3	aux	_	_
2	further	far	RB	RB	_	3	advmod	_	_
3	ensure	ensure	VB	VB	sem=PRP	23	advcl	_	_
4	we	we	PRP	PRP	_	6	nsubj	_	_
5	could	could	MD	MD	_	6	aux	_	_
6	detect	detect	VB	VB	_	3	advcl	_	_
7	any	any	DT	DT	_	10	det	_	_
8	such	such	JJ	JJ	_	10	amod	_	_
9	insoluble	insoluble	JJ	JJ	_	10	amod	_	_
10	aggregates	aggregate	NNS	NNS	_	6	dobj	_	_
11	that	that	WDT	WDT	_	13	dep	_	10:ref
12	might	might	MD	MD	_	13	aux	_	_
13	bias	bias	VB	VB	_	10	relcl	_	_
14	our	our	PRP$	PRP$	_	15	poss	_	_
15	measure	measure	NN	NN	_	13	dobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	changes	change	NNS	NNS	_	16	pobj	_	_
18	in	in	IN	IN	_	13	prep	_	_
19	peptide	peptide	NN	NN	_	20	compound	_	_
20	synthesis	synthesis	NN	NN	_	18	pobj	_	_
21	,	,	,	,	_	23	punct	_	_
22	we	we	PRP	PRP	_	23	nsubj	_	_
23	performed	performed	VBD	VBD	_	0	root	_	_
24	a	a	DT	DT	_	29	det	_	_
25	sequential	sequential	JJ	JJ	_	29	amod	_	_
26	three	#crd#	CD	CD	_	28	nummod	_	_
27	-	-	HYPH	HYPH	_	28	punct	_	_
28	step	step	NN	NN	_	29	compound	_	_
29	extraction	extraction	NN	NN	_	23	dobj	_	_
30	with	with	IN	IN	_	29	prep	_	_
31	PBS	pbs	NN	NN	_	30	pobj	_	_
32	,	,	,	,	_	31	punct	_	_
33	2	0	CD	CD	_	34	nummod	_	_
34	%	%	NN	NN	_	35	compound	_	_
35	SDS	sds	NN	NN	_	31	conj	_	_
36	,	,	,	,	_	35	punct	_	_
37	and	and	CC	CC	_	35	cc	_	_
38	70	0	CD	CD	_	39	nummod	_	_
39	%	%	NN	NN	_	40	compound	_	_
40	FA	fa	NN	NN	_	35	conj	_	_
41	that	that	WDT	WDT	_	43	dep	_	29:ref
42	would	would	MD	MD	_	43	aux	_	_
43	separate	separate	VB	VB	_	29	relcl	_	_
44	peptides	peptide	NNS	NNS	_	43	dobj	_	_
45	by	by	IN	IN	sem=MNR	43	prep	_	_
46	solubility	solubility	NN	NN	_	45	pobj	_	_
47	.	.	.	.	_	23	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	compared	compare	VBD	VBD	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	levels	level	NNS	NNS	_	2	dobj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	human	human	JJ	JJ	_	7	amod	_	_
7	transgene	transgene	NN	NN	_	9	npadvmod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	derived	derive	VBN	VBN	_	10	amod	_	_
10	Aβ40	aβ0	NN	NN	_	5	pobj	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	Aβ42	aβ0	NN	NN	_	10	conj	_	_
13	in	in	IN	IN	sem=LOC	4	prep	_	_
14	untreated	untreated	JJ	JJ	_	15	amod	_	_
15	mice	mouse	NNS	NNS	_	13	pobj	_	_
16	at	at	IN	IN	sem=TMP	4	prep	_	_
17	4	0	CD	CD	_	20	nummod	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	6	0	CD	CD	_	17	conj	_	_
20	wk	wk	NN	NN	_	16	pobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	age	age	NN	NN	_	21	pobj	_	_
23	to	to	IN	IN	_	2	prep	_	_
24	animals	animal	NNS	NNS	_	23	pobj	_	_
25	that	that	WDT	WDT	_	29	dep	_	24:ref
26	had	have	VBD	VBD	_	29	aux	_	_
27	either	either	CC	CC	_	29	preconj	_	_
28	been	be	VBN	VBN	_	29	auxpass	_	_
29	born	bear	VBN	VBN	_	24	advcl	_	_
30	and	and	CC	CC	_	29	cc	_	_
31	raised	raise	VBN	VBN	_	29	conj	_	_
32	on	on	IN	IN	_	31	prep	_	_
33	dox	dox	NN	NN	_	32	pobj	_	_
34	or	or	CC	CC	_	29	cc	_	_
35	that	that	WDT	WDT	_	38	dep	_	24:ref
36	had	have	VBD	VBD	_	38	aux	_	_
37	been	be	VBN	VBN	_	38	auxpass	_	_
38	left	leave	VBN	VBN	_	29	conj	_	_
39	untreated	untreated	JJ	JJ	syn=PRD	38	oprd	_	_
40	for	for	IN	IN	sem=TMP	38	prep	_	_
41	4	0	CD	CD	_	42	nummod	_	_
42	wk	wk	NN	NN	_	40	pobj	_	_
43	and	and	CC	CC	_	38	cc	_	_
44	then	then	RB	RB	sem=TMP	45	advmod	_	_
45	placed	place	VBN	VBN	_	38	conj	_	_
46	on	on	IN	IN	_	45	prep	_	_
47	dox	dox	NN	NN	_	48	compound	_	_
48	chow	chow	NN	NN	_	46	pobj	_	_
49	for	for	IN	IN	sem=TMP	45	prep	_	_
50	2	0	CD	CD	_	51	nummod	_	_
51	wk	wk	NN	NN	_	49	pobj	_	_
52	prior	prior	JJ	JJ	_	53	amod	_	_
53	to	to	IN	IN	sem=TMP	51	prep	_	_
54	harvest	harvest	NN	NN	_	53	pobj	_	_
55	(	(	-LRB-	-LRB-	_	70	punct	_	_
56	the	the	DT	DT	_	58	det	_	_
57	same	same	JJ	JJ	_	58	amod	_	_
58	groups	group	NNS	NNS	_	70	dep	_	_
59	described	describe	VBN	VBN	_	58	acl	_	_
60	above	above	RB	RB	_	59	advmod	_	_
61	for	for	IN	IN	_	59	prep	_	_
62	immunoblot	immunoblot	NN	NN	_	63	compound	_	_
63	analysis	analysis	NN	NN	_	61	pobj	_	_
64	of	of	IN	IN	_	63	prep	_	_
65	APPswe	appswe	NN	NN	_	67	compound	_	_
66	/	/	HYPH	HYPH	_	67	punct	_	_
67	ind	ind	NN	NN	_	68	compound	_	_
68	levels	level	NNS	NNS	_	64	pobj	_	_
69	,	,	,	,	_	70	punct	_	_
70	line	line	NN	NN	_	45	parataxis	_	_
71	107	0	CD	CD	_	70	nummod	_	_
72	)	)	-RRB-	-RRB-	_	70	punct	_	_
73	.	.	.	.	_	2	punct	_	_

1	Consistent	consistent	JJ	JJ	syn=PRD	23	advcl	_	_
2	with	with	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	4	det	_	_
4	reduction	reduction	NN	NN	_	2	pobj	_	_
5	in	in	IN	IN	_	4	prep	_	_
6	full	full	JJ	JJ	_	8	amod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	length	length	NN	NN	_	12	compound	_	_
9	APPswe	appswe	NN	NN	_	11	compound	_	_
10	/	/	HYPH	HYPH	_	11	punct	_	_
11	ind	ind	NN	NN	_	12	compound	_	_
12	synthesis	synthesis	NN	NN	_	5	pobj	_	_
13	shown	show	VBN	VBN	_	4	acl	_	_
14	by	by	IN	IN	_	13	agent	_	_
15	immunoblot	immunoblot	NN	NN	_	14	pobj	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	see	see	VB	VB	_	1	parataxis	_	_
18	Figure	figure	NN	NN	_	17	dobj	_	_
19	1	0	CD	CD	_	18	nummod	_	_
20	)	)	-RRB-	-RRB-	_	17	punct	_	_
21	,	,	,	,	_	23	punct	_	_
22	we	we	PRP	PRP	_	23	nsubj	_	_
23	found	find	VBD	VBD	_	0	root	_	_
24	that	that	IN	IN	_	32	mark	_	_
25	transgene	transgene	NN	NN	_	27	npadvmod	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	derived	derive	VBN	VBN	_	29	amod	_	_
28	Aβ	aβ	NN	NN	_	29	compound	_	_
29	levels	level	NNS	NNS	_	32	nsubjpass	_	_
30	were	be	VBD	VBD	_	32	auxpass	_	_
31	completely	completely	RB	RB	_	32	advmod	_	_
32	suppressed	suppress	VBN	VBN	_	23	ccomp	_	_
33	in	in	IN	IN	sem=LOC	32	prep	_	_
34	animals	animal	NNS	NNS	_	33	pobj	_	_
35	born	bear	VBN	VBN	_	34	acl	_	_
36	and	and	CC	CC	_	35	cc	_	_
37	raised	raise	VBN	VBN	_	35	conj	_	_
38	on	on	IN	IN	_	37	prep	_	_
39	dox	dox	NN	NN	_	38	pobj	_	_
40	,	,	,	,	_	32	punct	_	_
41	and	and	CC	CC	_	32	cc	_	_
42	were	be	VBD	VBD	_	44	auxpass	_	_
43	sharply	sharply	RB	RB	_	44	advmod	_	_
44	reduced	reduce	VBN	VBN	_	32	conj	_	_
45	following	follow	VBG	VBG	sem=TMP	44	prep	_	_
46	acute	acute	JJ	JJ	_	52	amod	_	_
47	(	(	-LRB-	-LRB-	_	49	punct	_	_
48	2	0	CD	CD	_	49	nummod	_	_
49	wk	wk	NN	NN	_	46	parataxis	_	_
50	)	)	-RRB-	-RRB-	_	49	punct	_	_
51	antibiotic	antibiotic	JJ	JJ	_	52	amod	_	_
52	treatment	treatment	NN	NN	_	45	pobj	_	_
53	.	.	.	.	_	23	punct	_	_

1	Compared	compare	VBN	VBN	_	18	prep	_	_
2	to	to	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	4	det	_	_
4	levels	level	NNS	NNS	_	2	pobj	_	_
5	in	in	IN	IN	sem=LOC	4	prep	_	_
6	untreated	untreated	JJ	JJ	_	12	amod	_	_
7	4	0	CD	CD	_	9	nummod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	wk	wk	NN	NN	_	11	npadvmod	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	old	old	JJ	JJ	_	12	amod	_	_
12	mice	mouse	NNS	NNS	_	5	pobj	_	_
13	,	,	,	,	_	18	punct	_	_
14	PBS	pbs	NN	NN	_	16	npadvmod	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	soluble	soluble	JJ	JJ	_	17	amod	_	_
17	Aβ42	aβ0	NN	NN	_	18	nsubj	_	_
18	dropped	drop	VBD	VBD	_	0	root	_	_
19	by	by	IN	IN	sem=EXT	18	prep	_	19:gap
20	95.2	0	CD	CD	_	21	nummod	_	_
21	%	%	NN	NN	_	19	pobj	_	_
22	following	follow	VBG	VBG	sem=TMP	18	prep	_	_
23	2	0	CD	CD	_	24	nummod	_	_
24	wk	wk	NN	NN	_	22	pobj	_	_
25	of	of	IN	IN	_	24	prep	_	_
26	dox	dox	NN	NN	_	27	compound	_	_
27	treatment	treatment	NN	NN	_	25	pobj	_	_
28	and	and	CC	CC	_	18	cc	_	_
29	by	by	IN	IN	sem=EXT	32	prep	_	19:gap
30	99.2	0	CD	CD	_	31	nummod	_	_
31	%	%	NN	NN	_	29	pobj	_	_
32	with	with	IN	IN	_	18	conj	_	_
33	chronic	chronic	JJ	JJ	_	34	amod	_	_
34	treatment	treatment	NN	NN	_	32	pobj	_	_
35	(	(	-LRB-	-LRB-	_	37	punct	_	_
36	Figure	figure	NN	NN	_	37	compound	_	_
37	2A	0a	NN	NN	_	32	parataxis	_	_
38	)	)	-RRB-	-RRB-	_	37	punct	_	_
39	.	.	.	.	_	18	punct	_	_

1	Similarly	similarly	RB	RB	_	7	advmod	_	_
2	,	,	,	,	_	7	punct	_	_
3	SDS	sds	NN	NN	_	5	npadvmod	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	soluble	soluble	JJ	JJ	_	6	amod	_	_
6	Aβ42	aβ0	NN	NN	_	7	nsubj	_	_
7	decreased	decrease	VBD	VBD	_	0	root	_	_
8	by	by	IN	IN	sem=EXT	7	prep	_	_
9	75.2	0	CD	CD	_	10	nummod	_	_
10	%	%	NN	NN	_	8	pobj	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	94.8	0	CD	CD	_	13	nummod	_	_
13	%	%	NN	NN	_	10	conj	_	_
14	following	follow	VBG	VBG	_	7	prep	_	_
15	2	0	CD	CD	_	17	nummod	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	wk	wk	NN	NN	_	21	nmod	_	_
18	or	or	CC	CC	_	17	cc	_	_
19	lifelong	lifelong	JJ	JJ	_	17	conj	_	_
20	dox	dox	NN	NN	_	21	compound	_	_
21	treatment	treatment	NN	NN	_	14	pobj	_	_
22	(	(	-LRB-	-LRB-	_	24	punct	_	_
23	Figure	figure	NN	NN	_	24	compound	_	_
24	2B	0b	NN	NN	_	7	parataxis	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	.	.	.	.	_	7	punct	_	_

1	Only	only	RB	RB	_	4	advmod	_	_
2	the	the	DT	DT	_	4	det	_	_
3	FA	fa	NN	NN	_	4	compound	_	_
4	fraction	fraction	NN	NN	_	5	nsubj	_	_
5	revealed	reveal	VBD	VBD	_	0	root	_	_
6	a	a	DT	DT	_	11	det	_	_
7	small	small	JJ	JJ	_	11	amod	_	_
8	dox	dox	NN	NN	_	10	npadvmod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	resistant	resistant	JJ	JJ	_	11	amod	_	_
11	pool	pool	NN	NN	_	5	dobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	peptide	peptide	NN	NN	_	12	pobj	_	_
14	in	in	IN	IN	sem=LOC	11	prep	_	_
15	acutely	acutely	RB	RB	_	16	advmod	_	_
16	treated	treat	VBN	VBN	_	17	amod	_	_
17	animals	animal	NNS	NNS	_	14	pobj	_	_
18	that	that	WDT	WDT	_	20	dep	_	11:ref
19	we	we	PRP	PRP	_	20	nsubj	_	_
20	believe	believe	VBP	VBP	_	11	relcl	_	_
21	represents	represent	VBZ	VBZ	_	20	advcl	_	_
22	stable	stable	JJ	JJ	_	24	amod	_	_
23	predeposit	predeposit	JJ	JJ	_	24	amod	_	_
24	aggregates	aggregate	NNS	NNS	_	21	dobj	_	_
25	that	that	WDT	WDT	_	28	dep	_	24:ref
26	have	have	VBP	VBP	_	28	aux	_	_
27	already	already	RB	RB	_	28	advmod	_	_
28	accumulated	accumulate	VBN	VBN	_	24	relcl	_	_
29	by	by	IN	IN	sem=TMP	28	prep	_	_
30	4	0	CD	CD	_	31	nummod	_	_
31	wk	wk	NN	NN	_	29	pobj	_	_
32	of	of	IN	IN	_	31	prep	_	_
33	age	age	NN	NN	_	32	pobj	_	_
34	when	when	WRB	WRB	_	37	advmod	_	_
35	treatment	treatment	NN	NN	_	37	nsubjpass	_	_
36	was	be	VBD	VBD	_	37	auxpass	_	_
37	begun	begin	VBN	VBN	sem=TMP	28	advcl	_	_
38	(	(	-LRB-	-LRB-	_	40	punct	_	_
39	Figure	figure	NN	NN	_	40	compound	_	_
40	2C	0c	NN	NN	_	5	parataxis	_	_
41	)	)	-RRB-	-RRB-	_	40	punct	_	_
42	.	.	.	.	_	5	punct	_	_

1	Indeed	indeed	RB	RB	_	13	advmod	_	_
2	,	,	,	,	_	13	punct	_	_
3	animals	animal	NNS	NNS	_	13	nsubj	_	_
4	that	that	WDT	WDT	_	6	dep	_	3:ref
5	were	be	VBD	VBD	_	6	auxpass	_	_
6	born	bear	VBN	VBN	_	3	relcl	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	raised	raise	VBN	VBN	_	6	conj	_	_
9	on	on	IN	IN	_	8	prep	_	_
10	dox	dox	NN	NN	_	9	pobj	_	_
11	did	do	VBD	VBD	_	13	aux	_	_
12	not	not	RB	RB	_	13	neg	_	_
13	harbor	harbor	VB	VB	_	0	root	_	_
14	this	this	DT	DT	_	15	det	_	_
15	reservoir	reservoir	NN	NN	_	13	dobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	treatment	treatment	NN	NN	_	19	npadvmod	_	_
18	-	-	HYPH	HYPH	_	19	punct	_	_
19	resistant	resistant	JJ	JJ	_	20	amod	_	_
20	peptide	peptide	NN	NN	_	16	pobj	_	_
21	,	,	,	,	_	13	punct	_	_
22	with	with	IN	IN	_	13	prep	_	_
23	96.3	0	CD	CD	_	24	nummod	_	_
24	%	%	NN	NN	_	25	npadvmod	_	_
25	less	less	JJR	JJR	_	26	amod	_	_
26	Aβ42	aβ0	NN	NN	_	22	pobj	_	_
27	than	than	IN	IN	_	26	prep	_	_
28	untreated	untreated	JJ	JJ	_	34	amod	_	_
29	4	0	CD	CD	_	31	nummod	_	_
30	-	-	HYPH	HYPH	_	31	punct	_	_
31	wk	wk	NN	NN	_	33	npadvmod	_	_
32	-	-	HYPH	HYPH	_	33	punct	_	_
33	old	old	JJ	JJ	_	34	amod	_	_
34	mice	mouse	NNS	NNS	_	27	pobj	_	_
35	.	.	.	.	_	13	punct	_	_

1	Measurement	measurement	NN	NN	_	18	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	total	total	JJ	JJ	_	4	amod	_	_
4	Aβ	aβ	NN	NN	_	2	pobj	_	_
5	in	in	IN	IN	sem=LOC	1	prep	_	_
6	chronically	chronically	RB	RB	_	7	advmod	_	_
7	treated	treat	VBN	VBN	_	8	amod	_	_
8	mice	mouse	NNS	NNS	_	5	pobj	_	_
9	,	,	,	,	_	1	punct	_	_
10	including	include	VBG	VBG	_	1	prep	_	_
11	endogenous	endogenous	JJ	JJ	_	16	amod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	transgene	transgene	NN	NN	_	15	npadvmod	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	derived	derive	VBN	VBN	_	11	conj	_	_
16	peptide	peptide	NN	NN	_	10	pobj	_	_
17	,	,	,	,	_	18	punct	_	_
18	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
19	that	that	IN	IN	_	29	mark	_	_
20	Aβ	aβ	NN	NN	_	21	compound	_	_
21	levels	level	NNS	NNS	_	29	nsubjpass	_	_
22	in	in	IN	IN	sem=LOC	21	prep	_	_
23	tet	tet	NN	NN	_	25	compound	_	_
24	-	-	HYPH	HYPH	_	25	punct	_	_
25	off	off	NN	NN	_	27	compound	_	_
26	APP	app	NN	NN	_	27	compound	_	_
27	mice	mouse	NNS	NNS	_	22	pobj	_	_
28	were	be	VBD	VBD	_	29	auxpass	_	_
29	reduced	reduce	VBN	VBN	_	18	ccomp	_	_
30	to	to	IN	IN	_	29	prep	_	_
31	the	the	DT	DT	_	32	det	_	_
32	level	level	NN	NN	_	30	pobj	_	_
33	of	of	IN	IN	_	32	prep	_	_
34	endogenous	endogenous	JJ	JJ	_	35	amod	_	_
35	peptide	peptide	NN	NN	_	33	pobj	_	_
36	found	find	VBN	VBN	_	32	acl	_	_
37	in	in	IN	IN	sem=LOC	36	prep	_	_
38	nontransgenic	nontransgenic	JJ	JJ	_	39	amod	_	_
39	animals	animal	NNS	NNS	_	37	pobj	_	_
40	(	(	-LRB-	-LRB-	_	42	punct	_	_
41	Figure	figure	NN	NN	_	42	compound	_	_
42	2D	0d	NN	NN	_	29	parataxis	_	_
43	)	)	-RRB-	-RRB-	_	42	punct	_	_
44	.	.	.	.	_	18	punct	_	_

1	Taken	take	VBN	VBN	syn=ADV	18	advcl	_	_
2	together	together	RB	RB	_	1	advmod	_	_
3	with	with	IN	IN	_	1	prep	_	_
4	the	the	DT	DT	_	6	det	_	_
5	immunoblotting	immunoblotting	NN	NN	_	6	compound	_	_
6	data	datum	NNS	NNS	_	3	pobj	_	_
7	for	for	IN	IN	_	6	prep	_	_
8	full	full	JJ	JJ	_	10	amod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	length	length	NN	NN	_	13	compound	_	_
11	APPswe	appswe	NN	NN	_	13	compound	_	_
12	/	/	HYPH	HYPH	_	13	punct	_	_
13	ind	ind	NN	NN	_	7	pobj	_	_
14	,	,	,	,	_	18	punct	_	_
15	the	the	DT	DT	_	17	det	_	_
16	ELISA	elisa	NN	NN	_	17	compound	_	_
17	measurements	measurement	NNS	NNS	_	18	nsubj	_	_
18	indicate	indicate	VBP	VBP	_	0	root	_	_
19	that	that	IN	IN	_	30	mark	_	_
20	dox	dox	NN	NN	_	22	npadvmod	_	_
21	-	-	HYPH	HYPH	_	22	punct	_	_
22	mediated	mediate	VBN	VBN	_	23	amod	_	_
23	suppression	suppression	NN	NN	_	30	nsubj	_	_
24	of	of	IN	IN	_	23	prep	_	_
25	transgenic	transgenic	JJ	JJ	_	29	amod	_	_
26	APPswe	appswe	NN	NN	_	28	compound	_	_
27	/	/	HYPH	HYPH	_	28	punct	_	_
28	ind	ind	NN	NN	_	29	compound	_	_
29	synthesis	synthesis	NN	NN	_	24	pobj	_	_
30	leads	lead	VBZ	VBZ	_	18	ccomp	_	_
31	to	to	IN	IN	_	30	prep	_	_
32	parallel	parallel	JJ	JJ	_	33	amod	_	_
33	reduction	reduction	NN	NN	_	31	pobj	_	_
34	of	of	IN	IN	_	33	prep	_	_
35	Aβ	aβ	NN	NN	_	36	compound	_	_
36	levels	level	NNS	NNS	_	34	pobj	_	_
37	.	.	.	.	_	18	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	ELISA	elisa	NN	NN	_	3	compound	_	_
3	data	datum	NNS	NNS	_	5	nsubj	_	_
4	also	also	RB	RB	_	5	advmod	_	_
5	confirmed	confirm	VBD	VBD	_	0	root	_	_
6	that	that	IN	IN	_	14	mark	_	_
7	incorporation	incorporation	NN	NN	_	14	nsubj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	13	det	_	_
10	Swedish	swedish	JJ	JJ	_	13	amod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	Indiana	indiana	NNP	NNP	_	10	conj	_	_
13	mutations	mutation	NNS	NNS	_	8	pobj	_	_
14	led	lead	VBD	VBD	_	5	ccomp	_	_
15	to	to	IN	IN	_	14	prep	_	_
16	high	high	JJ	JJ	_	17	amod	_	_
17	levels	level	NNS	NNS	_	15	pobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	Aβ42	aβ0	NN	NN	_	18	pobj	_	_
20	,	,	,	,	_	17	punct	_	_
21	which	which	WDT	WDT	_	23	dep	_	17:ref
22	we	we	PRP	PRP	_	23	nsubj	_	_
23	predicted	predict	VBD	VBD	_	17	relcl	_	_
24	would	would	MD	MD	_	25	aux	_	_
25	induce	induce	VB	VB	_	23	advcl	_	_
26	rapid	rapid	JJ	JJ	_	28	amod	_	_
27	plaque	plaque	NN	NN	_	28	compound	_	_
28	formation	formation	NN	NN	_	25	dobj	_	_
29	in	in	IN	IN	sem=LOC	25	prep	_	_
30	untreated	untreated	JJ	JJ	_	31	amod	_	_
31	animals	animal	NNS	NNS	_	29	pobj	_	_
32	.	.	.	.	_	5	punct	_	_

1	Histological	histological	JJ	JJ	_	2	parataxis	_	_
2	characterization	characterization	NN	NN	_	18	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	double	double	JJ	JJ	_	17	amod	_	_
5	transgenic	transgenic	JJ	JJ	_	17	amod	_	_
6	(	(	-LRB-	-LRB-	_	13	punct	_	_
7	CaMKIIα	camkiiα	NN	NN	_	13	nmod	_	_
8	-	-	HYPH	HYPH	_	13	punct	_	_
9	tTA	tta	NN	NN	_	13	nmod	_	_
10	×	×	SYM	SYM	_	13	punct	_	_
11	tet	tet	NN	NN	_	13	compound	_	_
12	-	-	HYPH	HYPH	_	13	punct	_	_
13	APPswe	appswe	NN	NN	_	17	parataxis	_	_
14	/	/	HYPH	HYPH	_	13	punct	_	_
15	ind	ind	JJ	JJ	_	13	amod	_	_
16	)	)	-RRB-	-RRB-	_	13	punct	_	_
17	mice	mouse	NNS	NNS	_	3	pobj	_	_
18	revealed	reveal	VBD	VBD	_	0	root	_	_
19	early	early	JJ	JJ	_	21	amod	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	onset	onset	NN	NN	_	23	compound	_	_
22	amyloid	amyloid	NN	NN	_	23	compound	_	_
23	formation	formation	NN	NN	_	18	dobj	_	_
24	in	in	IN	IN	_	18	prep	_	_
25	all	all	DT	DT	_	28	det	_	_
26	four	#crd#	CD	CD	_	28	nummod	_	_
27	new	new	JJ	JJ	_	28	amod	_	_
28	lines	line	NNS	NNS	_	24	pobj	_	_
29	.	.	.	.	_	18	punct	_	_

1	Amyloid	amyloid	NN	NN	_	2	compound	_	_
2	plaques	plaque	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	seen	see	VBN	VBN	_	0	root	_	_
5	in	in	IN	IN	sem=LOC	4	prep	_	_
6	mice	mouse	NNS	NNS	_	5	pobj	_	_
7	as	as	RB	RB	_	8	advmod	_	_
8	young	young	JJ	JJ	_	6	amod	_	_
9	as	as	IN	IN	_	8	prep	_	_
10	8	0	CD	CD	_	11	nummod	_	_
11	wk	wk	NN	NN	_	9	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	age	age	NN	NN	_	12	pobj	_	_
14	(	(	-LRB-	-LRB-	_	17	punct	_	_
15	data	datum	NNS	NNS	_	17	nsubj	_	_
16	not	not	RB	RB	_	17	neg	_	_
17	shown	show	VBN	VBN	_	4	parataxis	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	.	.	.	.	_	4	punct	_	_

1	Plaques	plaque	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	limited	limit	VBN	VBN	_	0	root	_	_
4	to	to	IN	IN	_	3	prep	_	_
5	the	the	DT	DT	_	6	det	_	_
6	forebrain	forebrain	NN	NN	_	4	pobj	_	_
7	,	,	,	,	_	6	punct	_	_
8	including	include	VBG	VBG	_	6	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	cortex	cortex	NN	NN	_	8	pobj	_	_
11	,	,	,	,	_	10	punct	_	_
12	hippocampus	hippocampus	NN	NN	_	10	conj	_	_
13	,	,	,	,	_	12	punct	_	_
14	olfactory	olfactory	JJ	JJ	_	15	amod	_	_
15	bulb	bulb	NN	NN	_	12	conj	_	_
16	,	,	,	,	_	15	punct	_	_
17	and	and	CC	CC	_	15	cc	_	_
18	striatum	striatum	NN	NN	_	15	conj	_	_
19	,	,	,	,	_	6	punct	_	_
20	where	where	WRB	WRB	_	25	advmod	_	6:ref
21	the	the	DT	DT	_	23	det	_	_
22	CaMKIIα	camkiiα	NN	NN	_	23	compound	_	_
23	promoter	promoter	NN	NN	_	25	nsubjpass	_	_
24	is	be	VBZ	VBZ	_	25	auxpass	_	_
25	known	know	VBN	VBN	_	6	relcl	_	_
26	to	to	TO	TO	_	27	aux	_	_
27	be	be	VB	VB	_	25	xcomp	_	_
28	most	most	RBS	RBS	_	29	advmod	_	_
29	active	active	JJ	JJ	syn=PRD	27	acomp	_	_
30	[	[	-LRB-	-LRB-	_	33	punct	_	_
31	16	0	CD	CD	_	33	nummod	_	_
32	,	,	,	,	_	33	punct	_	_
33	28	0	CD	CD	_	25	parataxis	_	_
34	]	]	-RRB-	-RRB-	_	33	punct	_	_
35	(	(	-LRB-	-LRB-	_	37	punct	_	_
36	Figure	figure	NN	NN	_	37	compound	_	_
37	S2	s0	NN	NN	_	3	parataxis	_	_
38	)	)	-RRB-	-RRB-	_	37	punct	_	_
39	.	.	.	.	_	3	punct	_	_

1	By	by	IN	IN	sem=TMP	9	prep	_	_
2	6	0	CD	CD	_	3	nummod	_	_
3	mo	mo	NN	NN	_	1	pobj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	age	age	NN	NN	_	4	pobj	_	_
6	,	,	,	,	_	9	punct	_	_
7	amyloid	amyloid	NN	NN	_	8	compound	_	_
8	burden	burden	NN	NN	_	9	nsubj	_	_
9	became	become	VBD	VBD	_	0	root	_	_
10	severe	severe	JJ	JJ	syn=PRD	9	acomp	_	_
11	,	,	,	,	_	9	punct	_	_
12	covering	cover	VBG	VBG	syn=ADV	9	advcl	_	_
13	large	large	JJ	JJ	_	14	amod	_	_
14	areas	area	NNS	NNS	_	12	dobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	the	the	DT	DT	_	17	det	_	_
17	cortex	cortex	NN	NN	_	15	pobj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	hippocampus	hippocampus	NN	NN	_	17	conj	_	_
20	(	(	-LRB-	-LRB-	_	22	punct	_	_
21	Figure	figure	NN	NN	_	22	compound	_	_
22	S3	s0	NN	NN	_	12	parataxis	_	_
23	)	)	-RRB-	-RRB-	_	22	punct	_	_
24	.	.	.	.	_	9	punct	_	_

1	No	no	DT	DT	_	2	det	_	_
2	lesions	lesion	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	seen	see	VBN	VBN	_	0	root	_	_
5	in	in	IN	IN	sem=LOC	4	prep	_	_
6	the	the	DT	DT	_	7	det	_	_
7	cerebellum	cerebellum	NN	NN	_	5	pobj	_	_
8	or	or	CC	CC	_	7	cc	_	_
9	brain	brain	NN	NN	_	10	compound	_	_
10	stem	stem	NN	NN	_	7	conj	_	_
11	even	even	RB	RB	_	12	advmod	_	_
12	at	at	IN	IN	sem=TMP	4	prep	_	_
13	late	late	JJ	JJ	_	14	amod	_	_
14	ages	age	NNS	NNS	_	12	pobj	_	_
15	,	,	,	,	_	4	punct	_	_
16	consistent	consistent	JJ	JJ	syn=PRD	4	advcl	_	_
17	with	with	IN	IN	_	16	prep	_	_
18	CaMKIIα	camkiiα	NN	NN	_	20	npadvmod	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	controlled	control	VBN	VBN	_	22	amod	_	_
21	transgene	transgene	NN	NN	_	22	compound	_	_
22	expression	expression	NN	NN	_	17	pobj	_	_
23	.	.	.	.	_	4	punct	_	_

1	Unlike	unlike	IN	IN	_	23	prep	_	_
2	what	what	WP	WP	_	4	dep	_	_
3	is	be	VBZ	VBZ	_	4	auxpass	_	_
4	thought	think	VBN	VBN	syn=NOM	1	pcomp	_	_
5	to	to	TO	TO	_	6	aux	_	_
6	occur	occur	VB	VB	_	4	xcomp	_	_
7	in	in	IN	IN	sem=LOC	6	prep	_	_
8	the	the	DT	DT	_	10	det	_	_
9	human	human	JJ	JJ	_	10	amod	_	_
10	disease	disease	NN	NN	_	7	pobj	_	_
11	,	,	,	,	_	23	punct	_	_
12	the	the	DT	DT	_	15	det	_	_
13	first	#ord#	JJ	JJ	_	15	amod	_	_
14	visible	visible	JJ	JJ	_	15	amod	_	_
15	plaques	plaque	NNS	NNS	_	23	nsubj	_	_
16	in	in	IN	IN	sem=LOC	15	prep	_	_
17	the	the	DT	DT	_	22	det	_	_
18	tet	tet	NN	NN	_	20	compound	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	off	off	NN	NN	_	22	compound	_	_
21	APP	app	NN	NN	_	22	compound	_	_
22	mice	mouse	NNS	NNS	_	16	pobj	_	_
23	are	be	VBP	VBP	_	0	root	_	_
24	fibrillar	fibrillar	JJ	JJ	_	26	amod	_	_
25	-	-	HYPH	HYPH	_	26	punct	_	_
26	cored	core	VBN	VBN	_	27	amod	_	_
27	deposits	deposit	NNS	NNS	syn=PRD	23	attr	_	_
28	.	.	.	.	_	23	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	noted	note	VBN	VBN	_	0	root	_	_
4	the	the	DT	DT	_	7	det	_	_
5	same	same	JJ	JJ	_	7	amod	_	_
6	early	early	JJ	JJ	_	7	amod	_	_
7	appearance	appearance	NN	NN	_	3	dobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	cored	core	VBN	VBN	_	10	amod	_	_
10	deposits	deposit	NNS	NNS	_	8	pobj	_	_
11	in	in	IN	IN	sem=LOC	7	prep	_	_
12	other	other	JJ	JJ	_	13	amod	_	_
13	lines	line	NNS	NNS	_	11	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	APP	app	NN	NN	_	17	nmod	_	_
16	transgenic	transgenic	JJ	JJ	_	17	amod	_	_
17	mice	mouse	NNS	NNS	_	14	pobj	_	_
18	that	that	WDT	WDT	_	19	dep	_	13:ref
19	harbor	harbor	VBP	VBP	_	13	relcl	_	_
20	the	the	DT	DT	_	22	det	_	_
21	Swedish	swedish	JJ	JJ	_	22	amod	_	_
22	mutation	mutation	NN	NN	_	19	dobj	_	_
23	[	[	-LRB-	-LRB-	_	24	punct	_	_
24	27	0	CD	CD	_	3	parataxis	_	_
25	]	]	-RRB-	-RRB-	_	24	punct	_	_
26	.	.	.	.	_	3	punct	_	_

1	Diffuse	diffuse	NN	NN	_	2	compound	_	_
2	plaques	plaque	NNS	NNS	_	3	nsubj	_	_
3	were	be	VBD	VBD	_	0	root	_	_
4	apparent	apparent	JJ	JJ	syn=PRD	3	acomp	_	_
5	in	in	IN	IN	sem=LOC	3	prep	_	_
6	6	0	CD	CD	_	8	nummod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	mo	mo	NN	NN	_	10	npadvmod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	old	old	JJ	JJ	_	14	amod	_	_
11	tTA	tta	NN	NN	_	13	compound	_	_
12	/	/	HYPH	HYPH	_	13	punct	_	_
13	APP	app	NN	NN	_	14	compound	_	_
14	mice	mouse	NNS	NNS	_	5	pobj	_	_
15	,	,	,	,	_	3	punct	_	_
16	and	and	CC	CC	_	3	cc	_	_
17	became	become	VBD	VBD	_	3	conj	_	_
18	relatively	relatively	RB	RB	_	19	advmod	_	_
19	abundant	abundant	JJ	JJ	syn=PRD	17	acomp	_	_
20	by	by	IN	IN	sem=TMP	17	prep	_	_
21	9	0	CD	CD	_	22	nummod	_	_
22	mo	mo	NN	NN	_	20	pobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	age	age	NN	NN	_	23	pobj	_	_
25	.	.	.	.	_	3	punct	_	_

1	At	at	IN	IN	sem=TMP	12	prep	_	_
2	older	old	JJR	JJR	_	3	amod	_	_
3	ages	age	NNS	NNS	_	1	pobj	_	_
4	(	(	-LRB-	-LRB-	_	3	punct	_	_
5	9	0	CD	CD	_	7	quantmod	_	_
6	–	-	SYM	SYM	_	7	punct	_	_
7	12	0	CD	CD	_	8	nummod	_	_
8	mo	mo	NN	NN	_	3	appos	_	_
9	)	)	-RRB-	-RRB-	_	12	punct	_	_
10	amyloid	amyloid	NN	NN	_	11	compound	_	_
11	deposits	deposit	NNS	NNS	_	12	nsubj	_	_
12	were	be	VBD	VBD	_	0	root	_	_
13	visible	visible	JJ	JJ	syn=PRD	12	acomp	_	_
14	in	in	IN	IN	sem=LOC	12	prep	_	_
15	the	the	DT	DT	_	16	det	_	_
16	thalamus	thalamus	NN	NN	_	14	pobj	_	_
17	,	,	,	,	_	16	punct	_	_
18	which	which	WDT	WDT	_	22	dep	_	16:ref
19	has	have	VBZ	VBZ	_	22	aux	_	_
20	also	also	RB	RB	_	22	advmod	_	_
21	been	be	VBN	VBN	_	22	auxpass	_	_
22	observed	observe	VBN	VBN	_	16	relcl	_	_
23	in	in	IN	IN	sem=LOC	22	prep	_	_
24	mice	mouse	NNS	NNS	_	23	pobj	_	_
25	expressing	express	VBG	VBG	_	24	acl	_	_
26	mutant	mutant	NN	NN	_	27	compound	_	_
27	APP	app	NN	NN	_	25	dobj	_	_
28	via	via	IN	IN	sem=MNR	25	prep	_	_
29	the	the	DT	DT	_	33	det	_	_
30	Thy	thy	NN	NN	_	33	nmod	_	_
31	-	-	HYPH	HYPH	_	30	punct	_	_
32	1	0	CD	CD	_	30	nummod	_	_
33	promoter	promoter	NN	NN	_	28	pobj	_	_
34	.	.	.	.	_	12	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	presence	presence	NN	NN	_	11	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	amyloid	amyloid	NN	NN	_	5	compound	_	_
5	pathology	pathology	NN	NN	_	3	pobj	_	_
6	in	in	IN	IN	sem=LOC	2	prep	_	_
7	this	this	DT	DT	_	8	det	_	_
8	region	region	NN	NN	_	6	pobj	_	_
9	has	have	VBZ	VBZ	_	11	aux	_	_
10	been	be	VBN	VBN	_	11	auxpass	_	_
11	attributed	attribute	VBN	VBN	_	0	root	_	_
12	to	to	IN	IN	_	11	prep	_	_
13	axonal	axonal	JJ	JJ	_	14	amod	_	_
14	transport	transport	NN	NN	_	12	pobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	APP	app	NN	NN	_	18	compound	_	_
17	/	/	HYPH	HYPH	_	18	punct	_	_
18	Aβ	aβ	NN	NN	_	15	pobj	_	_
19	to	to	IN	IN	_	14	prep	_	_
20	the	the	DT	DT	_	21	det	_	_
21	terminals	terminal	NNS	NNS	_	19	pobj	_	_
22	of	of	IN	IN	_	21	prep	_	_
23	cortical	cortical	JJ	JJ	_	24	amod	_	_
24	neurons	neuron	NNS	NNS	_	22	pobj	_	_
25	in	in	IN	IN	sem=LOC	21	prep	_	_
26	the	the	DT	DT	_	27	det	_	_
27	thalamus	thalamus	NN	NN	_	25	pobj	_	_
28	[	[	-LRB-	-LRB-	_	29	punct	_	_
29	29	0	CD	CD	_	11	parataxis	_	_
30	]	]	-RRB-	-RRB-	_	29	punct	_	_
31	.	.	.	.	_	11	punct	_	_

1	Most	most	RBS	RBS	_	2	advmod	_	_
2	importantly	importantly	RB	RB	_	17	advmod	_	_
3	,	,	,	,	_	17	punct	_	_
4	only	only	RB	RB	_	7	advmod	_	_
5	double	double	JJ	JJ	_	6	amod	_	_
6	transgenic	transgenic	JJ	JJ	_	7	amod	_	_
7	mice	mouse	NNS	NNS	_	17	nsubj	_	_
8	,	,	,	,	_	7	punct	_	_
9	expressing	express	VBG	VBG	_	7	acl	_	_
10	both	both	CC	CC	_	15	preconj	_	_
11	the	the	DT	DT	_	15	det	_	_
12	tTA	tta	NN	NN	_	15	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	APP	app	NN	NN	_	12	conj	_	_
15	transgenes	transgene	NNS	NNS	_	9	dobj	_	_
16	,	,	,	,	_	17	punct	_	_
17	developed	develop	VBD	VBD	_	0	root	_	_
18	amyloid	amyloid	NN	NN	_	19	compound	_	_
19	lesions	lesion	NNS	NNS	_	17	dobj	_	_
20	.	.	.	.	_	17	punct	_	_

1	Single	single	JJ	JJ	_	2	amod	_	_
2	transgenic	transgenic	JJ	JJ	_	3	amod	_	_
3	mice	mouse	NNS	NNS	_	10	nsubj	_	_
4	up	up	IN	IN	_	6	quantmod	_	_
5	to	to	IN	IN	_	6	quantmod	_	_
6	15	0	CD	CD	_	7	nummod	_	_
7	mo	mo	NN	NN	sem=TMP	3	npadvmod	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	age	age	NN	NN	_	8	pobj	_	_
10	showed	show	VBD	VBD	_	0	root	_	_
11	no	no	DT	DT	_	12	det	_	_
12	sign	sign	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	pathology	pathology	NN	NN	_	13	pobj	_	_
15	(	(	-LRB-	-LRB-	_	17	punct	_	_
16	Figure	figure	NN	NN	_	17	compound	_	_
17	S3	s0	NN	NN	_	10	parataxis	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	.	.	.	.	_	10	punct	_	_

1	Similarly	similarly	RB	RB	_	8	advmod	_	_
2	,	,	,	,	_	8	punct	_	_
3	amyloid	amyloid	NN	NN	_	4	compound	_	_
4	pathology	pathology	NN	NN	_	8	nsubjpass	_	_
5	can	can	MD	MD	_	8	aux	_	_
6	be	be	VB	VB	_	8	auxpass	_	_
7	completely	completely	RB	RB	_	8	advmod	_	_
8	prevented	prevent	VBN	VBN	_	0	root	_	_
9	in	in	IN	IN	sem=LOC	8	prep	_	_
10	double	double	JJ	JJ	_	11	amod	_	_
11	transgenic	transgenic	JJ	JJ	_	12	amod	_	_
12	animals	animal	NNS	NNS	_	9	pobj	_	_
13	born	bear	VBN	VBN	_	12	acl	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	raised	raise	VBN	VBN	_	13	conj	_	_
16	on	on	IN	IN	_	15	prep	_	_
17	dox	dox	NN	NN	_	16	pobj	_	_
18	.	.	.	.	_	8	punct	_	_

1	Animals	animal	NNS	NNS	_	19	nsubj	_	_
2	from	from	IN	IN	_	1	prep	_	_
3	our	our	PRP$	PRP$	_	6	poss	_	_
4	highest	high	JJS	JJS	_	5	amod	_	_
5	expressing	express	VBG	VBG	_	6	amod	_	_
6	line	line	NN	NN	_	2	pobj	_	_
7	(	(	-LRB-	-LRB-	_	6	punct	_	_
8	line	line	NN	NN	_	6	appos	_	_
9	885	0	CD	CD	_	8	nummod	_	_
10	)	)	-RRB-	-RRB-	_	1	punct	_	_
11	maintained	maintain	VBN	VBN	_	1	acl	_	_
12	on	on	IN	IN	_	11	prep	_	_
13	dox	dox	NN	NN	_	12	pobj	_	_
14	for	for	IN	IN	sem=TMP	11	prep	_	_
15	up	up	IN	IN	_	14	prep	_	_
16	to	to	IN	IN	_	15	prep	_	_
17	1	0	CD	CD	_	18	nummod	_	_
18	y	y	NN	NN	_	16	pobj	_	_
19	harbored	harbor	VBD	VBD	_	0	root	_	_
20	no	no	DT	DT	_	22	det	_	_
21	amyloid	amyloid	NN	NN	_	22	compound	_	_
22	pathology	pathology	NN	NN	_	19	dobj	_	_
23	(	(	-LRB-	-LRB-	_	26	punct	_	_
24	data	datum	NNS	NNS	_	26	nsubj	_	_
25	not	not	RB	RB	_	26	neg	_	_
26	shown	show	VBN	VBN	_	22	parataxis	_	_
27	)	)	-RRB-	-RRB-	_	22	punct	_	_
28	,	,	,	,	_	19	punct	_	_
29	indicating	indicate	VBG	VBG	syn=ADV	19	advcl	_	_
30	that	that	IN	IN	_	43	mark	_	_
31	residual	residual	JJ	JJ	_	32	amod	_	_
32	leakage	leakage	NN	NN	_	43	nsubj	_	_
33	of	of	IN	IN	_	32	prep	_	_
34	transgene	transgene	NN	NN	_	35	compound	_	_
35	expression	expression	NN	NN	_	33	pobj	_	_
36	in	in	IN	IN	_	32	prep	_	_
37	the	the	DT	DT	_	38	det	_	_
38	presence	presence	NN	NN	_	36	pobj	_	_
39	of	of	IN	IN	_	38	prep	_	_
40	dox	dox	NN	NN	_	39	pobj	_	_
41	does	do	VBZ	VBZ	_	43	aux	_	_
42	not	not	RB	RB	_	43	neg	_	_
43	provide	provide	VB	VB	_	29	ccomp	_	_
44	sufficient	sufficient	JJ	JJ	_	46	amod	_	_
45	Aβ	aβ	NN	NN	_	46	compound	_	_
46	peptide	peptide	NN	NN	_	43	dobj	_	_
47	to	to	TO	TO	_	48	aux	_	_
48	induce	induce	VB	VB	_	46	acl	_	_
49	amyloid	amyloid	NN	NN	_	50	compound	_	_
50	formation	formation	NN	NN	_	48	dobj	_	_
51	even	even	RB	RB	_	52	advmod	_	_
52	over	over	IN	IN	sem=TMP	48	prep	_	_
53	long	long	JJ	JJ	_	54	amod	_	_
54	periods	period	NNS	NNS	_	52	pobj	_	_
55	.	.	.	.	_	19	punct	_	_

1	To	to	TO	TO	_	2	aux	_	_
2	mimic	mimic	VB	VB	sem=PRP	12	advcl	_	_
3	therapeutic	therapeutic	JJ	JJ	_	4	amod	_	_
4	intervention	intervention	NN	NN	_	2	dobj	_	_
5	with	with	IN	IN	sem=MNR	2	prep	_	_
6	inhibitors	inhibitor	NNS	NNS	_	5	pobj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	Aβ	aβ	NN	NN	_	9	compound	_	_
9	production	production	NN	NN	_	7	pobj	_	_
10	,	,	,	,	_	12	punct	_	_
11	we	we	PRP	PRP	_	12	nsubj	_	_
12	raised	raise	VBD	VBD	_	0	root	_	_
13	a	a	DT	DT	_	14	det	_	_
14	group	group	NN	NN	_	12	dobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	25	0	CD	CD	_	19	nummod	_	_
17	double	double	JJ	JJ	_	18	amod	_	_
18	transgenic	transgenic	JJ	JJ	_	19	amod	_	_
19	mice	mouse	NNS	NNS	_	15	pobj	_	_
20	(	(	-LRB-	-LRB-	_	25	punct	_	_
21	CaMKIIα	camkiiα	NN	NN	_	25	nmod	_	_
22	-	-	HYPH	HYPH	_	25	punct	_	_
23	tTA	tta	NN	NN	_	25	nmod	_	_
24	×	×	SYM	SYM	_	25	punct	_	_
25	APP	app	NN	NN	_	19	parataxis	_	_
26	line	line	NN	NN	_	25	appos	_	_
27	107	0	CD	CD	_	26	nummod	_	_
28	)	)	-RRB-	-RRB-	_	25	punct	_	_
29	on	on	IN	IN	_	12	prep	_	_
30	normal	normal	JJ	JJ	_	31	amod	_	_
31	food	food	NN	NN	_	29	pobj	_	_
32	until	until	IN	IN	sem=TMP	12	prep	_	_
33	6	0	CD	CD	_	34	nummod	_	_
34	mo	mo	NN	NN	_	32	pobj	_	_
35	of	of	IN	IN	_	34	prep	_	_
36	age	age	NN	NN	_	35	pobj	_	_
37	,	,	,	,	_	12	punct	_	_
38	when	when	WRB	WRB	_	40	advmod	_	_
39	we	we	PRP	PRP	_	40	nsubj	_	_
40	knew	know	VBD	VBD	sem=TMP	12	advcl	_	_
41	amyloid	amyloid	NN	NN	_	42	compound	_	_
42	formation	formation	NN	NN	_	43	nsubj	_	_
43	was	be	VBD	VBD	_	40	advcl	_	_
44	already	already	RB	RB	_	43	advmod	_	_
45	well	well	RB	RB	_	46	advmod	_	_
46	underway	underway	JJ	JJ	syn=PRD	43	acomp	_	_
47	in	in	IN	IN	sem=LOC	43	prep	_	_
48	the	the	DT	DT	_	49	det	_	_
49	brain	brain	NN	NN	_	47	pobj	_	_
50	.	.	.	.	_	12	punct	_	_

1	At	at	IN	IN	sem=TMP	10	prep	_	_
2	6	0	CD	CD	_	3	nummod	_	_
3	mo	mo	NN	NN	_	1	pobj	_	_
4	,	,	,	,	_	10	punct	_	_
5	half	half	NN	NN	_	10	nsubjpass	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	the	the	DT	DT	_	8	det	_	_
8	animals	animal	NNS	NNS	_	6	pobj	_	_
9	were	be	VBD	VBD	_	10	auxpass	_	_
10	switched	switch	VBN	VBN	_	0	root	_	_
11	from	from	IN	IN	_	10	prep	_	_
12	normal	normal	JJ	JJ	_	13	amod	_	_
13	chow	chow	NN	NN	_	11	pobj	_	_
14	to	to	IN	IN	_	10	prep	_	_
15	food	food	NN	NN	_	14	pobj	_	_
16	containing	contain	VBG	VBG	_	15	acl	_	_
17	dox	dox	NN	NN	_	16	dobj	_	_
18	at	at	IN	IN	_	16	prep	_	_
19	200	0	CD	CD	_	20	nummod	_	_
20	mg	mg	NN	NN	_	18	pobj	_	_
21	/	/	SYM	SYM	_	22	punct	_	_
22	kg	kg	NN	NN	_	20	prep	_	_
23	until	until	IN	IN	_	26	mark	_	_
24	they	they	PRP	PRP	_	26	nsubjpass	_	_
25	were	be	VBD	VBD	_	26	auxpass	_	_
26	sacrificed	sacrifice	VBN	VBN	sem=TMP	10	advcl	_	_
27	at	at	IN	IN	sem=TMP	26	prep	_	_
28	9	0	CD	CD	_	31	nummod	_	_
29	or	or	CC	CC	_	28	cc	_	_
30	12	0	CD	CD	_	28	conj	_	_
31	mo	mo	NN	NN	_	27	pobj	_	_
32	of	of	IN	IN	_	31	prep	_	_
33	age	age	NN	NN	_	32	pobj	_	_
34	.	.	.	.	_	10	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	remaining	remain	VBG	VBG	_	4	amod	_	_
3	control	control	NN	NN	_	4	compound	_	_
4	animals	animal	NNS	NNS	_	6	nsubjpass	_	_
5	were	be	VBD	VBD	_	6	auxpass	_	_
6	kept	keep	VBN	VBN	_	0	root	_	_
7	on	on	IN	IN	_	6	prep	_	_
8	standard	standard	JJ	JJ	_	9	amod	_	_
9	chow	chow	NN	NN	_	7	pobj	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	untreated	untreated	JJ	JJ	_	6	parataxis	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	.	.	.	.	_	6	punct	_	_

1	In	in	IN	IN	_	7	prep	_	_
2	all	all	DT	DT	_	1	pobj	_	_
3	,	,	,	,	_	7	punct	_	_
4	four	#crd#	CD	CD	_	5	nummod	_	_
5	cohorts	cohort	NNS	NNS	_	7	nsubjpass	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	created	create	VBN	VBN	_	0	root	_	_
8	:	:	:	:	_	7	punct	_	_
9	6	0	CD	CD	_	10	nummod	_	_
10	mo	mo	NN	NN	_	7	dobj	_	_
11	untreated	untreated	JJ	JJ	_	10	amod	_	_
12	(	(	-LRB-	-LRB-	_	15	punct	_	_
13	n	n	NN	NN	_	15	nsubj	_	_
14	=	=	SYM	SYM	_	15	punct	_	_
15	7	0	CD	CD	_	10	parataxis	_	_
16	)	)	-RRB-	-RRB-	_	15	punct	_	_
17	,	,	,	,	_	10	punct	_	_
18	9	0	CD	CD	_	19	nummod	_	_
19	mo	mo	NN	NN	_	10	conj	_	_
20	untreated	untreated	JJ	JJ	_	19	amod	_	_
21	(	(	-LRB-	-LRB-	_	24	punct	_	_
22	n	n	NN	NN	_	24	nsubj	_	_
23	=	=	SYM	SYM	_	24	punct	_	_
24	5	0	CD	CD	_	19	parataxis	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	,	,	,	,	_	19	punct	_	_
27	6	0	CD	CD	_	28	nummod	_	_
28	mo	mo	NN	NN	_	19	conj	_	_
29	+	+	SYM	SYM	_	28	punct	_	_
30	3	0	CD	CD	_	31	nummod	_	_
31	mo	mo	NN	NN	_	28	appos	_	_
32	treated	treat	VBN	VBN	_	28	amod	_	_
33	(	(	-LRB-	-LRB-	_	36	punct	_	_
34	n	n	NN	NN	_	36	nsubj	_	_
35	=	=	SYM	SYM	_	36	punct	_	_
36	8	0	CD	CD	_	28	parataxis	_	_
37	)	)	-RRB-	-RRB-	_	36	punct	_	_
38	,	,	,	,	_	28	punct	_	_
39	and	and	CC	CC	_	28	cc	_	_
40	6	0	CD	CD	_	41	nummod	_	_
41	mo	mo	NN	NN	_	28	conj	_	_
42	+	+	SYM	SYM	_	41	punct	_	_
43	6	0	CD	CD	_	44	nummod	_	_
44	mo	mo	NN	NN	_	41	appos	_	_
45	treated	treat	VBN	VBN	_	41	amod	_	_
46	(	(	-LRB-	-LRB-	_	49	punct	_	_
47	n	n	NN	NN	_	49	nsubj	_	_
48	=	=	SYM	SYM	_	49	punct	_	_
49	5	0	CD	CD	_	41	parataxis	_	_
50	)	)	-RRB-	-RRB-	_	49	punct	_	_
51	.	.	.	.	_	7	punct	_	_

1	Full	full	JJ	JJ	_	2	amod	_	_
2	suppression	suppression	NN	NN	_	21	nsubjpass	_	_
3	(	(	-LRB-	-LRB-	_	6	punct	_	_
4	>	>	SYM	SYM	_	5	punct	_	_
5	95	0	CD	CD	_	6	nummod	_	_
6	%	%	NN	NN	_	2	parataxis	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	of	of	IN	IN	_	2	prep	_	_
9	transgenic	transgenic	JJ	JJ	_	13	amod	_	_
10	APPswe	appswe	NN	NN	_	12	compound	_	_
11	/	/	HYPH	HYPH	_	12	punct	_	_
12	ind	ind	NN	NN	_	13	compound	_	_
13	levels	level	NNS	NNS	_	8	pobj	_	_
14	in	in	IN	IN	sem=LOC	13	prep	_	_
15	the	the	DT	DT	_	19	det	_	_
16	dox	dox	NN	NN	_	18	npadvmod	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	treated	treat	VBN	VBN	_	19	amod	_	_
19	animals	animal	NNS	NNS	_	14	pobj	_	_
20	was	be	VBD	VBD	_	21	auxpass	_	_
21	confirmed	confirm	VBN	VBN	_	0	root	_	_
22	by	by	IN	IN	sem=MNR	21	prep	_	_
23	immunoblot	immunoblot	NN	NN	_	22	pobj	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	Figure	figure	NN	NN	_	21	parataxis	_	_
26	3	0	CD	CD	_	25	nummod	_	_
27	)	)	-RRB-	-RRB-	_	25	punct	_	_
28	.	.	.	.	_	21	punct	_	_

1	To	to	TO	TO	_	2	aux	_	_
2	ensure	ensure	VB	VB	sem=PRP	31	advcl	_	_
3	that	that	IN	IN	_	8	mark	_	_
4	the	the	DT	DT	_	5	det	_	_
5	transgene	transgene	NN	NN	_	8	nsubjpass	_	_
6	could	could	MD	MD	_	8	aux	_	_
7	be	be	VB	VB	_	8	auxpass	_	_
8	suppressed	suppress	VBN	VBN	_	2	ccomp	_	_
9	as	as	RB	RB	_	10	advmod	_	_
10	rapidly	rapidly	RB	RB	_	8	advmod	_	_
11	in	in	IN	IN	sem=LOC	8	prep	_	_
12	6	0	CD	CD	_	14	nummod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	mo	mo	NN	NN	_	16	npadvmod	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	old	old	JJ	JJ	_	17	amod	_	_
17	mice	mouse	NNS	NNS	_	11	pobj	_	_
18	with	with	IN	IN	_	17	prep	_	_
19	fulminant	fulminant	JJ	JJ	_	20	amod	_	_
20	pathology	pathology	NN	NN	_	18	pobj	_	_
21	as	as	IN	IN	_	23	mark	_	_
22	it	it	PRP	PRP	_	23	nsubj	_	_
23	can	can	MD	MD	_	8	advcl	_	_
24	in	in	IN	IN	sem=LOC	23	prep	_	_
25	young	young	JJ	JJ	_	28	amod	_	_
26	,	,	,	,	_	28	punct	_	_
27	predeposit	predeposit	JJ	JJ	_	28	amod	_	_
28	animals	animal	NNS	NNS	_	24	pobj	_	_
29	,	,	,	,	_	31	punct	_	_
30	we	we	PRP	PRP	_	31	nsubj	_	_
31	treated	treat	VBD	VBD	_	0	root	_	_
32	an	an	DT	DT	_	34	det	_	_
33	additional	additional	JJ	JJ	_	34	amod	_	_
34	set	set	NN	NN	_	31	dobj	_	_
35	of	of	IN	IN	_	34	prep	_	_
36	6	0	CD	CD	_	38	nummod	_	_
37	-	-	HYPH	HYPH	_	38	punct	_	_
38	mo	mo	NN	NN	_	40	npadvmod	_	_
39	-	-	HYPH	HYPH	_	40	punct	_	_
40	old	old	JJ	JJ	_	41	amod	_	_
41	animals	animal	NNS	NNS	_	35	pobj	_	_
42	with	with	IN	IN	_	41	prep	_	_
43	dox	dox	NN	NN	_	42	pobj	_	_
44	for	for	IN	IN	sem=TMP	34	prep	_	_
45	1	0	CD	CD	_	46	nummod	_	_
46	wk	wk	NN	NN	_	44	pobj	_	_
47	prior	prior	JJ	JJ	_	48	amod	_	_
48	to	to	IN	IN	sem=TMP	34	prep	_	_
49	harvest	harvest	NN	NN	_	48	pobj	_	_
50	.	.	.	.	_	31	punct	_	_

1	Importantly	importantly	RB	RB	_	17	advmod	_	_
2	,	,	,	,	_	17	punct	_	_
3	both	both	CC	CC	_	6	preconj	_	_
4	APPswe	appswe	NN	NN	_	6	compound	_	_
5	/	/	HYPH	HYPH	_	6	punct	_	_
6	ind	ind	NN	NN	_	12	npadvmod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	APP	app	NN	NN	_	10	compound	_	_
9	–	-	HYPH	HYPH	_	10	punct	_	_
10	C	c	NN	NN	_	6	conj	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	terminal	terminal	JJ	JJ	_	14	amod	_	_
13	fragment	fragment	NN	NN	_	14	compound	_	_
14	levels	level	NNS	NNS	_	17	nsubjpass	_	_
15	were	be	VBD	VBD	_	17	auxpass	_	_
16	fully	fully	RB	RB	_	17	advmod	_	_
17	suppressed	suppress	VBN	VBN	_	0	root	_	_
18	after	after	IN	IN	_	17	prep	_	_
19	only	only	RB	RB	_	21	advmod	_	_
20	1	0	CD	CD	_	21	nummod	_	_
21	wk	wk	NN	NN	_	18	pobj	_	_
22	of	of	IN	IN	_	21	prep	_	_
23	treatment	treatment	NN	NN	_	22	pobj	_	_
24	,	,	,	,	_	17	punct	_	_
25	indicating	indicate	VBG	VBG	syn=ADV	17	advcl	_	_
26	that	that	IN	IN	_	44	mark	_	_
27	the	the	DT	DT	_	32	det	_	_
28	in	in	FW	FW	_	29	advmod	_	_
29	vivo	vivo	FW	FW	_	32	amod	_	_
30	half	half	NN	NN	_	32	compound	_	_
31	-	-	HYPH	HYPH	_	32	punct	_	_
32	life	life	NN	NN	_	44	nsubj	_	_
33	of	of	IN	IN	_	32	prep	_	_
34	APPswe	appswe	NN	NN	_	36	compound	_	_
35	/	/	HYPH	HYPH	_	36	punct	_	_
36	ind	ind	NN	NN	_	33	pobj	_	_
37	and	and	CC	CC	_	32	cc	_	_
38	its	its	PRP$	PRP$	_	43	poss	_	_
39	processed	process	VBN	VBN	_	43	amod	_	_
40	C	c	NN	NN	_	42	npadvmod	_	_
41	-	-	HYPH	HYPH	_	42	punct	_	_
42	terminal	terminal	JJ	JJ	_	43	amod	_	_
43	fragments	fragment	NNS	NNS	_	32	conj	_	_
44	are	be	VBP	VBP	_	25	ccomp	_	_
45	relatively	relatively	RB	RB	_	46	advmod	_	_
46	short	short	JJ	JJ	syn=PRD	44	acomp	_	_
47	(	(	-LRB-	-LRB-	_	49	punct	_	_
48	Figure	figure	NN	NN	_	49	compound	_	_
49	3D	0d	NN	NN	_	17	parataxis	_	_
50	)	)	-RRB-	-RRB-	_	49	punct	_	_
51	.	.	.	.	_	17	punct	_	_

1	Tissue	tissue	NN	NN	_	2	compound	_	_
2	sections	section	NNS	NNS	_	12	nsubjpass	_	_
3	from	from	IN	IN	_	2	prep	_	_
4	each	each	DT	DT	_	5	det	_	_
5	animal	animal	NN	NN	_	3	pobj	_	_
6	in	in	IN	IN	sem=LOC	5	prep	_	_
7	the	the	DT	DT	_	10	det	_	_
8	four	#crd#	CD	CD	_	10	nummod	_	_
9	treatment	treatment	NN	NN	_	10	compound	_	_
10	groups	group	NNS	NNS	_	6	pobj	_	_
11	were	be	VBD	VBD	_	12	auxpass	_	_
12	stained	stain	VBN	VBN	_	0	root	_	_
13	for	for	IN	IN	sem=PRP	12	prep	_	_
14	amyloid	amyloid	NN	NN	_	15	compound	_	_
15	pathology	pathology	NN	NN	_	13	pobj	_	_
16	by	by	IN	IN	_	12	agent	_	_
17	Hirano	hirano	NNP	NNP	_	18	compound	_	_
18	silver	silver	NN	NN	_	16	pobj	_	_
19	,	,	,	,	_	18	punct	_	_
20	Campbell	campbell	NNP	NNP	_	22	compound	_	_
21	-	-	HYPH	HYPH	_	22	punct	_	_
22	Switzer	switzer	NNP	NNP	_	23	compound	_	_
23	silver	silver	NN	NN	_	18	conj	_	_
24	,	,	,	,	_	23	punct	_	_
25	thioflavin	thioflavin	NN	NN	_	27	compound	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	S	s	NN	NN	_	23	conj	_	_
28	,	,	,	,	_	27	punct	_	_
29	and	and	CC	CC	_	27	cc	_	_
30	Aβ	aβ	NN	NN	_	31	compound	_	_
31	immunohistochemistry	immunohistochemistry	NN	NN	_	27	conj	_	_
32	.	.	.	.	_	12	punct	_	_

1	As	as	IN	IN	_	2	mark	_	_
2	expected	expect	VBN	VBN	syn=ADV	9	advcl	_	_
3	,	,	,	,	_	9	punct	_	_
4	the	the	DT	DT	_	8	det	_	_
5	6	0	CD	CD	_	6	nummod	_	_
6	mo	mo	NN	NN	_	8	nmod	_	_
7	untreated	untreated	JJ	JJ	_	8	amod	_	_
8	cohort	cohort	NN	NN	_	9	nsubj	_	_
9	displayed	display	VBD	VBD	_	0	root	_	_
10	moderate	moderate	JJ	JJ	_	12	amod	_	_
11	amyloid	amyloid	NN	NN	_	12	compound	_	_
12	pathology	pathology	NN	NN	_	9	dobj	_	_
13	,	,	,	,	_	9	punct	_	_
14	and	and	CC	CC	_	9	cc	_	_
15	the	the	DT	DT	_	19	det	_	_
16	9	0	CD	CD	_	17	nummod	_	_
17	mo	mo	NN	NN	_	19	nmod	_	_
18	untreated	untreated	JJ	JJ	_	19	amod	_	_
19	cohort	cohort	NN	NN	_	20	nsubj	_	_
20	progressed	progress	VBD	VBD	_	9	conj	_	_
21	to	to	IN	IN	_	20	prep	_	_
22	a	a	DT	DT	_	25	det	_	_
23	severe	severe	JJ	JJ	_	25	amod	_	_
24	amyloid	amyloid	NN	NN	_	25	compound	_	_
25	burden	burden	NN	NN	_	21	pobj	_	_
26	.	.	.	.	_	20	punct	_	_

1	In	in	IN	IN	_	28	prep	_	_
2	contrast	contrast	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	28	punct	_	_
4	the	the	DT	DT	_	5	det	_	_
5	extent	extent	NN	NN	_	28	nsubj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	amyloid	amyloid	NN	NN	_	8	compound	_	_
8	pathology	pathology	NN	NN	_	6	pobj	_	_
9	in	in	IN	IN	sem=LOC	5	prep	_	_
10	mice	mouse	NNS	NNS	_	9	pobj	_	_
11	from	from	IN	IN	_	10	prep	_	_
12	the	the	DT	DT	_	26	det	_	_
13	6	0	CD	CD	_	14	nummod	_	_
14	mo	mo	NN	NN	_	18	npadvmod	_	_
15	+	+	SYM	SYM	_	14	punct	_	_
16	3	0	CD	CD	_	17	nummod	_	_
17	mo	mo	NN	NN	_	14	appos	_	_
18	treated	treat	VBN	VBN	_	26	amod	_	_
19	or	or	CC	CC	_	18	cc	_	_
20	6	0	CD	CD	_	21	nummod	_	_
21	mo	mo	NN	NN	_	25	npadvmod	_	_
22	+	+	SYM	SYM	_	21	punct	_	_
23	6	0	CD	CD	_	24	nummod	_	_
24	mo	mo	NN	NN	_	21	appos	_	_
25	treated	treat	VBN	VBN	_	18	conj	_	_
26	cohorts	cohort	NNS	NNS	_	11	pobj	_	_
27	closely	closely	RB	RB	_	28	advmod	_	_
28	resembled	resemble	VBD	VBD	_	0	root	_	_
29	that	that	DT	DT	_	28	dobj	_	_
30	of	of	IN	IN	_	29	prep	_	_
31	the	the	DT	DT	_	35	det	_	_
32	6	0	CD	CD	_	33	nummod	_	_
33	mo	mo	NN	NN	_	34	npadvmod	_	_
34	untreated	untreated	JJ	JJ	_	35	amod	_	_
35	cohort	cohort	NN	NN	_	30	pobj	_	_
36	,	,	,	,	_	28	punct	_	_
37	despite	despite	IN	IN	_	28	prep	_	_
38	the	the	DT	DT	_	41	det	_	_
39	significant	significant	JJ	JJ	_	41	amod	_	_
40	age	age	NN	NN	_	41	compound	_	_
41	difference	difference	NN	NN	_	37	pobj	_	_
42	between	between	IN	IN	_	41	prep	_	_
43	the	the	DT	DT	_	47	det	_	_
44	treated	treat	VBN	VBN	_	47	amod	_	_
45	and	and	CC	CC	_	44	cc	_	_
46	untreated	untreated	JJ	JJ	_	44	conj	_	_
47	groups	group	NNS	NNS	_	42	pobj	_	_
48	(	(	-LRB-	-LRB-	_	49	punct	_	_
49	Figures	figure	NNS	NNS	_	28	parataxis	_	_
50	4	0	CD	CD	_	49	nummod	_	_
51	and	and	CC	CC	_	49	cc	_	_
52	Figure	figure	NN	NN	_	53	compound	_	_
53	S3	s0	NN	NN	_	49	conj	_	_
54	)	)	-RRB-	-RRB-	_	49	punct	_	_
55	.	.	.	.	_	28	punct	_	_

1	Well	well	RB	RB	_	3	advmod	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	formed	form	VBN	VBN	_	4	amod	_	_
4	plaques	plaque	NNS	NNS	_	5	nsubj	_	_
5	remained	remain	VBD	VBD	_	0	root	_	_
6	in	in	IN	IN	sem=LOC	5	prep	_	_
7	the	the	DT	DT	_	9	det	_	_
8	treated	treat	VBN	VBN	_	9	amod	_	_
9	animals	animal	NNS	NNS	_	6	pobj	_	_
10	after	after	IN	IN	sem=TMP	5	prep	_	_
11	6	0	CD	CD	_	12	nummod	_	_
12	mo	mo	NN	NN	_	10	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	transgene	transgene	NN	NN	_	15	compound	_	_
15	suppression	suppression	NN	NN	_	13	pobj	_	_
16	,	,	,	,	_	5	punct	_	_
17	even	even	RB	RB	_	23	advmod	_	_
18	though	though	IN	IN	_	23	mark	_	_
19	as	as	RB	RB	_	20	advmod	_	_
20	much	much	JJ	JJ	_	21	amod	_	_
21	time	time	NN	NN	_	23	nsubjpass	_	_
22	was	be	VBD	VBD	_	23	auxpass	_	_
23	given	give	VBN	VBN	syn=ADV	5	advcl	_	_
24	to	to	TO	TO	_	25	aux	_	_
25	clear	clear	VB	VB	sem=PRP	23	advcl	_	_
26	the	the	DT	DT	_	27	det	_	_
27	lesions	lesion	NNS	NNS	_	25	dobj	_	_
28	as	as	IN	IN	_	31	mark	_	_
29	they	they	PRP	PRP	_	31	nsubj	_	_
30	had	have	VBD	VBD	_	31	aux	_	_
31	taken	take	VBN	VBN	_	23	advcl	_	_
32	to	to	TO	TO	_	33	aux	_	_
33	form	form	VB	VB	sem=PRP	31	advcl	_	_
34	.	.	.	.	_	5	punct	_	_

1	Moreover	moreover	RB	RB	_	12	advmod	_	_
2	,	,	,	,	_	12	punct	_	_
3	both	both	DT	DT	_	4	det	_	_
4	types	type	NNS	NNS	_	12	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	amyloid	amyloid	NN	NN	_	5	pobj	_	_
7	,	,	,	,	_	4	punct	_	_
8	diffuse	diffuse	JJ	JJ	_	4	amod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	fibrillar	fibrillar	JJ	JJ	_	8	conj	_	_
11	,	,	,	,	_	12	punct	_	_
12	remained	remain	VBD	VBD	_	0	root	_	_
13	intact	intact	JJ	JJ	syn=PRD	12	acomp	_	_
14	throughout	throughout	IN	IN	sem=TMP	12	prep	_	_
15	treatment	treatment	NN	NN	_	14	pobj	_	_
16	.	.	.	.	_	12	punct	_	_

1	Using	use	VBG	VBG	sem=MNR	16	advcl	_	_
2	the	the	DT	DT	_	7	det	_	_
3	Campbell	campbell	NNP	NNP	_	5	compound	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	Switzer	switzer	NNP	NNP	_	7	compound	_	_
6	silver	silver	NN	NN	_	7	compound	_	_
7	stain	stain	NN	NN	_	1	dobj	_	_
8	to	to	TO	TO	_	9	aux	_	_
9	distinguish	distinguish	VB	VB	sem=PRP	1	advcl	_	_
10	different	different	JJ	JJ	_	11	amod	_	_
11	forms	form	NNS	NNS	_	9	dobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	amyloid	amyloid	NN	NN	_	12	pobj	_	_
14	,	,	,	,	_	16	punct	_	_
15	we	we	PRP	PRP	_	16	nsubj	_	_
16	found	find	VBD	VBD	_	0	root	_	_
17	diffuse	diffuse	JJ	JJ	_	18	amod	_	_
18	plaques	plaque	NNS	NNS	_	19	nsubj	_	_
19	were	be	VBD	VBD	_	16	advcl	_	_
20	as	as	RB	RB	_	21	advmod	_	_
21	persistent	persistent	JJ	JJ	syn=PRD	19	acomp	_	_
22	as	as	IN	IN	_	21	prep	_	_
23	cored	core	VBN	VBN	_	24	amod	_	_
24	deposits	deposit	NNS	NNS	_	22	pobj	_	_
25	(	(	-LRB-	-LRB-	_	27	punct	_	_
26	Figure	figure	NN	NN	_	27	compound	_	_
27	S4	s0	NN	NN	_	16	parataxis	_	_
28	)	)	-RRB-	-RRB-	_	27	punct	_	_
29	.	.	.	.	_	16	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	was	be	VBD	VBD	_	0	root	_	_
3	nevertheless	nevertheless	RB	RB	_	2	advmod	_	_
4	clear	clear	JJ	JJ	syn=PRD	2	acomp	_	_
5	that	that	IN	IN	_	15	mark	_	_
6	dox	dox	NN	NN	_	8	npadvmod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	induced	induce	VBN	VBN	_	9	amod	_	_
9	suppression	suppression	NN	NN	_	15	nsubj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	transgenic	transgenic	JJ	JJ	_	12	amod	_	_
12	APP	app	NN	NN	_	10	pobj	_	_
13	had	have	VBD	VBD	_	15	aux	_	_
14	completely	completely	RB	RB	_	15	advmod	_	_
15	halted	halt	VBN	VBN	_	2	ccomp	_	_
16	the	the	DT	DT	_	17	det	_	_
17	progression	progression	NN	NN	_	15	dobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	pathology	pathology	NN	NN	_	18	pobj	_	_
20	.	.	.	.	_	2	punct	_	_

1	To	to	TO	TO	_	2	aux	_	_
2	confirm	confirm	VB	VB	sem=PRP	23	advcl	_	_
3	that	that	IN	IN	_	13	mark	_	_
4	the	the	DT	DT	_	5	det	_	_
5	arrest	arrest	NN	NN	_	13	nsubj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	plaques	plaque	NNS	NNS	_	6	pobj	_	_
8	without	without	IN	IN	_	5	prep	_	_
9	any	any	DT	DT	_	10	det	_	_
10	sign	sign	NN	NN	_	8	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	clearance	clearance	NN	NN	_	11	pobj	_	_
13	was	be	VBD	VBD	_	2	ccomp	_	_
14	not	not	RB	RB	_	13	neg	_	_
15	unique	unique	JJ	JJ	syn=PRD	13	acomp	_	_
16	to	to	IN	IN	_	15	prep	_	_
17	the	the	DT	DT	_	20	det	_	_
18	line	line	NN	NN	_	20	nmod	_	_
19	107	0	CD	CD	_	18	nummod	_	_
20	mice	mouse	NNS	NNS	_	16	pobj	_	_
21	,	,	,	,	_	23	punct	_	_
22	we	we	PRP	PRP	_	23	nsubj	_	_
23	repeated	repeat	VBD	VBD	_	0	root	_	_
24	the	the	DT	DT	_	28	det	_	_
25	dox	dox	NN	NN	_	27	compound	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	suppression	suppression	NN	NN	_	28	compound	_	_
28	experiment	experiment	NN	NN	_	23	dobj	_	_
29	in	in	IN	IN	sem=LOC	23	prep	_	_
30	a	a	DT	DT	_	32	det	_	_
31	second	#ord#	JJ	JJ	_	32	amod	_	_
32	line	line	NN	NN	_	29	pobj	_	_
33	of	of	IN	IN	_	32	prep	_	_
34	tet	tet	NN	NN	_	36	compound	_	_
35	-	-	HYPH	HYPH	_	36	punct	_	_
36	off	off	NN	NN	_	38	compound	_	_
37	APP	app	NN	NN	_	38	compound	_	_
38	mice	mouse	NNS	NNS	_	33	pobj	_	_
39	(	(	-LRB-	-LRB-	_	49	punct	_	_
40	CaMKIIα	camkiiα	NN	NN	_	48	nmod	_	_
41	-	-	HYPH	HYPH	_	48	punct	_	_
42	tTA	tta	NN	NN	_	48	nmod	_	_
43	×	×	SYM	SYM	_	48	punct	_	_
44	tet	tet	NN	NN	_	48	compound	_	_
45	-	-	HYPH	HYPH	_	48	punct	_	_
46	APPswe	appswe	NN	NN	_	48	compound	_	_
47	/	/	HYPH	HYPH	_	48	punct	_	_
48	ind	ind	NN	NN	_	49	compound	_	_
49	line	line	NN	NN	_	23	parataxis	_	_
50	18	0	CD	CD	_	49	nummod	_	_
51	;	;	:	:	_	49	punct	_	_
52	n	n	NN	NN	_	54	nsubj	_	_
53	=	=	SYM	SYM	_	54	punct	_	_
54	22	0	CD	CD	_	49	ccomp	_	_
55	)	)	-RRB-	-RRB-	_	49	punct	_	_
56	.	.	.	.	_	23	punct	_	_

1	Again	again	RB	RB	_	9	advmod	_	_
2	,	,	,	,	_	9	punct	_	_
3	long	long	JJ	JJ	_	5	amod	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	term	term	NN	NN	_	7	compound	_	_
6	dox	dox	NN	NN	_	7	compound	_	_
7	treatment	treatment	NN	NN	_	9	nsubjpass	_	_
8	was	be	VBD	VBD	_	9	auxpass	_	_
9	begun	begin	VBN	VBN	_	0	root	_	_
10	at	at	IN	IN	sem=TMP	9	prep	_	_
11	6	0	CD	CD	_	12	nummod	_	_
12	mo	mo	NN	NN	_	10	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	age	age	NN	NN	_	13	pobj	_	_
15	,	,	,	,	_	9	punct	_	_
16	and	and	CC	CC	_	9	cc	_	_
17	mice	mouse	NNS	NNS	_	19	nsubjpass	_	_
18	were	be	VBD	VBD	_	19	auxpass	_	_
19	harvested	harvest	VBN	VBN	_	9	conj	_	_
20	after	after	IN	IN	sem=TMP	19	prep	_	_
21	3	0	CD	CD	_	22	nummod	_	_
22	mo	mo	NN	NN	_	20	pobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	transgene	transgene	NN	NN	_	25	compound	_	_
25	suppression	suppression	NN	NN	_	23	pobj	_	_
26	(	(	-LRB-	-LRB-	_	52	punct	_	_
27	6	0	CD	CD	_	28	nummod	_	_
28	mo	mo	NN	NN	_	29	npadvmod	_	_
29	untreated	untreated	JJ	JJ	_	33	amod	_	_
30	,	,	,	,	_	33	punct	_	_
31	n	n	NN	NN	_	33	nsubj	_	_
32	=	=	SYM	SYM	_	33	punct	_	_
33	8	0	CD	CD	_	52	dep	_	_
34	;	;	:	:	_	52	punct	_	_
35	9	0	CD	CD	_	36	nummod	_	_
36	mo	mo	NN	NN	_	37	npadvmod	_	_
37	untreated	untreated	JJ	JJ	_	41	amod	_	_
38	,	,	,	,	_	41	punct	_	_
39	n	n	NN	NN	_	41	nsubj	_	_
40	=	=	SYM	SYM	_	41	punct	_	_
41	6	0	CD	CD	_	52	dep	_	_
42	;	;	:	:	_	52	punct	_	_
43	6	0	CD	CD	_	47	nummod	_	_
44	mo	mo	NN	NN	_	47	nmod	_	_
45	+	+	SYM	SYM	_	47	punct	_	_
46	3	0	CD	CD	_	47	nummod	_	_
47	mo	mo	NN	NN	_	48	npadvmod	_	_
48	treated	treat	VBN	VBN	_	52	amod	_	_
49	,	,	,	,	_	52	punct	_	_
50	n	n	NN	NN	_	52	nsubj	_	_
51	=	=	SYM	SYM	_	52	punct	_	_
52	8	0	CD	CD	_	19	parataxis	_	_
53	)	)	-RRB-	-RRB-	_	52	punct	_	_
54	.	.	.	.	_	19	punct	_	_

1	Immunoblotting	immunoblotting	NN	NN	_	4	nsubj	_	_
2	for	for	IN	IN	_	1	prep	_	_
3	APP	app	NN	NN	_	2	pobj	_	_
4	confirmed	confirm	VBD	VBD	_	0	root	_	_
5	full	full	JJ	JJ	_	7	amod	_	_
6	transgene	transgene	NN	NN	_	7	compound	_	_
7	suppression	suppression	NN	NN	_	4	dobj	_	_
8	in	in	IN	IN	sem=LOC	4	prep	_	_
9	the	the	DT	DT	_	11	det	_	_
10	treated	treat	VBN	VBN	_	11	amod	_	_
11	animals	animal	NNS	NNS	_	8	pobj	_	_
12	(	(	-LRB-	-LRB-	_	14	punct	_	_
13	Figure	figure	NN	NN	_	14	compound	_	_
14	S5	s0	NN	NN	_	4	parataxis	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	.	.	.	.	_	4	punct	_	_

1	As	as	IN	IN	_	12	prep	_	_
2	in	in	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	6	det	_	_
4	line	line	NN	NN	_	6	nmod	_	_
5	107	0	CD	CD	_	4	nummod	_	_
6	mice	mouse	NNS	NNS	_	2	pobj	_	_
7	described	describe	VBN	VBN	_	6	acl	_	_
8	above	above	RB	RB	_	7	advmod	_	_
9	,	,	,	,	_	12	punct	_	_
10	amyloid	amyloid	NN	NN	_	11	compound	_	_
11	burden	burden	NN	NN	_	12	nsubj	_	_
12	worsened	worsen	VBD	VBD	_	0	root	_	_
13	substantially	substantially	RB	RB	_	12	advmod	_	_
14	in	in	IN	IN	sem=LOC	12	prep	_	_
15	the	the	DT	DT	_	17	det	_	_
16	untreated	untreated	JJ	JJ	_	17	amod	_	_
17	mice	mouse	NNS	NNS	_	14	pobj	_	_
18	between	between	IN	IN	_	17	prep	_	_
19	6	0	CD	CD	_	22	nummod	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	9	0	CD	CD	_	19	conj	_	_
22	mo	mo	NN	NN	_	18	pobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	age	age	NN	NN	_	23	pobj	_	_
25	.	.	.	.	_	12	punct	_	_

1	Suppression	suppression	NN	NN	_	6	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	transgene	transgene	NN	NN	_	4	compound	_	_
4	expression	expression	NN	NN	_	2	pobj	_	_
5	abruptly	abruptly	RB	RB	_	6	advmod	_	_
6	arrested	arrest	VBD	VBD	_	0	root	_	_
7	progression	progression	NN	NN	_	6	dobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	pathology	pathology	NN	NN	_	8	pobj	_	_
10	(	(	-LRB-	-LRB-	_	12	punct	_	_
11	Figure	figure	NN	NN	_	12	compound	_	_
12	S6	s0	NN	NN	_	6	parataxis	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	,	,	,	,	_	6	punct	_	_
15	but	but	CC	CC	_	17	cc	_	_
16	again	again	RB	RB	sem=TMP	17	advmod	_	_
17	without	without	IN	IN	_	6	prep	_	_
18	any	any	DT	DT	_	19	det	_	_
19	sign	sign	NN	NN	_	17	pobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	reduction	reduction	NN	NN	_	20	pobj	_	_
22	.	.	.	.	_	6	punct	_	_

1	Both	both	CC	CC	_	2	preconj	_	_
2	silver	silver	NN	NN	_	9	npadvmod	_	_
3	-	-	HYPH	HYPH	_	2	punct	_	_
4	and	and	CC	CC	_	2	cc	_	_
5	thioflavin	thioflavin	NN	NN	_	7	compound	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	S	s	NN	NN	_	2	conj	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	positive	positive	JJ	JJ	_	10	amod	_	_
10	plaques	plaque	NNS	NNS	_	14	nsubjpass	_	_
11	could	could	MD	MD	_	14	aux	_	_
12	still	still	RB	RB	_	14	advmod	_	_
13	be	be	VB	VB	_	14	auxpass	_	_
14	found	find	VBN	VBN	_	0	root	_	_
15	in	in	IN	IN	sem=LOC	14	prep	_	_
16	each	each	DT	DT	_	15	pobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	the	the	DT	DT	_	22	det	_	_
19	dox	dox	NN	NN	_	21	npadvmod	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	treated	treat	VBN	VBN	_	22	amod	_	_
22	animals	animal	NNS	NNS	_	17	pobj	_	_
23	.	.	.	.	_	14	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	biochemically	biochemically	RB	RB	_	3	advmod	_	_
3	measured	measure	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	amount	amount	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	aggregated	aggregate	VBN	VBN	_	8	amod	_	_
8	Aβ	aβ	NN	NN	_	6	pobj	_	_
9	in	in	IN	IN	sem=LOC	3	prep	_	_
10	the	the	DT	DT	_	11	det	_	_
11	brains	brain	NNS	NNS	_	9	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	our	our	PRP$	PRP$	_	14	poss	_	_
14	mice	mouse	NNS	NNS	_	12	pobj	_	_
15	before	before	IN	IN	sem=TMP	3	prep	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	after	after	IN	IN	_	15	conj	_	_
18	transgene	transgene	NN	NN	_	19	compound	_	_
19	suppression	suppression	NN	NN	_	17	pobj	_	_
20	using	use	VBG	VBG	sem=MNR	3	advcl	_	_
21	filter	filter	NN	NN	_	22	compound	_	_
22	trap	trap	NN	NN	_	23	compound	_	_
23	analysis	analysis	NN	NN	_	20	dobj	_	_
24	of	of	IN	IN	_	23	prep	_	_
25	cortical	cortical	JJ	JJ	_	26	amod	_	_
26	tissue	tissue	NN	NN	_	24	pobj	_	_
27	from	from	IN	IN	_	26	prep	_	_
28	each	each	DT	DT	_	29	det	_	_
29	animal	animal	NN	NN	_	27	pobj	_	_
30	.	.	.	.	_	3	punct	_	_

1	In	in	IN	IN	_	11	prep	_	_
2	this	this	DT	DT	_	3	det	_	_
3	assay	assay	NN	NN	_	1	pobj	_	_
4	,	,	,	,	_	11	punct	_	_
5	serial	serial	JJ	JJ	_	6	amod	_	_
6	dilutions	dilution	NNS	NNS	_	11	nsubjpass	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	protein	protein	NN	NN	_	9	compound	_	_
9	homogenate	homogenate	NN	NN	_	7	pobj	_	_
10	are	be	VBP	VBP	_	11	auxpass	_	_
11	passed	pass	VBN	VBN	_	27	ccomp	_	_
12	through	through	IN	IN	sem=DIR	11	prep	_	_
13	a	a	DT	DT	_	16	det	_	_
14	cellulose	cellulose	NN	NN	_	16	compound	_	_
15	acetate	acetate	NN	NN	_	16	compound	_	_
16	filter	filter	NN	NN	_	12	pobj	_	_
17	;	;	:	:	_	27	punct	_	_
18	particles	particle	NNS	NNS	_	27	nsubj	_	_
19	larger	large	JJR	JJR	_	18	amod	_	_
20	than	than	IN	IN	_	19	prep	_	_
21	the	the	DT	DT	_	23	det	_	_
22	pore	pore	NN	NN	_	23	compound	_	_
23	size	size	NN	NN	_	20	pobj	_	_
24	of	of	IN	IN	_	23	prep	_	_
25	the	the	DT	DT	_	26	det	_	_
26	filter	filter	NN	NN	_	24	pobj	_	_
27	become	become	VBP	VBP	_	0	root	_	_
28	trapped	trapped	JJ	JJ	syn=PRD	27	acomp	_	_
29	in	in	IN	IN	sem=LOC	28	prep	_	_
30	the	the	DT	DT	_	31	det	_	_
31	membrane	membrane	NN	NN	_	29	pobj	_	_
32	and	and	CC	CC	_	27	cc	_	_
33	are	be	VBP	VBP	_	34	auxpass	_	_
34	revealed	reveal	VBN	VBN	_	27	conj	_	_
35	by	by	IN	IN	sem=MNR	34	prep	_	_
36	immunoblotting	immunoblotting	NN	NN	_	35	pobj	_	_
37	[	[	-LRB-	-LRB-	_	38	punct	_	_
38	22	0	CD	CD	_	34	parataxis	_	_
39	]	]	-RRB-	-RRB-	_	38	punct	_	_
40	.	.	.	.	_	27	punct	_	_

1	Consistent	consistent	JJ	JJ	syn=PRD	25	advcl	_	_
2	with	with	IN	IN	_	1	prep	_	_
3	our	our	PRP$	PRP$	_	5	poss	_	_
4	visual	visual	JJ	JJ	_	5	amod	_	_
5	analysis	analysis	NN	NN	_	2	pobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	the	the	DT	DT	_	9	det	_	_
8	histological	histological	JJ	JJ	_	9	amod	_	_
9	sections	section	NNS	NNS	_	6	pobj	_	_
10	,	,	,	,	_	25	punct	_	_
11	line	line	NN	NN	_	16	nmod	_	_
12	107	0	CD	CD	_	11	nummod	_	_
13	tTA	tta	NN	NN	_	15	compound	_	_
14	/	/	HYPH	HYPH	_	15	punct	_	_
15	APP	app	NN	NN	_	16	compound	_	_
16	mice	mouse	NNS	NNS	_	25	nsubj	_	_
17	treated	treat	VBN	VBN	_	16	acl	_	_
18	with	with	IN	IN	sem=MNR	17	prep	_	_
19	dox	dox	NN	NN	_	18	pobj	_	_
20	for	for	IN	IN	sem=TMP	17	prep	_	_
21	3	0	CD	CD	_	24	nummod	_	_
22	or	or	CC	CC	_	24	cc	_	_
23	6	0	CD	CD	_	24	nummod	_	_
24	mo	mo	NN	NN	_	20	pobj	_	_
25	had	have	VBD	VBD	_	0	root	_	_
26	the	the	DT	DT	_	28	det	_	_
27	same	same	JJ	JJ	_	28	amod	_	_
28	amount	amount	NN	NN	_	25	dobj	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	aggregated	aggregate	VBN	VBN	_	31	amod	_	_
31	Aβ	aβ	NN	NN	_	29	pobj	_	_
32	as	as	IN	IN	_	28	prep	_	_
33	when	when	WRB	WRB	_	35	advmod	_	_
34	they	they	PRP	PRP	_	35	nsubj	_	_
35	started	start	VBD	VBD	syn=NOM	32	pcomp	_	_
36	treatment	treatment	NN	NN	_	35	dobj	_	_
37	at	at	IN	IN	sem=TMP	35	prep	_	_
38	6	0	CD	CD	_	39	nummod	_	_
39	mo	mo	NN	NN	_	37	pobj	_	_
40	of	of	IN	IN	_	39	prep	_	_
41	age	age	NN	NN	_	40	pobj	_	_
42	(	(	-LRB-	-LRB-	_	44	punct	_	_
43	Figure	figure	NN	NN	_	44	compound	_	_
44	4A	0a	NN	NN	_	25	parataxis	_	_
45	and	and	CC	CC	_	44	cc	_	_
46	4B	0b	NN	NN	_	44	conj	_	_
47	)	)	-RRB-	-RRB-	_	44	punct	_	_
48	.	.	.	.	_	25	punct	_	_

1	In	in	IN	IN	_	11	prep	_	_
2	contrast	contrast	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	11	punct	_	_
4	untreated	untreated	JJ	JJ	_	10	amod	_	_
5	9	0	CD	CD	_	7	nummod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	mo	mo	NN	NN	_	9	npadvmod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	old	old	JJ	JJ	_	10	amod	_	_
10	mice	mouse	NNS	NNS	_	11	nsubj	_	_
11	had	have	VBD	VBD	_	0	root	_	_
12	almost	almost	RB	RB	_	13	advmod	_	_
13	twice	twice	RB	RB	_	15	advmod	_	_
14	as	as	RB	RB	_	15	advmod	_	_
15	much	much	JJ	JJ	_	17	amod	_	_
16	aggregated	aggregate	VBN	VBN	_	17	amod	_	_
17	Aβ	aβ	NN	NN	_	11	dobj	_	_
18	as	as	IN	IN	_	17	prep	_	_
19	either	either	DT	DT	_	18	pobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	the	the	DT	DT	_	23	det	_	_
22	treated	treat	VBN	VBN	_	23	amod	_	_
23	groups	group	NNS	NNS	_	20	pobj	_	_
24	.	.	.	.	_	11	punct	_	_

1	Filter	filter	NN	NN	_	3	compound	_	_
2	trap	trap	NN	NN	_	3	compound	_	_
3	analysis	analysis	NN	NN	_	11	nsubj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	line	line	NN	NN	_	10	nmod	_	_
6	18	0	CD	CD	_	5	nummod	_	_
7	tTA	tta	NN	NN	_	9	compound	_	_
8	/	/	HYPH	HYPH	_	9	punct	_	_
9	APP	app	NN	NN	_	10	compound	_	_
10	mice	mouse	NNS	NNS	_	4	pobj	_	_
11	yielded	yield	VBD	VBD	_	33	ccomp	_	_
12	similar	similar	JJ	JJ	_	13	amod	_	_
13	results	result	NNS	NNS	_	11	dobj	_	_
14	:	:	:	:	_	33	punct	_	_
15	the	the	DT	DT	_	16	det	_	_
16	increase	increase	NN	NN	_	33	nsubjpass	_	_
17	in	in	IN	IN	_	16	prep	_	_
18	aggregated	aggregate	VBN	VBN	_	19	amod	_	_
19	Aβ	aβ	NN	NN	_	17	pobj	_	_
20	observed	observe	VBN	VBN	_	16	acl	_	_
21	in	in	IN	IN	sem=LOC	20	prep	_	_
22	untreated	untreated	JJ	JJ	_	23	amod	_	_
23	animals	animal	NNS	NNS	_	21	pobj	_	_
24	between	between	IN	IN	_	23	prep	_	_
25	6	0	CD	CD	_	28	nummod	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	9	0	CD	CD	_	25	conj	_	_
28	mo	mo	NN	NN	_	24	pobj	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	age	age	NN	NN	_	29	pobj	_	_
31	was	be	VBD	VBD	_	33	auxpass	_	_
32	completely	completely	RB	RB	_	33	advmod	_	_
33	arrested	arrest	VBN	VBN	_	0	root	_	_
34	by	by	IN	IN	_	33	agent	_	_
35	transgene	transgene	NN	NN	_	36	compound	_	_
36	suppression	suppression	NN	NN	_	34	pobj	_	_
37	(	(	-LRB-	-LRB-	_	39	punct	_	_
38	Figure	figure	NN	NN	_	39	compound	_	_
39	S5C	s0c	NN	NN	_	33	parataxis	_	_
40	and	and	CC	CC	_	39	cc	_	_
41	S5D	s0d	NN	NN	_	39	conj	_	_
42	)	)	-RRB-	-RRB-	_	39	punct	_	_
43	.	.	.	.	_	33	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	next	next	RB	RB	sem=TMP	3	advmod	_	_
3	used	use	VBD	VBD	_	0	root	_	_
4	ELISA	elisa	NN	NN	_	3	dobj	_	_
5	to	to	TO	TO	_	6	aux	_	_
6	measure	measure	VB	VB	sem=PRP	3	advcl	_	_
7	total	total	JJ	JJ	_	8	amod	_	_
8	Aβ	aβ	NN	NN	_	6	dobj	_	_
9	in	in	IN	IN	sem=LOC	6	prep	_	_
10	the	the	DT	DT	_	11	det	_	_
11	brains	brain	NNS	NNS	_	9	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	each	each	DT	DT	_	14	det	_	_
14	group	group	NN	NN	_	12	pobj	_	_
15	to	to	TO	TO	_	16	aux	_	_
16	determine	determine	VB	VB	sem=PRP	6	advcl	_	_
17	whether	whether	IN	IN	_	27	mark	_	_
18	any	any	DT	DT	_	19	det	_	_
19	change	change	NN	NN	_	27	nsubj	_	_
20	in	in	IN	IN	_	19	prep	_	_
21	the	the	DT	DT	_	22	det	_	_
22	amount	amount	NN	NN	_	20	pobj	_	_
23	or	or	CC	CC	_	22	cc	_	_
24	solubility	solubility	NN	NN	_	22	conj	_	_
25	of	of	IN	IN	_	22	prep	_	_
26	peptide	peptide	NN	NN	_	25	pobj	_	_
27	occurred	occur	VBD	VBD	_	16	ccomp	_	_
28	while	while	IN	IN	_	34	mark	_	_
29	APPswe	appswe	NN	NN	_	31	compound	_	_
30	/	/	HYPH	HYPH	_	31	punct	_	_
31	ind	ind	NN	NN	_	32	compound	_	_
32	expression	expression	NN	NN	_	34	nsubjpass	_	_
33	was	be	VBD	VBD	_	34	auxpass	_	_
34	suppressed	suppress	VBN	VBN	sem=TMP	27	advcl	_	_
35	.	.	.	.	_	3	punct	_	_

1	Cortical	cortical	JJ	JJ	_	2	amod	_	_
2	homogenates	homogenate	NNS	NNS	_	5	nsubjpass	_	_
3	were	be	VBD	VBD	_	5	auxpass	_	_
4	sequentially	sequentially	RB	RB	sem=MNR	5	advmod	_	_
5	extracted	extract	VBN	VBN	_	30	ccomp	_	_
6	to	to	TO	TO	_	7	aux	_	_
7	separate	separate	VB	VB	sem=PRP	5	advcl	_	_
8	peptide	peptide	NN	NN	_	7	dobj	_	_
9	into	into	IN	IN	_	7	prep	_	_
10	PBS	pbs	NN	NN	_	19	npadvmod	_	_
11	-	-	HYPH	HYPH	_	10	punct	_	_
12	,	,	,	,	_	10	punct	_	_
13	SDS	sds	NN	NN	_	10	conj	_	_
14	-	-	HYPH	HYPH	_	13	punct	_	_
15	,	,	,	,	_	13	punct	_	_
16	and	and	CC	CC	_	13	cc	_	_
17	FA	fa	NN	NN	_	13	conj	_	_
18	-	-	HYPH	HYPH	_	19	punct	_	_
19	soluble	soluble	JJ	JJ	_	20	amod	_	_
20	fractions	fraction	NNS	NNS	_	9	pobj	_	_
21	,	,	,	,	_	30	punct	_	_
22	then	then	RB	RB	sem=TMP	30	advmod	_	_
23	transgene	transgene	NN	NN	_	25	npadvmod	_	_
24	-	-	HYPH	HYPH	_	25	punct	_	_
25	derived	derive	VBN	VBN	_	26	amod	_	_
26	Aβ40	aβ0	NN	NN	_	30	nsubjpass	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	Aβ42	aβ0	NN	NN	_	26	conj	_	_
29	were	be	VBD	VBD	_	30	auxpass	_	_
30	measured	measure	VBN	VBN	_	0	root	_	_
31	by	by	IN	IN	_	30	agent	_	_
32	human	human	JJ	JJ	_	34	amod	_	_
33	-	-	HYPH	HYPH	_	34	punct	_	_
34	specific	specific	JJ	JJ	_	35	amod	_	_
35	ELISA	elisa	NN	NN	_	31	pobj	_	_
36	[	[	-LRB-	-LRB-	_	37	punct	_	_
37	23	0	CD	CD	_	30	parataxis	_	_
38	]	]	-RRB-	-RRB-	_	37	punct	_	_
39	.	.	.	.	_	30	punct	_	_

1	In	in	IN	IN	_	9	prep	_	_
2	all	all	DT	DT	_	3	det	_	_
3	animals	animal	NNS	NNS	_	1	pobj	_	_
4	harboring	harbor	VBG	VBG	_	3	acl	_	_
5	amyloid	amyloid	NN	NN	_	6	compound	_	_
6	deposits	deposit	NNS	NNS	_	4	dobj	_	_
7	,	,	,	,	_	9	punct	_	_
8	we	we	PRP	PRP	_	9	nsubj	_	_
9	found	find	VBD	VBD	_	0	root	_	_
10	that	that	IN	IN	_	22	mark	_	_
11	the	the	DT	DT	_	13	det	_	_
12	vast	vast	JJ	JJ	_	13	amod	_	_
13	majority	majority	NN	NN	_	22	nsubjpass	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	Aβ	aβ	NN	NN	_	14	pobj	_	_
16	(	(	-LRB-	-LRB-	_	19	punct	_	_
17	>	>	SYM	SYM	_	18	punct	_	_
18	99	0	CD	CD	_	19	nummod	_	_
19	%	%	NN	NN	_	15	parataxis	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	was	be	VBD	VBD	_	22	auxpass	_	_
22	extracted	extract	VBN	VBN	_	9	ccomp	_	_
23	into	into	IN	IN	sem=LOC	22	prep	_	_
24	the	the	DT	DT	_	28	det	_	_
25	SDS	sds	NN	NN	_	28	nmod	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	FA	fa	NN	NN	_	25	conj	_	_
28	fractions	fraction	NNS	NNS	_	23	pobj	_	_
29	(	(	-LRB-	-LRB-	_	31	punct	_	_
30	Figure	figure	NN	NN	_	31	compound	_	_
31	5A	0a	NN	NN	_	22	parataxis	_	_
32	and	and	CC	CC	_	31	cc	_	_
33	5B	0b	NN	NN	_	31	conj	_	_
34	)	)	-RRB-	-RRB-	_	31	punct	_	_
35	.	.	.	.	_	9	punct	_	_

1	Consistent	consistent	JJ	JJ	syn=PRD	11	advcl	_	_
2	with	with	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	6	det	_	_
4	filter	filter	NN	NN	_	6	compound	_	_
5	trap	trap	NN	NN	_	6	compound	_	_
6	results	result	NNS	NNS	_	2	pobj	_	_
7	presented	present	VBN	VBN	_	6	acl	_	_
8	above	above	RB	RB	_	7	advmod	_	_
9	,	,	,	,	_	11	punct	_	_
10	there	there	EX	EX	_	11	expl	_	_
11	were	be	VBD	VBD	_	0	root	_	_
12	no	no	DT	DT	_	14	det	_	_
13	significant	significant	JJ	JJ	_	14	amod	_	_
14	differences	difference	NNS	NNS	syn=PRD	11	attr	_	_
15	in	in	IN	IN	sem=LOC	14	prep	_	_
16	SDS	sds	NN	NN	_	21	npadvmod	_	_
17	-	-	HYPH	HYPH	_	16	punct	_	_
18	or	or	CC	CC	_	16	cc	_	_
19	FA	fa	NN	NN	_	16	conj	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	soluble	soluble	JJ	JJ	_	22	amod	_	_
22	Aβ	aβ	NN	NN	_	15	pobj	_	_
23	between	between	IN	IN	_	14	prep	_	_
24	the	the	DT	DT	_	28	det	_	_
25	6	0	CD	CD	_	26	nummod	_	_
26	mo	mo	NN	NN	_	28	nmod	_	_
27	untreated	untreated	JJ	JJ	_	28	amod	_	_
28	cohort	cohort	NN	NN	_	23	pobj	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	either	either	CC	CC	_	45	preconj	_	_
31	the	the	DT	DT	_	45	det	_	_
32	6	0	CD	CD	_	33	nummod	_	_
33	mo	mo	NN	NN	_	45	nmod	_	_
34	+	+	SYM	SYM	_	33	punct	_	_
35	3	0	CD	CD	_	36	nummod	_	_
36	mo	mo	NN	NN	_	33	appos	_	_
37	treated	treat	VBN	VBN	_	36	acl	_	_
38	or	or	CC	CC	_	33	cc	_	_
39	6	0	CD	CD	_	40	nummod	_	_
40	mo	mo	NN	NN	_	33	conj	_	_
41	+	+	SYM	SYM	_	40	punct	_	_
42	6	0	CD	CD	_	43	nummod	_	_
43	mo	mo	NN	NN	_	40	appos	_	_
44	treated	treat	VBN	VBN	_	43	acl	_	_
45	cohorts	cohort	NNS	NNS	_	28	conj	_	_
46	.	.	.	.	_	11	punct	_	_

1	However	however	RB	RB	_	19	advmod	_	_
2	,	,	,	,	_	19	punct	_	_
3	brains	brain	NNS	NNS	_	19	nsubj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	both	both	CC	CC	_	7	preconj	_	_
6	6	0	CD	CD	_	7	nummod	_	_
7	mo	mo	NN	NN	_	17	npadvmod	_	_
8	+	+	SYM	SYM	_	7	punct	_	_
9	3	0	CD	CD	_	10	nummod	_	_
10	mo	mo	NN	NN	_	7	appos	_	_
11	and	and	CC	CC	_	7	cc	_	_
12	6	0	CD	CD	_	13	nummod	_	_
13	mo	mo	NN	NN	_	7	conj	_	_
14	+	+	SYM	SYM	_	13	punct	_	_
15	6	0	CD	CD	_	16	nummod	_	_
16	mo	mo	NN	NN	_	13	appos	_	_
17	treated	treat	VBN	VBN	_	18	amod	_	_
18	cohorts	cohort	NNS	NNS	_	4	pobj	_	_
19	contained	contain	VBD	VBD	_	0	root	_	_
20	roughly	roughly	RB	RB	_	21	advmod	_	_
21	twice	twice	RB	RB	_	23	advmod	_	_
22	as	as	RB	RB	_	23	advmod	_	_
23	much	much	JJ	JJ	_	27	amod	_	_
24	PBS	pbs	NN	NN	_	27	nmod	_	_
25	-	-	HYPH	HYPH	_	27	punct	_	_
26	soluble	soluble	JJ	JJ	_	27	amod	_	_
27	Aβ40	aβ0	NN	NN	_	19	dobj	_	_
28	as	as	IN	IN	_	27	prep	_	_
29	untreated	untreated	JJ	JJ	_	35	amod	_	_
30	6	0	CD	CD	_	32	nummod	_	_
31	-	-	HYPH	HYPH	_	32	punct	_	_
32	mo	mo	NN	NN	_	34	npadvmod	_	_
33	-	-	HYPH	HYPH	_	34	punct	_	_
34	old	old	JJ	JJ	_	35	amod	_	_
35	mice	mouse	NNS	NNS	_	28	pobj	_	_
36	(	(	-LRB-	-LRB-	_	38	punct	_	_
37	Figure	figure	NN	NN	_	38	compound	_	_
38	5C	0c	NN	NN	_	19	parataxis	_	_
39	)	)	-RRB-	-RRB-	_	38	punct	_	_
40	.	.	.	.	_	19	punct	_	_

1	Levels	level	NNS	NNS	_	4	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	Aβ42	aβ0	NN	NN	_	2	pobj	_	_
4	showed	show	VBD	VBD	_	0	root	_	_
5	a	a	DT	DT	_	7	det	_	_
6	similar	similar	JJ	JJ	_	7	amod	_	_
7	trend	trend	NN	NN	_	4	dobj	_	_
8	,	,	,	,	_	4	punct	_	_
9	but	but	CC	CC	_	4	cc	_	_
10	did	do	VBD	VBD	_	12	aux	_	_
11	not	not	RB	RB	_	12	neg	_	_
12	reach	reach	VB	VB	_	4	conj	_	_
13	statistical	statistical	JJ	JJ	_	14	amod	_	_
14	significance	significance	NN	NN	_	12	dobj	_	_
15	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	27	prep	_	_
2	fact	fact	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	27	punct	_	_
4	levels	level	NNS	NNS	_	27	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	PBS	pbs	NN	NN	_	8	npadvmod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	soluble	soluble	JJ	JJ	_	9	amod	_	_
9	Aβ40	aβ0	NN	NN	_	5	pobj	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	Aβ42	aβ0	NN	NN	_	9	conj	_	_
12	in	in	IN	IN	_	4	prep	_	_
13	the	the	DT	DT	_	26	det	_	_
14	6	0	CD	CD	_	15	nummod	_	_
15	mo	mo	NN	NN	_	26	nmod	_	_
16	+	+	SYM	SYM	_	15	punct	_	_
17	3	0	CD	CD	_	18	nummod	_	_
18	mo	mo	NN	NN	_	15	appos	_	_
19	and	and	CC	CC	_	15	cc	_	_
20	6	0	CD	CD	_	21	nummod	_	_
21	mo	mo	NN	NN	_	15	conj	_	_
22	+	+	SYM	SYM	_	21	punct	_	_
23	6	0	CD	CD	_	24	nummod	_	_
24	mo	mo	NN	NN	_	21	appos	_	_
25	treated	treat	VBN	VBN	_	21	acl	_	_
26	cohorts	cohort	NNS	NNS	_	12	pobj	_	_
27	were	be	VBD	VBD	_	0	root	_	_
28	most	most	RBS	RBS	_	29	advmod	_	_
29	similar	similar	JJ	JJ	syn=PRD	27	acomp	_	_
30	to	to	IN	IN	_	29	prep	_	_
31	that	that	DT	DT	_	30	pobj	_	_
32	of	of	IN	IN	_	31	prep	_	_
33	the	the	DT	DT	_	37	det	_	_
34	9	0	CD	CD	_	35	nummod	_	_
35	mo	mo	NN	NN	_	37	nmod	_	_
36	untreated	untreated	JJ	JJ	_	37	amod	_	_
37	cohort	cohort	NN	NN	_	32	pobj	_	_
38	,	,	,	,	_	27	punct	_	_
39	suggesting	suggest	VBG	VBG	syn=ADV	27	advcl	_	_
40	that	that	IN	IN	_	60	mark	_	_
41	age	age	NN	NN	_	60	nsubj	_	_
42	,	,	,	,	_	41	punct	_	_
43	as	as	IN	IN	_	41	prep	_	_
44	opposed	oppose	VBN	VBN	_	43	prep	_	_
45	to	to	IN	IN	_	44	prep	_	_
46	synthetic	synthetic	JJ	JJ	_	47	amod	_	_
47	rate	rate	NN	NN	_	45	pobj	_	_
48	(	(	-LRB-	-LRB-	_	47	punct	_	_
49	which	which	WDT	WDT	_	51	dep	_	47:ref
50	would	would	MD	MD	_	51	aux	_	_
51	be	be	VB	VB	_	47	relcl	_	_
52	negligible	negligible	JJ	JJ	syn=PRD	51	acomp	_	_
53	in	in	IN	IN	sem=LOC	51	prep	_	_
54	the	the	DT	DT	_	56	det	_	_
55	treated	treat	VBN	VBN	_	56	amod	_	_
56	animals	animal	NNS	NNS	_	53	pobj	_	_
57	)	)	-RRB-	-RRB-	_	60	punct	_	_
58	,	,	,	,	_	60	punct	_	_
59	may	may	MD	MD	_	60	aux	_	_
60	determine	determine	VB	VB	_	39	ccomp	_	_
61	the	the	DT	DT	_	62	det	_	_
62	fraction	fraction	NN	NN	_	60	dobj	_	_
63	of	of	IN	IN	_	62	prep	_	_
64	PBS	pbs	NN	NN	_	66	npadvmod	_	_
65	-	-	HYPH	HYPH	_	66	punct	_	_
66	soluble	soluble	JJ	JJ	_	67	amod	_	_
67	Aβ	aβ	NN	NN	_	63	pobj	_	_
68	in	in	IN	IN	sem=LOC	60	prep	_	_
69	these	these	DT	DT	_	70	det	_	_
70	animals	animal	NNS	NNS	_	68	pobj	_	_
71	.	.	.	.	_	27	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	assessed	assess	VBD	VBD	_	0	root	_	_
4	neuritic	neuritic	JJ	JJ	_	7	amod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	glial	glial	JJ	JJ	_	4	conj	_	_
7	pathology	pathology	NN	NN	_	3	dobj	_	_
8	surrounding	surround	VBG	VBG	_	7	acl	_	_
9	the	the	DT	DT	_	10	det	_	_
10	plaques	plaque	NNS	NNS	_	8	dobj	_	_
11	to	to	TO	TO	_	12	aux	_	_
12	determine	determine	VB	VB	sem=PRP	3	advcl	_	_
13	whether	whether	IN	IN	_	15	mark	_	_
14	there	there	EX	EX	_	15	expl	_	_
15	were	be	VBD	VBD	_	12	ccomp	_	_
16	any	any	DT	DT	_	17	det	_	_
17	changes	change	NNS	NNS	syn=PRD	15	attr	_	_
18	in	in	IN	IN	sem=LOC	17	prep	_	_
19	nearby	nearby	JJ	JJ	_	20	amod	_	_
20	tissue	tissue	NN	NN	_	18	pobj	_	_
21	following	follow	VBG	VBG	sem=TMP	15	prep	_	_
22	long	long	JJ	JJ	_	24	amod	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	term	term	NN	NN	_	26	compound	_	_
25	transgene	transgene	NN	NN	_	26	compound	_	_
26	suppression	suppression	NN	NN	_	21	pobj	_	_
27	.	.	.	.	_	3	punct	_	_

1	Both	both	CC	CC	_	4	preconj	_	_
2	Hirano	hirano	NNP	NNP	_	4	compound	_	_
3	silver	silver	NN	NN	_	4	compound	_	_
4	stain	stain	NN	NN	_	8	nsubj	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	ubiquitin	ubiquitin	NN	NN	_	7	compound	_	_
7	immunostaining	immunostaining	NN	NN	_	4	conj	_	_
8	showed	show	VBD	VBD	_	0	root	_	_
9	neuritic	neuritic	JJ	JJ	_	10	amod	_	_
10	pathology	pathology	NN	NN	_	8	dobj	_	_
11	in	in	IN	IN	sem=LOC	8	prep	_	_
12	all	all	DT	DT	_	14	det	_	_
13	treatment	treatment	NN	NN	_	14	compound	_	_
14	groups	group	NNS	NNS	_	11	pobj	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	Figure	figure	NN	NN	_	8	parataxis	_	_
17	6	0	CD	CD	_	16	nummod	_	_
18	)	)	-RRB-	-RRB-	_	16	punct	_	_
19	.	.	.	.	_	8	punct	_	_

1	Similarly	similarly	RB	RB	_	9	advmod	_	_
2	,	,	,	,	_	9	punct	_	_
3	activated	activate	VBN	VBN	_	4	amod	_	_
4	astrocytes	astrocyte	NNS	NNS	_	9	nsubjpass	_	_
5	immunostained	immunostained	VBN	VBN	_	4	acl	_	_
6	for	for	IN	IN	_	5	prep	_	_
7	GFAP	gfap	NN	NN	_	6	pobj	_	_
8	were	be	VBD	VBD	_	9	auxpass	_	_
9	found	find	VBN	VBN	_	0	root	_	_
10	near	near	IN	IN	sem=LOC	9	prep	_	_
11	plaques	plaque	NNS	NNS	_	10	pobj	_	_
12	in	in	IN	IN	sem=LOC	9	prep	_	_
13	all	all	DT	DT	_	14	det	_	_
14	animals	animal	NNS	NNS	_	12	pobj	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	Figure	figure	NN	NN	_	9	parataxis	_	_
17	6	0	CD	CD	_	16	nummod	_	_
18	)	)	-RRB-	-RRB-	_	16	punct	_	_
19	.	.	.	.	_	9	punct	_	_

1	Neuritic	neuritic	JJ	JJ	_	4	amod	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	glial	glial	JJ	JJ	_	1	conj	_	_
4	pathology	pathology	NN	NN	_	5	nsubj	_	_
5	were	be	VBD	VBD	_	0	root	_	_
6	more	more	RBR	RBR	_	7	advmod	_	_
7	severe	severe	JJ	JJ	syn=PRD	5	acomp	_	_
8	in	in	IN	IN	sem=LOC	5	prep	_	_
9	the	the	DT	DT	_	12	det	_	_
10	older	old	JJR	JJR	_	12	amod	_	_
11	untreated	untreated	JJ	JJ	_	12	amod	_	_
12	mice	mouse	NNS	NNS	_	8	pobj	_	_
13	.	.	.	.	_	5	punct	_	_

1	In	in	IN	IN	_	6	prep	_	_
2	contrast	contrast	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	6	punct	_	_
4	transgene	transgene	NN	NN	_	5	compound	_	_
5	suppression	suppression	NN	NN	_	6	nsubj	_	_
6	prevented	prevent	VBD	VBD	_	0	root	_	_
7	the	the	DT	DT	_	8	det	_	_
8	growth	growth	NN	NN	_	6	dobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	individual	individual	JJ	JJ	_	11	amod	_	_
11	deposits	deposit	NNS	NNS	_	9	pobj	_	_
12	apparent	apparent	JJ	JJ	syn=PRD	11	relcl	_	_
13	in	in	IN	IN	sem=LOC	12	prep	_	_
14	untreated	untreated	JJ	JJ	_	15	amod	_	_
15	mice	mouse	NNS	NNS	_	13	pobj	_	_
16	,	,	,	,	_	6	punct	_	_
17	and	and	CC	CC	_	6	cc	_	_
18	limited	limit	VBD	VBD	_	6	conj	_	_
19	the	the	DT	DT	_	21	det	_	_
20	surrounding	surround	VBG	VBG	_	21	amod	_	_
21	pathology	pathology	NN	NN	_	18	dobj	_	_
22	to	to	IN	IN	_	18	prep	_	_
23	what	what	WP	WP	_	24	dep	_	_
24	was	be	VBD	VBD	syn=NOM	22	pcomp	_	_
25	already	already	RB	RB	_	24	advmod	_	_
26	present	present	JJ	JJ	syn=PRD	24	acomp	_	_
27	when	when	WRB	WRB	_	29	advmod	_	_
28	treatment	treatment	NN	NN	_	29	nsubj	_	_
29	began	begin	VBD	VBD	sem=TMP	24	advcl	_	_
30	.	.	.	.	_	6	punct	_	_

1	An	an	DT	DT	_	3	det	_	_
2	obvious	obvious	JJ	JJ	_	3	amod	_	_
3	question	question	NN	NN	_	8	nsubj	_	_
4	we	we	PRP	PRP	_	5	nsubj	_	_
5	sought	seek	VBD	VBD	_	3	advcl	_	_
6	to	to	TO	TO	_	7	aux	_	_
7	address	address	VB	VB	_	5	xcomp	_	_
8	was	be	VBD	VBD	_	0	root	_	_
9	whether	whether	IN	IN	_	14	mark	_	_
10	the	the	DT	DT	_	11	det	_	_
11	deposition	deposition	NN	NN	_	14	nsubj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	Aβ	aβ	NN	NN	_	12	pobj	_	_
14	diminished	diminish	VBD	VBD	syn=NOM	8	attr	_	_
15	cognitive	cognitive	JJ	JJ	_	16	amod	_	_
16	ability	ability	NN	NN	_	14	dobj	_	_
17	in	in	IN	IN	sem=LOC	16	prep	_	_
18	untreated	untreated	JJ	JJ	_	19	amod	_	_
19	mice	mouse	NNS	NNS	_	17	pobj	_	_
20	,	,	,	,	_	14	punct	_	_
21	and	and	CC	CC	_	14	cc	_	_
22	what	what	WP	WP	_	24	dep	_	_
23	might	might	MD	MD	_	24	aux	_	_
24	happen	happen	VB	VB	syn=NOM	14	conj	_	_
25	to	to	IN	IN	_	24	prep	_	_
26	cognition	cognition	NN	NN	_	25	pobj	_	_
27	when	when	WRB	WRB	_	31	advmod	_	_
28	the	the	DT	DT	_	29	det	_	_
29	process	process	NN	NN	_	31	nsubjpass	_	_
30	was	be	VBD	VBD	_	31	auxpass	_	_
31	interrupted	interrupt	VBN	VBN	sem=TMP	24	advcl	_	_
32	.	.	.	.	_	8	punct	_	_

1	Unfortunately	unfortunately	RB	RB	_	9	advmod	_	_
2	,	,	,	,	_	9	punct	_	_
3	efforts	effort	NNS	NNS	_	9	nsubjpass	_	_
4	to	to	TO	TO	_	5	aux	_	_
5	characterize	characterize	VB	VB	_	3	acl	_	_
6	cognitive	cognitive	JJ	JJ	_	7	amod	_	_
7	behavior	behavior	NN	NN	_	5	dobj	_	_
8	were	be	VBD	VBD	_	9	auxpass	_	_
9	compromised	compromise	VBN	VBN	_	0	root	_	_
10	by	by	IN	IN	_	9	agent	_	_
11	severe	severe	JJ	JJ	_	12	amod	_	_
12	hyperactivity	hyperactivity	NN	NN	_	10	pobj	_	_
13	in	in	IN	IN	sem=LOC	12	prep	_	_
14	untreated	untreated	JJ	JJ	_	17	amod	_	_
15	double	double	JJ	JJ	_	16	amod	_	_
16	transgenic	transgenic	JJ	JJ	_	17	amod	_	_
17	mice	mouse	NNS	NNS	_	13	pobj	_	_
18	.	.	.	.	_	9	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	tTA	tta	NN	NN	_	4	compound	_	_
3	/	/	HYPH	HYPH	_	4	punct	_	_
4	APP	app	NN	NN	_	5	compound	_	_
5	animals	animal	NNS	NNS	_	8	nsubjpass	_	_
6	were	be	VBD	VBD	_	8	auxpass	_	_
7	often	often	RB	RB	sem=TMP	8	advmod	_	_
8	seen	see	VBN	VBN	_	0	root	_	_
9	running	run	VBG	VBG	syn=ADV	8	advcl	_	_
10	in	in	IN	IN	_	9	prep	_	_
11	circles	circle	NNS	NNS	_	10	pobj	_	_
12	around	around	IN	IN	sem=DIR	9	prep	_	_
13	the	the	DT	DT	_	14	det	_	_
14	perimeter	perimeter	NN	NN	_	12	pobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	their	their	PRP$	PRP$	_	17	poss	_	_
17	cages	cage	NNS	NNS	_	15	pobj	_	_
18	,	,	,	,	_	8	punct	_	_
19	and	and	CC	CC	_	8	cc	_	_
20	a	a	DT	DT	_	23	det	_	_
21	similar	similar	JJ	JJ	_	23	amod	_	_
22	swimming	swimming	NN	NN	_	23	compound	_	_
23	pattern	pattern	NN	NN	_	25	nsubjpass	_	_
24	was	be	VBD	VBD	_	25	auxpass	_	_
25	noted	note	VBN	VBN	_	8	conj	_	_
26	when	when	WRB	WRB	_	30	advmod	_	_
27	the	the	DT	DT	_	28	det	_	_
28	mice	mouse	NNS	NNS	_	30	nsubjpass	_	_
29	were	be	VBD	VBD	_	30	auxpass	_	_
30	tested	test	VBN	VBN	sem=TMP	25	advcl	_	_
31	in	in	IN	IN	sem=LOC	30	prep	_	_
32	the	the	DT	DT	_	35	det	_	_
33	Morris	morris	NNP	NNP	_	35	compound	_	_
34	water	water	NN	NN	_	35	compound	_	_
35	maze	maze	NN	NN	_	31	pobj	_	_
36	.	.	.	.	_	25	punct	_	_

1	In	in	IN	IN	sem=LOC	11	prep	_	_
2	the	the	DT	DT	_	5	det	_	_
3	radial	radial	JJ	JJ	_	5	amod	_	_
4	water	water	NN	NN	_	5	compound	_	_
5	maze	maze	NN	NN	_	1	pobj	_	_
6	,	,	,	,	_	11	punct	_	_
7	repetitive	repetitive	JJ	JJ	_	9	amod	_	_
8	swim	swim	NN	NN	_	9	compound	_	_
9	patterns	pattern	NNS	NNS	_	11	nsubjpass	_	_
10	were	be	VBD	VBD	_	11	auxpass	_	_
11	noted	note	VBN	VBN	_	0	root	_	_
12	with	with	IN	IN	_	11	prep	_	_
13	no	no	DT	DT	_	14	det	_	_
14	evidence	evidence	NN	NN	_	12	pobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	choice	choice	NN	NN	_	18	npadvmod	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	motivated	motivate	VBN	VBN	_	19	amod	_	_
19	actions	action	NNS	NNS	_	15	pobj	_	_
20	.	.	.	.	_	11	punct	_	_

1	Other	other	JJ	JJ	_	2	amod	_	_
2	studies	study	NNS	NNS	_	4	nsubj	_	_
3	have	have	VBP	VBP	_	4	aux	_	_
4	dealt	deal	VBN	VBN	_	0	root	_	_
5	with	with	IN	IN	_	4	prep	_	_
6	similar	similar	JJ	JJ	_	7	amod	_	_
7	problems	problem	NNS	NNS	_	5	pobj	_	_
8	by	by	IN	IN	sem=MNR	4	prep	_	_
9	excluding	exclude	VBG	VBG	syn=NOM	8	pcomp	_	_
10	animals	animal	NNS	NNS	_	9	dobj	_	_
11	that	that	WDT	WDT	_	14	dep	_	10:ref
12	do	do	VBP	VBP	_	14	aux	_	_
13	not	not	RB	RB	_	14	neg	_	_
14	show	show	VB	VB	_	10	relcl	_	_
15	adequate	adequate	JJ	JJ	_	16	amod	_	_
16	attention	attention	NN	NN	_	14	dobj	_	_
17	to	to	IN	IN	_	16	prep	_	_
18	the	the	DT	DT	_	19	det	_	_
19	task	task	NN	NN	_	17	pobj	_	_
20	,	,	,	,	_	14	punct	_	_
21	retaining	retain	VBG	VBG	syn=ADV	14	advcl	_	_
22	only	only	RB	RB	_	24	advmod	_	_
23	those	those	DT	DT	_	24	det	_	_
24	mice	mouse	NNS	NNS	_	21	dobj	_	_
25	that	that	WDT	WDT	_	26	dep	_	24:ref
26	meet	meet	VBP	VBP	_	24	relcl	_	_
27	certain	certain	JJ	JJ	_	29	amod	_	_
28	performance	performance	NN	NN	_	29	compound	_	_
29	criteria	criterion	NNS	NNS	_	26	dobj	_	_
30	[	[	-LRB-	-LRB-	_	31	punct	_	_
31	30	0	CD	CD	_	4	parataxis	_	_
32	]	]	-RRB-	-RRB-	_	31	punct	_	_
33	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	9	prep	_	_
2	our	our	PRP$	PRP$	_	3	poss	_	_
3	case	case	NN	NN	_	1	pobj	_	_
4	,	,	,	,	_	9	punct	_	_
5	the	the	DT	DT	_	6	det	_	_
6	penetrance	penetrance	NN	NN	_	9	nsubj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	hyperactivity	hyperactivity	NN	NN	_	7	pobj	_	_
9	was	be	VBD	VBD	_	0	root	_	_
10	close	close	JJ	JJ	_	12	amod	_	_
11	to	to	IN	IN	_	12	quantmod	_	_
12	100	0	CD	CD	_	13	nummod	_	_
13	%	%	NN	NN	syn=PRD	9	attr	_	_
14	,	,	,	,	_	9	punct	_	_
15	leaving	leave	VBG	VBG	syn=ADV	9	advcl	_	_
16	us	us	PRP	PRP	_	15	dobj	_	_
17	with	with	IN	IN	_	15	prep	_	_
18	no	no	DT	DT	_	20	det	_	_
19	testable	testable	JJ	JJ	_	20	amod	_	_
20	animals	animal	NNS	NNS	_	17	pobj	_	_
21	.	.	.	.	_	9	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	phenotype	phenotype	NN	NN	_	5	nsubj	_	_
3	has	have	VBZ	VBZ	_	5	aux	_	_
4	not	not	RB	RB	_	5	neg	_	_
5	affected	affect	VBN	VBN	_	0	root	_	_
6	previous	previous	JJ	JJ	_	7	amod	_	_
7	lines	line	NNS	NNS	_	5	dobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	APPswe	appswe	NN	NN	_	10	compound	_	_
10	mice	mouse	NNS	NNS	_	8	pobj	_	_
11	we	we	PRP	PRP	_	13	nsubj	_	_
12	have	have	VBP	VBP	_	13	aux	_	_
13	produced	produce	VBN	VBN	_	7	advcl	_	_
14	,	,	,	,	_	7	punct	_	_
15	such	such	JJ	JJ	_	16	amod	_	_
16	as	as	IN	IN	_	7	prep	_	_
17	lines	line	NNS	NNS	_	18	compound	_	_
18	E1	e0	NN	NN	_	16	pobj	_	_
19	–	-	HYPH	HYPH	_	18	punct	_	_
20	2	0	CD	CD	_	18	nummod	_	_
21	or	or	CC	CC	_	18	cc	_	_
22	C3	c0	NN	NN	_	18	conj	_	_
23	–	-	HYPH	HYPH	_	22	punct	_	_
24	3	0	CD	CD	_	22	nummod	_	_
25	,	,	,	,	_	7	punct	_	_
26	that	that	WDT	WDT	_	27	dep	_	7:ref
27	express	express	VBP	VBP	_	7	relcl	_	_
28	lower	low	JJR	JJR	_	29	amod	_	_
29	levels	level	NNS	NNS	_	27	dobj	_	_
30	of	of	IN	IN	_	29	prep	_	_
31	transgenic	transgenic	JJ	JJ	_	32	amod	_	_
32	protein	protein	NN	NN	_	30	pobj	_	_
33	.	.	.	.	_	5	punct	_	_

1	Indeed	indeed	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	in	in	IN	IN	_	14	prep	_	_
4	past	past	JJ	JJ	_	5	amod	_	_
5	studies	study	NNS	NNS	_	3	pobj	_	_
6	where	where	WRB	WRB	_	8	advmod	_	5:ref
7	hyperactivity	hyperactivity	NN	NN	_	8	nsubj	_	_
8	was	be	VBD	VBD	_	5	relcl	_	_
9	not	not	RB	RB	_	8	neg	_	_
10	a	a	DT	DT	_	11	det	_	_
11	factor	factor	NN	NN	syn=PRD	8	attr	_	_
12	,	,	,	,	_	14	punct	_	_
13	we	we	PRP	PRP	_	14	nsubj	_	_
14	established	establish	VBD	VBD	_	0	root	_	_
15	a	a	DT	DT	_	17	det	_	_
16	clear	clear	JJ	JJ	_	17	amod	_	_
17	relationship	relationship	NN	NN	_	14	dobj	_	_
18	between	between	IN	IN	_	17	prep	_	_
19	amyloid	amyloid	NN	NN	_	20	compound	_	_
20	load	load	NN	NN	_	18	pobj	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	cognitive	cognitive	JJ	JJ	_	23	amod	_	_
23	ability	ability	NN	NN	_	20	conj	_	_
24	[	[	-LRB-	-LRB-	_	25	punct	_	_
25	31	0	CD	CD	_	14	parataxis	_	_
26	]	]	-RRB-	-RRB-	_	25	punct	_	_
27	.	.	.	.	_	14	punct	_	_

1	However	however	RB	RB	_	9	advmod	_	_
2	,	,	,	,	_	9	punct	_	_
3	in	in	IN	IN	_	9	prep	_	_
4	the	the	DT	DT	_	6	det	_	_
5	current	current	JJ	JJ	_	6	amod	_	_
6	study	study	NN	NN	_	3	pobj	_	_
7	,	,	,	,	_	9	punct	_	_
8	we	we	PRP	PRP	_	9	nsubj	_	_
9	feel	feel	VBP	VBP	_	0	root	_	_
10	that	that	IN	IN	_	38	mark	_	_
11	although	although	IN	IN	_	28	mark	_	_
12	the	the	DT	DT	_	14	det	_	_
13	poor	poor	JJ	JJ	_	14	amod	_	_
14	performance	performance	NN	NN	_	28	nsubjpass	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	the	the	DT	DT	_	20	det	_	_
17	tTA	tta	NN	NN	_	19	compound	_	_
18	/	/	HYPH	HYPH	_	19	punct	_	_
19	APP	app	NN	NN	_	20	compound	_	_
20	mice	mouse	NNS	NNS	_	15	pobj	_	_
21	in	in	IN	IN	_	14	prep	_	_
22	the	the	DT	DT	_	24	det	_	_
23	maze	maze	NN	NN	_	24	compound	_	_
24	tests	test	NNS	NNS	_	21	pobj	_	_
25	could	could	MD	MD	_	28	aux	_	_
26	technically	technically	RB	RB	sem=MNR	28	advmod	_	_
27	be	be	VB	VB	_	28	auxpass	_	_
28	scored	score	VBN	VBN	syn=ADV	38	advcl	_	_
29	as	as	IN	IN	_	28	prep	_	_
30	cognitive	cognitive	JJ	JJ	_	31	amod	_	_
31	impairment	impairment	NN	NN	_	29	pobj	_	_
32	,	,	,	,	_	38	punct	_	_
33	the	the	DT	DT	_	34	det	_	_
34	animals	animal	NNS	NNS	_	37	poss	_	_
35	'	'	POS	POS	_	34	case	_	_
36	severe	severe	JJ	JJ	_	37	amod	_	_
37	hyperactivity	hyperactivity	NN	NN	_	38	nsubj	_	_
38	made	make	VBD	VBD	_	9	ccomp	_	_
39	interpretation	interpretation	NN	NN	_	44	nsubj	_	_
40	of	of	IN	IN	_	39	prep	_	_
41	the	the	DT	DT	_	43	det	_	_
42	cognitive	cognitive	JJ	JJ	_	43	amod	_	_
43	tasks	task	NNS	NNS	_	40	pobj	_	_
44	impossible	impossible	JJ	JJ	syn=PRD	38	ccomp	_	_
45	.	.	.	.	_	9	punct	_	_

1	In	in	IN	IN	sem=PRP	19	prep	_	_
2	order	order	NN	NN	_	1	pobj	_	_
3	to	to	TO	TO	_	4	aux	_	_
4	understand	understand	VB	VB	_	2	acl	_	_
5	the	the	DT	DT	_	6	det	_	_
6	nature	nature	NN	NN	_	4	dobj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	extent	extent	NN	NN	_	6	conj	_	_
9	of	of	IN	IN	_	6	prep	_	_
10	hyperactivity	hyperactivity	NN	NN	_	9	pobj	_	_
11	in	in	IN	IN	sem=LOC	10	prep	_	_
12	the	the	DT	DT	_	16	det	_	_
13	tTA	tta	NN	NN	_	15	compound	_	_
14	/	/	HYPH	HYPH	_	15	punct	_	_
15	APP	app	NN	NN	_	16	compound	_	_
16	mice	mouse	NNS	NNS	_	11	pobj	_	_
17	,	,	,	,	_	19	punct	_	_
18	we	we	PRP	PRP	_	19	nsubj	_	_
19	quantified	quantify	VBD	VBD	_	0	root	_	_
20	daily	daily	JJ	JJ	_	22	amod	_	_
21	activity	activity	NN	NN	_	22	compound	_	_
22	levels	level	NNS	NNS	_	19	dobj	_	_
23	in	in	IN	IN	sem=LOC	22	prep	_	_
24	double	double	JJ	JJ	_	25	amod	_	_
25	transgenic	transgenic	JJ	JJ	_	26	amod	_	_
26	animals	animal	NNS	NNS	_	23	pobj	_	_
27	along	along	IN	IN	_	22	prep	_	_
28	with	with	IN	IN	_	27	prep	_	_
29	their	their	PRP$	PRP$	_	34	poss	_	_
30	single	single	JJ	JJ	_	31	amod	_	_
31	transgenic	transgenic	JJ	JJ	_	34	amod	_	_
32	and	and	CC	CC	_	31	cc	_	_
33	nontransgenic	nontransgenic	JJ	JJ	_	31	conj	_	_
34	siblings	sibling	NNS	NNS	_	28	pobj	_	_
35	using	use	VBG	VBG	_	34	acl	_	_
36	four	#crd#	CD	CD	_	38	nummod	_	_
37	-	-	HYPH	HYPH	_	38	punct	_	_
38	beam	beam	NN	NN	_	39	compound	_	_
39	frames	frame	NNS	NNS	_	35	dobj	_	_
40	designed	design	VBN	VBN	_	39	acl	_	_
41	to	to	TO	TO	_	42	aux	_	_
42	monitor	monitor	VB	VB	sem=PRP	40	advcl	_	_
43	ambulation	ambulation	NN	NN	_	42	dobj	_	_
44	within	within	IN	IN	sem=LOC	42	prep	_	_
45	an	an	DT	DT	_	47	det	_	_
46	enclosed	enclose	VBN	VBN	_	47	amod	_	_
47	cage	cage	NN	NN	_	44	pobj	_	_
48	.	.	.	.	_	19	punct	_	_

1	As	as	IN	IN	_	2	mark	_	_
2	shown	show	VBN	VBN	syn=ADV	11	advcl	_	_
3	in	in	IN	IN	_	2	prep	_	_
4	Figure	figure	NN	NN	_	3	pobj	_	_
5	7	0	CD	CD	_	4	nummod	_	_
6	,	,	,	,	_	11	punct	_	_
7	the	the	DT	DT	_	10	det	_	_
8	double	double	JJ	JJ	_	9	amod	_	_
9	transgenic	transgenic	JJ	JJ	_	10	nmod	_	_
10	mice	mouse	NNS	NNS	_	11	nsubj	_	_
11	were	be	VBD	VBD	_	0	root	_	_
12	up	up	IN	IN	_	14	quantmod	_	_
13	to	to	IN	IN	_	14	quantmod	_	_
14	10-fold	0-fold	RB	RB	_	16	advmod	_	_
15	more	more	RBR	RBR	_	16	advmod	_	_
16	active	active	JJ	JJ	syn=PRD	11	acomp	_	_
17	during	during	IN	IN	sem=TMP	11	prep	_	_
18	the	the	DT	DT	_	20	det	_	_
19	dark	dark	NN	NN	_	20	compound	_	_
20	phase	phase	NN	NN	_	17	pobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	the	the	DT	DT	_	26	det	_	_
23	day	day	NN	NN	_	25	compound	_	_
24	–	-	HYPH	HYPH	_	25	punct	_	_
25	night	night	NN	NN	_	26	compound	_	_
26	cycle	cycle	NN	NN	_	21	pobj	_	_
27	than	than	IN	IN	_	11	prep	_	_
28	any	any	DT	DT	_	27	pobj	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	the	the	DT	DT	_	32	det	_	_
31	control	control	NN	NN	_	32	compound	_	_
32	groups	group	NNS	NNS	_	29	pobj	_	_
33	.	.	.	.	_	11	punct	_	_

1	Activity	activity	NN	NN	_	2	compound	_	_
2	levels	level	NNS	NNS	_	3	nsubj	_	_
3	appeared	appear	VBD	VBD	_	0	root	_	_
4	to	to	TO	TO	_	5	aux	_	_
5	follow	follow	VB	VB	_	3	xcomp	_	_
6	a	a	DT	DT	_	10	det	_	_
7	relatively	relatively	RB	RB	_	8	advmod	_	_
8	normal	normal	JJ	JJ	_	10	amod	_	_
9	diurnal	diurnal	JJ	JJ	_	10	amod	_	_
10	cycle	cycle	NN	NN	_	5	dobj	_	_
11	,	,	,	,	_	5	punct	_	_
12	decreasing	decrease	VBG	VBG	syn=ADV	5	advcl	_	_
13	substantially	substantially	RB	RB	sem=MNR	12	advmod	_	_
14	during	during	IN	IN	sem=TMP	12	prep	_	_
15	the	the	DT	DT	_	17	det	_	_
16	daylight	daylight	NN	NN	_	17	compound	_	_
17	hours	hour	NNS	NNS	_	14	pobj	_	_
18	.	.	.	.	_	3	punct	_	_

1	However	however	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	even	even	RB	RB	_	4	advmod	_	_
4	during	during	IN	IN	sem=TMP	14	prep	_	_
5	the	the	DT	DT	_	7	det	_	_
6	light	light	NN	NN	_	7	compound	_	_
7	phase	phase	NN	NN	_	4	pobj	_	_
8	,	,	,	,	_	14	punct	_	_
9	the	the	DT	DT	_	13	det	_	_
10	tTA	tta	NN	NN	_	12	compound	_	_
11	/	/	HYPH	HYPH	_	12	punct	_	_
12	APP	app	NN	NN	_	13	compound	_	_
13	mice	mouse	NNS	NNS	_	14	nsubj	_	_
14	remained	remain	VBD	VBD	_	0	root	_	_
15	many-fold	many-fold	RB	RB	_	16	advmod	_	_
16	more	more	RBR	RBR	_	17	advmod	_	_
17	active	active	JJ	JJ	syn=PRD	14	acomp	_	_
18	than	than	IN	IN	_	17	prep	_	_
19	normal	normal	JJ	JJ	_	20	amod	_	_
20	controls	control	NNS	NNS	_	18	pobj	_	_
21	.	.	.	.	_	14	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	behavior	behavior	NN	NN	_	10	nsubjpass	_	_
3	was	be	VBD	VBD	_	10	auxpass	_	_
4	partially	partially	RB	RB	sem=MNR	10	advmod	_	_
5	,	,	,	,	_	4	punct	_	_
6	but	but	CC	CC	_	4	cc	_	_
7	not	not	RB	RB	_	6	neg	_	_
8	consistently	consistently	RB	RB	_	4	conj	_	_
9	,	,	,	,	_	10	punct	_	_
10	reversed	reverse	VBN	VBN	_	0	root	_	_
11	by	by	IN	IN	sem=TMP	10	prep	_	_
12	1	0	CD	CD	_	13	nummod	_	_
13	mo	mo	NN	NN	_	11	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	transgene	transgene	NN	NN	_	16	compound	_	_
16	suppression	suppression	NN	NN	_	14	pobj	_	_
17	beginning	begin	VBG	VBG	_	13	acl	_	_
18	at	at	IN	IN	sem=TMP	17	prep	_	_
19	4	0	CD	CD	_	21	quantmod	_	_
20	–	-	SYM	SYM	_	21	punct	_	_
21	5	0	CD	CD	_	22	nummod	_	_
22	mo	mo	NN	NN	_	18	pobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	age	age	NN	NN	_	23	pobj	_	_
25	(	(	-LRB-	-LRB-	_	28	punct	_	_
26	data	datum	NNS	NNS	_	28	nsubj	_	_
27	not	not	RB	RB	_	28	neg	_	_
28	shown	show	VBN	VBN	_	10	parataxis	_	_
29	)	)	-RRB-	-RRB-	_	28	punct	_	_
30	.	.	.	.	_	10	punct	_	_

1	In	in	IN	IN	_	7	prep	_	_
2	contrast	contrast	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	7	punct	_	_
4	hyperactivity	hyperactivity	NN	NN	_	7	nsubjpass	_	_
5	was	be	VBD	VBD	_	7	auxpass	_	_
6	completely	completely	RB	RB	_	7	advmod	_	_
7	abolished	abolish	VBN	VBN	_	0	root	_	_
8	by	by	IN	IN	sem=MNR	7	prep	_	_
9	rearing	rear	VBG	VBG	syn=NOM	8	pcomp	_	_
10	tTA	tta	NN	NN	_	12	compound	_	_
11	/	/	HYPH	HYPH	_	12	punct	_	_
12	APP	app	NN	NN	_	13	compound	_	_
13	mice	mouse	NNS	NNS	_	9	dobj	_	_
14	on	on	IN	IN	_	9	prep	_	_
15	dox	dox	NN	NN	_	14	pobj	_	_
16	.	.	.	.	_	7	punct	_	_

1	Animals	animal	NNS	NNS	_	7	nsubj	_	_
2	born	bear	VBN	VBN	_	1	acl	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	raised	raise	VBN	VBN	_	2	conj	_	_
5	on	on	IN	IN	_	4	prep	_	_
6	dox	dox	NN	NN	_	5	pobj	_	_
7	showed	show	VBD	VBD	_	0	root	_	_
8	activity	activity	NN	NN	_	9	compound	_	_
9	levels	level	NNS	NNS	_	7	dobj	_	_
10	similar	similar	JJ	JJ	_	9	amod	_	_
11	to	to	IN	IN	_	10	prep	_	_
12	the	the	DT	DT	_	14	det	_	_
13	untreated	untreated	JJ	JJ	_	14	amod	_	_
14	controls	control	NNS	NNS	_	11	pobj	_	_
15	(	(	-LRB-	-LRB-	_	17	punct	_	_
16	Figure	figure	NN	NN	_	17	compound	_	_
17	7C	0c	NN	NN	_	7	parataxis	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	.	.	.	.	_	7	punct	_	_

1	Intriguingly	intriguingly	RB	RB	_	18	advmod	_	_
2	,	,	,	,	_	18	punct	_	_
3	all	all	DT	DT	_	18	nsubj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	the	the	DT	DT	_	9	det	_	_
6	dox	dox	NN	NN	_	8	npadvmod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	reared	rear	VBN	VBN	_	9	amod	_	_
9	animals	animal	NNS	NNS	_	4	pobj	_	_
10	,	,	,	,	_	3	punct	_	_
11	both	both	CC	CC	_	12	preconj	_	_
12	transgenic	transgenic	JJ	JJ	_	3	amod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	wild	wild	JJ	JJ	_	16	amod	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	type	type	NN	NN	_	12	conj	_	_
17	,	,	,	,	_	18	punct	_	_
18	showed	show	VBD	VBD	_	0	root	_	_
19	altered	alter	VBN	VBN	_	21	amod	_	_
20	circadian	circadian	JJ	JJ	_	21	amod	_	_
21	rhythms	rhythm	NNS	NNS	_	18	dobj	_	_
22	with	with	IN	IN	_	21	prep	_	_
23	far	far	RB	RB	_	24	advmod	_	_
24	less	less	JJR	JJR	_	25	amod	_	_
25	distinction	distinction	NN	NN	_	22	pobj	_	_
26	between	between	IN	IN	_	25	prep	_	_
27	their	their	PRP$	PRP$	_	33	poss	_	_
28	day	day	NN	NN	_	33	nmod	_	_
29	-	-	HYPH	HYPH	_	28	punct	_	_
30	and	and	CC	CC	_	28	cc	_	_
31	nighttime	nighttime	NN	NN	_	28	conj	_	_
32	activity	activity	NN	NN	_	33	compound	_	_
33	levels	level	NNS	NNS	_	26	pobj	_	_
34	.	.	.	.	_	18	punct	_	_

1	Discussion	discussion	NN	NN	_	0	root	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	present	present	VBP	VBP	_	0	root	_	_
3	a	a	DT	DT	_	6	det	_	_
4	new	new	JJ	JJ	_	6	amod	_	_
5	mouse	mouse	NN	NN	_	6	compound	_	_
6	model	model	NN	NN	_	2	dobj	_	_
7	for	for	IN	IN	_	6	prep	_	_
8	AD	ad	NN	NN	_	7	pobj	_	_
9	that	that	WDT	WDT	_	11	dep	_	6:ref
10	was	be	VBD	VBD	_	11	auxpass	_	_
11	designed	design	VBN	VBN	_	6	relcl	_	_
12	to	to	TO	TO	_	13	aux	_	_
13	test	test	VB	VB	sem=PRP	11	advcl	_	_
14	the	the	DT	DT	_	15	det	_	_
15	consequences	consequence	NNS	NNS	_	13	dobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	inhibiting	inhibit	VBG	VBG	syn=NOM	16	pcomp	_	_
18	Aβ	aβ	NN	NN	_	19	compound	_	_
19	production	production	NN	NN	_	17	dobj	_	_
20	after	after	IN	IN	sem=TMP	17	prep	_	_
21	the	the	DT	DT	_	22	det	_	_
22	onset	onset	NN	NN	_	20	pobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	amyloid	amyloid	NN	NN	_	25	compound	_	_
25	pathology	pathology	NN	NN	_	23	pobj	_	_
26	.	.	.	.	_	2	punct	_	_

1	New	new	JJ	JJ	_	2	amod	_	_
2	lines	line	NNS	NNS	_	7	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	transgenic	transgenic	JJ	JJ	_	5	amod	_	_
5	mice	mouse	NNS	NNS	_	3	pobj	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	developed	develop	VBN	VBN	_	0	root	_	_
8	for	for	IN	IN	_	7	prep	_	_
9	this	this	DT	DT	_	10	det	_	_
10	study	study	NN	NN	_	8	pobj	_	_
11	that	that	WDT	WDT	_	12	dep	_	_
12	express	express	VBP	VBP	_	7	ccomp	_	_
13	high	high	JJ	JJ	_	14	amod	_	_
14	levels	level	NNS	NNS	_	12	dobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	APPswe	appswe	NN	NN	_	18	compound	_	_
17	/	/	HYPH	HYPH	_	18	punct	_	_
18	ind	ind	NN	NN	_	15	pobj	_	_
19	under	under	IN	IN	_	12	prep	_	_
20	the	the	DT	DT	_	21	det	_	_
21	control	control	NN	NN	_	19	pobj	_	_
22	of	of	IN	IN	_	21	prep	_	_
23	a	a	DT	DT	_	27	det	_	_
24	tetracycline	tetracycline	NN	NN	_	26	npadvmod	_	_
25	-	-	HYPH	HYPH	_	26	punct	_	_
26	responsive	responsive	JJ	JJ	_	27	amod	_	_
27	promoter	promoter	NN	NN	_	22	pobj	_	_
28	.	.	.	.	_	7	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	7	mark	_	_
4	treatment	treatment	NN	NN	_	7	nsubj	_	_
5	with	with	IN	IN	_	4	prep	_	_
6	dox	dox	NN	NN	_	5	pobj	_	_
7	suppresses	suppress	VBZ	VBZ	_	2	ccomp	_	_
8	steady	steady	JJ	JJ	_	10	amod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	state	state	NN	NN	_	11	compound	_	_
11	levels	level	NNS	NNS	_	7	dobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	both	both	CC	CC	_	16	preconj	_	_
14	APPswe	appswe	NN	NN	_	16	compound	_	_
15	/	/	HYPH	HYPH	_	16	punct	_	_
16	ind	ind	NN	NN	_	12	pobj	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	its	its	PRP$	PRP$	_	22	poss	_	_
19	C	c	NN	NN	_	22	nmod	_	_
20	-	-	HYPH	HYPH	_	22	punct	_	_
21	terminal	terminal	JJ	JJ	_	22	amod	_	_
22	fragments	fragment	NNS	NNS	_	16	conj	_	_
23	,	,	,	,	_	7	punct	_	_
24	indicating	indicate	VBG	VBG	syn=ADV	7	advcl	_	_
25	that	that	IN	IN	_	29	mark	_	_
26	the	the	DT	DT	_	28	det	_	_
27	mutant	mutant	NN	NN	_	28	compound	_	_
28	proteins	proteins	NN	NN	_	29	nsubj	_	_
29	have	have	VBP	VBP	_	24	ccomp	_	_
30	a	a	DT	DT	_	35	det	_	_
31	relatively	relatively	RB	RB	_	32	advmod	_	_
32	short	short	JJ	JJ	_	35	amod	_	_
33	half	half	NN	NN	_	35	compound	_	_
34	-	-	HYPH	HYPH	_	35	punct	_	_
35	life	life	NN	NN	_	29	dobj	_	_
36	in	in	FW	FW	_	37	advmod	_	_
37	vivo	vivo	FW	FW	_	29	advmod	_	_
38	.	.	.	.	_	2	punct	_	_

1	Transgenic	transgenic	JJ	JJ	_	2	amod	_	_
2	expression	expression	NN	NN	_	12	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	APPswe	appswe	NN	NN	_	6	compound	_	_
5	/	/	HYPH	HYPH	_	6	punct	_	_
6	ind	ind	NN	NN	_	3	pobj	_	_
7	and	and	CC	CC	_	2	cc	_	_
8	consequent	consequent	JJ	JJ	_	9	amod	_	_
9	overproduction	overproduction	NN	NN	_	2	conj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	Aβ42	aβ0	NN	NN	_	10	pobj	_	_
12	cause	cause	VBP	VBP	_	0	root	_	_
13	early	early	JJ	JJ	_	15	amod	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	onset	onset	NN	NN	_	17	compound	_	_
16	amyloid	amyloid	NN	NN	_	17	compound	_	_
17	deposition	deposition	NN	NN	_	12	dobj	_	_
18	in	in	IN	IN	sem=LOC	12	prep	_	_
19	untreated	untreated	JJ	JJ	_	20	amod	_	_
20	mice	mouse	NNS	NNS	_	18	pobj	_	_
21	,	,	,	,	_	20	punct	_	_
22	in	in	IN	IN	_	25	prep	_	_
23	which	which	WDT	WDT	_	22	pobj	_	20:ref
24	deposits	deposit	NNS	NNS	_	25	nsubj	_	_
25	appear	appear	VBP	VBP	_	20	relcl	_	_
26	as	as	RB	RB	_	27	advmod	_	_
27	early	early	RB	RB	sem=TMP	25	advmod	_	_
28	as	as	IN	IN	_	27	prep	_	_
29	2	0	CD	CD	_	30	nummod	_	_
30	mo	mo	NN	NN	_	28	pobj	_	_
31	of	of	IN	IN	_	30	prep	_	_
32	age	age	NN	NN	_	31	pobj	_	_
33	.	.	.	.	_	12	punct	_	_

1	Amyloid	amyloid	NN	NN	_	2	compound	_	_
2	burden	burden	NN	NN	_	3	nsubj	_	_
3	worsens	worsen	VBZ	VBZ	_	0	root	_	_
4	significantly	significantly	RB	RB	_	3	advmod	_	_
5	with	with	IN	IN	_	3	prep	_	_
6	age	age	NN	NN	_	5	pobj	_	_
7	,	,	,	,	_	3	punct	_	_
8	and	and	CC	CC	_	3	cc	_	_
9	by	by	IN	IN	_	22	prep	_	_
10	9	0	CD	CD	_	11	nummod	_	_
11	mo	mo	NN	NN	_	9	pobj	_	_
12	,	,	,	,	_	22	punct	_	_
13	the	the	DT	DT	_	14	det	_	_
14	hippocampus	hippocampus	NN	NN	_	22	nsubjpass	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	cortex	cortex	NN	NN	_	14	conj	_	_
17	of	of	IN	IN	_	14	prep	_	_
18	untreated	untreated	JJ	JJ	_	19	amod	_	_
19	mice	mouse	NNS	NNS	_	17	pobj	_	_
20	are	be	VBP	VBP	_	22	auxpass	_	_
21	largely	largely	RB	RB	_	22	advmod	_	_
22	filled	fill	VBN	VBN	_	3	conj	_	_
23	with	with	IN	IN	sem=MNR	22	prep	_	_
24	aggregated	aggregate	VBN	VBN	_	25	amod	_	_
25	peptide	peptide	NN	NN	_	23	pobj	_	_
26	.	.	.	.	_	22	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	find	find	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	14	mark	_	_
4	suppression	suppression	NN	NN	_	14	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	transgenic	transgenic	JJ	JJ	_	7	amod	_	_
7	APP	app	NN	NN	_	5	pobj	_	_
8	by	by	IN	IN	_	4	prep	_	_
9	more	more	JJR	JJR	_	11	amod	_	_
10	than	than	IN	IN	_	11	quantmod	_	_
11	95	0	CD	CD	_	12	nummod	_	_
12	%	%	NN	NN	_	8	pobj	_	_
13	abruptly	abruptly	RB	RB	_	14	advmod	_	_
14	halts	halt	VBZ	VBZ	_	2	ccomp	_	_
15	the	the	DT	DT	_	16	det	_	_
16	progression	progression	NN	NN	_	14	dobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	amyloid	amyloid	NN	NN	_	19	compound	_	_
19	pathology	pathology	NN	NN	_	17	pobj	_	_
20	.	.	.	.	_	2	punct	_	_

1	Importantly	importantly	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	this	this	DT	DT	_	4	det	_	_
4	outcome	outcome	NN	NN	_	5	nsubj	_	_
5	occurs	occur	VBZ	VBZ	_	0	root	_	_
6	in	in	IN	IN	sem=LOC	5	prep	_	_
7	animals	animal	NNS	NNS	_	6	pobj	_	_
8	already	already	RB	RB	_	9	advmod	_	_
9	harboring	harbor	VBG	VBG	_	7	acl	_	_
10	considerable	considerable	JJ	JJ	_	12	amod	_	_
11	amyloid	amyloid	NN	NN	_	12	compound	_	_
12	pathology	pathology	NN	NN	_	9	dobj	_	_
13	,	,	,	,	_	5	punct	_	_
14	a	a	DT	DT	_	15	det	_	_
15	situation	situation	NN	NN	syn=ADV	5	npadvmod	_	_
16	similar	similar	JJ	JJ	_	15	amod	_	_
17	to	to	IN	IN	_	16	prep	_	_
18	what	what	WP	WP	_	21	dep	_	_
19	might	might	MD	MD	_	21	aux	_	_
20	be	be	VB	VB	_	21	auxpass	_	_
21	expected	expect	VBN	VBN	syn=NOM	17	pcomp	_	_
22	in	in	IN	IN	sem=LOC	21	prep	_	_
23	patients	patient	NNS	NNS	_	22	pobj	_	_
24	to	to	TO	TO	_	26	aux	_	_
25	be	be	VB	VB	_	26	auxpass	_	_
26	treated	treat	VBN	VBN	_	23	advcl	_	_
27	with	with	IN	IN	_	26	prep	_	_
28	secretase	secretase	NN	NN	_	29	compound	_	_
29	inhibitors	inhibitor	NNS	NNS	_	27	pobj	_	_
30	.	.	.	.	_	5	punct	_	_

1	Somewhat	somewhat	RB	RB	_	2	advmod	_	_
2	unexpectedly	unexpectedly	RB	RB	_	5	advmod	_	_
3	,	,	,	,	_	5	punct	_	_
4	we	we	PRP	PRP	_	5	nsubj	_	_
5	observe	observe	VBP	VBP	_	0	root	_	_
6	no	no	DT	DT	_	8	det	_	_
7	appreciable	appreciable	JJ	JJ	_	8	amod	_	_
8	clearance	clearance	NN	NN	_	5	dobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	deposited	deposit	VBN	VBN	_	11	amod	_	_
11	amyloid	amyloid	NN	NN	_	9	pobj	_	_
12	even	even	RB	RB	_	13	advmod	_	_
13	following	follow	VBG	VBG	sem=TMP	5	prep	_	_
14	periods	period	NNS	NNS	_	13	pobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	transgene	transgene	NN	NN	_	17	compound	_	_
17	suppression	suppression	NN	NN	_	15	pobj	_	_
18	equal	equal	JJ	JJ	_	14	amod	_	_
19	to	to	IN	IN	_	18	prep	_	_
20	the	the	DT	DT	_	21	det	_	_
21	time	time	NN	NN	_	19	pobj	_	_
22	taken	take	VBN	VBN	_	21	advcl	_	_
23	for	for	IN	IN	_	26	mark	_	_
24	plaques	plaque	NNS	NNS	_	26	nsubj	_	_
25	to	to	TO	TO	_	26	aux	_	_
26	form	form	VB	VB	sem=TMP	22	advcl	_	_
27	.	.	.	.	_	5	punct	_	_

1	This	this	DT	DT	_	3	det	_	_
2	latter	latter	JJ	JJ	_	3	amod	_	_
3	finding	finding	NN	NN	_	4	nsubj	_	_
4	indicates	indicate	VBZ	VBZ	_	0	root	_	_
5	that	that	IN	IN	_	35	mark	_	_
6	compared	compare	VBN	VBN	_	35	prep	_	_
7	to	to	IN	IN	_	6	prep	_	_
8	other	other	JJ	JJ	_	13	amod	_	_
9	disease	disease	NN	NN	_	11	npadvmod	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	associated	associate	VBN	VBN	_	13	amod	_	_
12	protein	protein	NN	NN	_	13	compound	_	_
13	aggregates	aggregate	NNS	NNS	_	7	pobj	_	_
14	such	such	JJ	JJ	_	15	amod	_	_
15	as	as	IN	IN	_	13	prep	_	_
16	mutant	mutant	NN	NN	_	17	compound	_	_
17	huntingtin	huntingtin	NN	NN	_	15	pobj	_	_
18	,	,	,	,	_	17	punct	_	_
19	which	which	WDT	WDT	_	20	dep	_	17:ref
20	clear	clear	VBP	VBP	_	17	relcl	_	_
21	in	in	IN	IN	sem=TMP	20	prep	_	_
22	less	less	JJR	JJR	_	24	amod	_	_
23	than	than	IN	IN	_	24	quantmod	_	_
24	3	0	CD	CD	_	25	nummod	_	_
25	mo	mo	NN	NN	_	21	pobj	_	_
26	[	[	-LRB-	-LRB-	_	27	punct	_	_
27	32	0	CD	CD	_	20	parataxis	_	_
28	]	]	-RRB-	-RRB-	_	27	punct	_	_
29	,	,	,	,	_	35	punct	_	_
30	the	the	DT	DT	_	31	det	_	_
31	disaggregation	disaggregation	NN	NN	_	35	nsubj	_	_
32	of	of	IN	IN	_	31	prep	_	_
33	extracellular	extracellular	JJ	JJ	_	34	amod	_	_
34	amyloid	amyloid	NN	NN	_	32	pobj	_	_
35	is	be	VBZ	VBZ	_	4	ccomp	_	_
36	relatively	relatively	RB	RB	_	37	advmod	_	_
37	slow	slow	JJ	JJ	syn=PRD	35	acomp	_	_
38	.	.	.	.	_	4	punct	_	_

1	Notably	notably	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	pharmaceutical	pharmaceutical	JJ	JJ	_	7	amod	_	_
4	γ	γ	SYM	SYM	_	6	punct	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	secretase	secretase	NN	NN	_	7	compound	_	_
7	inhibitors	inhibitor	NNS	NNS	_	11	nsubj	_	_
8	published	publish	VBN	VBN	_	7	acl	_	_
9	to	to	IN	IN	sem=TMP	8	prep	_	_
10	date	date	NN	NN	_	9	pobj	_	_
11	show	show	VBP	VBP	_	0	root	_	_
12	less	less	RBR	RBR	_	13	advmod	_	_
13	strict	strict	JJ	JJ	_	14	amod	_	_
14	regulation	regulation	NN	NN	_	11	dobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	Aβ	aβ	NN	NN	_	17	compound	_	_
17	production	production	NN	NN	_	15	pobj	_	_
18	following	follow	VBG	VBG	sem=TMP	14	prep	_	_
19	chronic	chronic	JJ	JJ	_	20	amod	_	_
20	administration	administration	NN	NN	_	18	pobj	_	_
21	than	than	IN	IN	_	24	mark	_	_
22	we	we	PRP	PRP	_	24	nsubj	_	_
23	have	have	VBP	VBP	_	24	aux	_	_
24	attained	attain	VBN	VBN	_	14	advcl	_	_
25	here	here	RB	RB	_	24	advmod	_	_
26	.	.	.	.	_	11	punct	_	_

1	Two	#crd#	CD	CD	_	3	nummod	_	_
2	independent	independent	JJ	JJ	_	3	amod	_	_
3	compounds	compound	NNS	NNS	_	17	nsubj	_	_
4	tested	test	VBN	VBN	_	3	acl	_	_
5	in	in	IN	IN	sem=LOC	4	prep	_	_
6	Tg2576	tg0	NN	NN	_	15	npadvmod	_	_
7	[	[	-LRB-	-LRB-	_	8	punct	_	_
8	33	0	CD	CD	_	6	parataxis	_	_
9	]	]	-RRB-	-RRB-	_	8	punct	_	_
10	and	and	CC	CC	_	6	cc	_	_
11	TgCRND8	tgcrnd0	NN	NN	_	6	conj	_	_
12	[	[	-LRB-	-LRB-	_	13	punct	_	_
13	34	0	CD	CD	_	11	parataxis	_	_
14	]	]	-RRB-	-RRB-	_	13	punct	_	_
15	transgenic	transgenic	JJ	JJ	_	16	amod	_	_
16	mice	mouse	NNS	NNS	_	5	pobj	_	_
17	show	show	VBP	VBP	_	0	root	_	_
18	no	no	RB	RB	_	21	neg	_	_
19	more	more	JJR	JJR	_	21	amod	_	_
20	than	than	IN	IN	_	21	quantmod	_	_
21	85	0	CD	CD	_	22	nummod	_	_
22	%	%	NN	NN	_	23	compound	_	_
23	suppression	suppression	NN	NN	_	17	dobj	_	_
24	of	of	IN	IN	_	23	prep	_	_
25	Aβ40	aβ0	NN	NN	_	26	compound	_	_
26	levels	level	NNS	NNS	_	24	pobj	_	_
27	,	,	,	,	_	23	punct	_	_
28	and	and	CC	CC	_	23	cc	_	_
29	where	where	WRB	WRB	_	30	advmod	_	_
30	measured	measure	VBN	VBN	sem=LOC	34	advcl	_	_
31	,	,	,	,	_	34	punct	_	_
32	even	even	RB	RB	_	33	advmod	_	_
33	less	less	JJR	JJR	_	34	amod	_	_
34	suppression	suppression	NN	NN	_	23	conj	_	_
35	of	of	IN	IN	_	34	prep	_	_
36	Aβ42	aβ0	NN	NN	_	35	pobj	_	_
37	(	(	-LRB-	-LRB-	_	40	punct	_	_
38	approximately	approximately	RB	RB	_	39	advmod	_	_
39	60	0	CD	CD	_	40	nummod	_	_
40	%	%	NN	NN	_	36	parataxis	_	_
41	)	)	-RRB-	-RRB-	_	40	punct	_	_
42	[	[	-LRB-	-LRB-	_	45	punct	_	_
43	35	0	CD	CD	_	45	nummod	_	_
44	,	,	,	,	_	45	punct	_	_
45	36	0	CD	CD	_	17	parataxis	_	_
46	]	]	-RRB-	-RRB-	_	45	punct	_	_
47	.	.	.	.	_	17	punct	_	_

1	Thus	thus	RB	RB	_	26	advmod	_	_
2	,	,	,	,	_	26	punct	_	_
3	even	even	RB	RB	_	4	advmod	_	_
4	after	after	IN	IN	sem=TMP	26	prep	_	_
5	accounting	account	VBG	VBG	syn=NOM	4	pcomp	_	_
6	for	for	IN	IN	_	5	prep	_	_
7	the	the	DT	DT	_	12	det	_	_
8	much	much	RB	RB	_	9	advmod	_	_
9	higher	high	JJR	JJR	_	12	amod	_	_
10	APP	app	NN	NN	_	12	compound	_	_
11	expression	expression	NN	NN	_	12	compound	_	_
12	levels	level	NNS	NNS	_	6	pobj	_	_
13	in	in	IN	IN	sem=LOC	12	prep	_	_
14	our	our	PRP$	PRP$	_	15	poss	_	_
15	mice	mouse	NNS	NNS	_	13	pobj	_	_
16	than	than	IN	IN	_	12	prep	_	_
17	in	in	IN	IN	sem=LOC	16	prep	_	_
18	the	the	DT	DT	_	22	det	_	_
19	Tg2576	tg0	NN	NN	_	22	nmod	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	TgCRND8	tgcrnd0	NN	NN	_	19	conj	_	_
22	lines	line	NNS	NNS	_	17	pobj	_	_
23	,	,	,	,	_	26	punct	_	_
24	we	we	PRP	PRP	_	26	nsubj	_	_
25	have	have	VBP	VBP	_	26	aux	_	_
26	achieved	achieve	VBN	VBN	_	0	root	_	_
27	better	well	RBR	RBR	_	29	advmod	_	_
28	absolute	absolute	JJ	JJ	_	29	amod	_	_
29	suppression	suppression	NN	NN	_	26	dobj	_	_
30	of	of	IN	IN	_	29	prep	_	_
31	Aβ	aβ	NN	NN	_	32	compound	_	_
32	production	production	NN	NN	_	30	pobj	_	_
33	with	with	IN	IN	_	29	prep	_	_
34	the	the	DT	DT	_	38	det	_	_
35	tet	tet	NN	NN	_	37	compound	_	_
36	-	-	HYPH	HYPH	_	37	punct	_	_
37	off	off	NN	NN	_	38	compound	_	_
38	system	system	NN	NN	_	33	pobj	_	_
39	than	than	IN	IN	_	40	mark	_	_
40	is	be	VBZ	VBZ	_	29	advcl	_	_
41	currently	currently	RB	RB	sem=TMP	40	advmod	_	_
42	possible	possible	JJ	JJ	syn=PRD	40	acomp	_	_
43	with	with	IN	IN	_	40	prep	_	_
44	published	publish	VBN	VBN	_	48	amod	_	_
45	γ	γ	SYM	SYM	_	47	punct	_	_
46	-	-	HYPH	HYPH	_	47	punct	_	_
47	secretase	secretase	NN	NN	_	48	compound	_	_
48	inhibitors	inhibitor	NNS	NNS	_	43	pobj	_	_
49	.	.	.	.	_	26	punct	_	_

1	Since	since	IN	IN	_	9	mark	_	_
2	even	even	RB	RB	_	8	advmod	_	_
3	the	the	DT	DT	_	8	det	_	_
4	most	most	RBS	RBS	_	5	advmod	_	_
5	advanced	advanced	JJ	JJ	_	8	amod	_	_
6	future	future	JJ	JJ	_	8	amod	_	_
7	pharmaceutical	pharmaceutical	JJ	JJ	_	8	amod	_	_
8	agents	agent	NNS	NNS	_	9	nsubj	_	_
9	are	be	VBP	VBP	sem=PRP	25	advcl	_	_
10	unlikely	unlikely	JJ	JJ	syn=PRD	9	acomp	_	_
11	to	to	TO	TO	_	12	aux	_	_
12	attain	attain	VB	VB	_	10	xcomp	_	_
13	more	more	RBR	RBR	_	14	advmod	_	_
14	complete	complete	JJ	JJ	_	15	amod	_	_
15	control	control	NN	NN	_	12	dobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	Aβ	aβ	NN	NN	_	18	compound	_	_
18	production	production	NN	NN	_	16	pobj	_	_
19	than	than	IN	IN	_	20	mark	_	_
20	achieved	achieve	VBN	VBN	_	15	advcl	_	_
21	here	here	RB	RB	_	20	advmod	_	_
22	,	,	,	,	_	25	punct	_	_
23	this	this	DT	DT	_	24	det	_	_
24	system	system	NN	NN	_	25	nsubj	_	_
25	provides	provide	VBZ	VBZ	_	0	root	_	_
26	a	a	DT	DT	_	28	det	_	_
27	salient	salient	JJ	JJ	_	28	amod	_	_
28	test	test	NN	NN	_	25	dobj	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	therapeutic	therapeutic	JJ	JJ	_	31	amod	_	_
31	intervention	intervention	NN	NN	_	29	pobj	_	_
32	with	with	IN	IN	_	31	prep	_	_
33	Aβ	aβ	NN	NN	_	35	npadvmod	_	_
34	-	-	HYPH	HYPH	_	35	punct	_	_
35	lowering	lower	VBG	VBG	_	36	amod	_	_
36	compounds	compound	NNS	NNS	_	32	pobj	_	_
37	.	.	.	.	_	25	punct	_	_

1	Although	although	IN	IN	_	9	mark	_	_
2	the	the	DT	DT	_	3	det	_	_
3	progression	progression	NN	NN	_	9	nsubjpass	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	amyloid	amyloid	NN	NN	_	6	compound	_	_
6	deposition	deposition	NN	NN	_	4	pobj	_	_
7	was	be	VBD	VBD	_	9	auxpass	_	_
8	sharply	sharply	RB	RB	_	9	advmod	_	_
9	arrested	arrest	VBN	VBN	syn=ADV	15	advcl	_	_
10	by	by	IN	IN	_	9	agent	_	_
11	this	this	DT	DT	_	12	det	_	_
12	approach	approach	NN	NN	_	10	pobj	_	_
13	,	,	,	,	_	15	punct	_	_
14	we	we	PRP	PRP	_	15	nsubj	_	_
15	found	find	VBD	VBD	_	0	root	_	_
16	that	that	IN	IN	_	21	mark	_	_
17	a	a	DT	DT	_	20	det	_	_
18	substantial	substantial	JJ	JJ	_	20	amod	_	_
19	amyloid	amyloid	NN	NN	_	20	compound	_	_
20	burden	burden	NN	NN	_	21	nsubj	_	_
21	remained	remain	VBD	VBD	_	15	ccomp	_	_
22	even	even	RB	RB	_	23	advmod	_	_
23	after	after	IN	IN	sem=TMP	21	prep	_	_
24	long	long	JJ	JJ	_	25	amod	_	_
25	periods	period	NNS	NNS	_	23	pobj	_	_
26	of	of	IN	IN	_	25	prep	_	_
27	transgene	transgene	NN	NN	_	28	compound	_	_
28	suppression	suppression	NN	NN	_	26	pobj	_	_
29	.	.	.	.	_	15	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	examined	examine	VBD	VBD	_	0	root	_	_
3	a	a	DT	DT	_	5	det	_	_
4	small	small	JJ	JJ	_	5	amod	_	_
5	number	number	NN	NN	_	2	dobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	animals	animal	NNS	NNS	_	6	pobj	_	_
8	after	after	IN	IN	sem=TMP	2	prep	_	_
9	12	0	CD	CD	_	10	nummod	_	_
10	mo	mo	NN	NN	_	8	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	dox	dox	NN	NN	_	13	compound	_	_
13	treatment	treatment	NN	NN	_	11	pobj	_	_
14	(	(	-LRB-	-LRB-	_	13	punct	_	_
15	beginning	begin	VBG	VBG	_	13	acl	_	_
16	at	at	IN	IN	sem=TMP	15	prep	_	_
17	6	0	CD	CD	_	18	nummod	_	_
18	mo	mo	NN	NN	_	16	pobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	age	age	NN	NN	_	19	pobj	_	_
21	)	)	-RRB-	-RRB-	_	13	punct	_	_
22	,	,	,	,	_	2	punct	_	_
23	and	and	CC	CC	_	2	cc	_	_
24	found	find	VBD	VBD	_	2	conj	_	_
25	that	that	IN	IN	_	28	mark	_	_
26	amyloid	amyloid	NN	NN	_	27	compound	_	_
27	deposits	deposit	NNS	NNS	_	28	nsubj	_	_
28	were	be	VBD	VBD	_	24	ccomp	_	_
29	still	still	RB	RB	sem=TMP	28	advmod	_	_
30	relatively	relatively	RB	RB	_	31	advmod	_	_
31	abundant	abundant	JJ	JJ	syn=PRD	28	acomp	_	_
32	.	.	.	.	_	2	punct	_	_

1	Longer	longer	JJ	JJ	_	3	amod	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	term	term	NN	NN	_	4	compound	_	_
4	treatments	treatment	NNS	NNS	_	5	nsubj	_	_
5	are	be	VBP	VBP	_	0	root	_	_
6	now	now	RB	RB	sem=TMP	5	advmod	_	_
7	in	in	IN	IN	syn=PRD	5	prep	_	_
8	progress	progress	NN	NN	_	7	pobj	_	_
9	.	.	.	.	_	5	punct	_	_

1	At	at	IN	IN	_	16	prep	_	_
2	the	the	DT	DT	_	5	det	_	_
3	latest	late	JJS	JJS	_	5	amod	_	_
4	treatment	treatment	NN	NN	_	5	compound	_	_
5	interval	interval	NN	NN	_	1	pobj	_	_
6	analyzed	analyze	VBN	VBN	_	5	acl	_	_
7	by	by	IN	IN	_	6	agent	_	_
8	ELISA	elisa	NN	NN	_	7	pobj	_	_
9	,	,	,	,	_	16	punct	_	_
10	animals	animal	NNS	NNS	_	16	nsubj	_	_
11	administered	administer	VBN	VBN	_	10	acl	_	_
12	dox	dox	NN	NN	_	11	dobj	_	_
13	for	for	IN	IN	sem=TMP	11	prep	_	_
14	6	0	CD	CD	_	15	nummod	_	_
15	mo	mo	NN	NN	_	13	pobj	_	_
16	showed	show	VBD	VBD	_	0	root	_	_
17	elevated	elevate	VBN	VBN	_	18	amod	_	_
18	levels	level	NNS	NNS	_	16	dobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	PBS	pbs	NN	NN	_	22	npadvmod	_	_
21	-	-	HYPH	HYPH	_	22	punct	_	_
22	soluble	soluble	JJ	JJ	_	23	amod	_	_
23	Aβ	aβ	NN	NN	_	19	pobj	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	see	see	VB	VB	_	23	parataxis	_	_
26	Figure	figure	NN	NN	_	25	dobj	_	_
27	5	0	CD	CD	_	26	nummod	_	_
28	)	)	-RRB-	-RRB-	_	25	punct	_	_
29	that	that	WDT	WDT	_	32	dep	_	18:ref
30	could	could	MD	MD	_	32	aux	_	_
31	be	be	VB	VB	_	32	auxpass	_	_
32	interpreted	interpret	VBN	VBN	_	18	relcl	_	_
33	as	as	IN	IN	_	32	prep	_	_
34	an	an	DT	DT	_	35	det	_	_
35	indication	indication	NN	NN	_	33	pobj	_	_
36	that	that	IN	IN	_	41	mark	_	_
37	the	the	DT	DT	_	38	det	_	_
38	plaques	plaque	NNS	NNS	_	41	nsubj	_	_
39	are	be	VBP	VBP	_	41	aux	_	_
40	slowly	slowly	RB	RB	sem=TMP	41	advmod	_	_
41	releasing	release	VBG	VBG	_	35	acl	_	_
42	peptide	peptide	NN	NN	_	41	dobj	_	_
43	(	(	-LRB-	-LRB-	_	42	punct	_	_
44	or	or	CC	CC	_	42	cc	_	_
45	oligomeric	oligomeric	JJ	JJ	_	46	amod	_	_
46	Aβ	aβ	NN	NN	_	42	conj	_	_
47	)	)	-RRB-	-RRB-	_	46	punct	_	_
48	into	into	IN	IN	sem=LOC	41	prep	_	_
49	the	the	DT	DT	_	51	det	_	_
50	soluble	soluble	JJ	JJ	_	51	amod	_	_
51	pool	pool	NN	NN	_	48	pobj	_	_
52	and	and	CC	CC	_	41	cc	_	_
53	might	might	MD	MD	_	55	aux	_	_
54	eventually	eventually	RB	RB	sem=TMP	55	advmod	_	_
55	dissolve	dissolve	VB	VB	_	41	conj	_	_
56	.	.	.	.	_	16	punct	_	_

1	Whether	whether	IN	IN	_	15	mark	_	_
2	inhibiting	inhibit	VBG	VBG	syn=NOM	15	csubj	_	_
3	Aβ	aβ	NN	NN	_	4	compound	_	_
4	production	production	NN	NN	_	2	dobj	_	_
5	longer	long	RBR	RBR	sem=TMP	2	advmod	_	_
6	than	than	IN	IN	_	5	prep	_	_
7	6	0	CD	CD	_	12	nummod	_	_
8	(	(	-LRB-	-LRB-	_	7	punct	_	_
9	or	or	CC	CC	_	7	cc	_	_
10	12	0	CD	CD	_	7	conj	_	_
11	)	)	-RRB-	-RRB-	_	12	punct	_	_
12	mo	mo	NN	NN	_	6	pobj	_	_
13	may	may	MD	MD	_	15	aux	_	_
14	ultimately	ultimately	RB	RB	_	15	advmod	_	_
15	result	result	VB	VB	syn=NOM	20	csubj	_	_
16	in	in	IN	IN	_	15	prep	_	_
17	clearance	clearance	NN	NN	_	16	pobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	amyloid	amyloid	NN	NN	_	18	pobj	_	_
20	is	be	VBZ	VBZ	_	33	ccomp	_	_
21	under	under	IN	IN	syn=PRD	20	prep	_	_
22	investigation	investigation	NN	NN	_	21	pobj	_	_
23	;	;	:	:	_	33	punct	_	_
24	unfortunately	unfortunately	RB	RB	_	33	advmod	_	_
25	,	,	,	,	_	33	punct	_	_
26	the	the	DT	DT	_	28	det	_	_
27	life	life	NN	NN	_	28	compound	_	_
28	span	span	NN	NN	_	33	nsubj	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	the	the	DT	DT	_	31	det	_	_
31	model	model	NN	NN	_	29	pobj	_	_
32	eventually	eventually	RB	RB	sem=TMP	33	advmod	_	_
33	limits	limit	VBZ	VBZ	_	0	root	_	_
34	this	this	DT	DT	_	35	det	_	_
35	experiment	experiment	NN	NN	_	33	dobj	_	_
36	.	.	.	.	_	33	punct	_	_

1	Therapeutics	therapeutic	NNS	NNS	_	6	nsubj	_	_
2	used	use	VBN	VBN	_	1	acl	_	_
3	in	in	IN	IN	sem=LOC	2	prep	_	_
4	humans	human	NNS	NNS	_	3	pobj	_	_
5	will	will	MD	MD	_	6	aux	_	_
6	have	have	VB	VB	_	0	root	_	_
7	considerably	considerably	RB	RB	_	8	advmod	_	_
8	more	more	JJR	JJR	_	9	amod	_	_
9	time	time	NN	NN	_	6	dobj	_	_
10	to	to	TO	TO	_	11	aux	_	_
11	act	act	VB	VB	_	9	advcl	_	_
12	than	than	IN	IN	_	13	mark	_	_
13	is	be	VBZ	VBZ	_	9	advcl	_	_
14	possible	possible	JJ	JJ	syn=PRD	13	acomp	_	_
15	within	within	IN	IN	_	13	prep	_	_
16	the	the	DT	DT	_	18	det	_	_
17	life	life	NN	NN	_	18	compound	_	_
18	span	span	NN	NN	_	15	pobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	rodent	rodent	NN	NN	_	21	compound	_	_
21	models	model	NNS	NNS	_	19	pobj	_	_
22	.	.	.	.	_	6	punct	_	_

1	Long	long	JJ	JJ	_	3	amod	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	term	term	NN	NN	_	4	compound	_	_
4	treatments	treatment	NNS	NNS	_	7	nsubj	_	_
5	would	would	MD	MD	_	7	aux	_	_
6	certainly	certainly	RB	RB	_	7	advmod	_	_
7	be	be	VB	VB	_	0	root	_	_
8	possible	possible	JJ	JJ	syn=PRD	7	acomp	_	_
9	and	and	CC	CC	_	7	cc	_	_
10	could	could	MD	MD	_	11	aux	_	_
11	be	be	VB	VB	_	7	conj	_	_
12	a	a	DT	DT	_	13	det	_	_
13	key	key	NN	NN	syn=PRD	11	attr	_	_
14	to	to	IN	IN	_	13	prep	_	_
15	effective	effective	JJ	JJ	_	16	amod	_	_
16	therapy	therapy	NN	NN	_	14	pobj	_	_
17	.	.	.	.	_	7	punct	_	_

1	Overall	overall	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	however	however	RB	RB	_	6	advmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	interpret	interpret	VBP	VBP	_	0	root	_	_
7	our	our	PRP$	PRP$	_	8	poss	_	_
8	findings	finding	NNS	NNS	_	6	dobj	_	_
9	as	as	IN	IN	_	6	prep	_	_
10	evidence	evidence	NN	NN	_	9	pobj	_	_
11	that	that	IN	IN	_	35	mark	_	_
12	AD	ad	NN	NN	_	13	compound	_	_
13	therapies	therapy	NNS	NNS	_	35	nsubj	_	_
14	that	that	WDT	WDT	_	16	dep	_	13:ref
15	significantly	significantly	RB	RB	_	16	advmod	_	_
16	lower	lower	VBP	VBP	_	13	relcl	_	_
17	the	the	DT	DT	_	18	det	_	_
18	production	production	NN	NN	_	16	dobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	Aβ	aβ	NN	NN	_	19	pobj	_	_
21	(	(	-LRB-	-LRB-	_	16	punct	_	_
22	by	by	IN	IN	sem=MNR	16	prep	_	_
23	either	either	CC	CC	_	24	preconj	_	_
24	inhibiting	inhibit	VBG	VBG	syn=NOM	22	pcomp	_	_
25	secretase	secretase	NN	NN	_	26	compound	_	_
26	activity	activity	NN	NN	_	24	dobj	_	_
27	or	or	CC	CC	_	24	cc	_	_
28	inhibiting	inhibit	VBG	VBG	_	24	conj	_	_
29	APP	app	NN	NN	_	30	compound	_	_
30	expression	expression	NN	NN	_	28	dobj	_	_
31	)	)	-RRB-	-RRB-	_	16	punct	_	_
32	may	may	MD	MD	_	35	aux	_	_
33	not	not	RB	RB	_	35	neg	_	_
34	quickly	quickly	RB	RB	sem=TMP	35	advmod	_	_
35	reverse	reverse	VB	VB	_	10	acl	_	_
36	preexisting	preexisting	JJ	JJ	_	37	amod	_	_
37	pathology	pathology	NN	NN	_	35	dobj	_	_
38	,	,	,	,	_	35	punct	_	_
39	but	but	CC	CC	_	35	cc	_	_
40	should	should	MD	MD	_	42	aux	_	_
41	effectively	effectively	RB	RB	_	42	advmod	_	_
42	halt	halt	VB	VB	_	35	conj	_	_
43	further	far	JJ	JJ	_	44	amod	_	_
44	deposition	deposition	NN	NN	_	42	dobj	_	_
45	of	of	IN	IN	_	44	prep	_	_
46	amyloid	amyloid	NN	NN	_	45	pobj	_	_
47	.	.	.	.	_	6	punct	_	_

1	In	in	IN	IN	_	9	prep	_	_
2	interpreting	interpret	VBG	VBG	syn=NOM	1	pcomp	_	_
3	our	our	PRP$	PRP$	_	4	poss	_	_
4	study	study	NN	NN	_	2	dobj	_	_
5	,	,	,	,	_	9	punct	_	_
6	it	it	PRP	PRP	_	9	nsubjpass	_	_
7	should	should	MD	MD	_	9	aux	_	_
8	be	be	VB	VB	_	9	auxpass	_	_
9	remembered	remember	VBN	VBN	_	0	root	_	_
10	that	that	IN	IN	_	32	mark	_	_
11	the	the	DT	DT	_	13	det	_	_
12	earliest	early	JJS	JJS	_	13	amod	_	_
13	plaques	plaque	NNS	NNS	_	32	nsubj	_	_
14	to	to	TO	TO	_	15	aux	_	_
15	appear	appear	VB	VB	_	13	advcl	_	_
16	in	in	IN	IN	sem=LOC	15	prep	_	_
17	these	these	DT	DT	_	18	det	_	_
18	mice	mouse	NNS	NNS	_	16	pobj	_	_
19	,	,	,	,	_	13	punct	_	_
20	like	like	IN	IN	_	13	prep	_	_
21	other	other	JJ	JJ	_	23	amod	_	_
22	APP	app	NN	NN	_	23	compound	_	_
23	transgenics	transgenics	NNS	NNS	_	20	pobj	_	_
24	harboring	harbor	VBG	VBG	_	23	acl	_	_
25	the	the	DT	DT	_	27	det	_	_
26	Swedish	swedish	JJ	JJ	_	27	amod	_	_
27	mutation	mutation	NN	NN	_	24	dobj	_	_
28	[	[	-LRB-	-LRB-	_	29	punct	_	_
29	27	0	CD	CD	_	24	parataxis	_	_
30	]	]	-RRB-	-RRB-	_	29	punct	_	_
31	,	,	,	,	_	32	punct	_	_
32	are	be	VBP	VBP	_	9	ccomp	_	_
33	predominantly	predominantly	RB	RB	_	32	advmod	_	_
34	fibrillar	fibrillar	JJ	JJ	_	35	amod	_	_
35	deposits	deposit	NNS	NNS	syn=PRD	32	attr	_	_
36	,	,	,	,	_	35	punct	_	_
37	which	which	WDT	WDT	_	39	dep	_	35:ref
38	may	may	MD	MD	_	39	aux	_	_
39	be	be	VB	VB	_	35	relcl	_	_
40	less	less	RBR	RBR	_	41	advmod	_	_
41	tractable	tractable	JJ	JJ	syn=PRD	39	acomp	_	_
42	than	than	IN	IN	_	41	prep	_	_
43	the	the	DT	DT	_	45	det	_	_
44	diffuse	diffuse	JJ	JJ	_	45	amod	_	_
45	aggregates	aggregate	NNS	NNS	_	42	pobj	_	_
46	thought	think	VBN	VBN	_	45	acl	_	_
47	to	to	TO	TO	_	48	aux	_	_
48	come	come	VB	VB	_	46	xcomp	_	_
49	first	#ord#	RB	RB	sem=TMP	48	advmod	_	_
50	in	in	IN	IN	_	48	prep	_	_
51	the	the	DT	DT	_	52	det	_	_
52	course	course	NN	NN	_	50	pobj	_	_
53	of	of	IN	IN	_	52	prep	_	_
54	the	the	DT	DT	_	56	det	_	_
55	human	human	JJ	JJ	_	56	amod	_	_
56	disease	disease	NN	NN	_	53	pobj	_	_
57	.	.	.	.	_	9	punct	_	_

1	However	however	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	our	our	PRP$	PRP$	_	4	poss	_	_
4	data	datum	NNS	NNS	_	5	nsubj	_	_
5	suggest	suggest	VBP	VBP	_	0	root	_	_
6	that	that	IN	IN	_	21	mark	_	_
7	once	once	IN	IN	_	11	mark	_	_
8	diffuse	diffuse	JJ	JJ	_	9	amod	_	_
9	deposits	deposit	NNS	NNS	_	11	nsubjpass	_	_
10	are	be	VBP	VBP	_	11	auxpass	_	_
11	formed	form	VBN	VBN	sem=TMP	21	advcl	_	_
12	in	in	IN	IN	sem=LOC	11	prep	_	_
13	these	these	DT	DT	_	14	det	_	_
14	mice	mouse	NNS	NNS	_	12	pobj	_	_
15	,	,	,	,	_	21	punct	_	_
16	they	they	PRP	PRP	_	21	nsubjpass	_	_
17	are	be	VBP	VBP	_	21	auxpass	_	_
18	no	no	RB	RB	_	19	neg	_	_
19	more	more	RBR	RBR	_	20	advmod	_	_
20	easily	easily	RB	RB	sem=MNR	21	advmod	_	_
21	cleared	clear	VBN	VBN	_	5	ccomp	_	_
22	in	in	IN	IN	sem=LOC	21	prep	_	_
23	our	our	PRP$	PRP$	_	24	poss	_	_
24	system	system	NN	NN	_	22	pobj	_	_
25	than	than	IN	IN	_	21	prep	_	_
26	cored	core	VBN	VBN	_	27	amod	_	_
27	plaques	plaque	NNS	NNS	_	25	pobj	_	_
28	(	(	-LRB-	-LRB-	_	29	punct	_	_
29	see	see	VB	VB	_	21	parataxis	_	_
30	Figure	figure	NN	NN	_	31	compound	_	_
31	S4	s0	NN	NN	_	29	dobj	_	_
32	)	)	-RRB-	-RRB-	_	29	punct	_	_
33	.	.	.	.	_	5	punct	_	_

1	An	an	DT	DT	_	3	det	_	_
2	additional	additional	JJ	JJ	_	3	amod	_	_
3	consideration	consideration	NN	NN	_	6	nsubj	_	_
4	we	we	PRP	PRP	_	5	nsubj	_	_
5	recognize	recognize	VBP	VBP	_	3	advcl	_	_
6	is	be	VBZ	VBZ	_	0	root	_	_
7	that	that	IN	IN	_	14	mark	_	_
8	a	a	DT	DT	_	10	det	_	_
9	small	small	JJ	JJ	_	10	amod	_	_
10	amount	amount	NN	NN	_	14	nsubj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	transgene	transgene	NN	NN	_	13	compound	_	_
13	expression	expression	NN	NN	_	11	pobj	_	_
14	continues	continue	VBZ	VBZ	syn=PRD	6	advcl	_	_
15	in	in	IN	IN	_	14	prep	_	_
16	the	the	DT	DT	_	17	det	_	_
17	presence	presence	NN	NN	_	15	pobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	dox	dox	NN	NN	_	18	pobj	_	_
20	and	and	CC	CC	_	14	cc	_	_
21	that	that	IN	IN	_	25	mark	_	_
22	endogenous	endogenous	JJ	JJ	_	24	amod	_	_
23	mouse	mouse	NN	NN	_	24	compound	_	_
24	Aβ	aβ	NN	NN	_	25	nsubj	_	_
25	continues	continue	VBZ	VBZ	_	14	conj	_	_
26	to	to	TO	TO	_	28	aux	_	_
27	be	be	VB	VB	_	28	auxpass	_	_
28	produced	produce	VBN	VBN	_	25	xcomp	_	_
29	.	.	.	.	_	6	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	possible	possible	JJ	JJ	syn=PRD	2	acomp	_	_
4	that	that	IN	IN	_	17	mark	_	_
5	the	the	DT	DT	_	8	det	_	_
6	combined	combine	VBN	VBN	_	8	amod	_	_
7	low	low	JJ	JJ	_	8	amod	_	_
8	levels	level	NNS	NNS	_	17	nsubj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	endogenous	endogenous	JJ	JJ	_	12	amod	_	_
11	mouse	mouse	NN	NN	_	12	nmod	_	_
12	Aβ	aβ	NN	NN	_	16	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	nonsuppressed	nonsuppressed	JJ	JJ	_	15	amod	_	_
15	human	human	JJ	JJ	_	12	conj	_	_
16	peptide	peptide	NN	NN	_	9	pobj	_	_
17	are	be	VBP	VBP	_	2	ccomp	_	_
18	sufficient	sufficient	JJ	JJ	syn=PRD	17	acomp	_	_
19	to	to	TO	TO	_	20	aux	_	_
20	maintain	maintain	VB	VB	_	18	xcomp	_	_
21	existing	exist	VBG	VBG	_	22	amod	_	_
22	deposits	deposit	NNS	NNS	_	20	dobj	_	_
23	.	.	.	.	_	2	punct	_	_

1	However	however	RB	RB	_	8	advmod	_	_
2	,	,	,	,	_	8	punct	_	_
3	these	these	DT	DT	_	5	det	_	_
4	low	low	JJ	JJ	_	5	amod	_	_
5	levels	level	NNS	NNS	_	8	nsubj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	peptide	peptide	NN	NN	_	6	pobj	_	_
8	are	be	VBP	VBP	_	0	root	_	_
9	not	not	RB	RB	_	8	neg	_	_
10	sufficient	sufficient	JJ	JJ	syn=PRD	8	acomp	_	_
11	to	to	TO	TO	_	12	aux	_	_
12	induce	induce	VB	VB	_	10	xcomp	_	_
13	new	new	JJ	JJ	_	15	amod	_	_
14	amyloid	amyloid	NN	NN	_	15	compound	_	_
15	formation	formation	NN	NN	_	12	dobj	_	_
16	,	,	,	,	_	8	punct	_	_
17	as	as	IN	IN	_	36	mark	_	_
18	CaMKIIα	camkiiα	NN	NN	_	24	nmod	_	_
19	-	-	HYPH	HYPH	_	24	punct	_	_
20	tTA	tta	NN	NN	_	24	nmod	_	_
21	×	×	SYM	SYM	_	24	punct	_	_
22	tetAPPswe	tetappswe	NN	NN	_	24	compound	_	_
23	/	/	HYPH	HYPH	_	24	punct	_	_
24	ind	ind	NN	NN	_	25	compound	_	_
25	mice	mouse	NNS	NNS	_	36	nsubj	_	_
26	raised	raise	VBN	VBN	_	25	acl	_	_
27	on	on	IN	IN	_	26	prep	_	_
28	dox	dox	NN	NN	_	27	pobj	_	_
29	for	for	IN	IN	sem=TMP	26	prep	_	_
30	up	up	IN	IN	_	32	quantmod	_	_
31	to	to	IN	IN	_	32	quantmod	_	_
32	a	a	DT	DT	_	33	nummod	_	_
33	year	year	NN	NN	_	29	pobj	_	_
34	do	do	VBP	VBP	_	36	aux	_	_
35	not	not	RB	RB	_	36	neg	_	_
36	develop	develop	VB	VB	sem=PRP	8	advcl	_	_
37	amyloid	amyloid	NN	NN	_	38	compound	_	_
38	lesions	lesion	NNS	NNS	_	36	dobj	_	_
39	(	(	-LRB-	-LRB-	_	42	punct	_	_
40	data	datum	NNS	NNS	_	42	nsubj	_	_
41	not	not	RB	RB	_	42	neg	_	_
42	shown	show	VBN	VBN	_	36	parataxis	_	_
43	)	)	-RRB-	-RRB-	_	42	punct	_	_
44	.	.	.	.	_	8	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	also	also	RB	RB	_	2	advmod	_	_
4	clear	clear	JJ	JJ	syn=PRD	2	acomp	_	_
5	that	that	IN	IN	_	13	mark	_	_
6	in	in	IN	IN	_	13	prep	_	_
7	this	this	DT	DT	_	9	det	_	_
8	genetic	genetic	JJ	JJ	_	9	amod	_	_
9	system	system	NN	NN	_	6	pobj	_	_
10	,	,	,	,	_	13	punct	_	_
11	we	we	PRP	PRP	_	13	nsubj	_	_
12	have	have	VBP	VBP	_	13	aux	_	_
13	raised	raise	VBN	VBN	_	2	ccomp	_	_
14	the	the	DT	DT	_	15	det	_	_
15	production	production	NN	NN	_	13	dobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	Aβ	aβ	NN	NN	_	16	pobj	_	_
18	to	to	IN	IN	_	13	prep	_	_
19	levels	level	NNS	NNS	_	18	pobj	_	_
20	not	not	RB	RB	_	21	neg	_	_
21	found	find	VBN	VBN	_	19	acl	_	_
22	in	in	IN	IN	sem=LOC	21	prep	_	_
23	humans	human	NNS	NNS	_	22	pobj	_	_
24	to	to	TO	TO	_	25	aux	_	_
25	accelerate	accelerate	VB	VB	sem=PRP	13	advcl	_	_
26	pathology	pathology	NN	NN	_	25	dobj	_	_
27	into	into	IN	IN	_	25	prep	_	_
28	an	an	DT	DT	_	32	det	_	_
29	experimentally	experimentally	RB	RB	_	30	advmod	_	_
30	feasible	feasible	JJ	JJ	_	32	amod	_	_
31	time	time	NN	NN	_	32	compound	_	_
32	frame	frame	NN	NN	_	27	pobj	_	_
33	.	.	.	.	_	2	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	system	system	NN	NN	_	3	nsubj	_	_
3	allowed	allow	VBD	VBD	_	35	ccomp	_	_
4	us	us	PRP	PRP	_	6	nsubj	_	_
5	to	to	TO	TO	_	6	aux	_	_
6	create	create	VB	VB	_	3	ccomp	_	_
7	an	an	DT	DT	_	10	det	_	_
8	approximately	approximately	RB	RB	_	9	advmod	_	_
9	20-fold	0-fold	JJ	JJ	_	10	amod	_	_
10	differential	differential	NN	NN	_	6	dobj	_	_
11	between	between	IN	IN	_	10	prep	_	_
12	APP	app	NN	NN	_	14	nmod	_	_
13	/	/	HYPH	HYPH	_	14	punct	_	_
14	Aβ	aβ	NN	NN	_	16	nmod	_	_
15	synthetic	synthetic	JJ	JJ	_	16	amod	_	_
16	rates	rate	NNS	NNS	_	11	pobj	_	_
17	before	before	IN	IN	sem=TMP	6	prep	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	after	after	IN	IN	_	17	conj	_	_
20	treatment	treatment	NN	NN	_	19	pobj	_	_
21	,	,	,	,	_	35	punct	_	_
22	yet	yet	RB	RB	_	35	advmod	_	_
23	the	the	DT	DT	_	26	det	_	_
24	in	in	FW	FW	_	25	advmod	_	_
25	vivo	vivo	FW	FW	_	26	amod	_	_
26	equilibrium	equilibrium	NN	NN	_	35	nsubj	_	_
27	between	between	IN	IN	_	26	prep	_	_
28	aggregated	aggregate	VBN	VBN	_	31	amod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	disaggregated	disaggregate	VBN	VBN	_	28	conj	_	_
31	states	state	NNS	NNS	_	27	pobj	_	_
32	of	of	IN	IN	_	31	prep	_	_
33	Aβ	aβ	NN	NN	_	32	pobj	_	_
34	still	still	RB	RB	_	35	advmod	_	_
35	favored	favor	VBD	VBD	_	0	root	_	_
36	the	the	DT	DT	_	37	det	_	_
37	maintenance	maintenance	NN	NN	_	35	dobj	_	_
38	of	of	IN	IN	_	37	prep	_	_
39	amyloid	amyloid	NN	NN	_	40	compound	_	_
40	deposits	deposit	NNS	NNS	_	38	pobj	_	_
41	.	.	.	.	_	35	punct	_	_

1	In	in	IN	IN	_	6	prep	_	_
2	our	our	PRP$	PRP$	_	3	poss	_	_
3	opinion	opinion	NN	NN	_	1	pobj	_	_
4	,	,	,	,	_	6	punct	_	_
5	it	it	PRP	PRP	_	6	nsubj	_	_
6	seems	seem	VBZ	VBZ	_	0	root	_	_
7	unlikely	unlikely	JJ	JJ	syn=PRD	6	oprd	_	_
8	that	that	IN	IN	_	15	mark	_	_
9	amyloid	amyloid	NN	NN	_	10	compound	_	_
10	deposits	deposit	NNS	NNS	_	15	nsubj	_	_
11	in	in	IN	IN	sem=LOC	10	prep	_	_
12	human	human	JJ	JJ	_	13	amod	_	_
13	brain	brain	NN	NN	_	11	pobj	_	_
14	would	would	MD	MD	_	15	aux	_	_
15	be	be	VB	VB	_	6	ccomp	_	_
16	inherently	inherently	RB	RB	_	15	advmod	_	_
17	any	any	DT	DT	_	19	advmod	_	_
18	less	less	RBR	RBR	_	19	advmod	_	_
19	stable	stable	JJ	JJ	syn=PRD	15	acomp	_	_
20	than	than	IN	IN	_	19	prep	_	_
21	those	those	DT	DT	_	20	pobj	_	_
22	formed	form	VBN	VBN	_	21	acl	_	_
23	in	in	IN	IN	sem=LOC	22	prep	_	_
24	mouse	mouse	NN	NN	_	25	compound	_	_
25	brain	brain	NN	NN	_	23	pobj	_	_
26	.	.	.	.	_	6	punct	_	_

1	However	however	RB	RB	_	7	advmod	_	_
2	,	,	,	,	_	7	punct	_	_
3	the	the	DT	DT	_	5	det	_	_
4	human	human	JJ	JJ	_	5	amod	_	_
5	brain	brain	NN	NN	_	7	nsubj	_	_
6	may	may	MD	MD	_	7	aux	_	_
7	harbor	harbor	VB	VB	_	0	root	_	_
8	clearance	clearance	NN	NN	_	9	compound	_	_
9	mechanisms	mechanism	NNS	NNS	_	7	dobj	_	_
10	not	not	RB	RB	_	11	neg	_	_
11	shared	share	VBN	VBN	_	9	acl	_	_
12	by	by	IN	IN	_	11	agent	_	_
13	mice	mouse	NNS	NNS	_	12	pobj	_	_
14	that	that	WDT	WDT	_	16	dep	_	9:ref
15	would	would	MD	MD	_	16	aux	_	_
16	allow	allow	VB	VB	_	9	relcl	_	_
17	more	more	RBR	RBR	_	18	advmod	_	_
18	efficient	efficient	JJ	JJ	_	19	amod	_	_
19	removal	removal	NN	NN	_	16	dobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	preexisting	preexist	VBG	VBG	_	22	amod	_	_
22	amyloid	amyloid	NN	NN	_	20	pobj	_	_
23	.	.	.	.	_	7	punct	_	_

1	One	#crd#	CD	CD	_	3	nummod	_	_
2	potential	potential	JJ	JJ	_	3	amod	_	_
3	mechanism	mechanism	NN	NN	_	21	nsubj	_	_
4	by	by	IN	IN	_	11	prep	_	_
5	which	which	WDT	WDT	_	4	pobj	_	3:ref
6	amyloid	amyloid	NN	NN	_	11	nsubjpass	_	_
7	may	may	MD	MD	_	11	aux	_	_
8	be	be	VB	VB	_	11	auxpass	_	_
9	more	more	RBR	RBR	_	10	advmod	_	_
10	efficiently	efficiently	RB	RB	_	11	advmod	_	_
11	removed	remove	VBN	VBN	_	3	relcl	_	_
12	in	in	IN	IN	sem=LOC	11	prep	_	_
13	the	the	DT	DT	_	15	det	_	_
14	human	human	JJ	JJ	_	15	amod	_	_
15	disease	disease	NN	NN	_	12	pobj	_	_
16	than	than	IN	IN	_	11	prep	_	_
17	in	in	IN	IN	sem=LOC	16	prep	_	_
18	the	the	DT	DT	_	20	det	_	_
19	mouse	mouse	NN	NN	_	20	compound	_	_
20	models	model	NNS	NNS	_	17	pobj	_	_
21	is	be	VBZ	VBZ	_	0	root	_	_
22	through	through	IN	IN	syn=PRD|sem=MNR	21	prep	_	_
23	microglial	microglial	JJ	JJ	_	24	amod	_	_
24	phagocytosis	phagocytosis	NN	NN	_	22	pobj	_	_
25	.	.	.	.	_	21	punct	_	_

1	Resident	resident	JJ	JJ	_	2	amod	_	_
2	microglia	microglia	NNS	NNS	_	7	nsubj	_	_
3	in	in	IN	IN	sem=LOC	2	prep	_	_
4	transgenic	transgenic	JJ	JJ	_	6	amod	_	_
5	mouse	mouse	NN	NN	_	6	compound	_	_
6	models	model	NNS	NNS	_	3	pobj	_	_
7	localize	localize	VBP	VBP	_	0	root	_	_
8	to	to	IN	IN	_	7	prep	_	_
9	tissue	tissue	NN	NN	_	8	pobj	_	_
10	surrounding	surround	VBG	VBG	_	9	acl	_	_
11	plaques	plaque	NNS	NNS	_	10	dobj	_	_
12	but	but	CC	CC	_	7	cc	_	_
13	show	show	VBP	VBP	_	7	conj	_	_
14	little	little	JJ	JJ	_	15	amod	_	_
15	evidence	evidence	NN	NN	_	13	dobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	amyloid	amyloid	NN	NN	_	18	compound	_	_
18	engulfment	engulfment	NN	NN	_	16	pobj	_	_
19	[	[	-LRB-	-LRB-	_	20	punct	_	_
20	37	0	CD	CD	_	13	parataxis	_	_
21	–	-	SYM	SYM	_	22	punct	_	_
22	40	0	CD	CD	_	20	prep	_	_
23	]	]	-RRB-	-RRB-	_	20	punct	_	_
24	.	.	.	.	_	7	punct	_	_

1	In	in	IN	IN	_	11	prep	_	_
2	contrast	contrast	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	11	punct	_	_
4	microglia	microglia	NNS	NNS	_	11	nsubj	_	_
5	surrounding	surround	VBG	VBG	_	4	acl	_	_
6	amyloid	amyloid	NN	NN	_	7	compound	_	_
7	plaques	plaque	NNS	NNS	_	5	dobj	_	_
8	in	in	IN	IN	sem=LOC	5	prep	_	_
9	human	human	JJ	JJ	_	10	amod	_	_
10	brain	brain	NN	NN	_	8	pobj	_	_
11	show	show	VBP	VBP	_	0	root	_	_
12	a	a	DT	DT	_	15	det	_	_
13	much	much	RB	RB	_	14	advmod	_	_
14	higher	high	JJR	JJR	_	15	amod	_	_
15	state	state	NN	NN	_	11	dobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	activation	activation	NN	NN	_	16	pobj	_	_
18	with	with	IN	IN	_	11	prep	_	_
19	greater	great	JJR	JJR	_	20	amod	_	_
20	expression	expression	NN	NN	_	18	pobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	complement	complement	NN	NN	_	23	compound	_	_
23	receptor	receptor	NN	NN	_	21	pobj	_	_
24	[	[	-LRB-	-LRB-	_	25	punct	_	_
25	40	0	CD	CD	_	11	parataxis	_	_
26	]	]	-RRB-	-RRB-	_	25	punct	_	_
27	.	.	.	.	_	11	punct	_	_

1	Thus	thus	RB	RB	_	10	advmod	_	_
2	,	,	,	,	_	10	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	role	role	NN	NN	_	10	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	microglia	microglia	NNS	NNS	_	5	pobj	_	_
7	in	in	IN	IN	_	4	prep	_	_
8	amyloid	amyloid	NN	NN	_	9	compound	_	_
9	metabolism	metabolism	NN	NN	_	7	pobj	_	_
10	is	be	VBZ	VBZ	_	0	root	_	_
11	minor	minor	JJ	JJ	syn=PRD	10	acomp	_	_
12	in	in	IN	IN	sem=LOC	10	prep	_	_
13	transgenic	transgenic	JJ	JJ	_	14	amod	_	_
14	models	model	NNS	NNS	_	12	pobj	_	_
15	compared	compare	VBN	VBN	_	10	prep	_	_
16	to	to	IN	IN	_	15	prep	_	_
17	the	the	DT	DT	_	19	det	_	_
18	human	human	JJ	JJ	_	19	amod	_	_
19	condition	condition	NN	NN	_	16	pobj	_	_
20	.	.	.	.	_	10	punct	_	_

1	Somewhat	somewhat	RB	RB	_	2	advmod	_	_
2	paradoxically	paradoxically	RB	RB	_	7	advmod	_	_
3	,	,	,	,	_	7	punct	_	_
4	several	several	JJ	JJ	_	5	amod	_	_
5	studies	study	NNS	NNS	_	7	nsubj	_	_
6	further	far	RB	RB	_	7	advmod	_	_
7	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
8	that	that	IN	IN	_	18	mark	_	_
9	treatment	treatment	NN	NN	_	18	nsubj	_	_
10	with	with	IN	IN	_	9	prep	_	_
11	anti-inflammatory	anti-inflammatory	JJ	JJ	_	12	amod	_	_
12	drugs	drug	NNS	NNS	_	10	pobj	_	_
13	to	to	TO	TO	_	14	aux	_	_
14	reduce	reduce	VB	VB	sem=PRP	9	advcl	_	_
15	microglial	microglial	JJ	JJ	_	16	amod	_	_
16	activation	activation	NN	NN	_	14	dobj	_	_
17	actually	actually	RB	RB	_	18	advmod	_	_
18	lowers	lower	VBZ	VBZ	_	7	ccomp	_	_
19	amyloid	amyloid	NN	NN	_	20	compound	_	_
20	load	load	NN	NN	_	18	dobj	_	_
21	in	in	IN	IN	sem=LOC	18	prep	_	_
22	APP	app	NN	NN	_	23	npadvmod	_	_
23	transgenic	transgenic	JJ	JJ	_	24	amod	_	_
24	mice	mouse	NNS	NNS	_	21	pobj	_	_
25	,	,	,	,	_	18	punct	_	_
26	suggesting	suggest	VBG	VBG	syn=ADV	18	advcl	_	_
27	a	a	DT	DT	_	28	det	_	_
28	role	role	NN	NN	_	26	dobj	_	_
29	for	for	IN	IN	_	28	prep	_	_
30	mouse	mouse	NN	NN	_	31	compound	_	_
31	microglia	microglia	NNS	NNS	_	29	pobj	_	_
32	in	in	IN	IN	_	28	prep	_	_
33	the	the	DT	DT	_	34	det	_	_
34	formation	formation	NN	NN	_	32	pobj	_	_
35	and	and	CC	CC	_	34	cc	_	_
36	maintenance	maintenance	NN	NN	_	34	conj	_	_
37	of	of	IN	IN	_	34	prep	_	_
38	amyloid	amyloid	NN	NN	_	39	compound	_	_
39	aggregates	aggregate	NNS	NNS	_	37	pobj	_	_
40	[	[	-LRB-	-LRB-	_	41	punct	_	_
41	41	0	CD	CD	_	18	parataxis	_	_
42	–	-	SYM	SYM	_	43	punct	_	_
43	43	0	CD	CD	_	41	prep	_	_
44	]	]	-RRB-	-RRB-	_	41	punct	_	_
45	.	.	.	.	_	7	punct	_	_

1	However	however	RB	RB	_	8	advmod	_	_
2	,	,	,	,	_	8	punct	_	_
3	this	this	DT	DT	_	4	det	_	_
4	outcome	outcome	NN	NN	_	8	nsubjpass	_	_
5	may	may	MD	MD	_	8	aux	_	_
6	be	be	VB	VB	_	8	auxpass	_	_
7	alternatively	alternatively	RB	RB	_	8	advmod	_	_
8	explained	explain	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	8	agent	_	_
10	direct	direct	JJ	JJ	_	11	amod	_	_
11	effects	effect	NNS	NNS	_	9	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	many	many	JJ	JJ	_	15	amod	_	_
14	anti-inflammatory	anti-inflammatory	JJ	JJ	_	15	amod	_	_
15	drugs	drug	NNS	NNS	_	12	pobj	_	_
16	on	on	IN	IN	_	11	prep	_	_
17	γ	γ	SYM	SYM	_	19	punct	_	_
18	-	-	HYPH	HYPH	_	19	punct	_	_
19	secretase	secretase	NN	NN	_	20	compound	_	_
20	cleavage	cleavage	NN	NN	_	16	pobj	_	_
21	[	[	-LRB-	-LRB-	_	22	punct	_	_
22	44	0	CD	CD	_	8	parataxis	_	_
23	–	-	SYM	SYM	_	24	punct	_	_
24	47	0	CD	CD	_	22	prep	_	_
25	]	]	-RRB-	-RRB-	_	22	punct	_	_
26	.	.	.	.	_	8	punct	_	_

1	Nonetheless	nonetheless	RB	RB	_	16	advmod	_	_
2	,	,	,	,	_	16	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	role	role	NN	NN	_	16	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	microglia	microglia	NNS	NNS	_	5	pobj	_	_
7	in	in	IN	IN	_	4	prep	_	_
8	both	both	CC	CC	_	11	preconj	_	_
9	the	the	DT	DT	_	11	det	_	_
10	human	human	JJ	JJ	_	11	amod	_	_
11	condition	condition	NN	NN	_	7	pobj	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	the	the	DT	DT	_	15	det	_	_
14	mouse	mouse	NN	NN	_	15	compound	_	_
15	models	model	NNS	NNS	_	11	conj	_	_
16	is	be	VBZ	VBZ	_	0	root	_	_
17	poorly	poorly	RB	RB	_	18	advmod	_	_
18	understood	understand	VBN	VBN	syn=PRD	16	acomp	_	_
19	,	,	,	,	_	16	punct	_	_
20	and	and	CC	CC	_	16	cc	_	_
21	differences	difference	NNS	NNS	_	29	nsubj	_	_
22	in	in	IN	IN	_	21	prep	_	_
23	microglial	microglial	JJ	JJ	_	24	amod	_	_
24	reactivity	reactivity	NN	NN	_	22	pobj	_	_
25	between	between	IN	IN	_	21	prep	_	_
26	the	the	DT	DT	_	27	det	_	_
27	two	#crd#	CD	CD	_	25	pobj	_	_
28	could	could	MD	MD	_	29	aux	_	_
29	lead	lead	VB	VB	_	16	conj	_	_
30	to	to	IN	IN	_	29	prep	_	_
31	significantly	significantly	RB	RB	_	32	advmod	_	_
32	faster	fast	JJR	JJR	_	34	amod	_	_
33	amyloid	amyloid	NN	NN	_	34	compound	_	_
34	clearance	clearance	NN	NN	_	30	pobj	_	_
35	in	in	IN	IN	sem=LOC	34	prep	_	_
36	the	the	DT	DT	_	37	det	_	_
37	brains	brain	NNS	NNS	_	35	pobj	_	_
38	of	of	IN	IN	_	37	prep	_	_
39	patients	patient	NNS	NNS	_	38	pobj	_	_
40	with	with	IN	IN	_	39	prep	_	_
41	AD	ad	NN	NN	_	40	pobj	_	_
42	than	than	IN	IN	_	44	mark	_	_
43	we	we	PRP	PRP	_	44	nsubj	_	_
44	observe	observe	VBP	VBP	_	34	advcl	_	_
45	in	in	IN	IN	sem=LOC	44	prep	_	_
46	the	the	DT	DT	_	51	det	_	_
47	tet	tet	NN	NN	_	49	compound	_	_
48	-	-	HYPH	HYPH	_	49	punct	_	_
49	off	off	NN	NN	_	51	compound	_	_
50	APP	app	NN	NN	_	51	compound	_	_
51	mice	mouse	NNS	NNS	_	45	pobj	_	_
52	.	.	.	.	_	29	punct	_	_

1	Given	give	VBN	VBN	_	17	prep	_	_
2	the	the	DT	DT	_	5	det	_	_
3	relatively	relatively	RB	RB	_	4	advmod	_	_
4	minor	minor	JJ	JJ	_	5	amod	_	_
5	role	role	NN	NN	_	1	pobj	_	_
6	played	play	VBN	VBN	_	5	acl	_	_
7	by	by	IN	IN	_	6	agent	_	_
8	microglia	microglia	NNS	NNS	_	7	pobj	_	_
9	in	in	IN	IN	sem=LOC	6	prep	_	_
10	other	other	JJ	JJ	_	12	amod	_	_
11	mouse	mouse	NN	NN	_	12	compound	_	_
12	models	model	NNS	NNS	_	9	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	amyloidosis	amyloidosis	NN	NN	_	13	pobj	_	_
15	,	,	,	,	_	17	punct	_	_
16	we	we	PRP	PRP	_	17	nsubj	_	_
17	think	think	VBP	VBP	_	0	root	_	_
18	it	it	PRP	PRP	_	19	nsubj	_	_
19	unlikely	unlikely	JJ	JJ	syn=PRD	17	advcl	_	_
20	that	that	IN	IN	_	24	mark	_	_
21	these	these	DT	DT	_	22	det	_	_
22	cells	cell	NNS	NNS	_	24	nsubj	_	_
23	have	have	VBP	VBP	_	24	aux	_	_
24	influenced	influence	VBN	VBN	_	19	advcl	_	_
25	the	the	DT	DT	_	26	det	_	_
26	rate	rate	NN	NN	_	24	dobj	_	_
27	of	of	IN	IN	_	26	prep	_	_
28	amyloid	amyloid	NN	NN	_	29	compound	_	_
29	clearance	clearance	NN	NN	_	27	pobj	_	_
30	in	in	IN	IN	sem=LOC	24	prep	_	_
31	the	the	DT	DT	_	36	det	_	_
32	tet	tet	NN	NN	_	34	compound	_	_
33	-	-	HYPH	HYPH	_	34	punct	_	_
34	off	off	NN	NN	_	36	compound	_	_
35	APP	app	NN	NN	_	36	compound	_	_
36	mice	mouse	NNS	NNS	_	30	pobj	_	_
37	.	.	.	.	_	17	punct	_	_

1	Even	even	RB	RB	_	2	advmod	_	_
2	so	so	RB	RB	_	5	advmod	_	_
3	,	,	,	,	_	5	punct	_	_
4	we	we	PRP	PRP	_	5	nsubj	_	_
5	considered	consider	VBD	VBD	_	0	root	_	_
6	the	the	DT	DT	_	7	det	_	_
7	possibility	possibility	NN	NN	_	5	dobj	_	_
8	that	that	IN	IN	_	14	mark	_	_
9	chronic	chronic	JJ	JJ	_	11	amod	_	_
10	dox	dox	NN	NN	_	11	compound	_	_
11	treatment	treatment	NN	NN	_	14	nsubj	_	_
12	may	may	MD	MD	_	14	aux	_	_
13	have	have	VB	VB	_	14	aux	_	_
14	altered	alter	VBN	VBN	_	7	acl	_	_
15	the	the	DT	DT	_	17	det	_	_
16	activation	activation	NN	NN	_	17	compound	_	_
17	state	state	NN	NN	_	14	dobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	microglia	microglia	NNS	NNS	_	18	pobj	_	_
20	in	in	IN	IN	sem=LOC	14	prep	_	_
21	our	our	PRP$	PRP$	_	23	poss	_	_
22	treated	treat	VBN	VBN	_	23	amod	_	_
23	mice	mouse	NNS	NNS	_	20	pobj	_	_
24	.	.	.	.	_	5	punct	_	_

1	Dox	dox	NN	NN	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	structurally	structurally	RB	RB	_	4	advmod	_	_
4	similar	similar	JJ	JJ	syn=PRD	2	acomp	_	_
5	to	to	IN	IN	_	4	prep	_	_
6	minocycline	minocycline	NN	NN	_	5	pobj	_	_
7	,	,	,	,	_	6	punct	_	_
8	a	a	DT	DT	_	11	det	_	_
9	reported	report	VBN	VBN	_	11	amod	_	_
10	anti-inflammatory	anti-inflammatory	JJ	JJ	_	11	amod	_	_
11	drug	drug	NN	NN	_	6	appos	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	inhibitor	inhibitor	NN	NN	_	11	conj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	microglial	microglial	JJ	JJ	_	16	amod	_	_
16	activation	activation	NN	NN	_	14	pobj	_	_
17	[	[	-LRB-	-LRB-	_	18	punct	_	_
18	48	0	CD	CD	_	2	parataxis	_	_
19	]	]	-RRB-	-RRB-	_	18	punct	_	_
20	.	.	.	.	_	2	punct	_	_

1	However	however	RB	RB	_	23	advmod	_	_
2	,	,	,	,	_	23	punct	_	_
3	if	if	IN	IN	_	6	mark	_	_
4	dox	dox	NN	NN	_	6	nsubj	_	_
5	does	do	VBZ	VBZ	_	6	aux	_	_
6	have	have	VB	VB	syn=ADV	23	advcl	_	_
7	anti-inflammatory	anti-inflammatory	JJ	JJ	_	8	amod	_	_
8	activity	activity	NN	NN	_	6	dobj	_	_
9	,	,	,	,	_	23	punct	_	_
10	then	then	RB	RB	sem=TMP	23	advmod	_	_
11	,	,	,	,	_	23	punct	_	_
12	based	base	VBN	VBN	sem=PRP	23	prep	_	_
13	on	on	IN	IN	_	12	prep	_	_
14	previous	previous	JJ	JJ	_	15	amod	_	_
15	studies	study	NNS	NNS	_	13	pobj	_	_
16	with	with	IN	IN	_	15	prep	_	_
17	other	other	JJ	JJ	_	18	amod	_	_
18	anti-inflammatories	anti-inflammatories	NNS	NNS	_	16	pobj	_	_
19	,	,	,	,	_	23	punct	_	_
20	we	we	PRP	PRP	_	23	nsubj	_	_
21	would	would	MD	MD	_	23	aux	_	_
22	have	have	VB	VB	_	23	aux	_	_
23	expected	expect	VBN	VBN	_	0	root	_	_
24	to	to	TO	TO	_	25	aux	_	_
25	find	find	VB	VB	_	23	xcomp	_	_
26	less	less	RBR	RBR	_	27	advmod	_	_
27	amyloid	amyloid	NN	NN	_	25	dobj	_	_
28	in	in	IN	IN	sem=LOC	25	prep	_	_
29	the	the	DT	DT	_	33	det	_	_
30	dox	dox	NN	NN	_	32	npadvmod	_	_
31	-	-	HYPH	HYPH	_	32	punct	_	_
32	treated	treat	VBN	VBN	_	33	amod	_	_
33	animals	animal	NNS	NNS	_	28	pobj	_	_
34	.	.	.	.	_	23	punct	_	_

1	Clearly	clearly	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	that	that	DT	DT	_	4	nsubj	_	_
4	was	be	VBD	VBD	_	0	root	_	_
5	not	not	RB	RB	_	4	neg	_	_
6	the	the	DT	DT	_	7	det	_	_
7	case	case	NN	NN	syn=PRD	4	attr	_	_
8	.	.	.	.	_	4	punct	_	_

1	While	while	IN	IN	_	3	mark	_	_
2	it	it	PRP	PRP	_	3	nsubj	_	_
3	is	be	VBZ	VBZ	syn=ADV	21	advcl	_	_
4	possible	possible	JJ	JJ	syn=PRD	3	acomp	_	_
5	that	that	IN	IN	_	7	mark	_	_
6	dox	dox	NN	NN	_	7	nsubj	_	_
7	acts	act	VBZ	VBZ	_	3	ccomp	_	_
8	in	in	IN	IN	sem=MNR	7	prep	_	_
9	some	some	DT	DT	_	11	det	_	_
10	other	other	JJ	JJ	_	11	amod	_	_
11	way	way	NN	NN	_	8	pobj	_	_
12	to	to	TO	TO	_	13	aux	_	_
13	slow	slow	VB	VB	sem=PRP	7	advcl	_	_
14	amyloid	amyloid	NN	NN	_	15	compound	_	_
15	clearance	clearance	NN	NN	_	13	dobj	_	_
16	,	,	,	,	_	21	punct	_	_
17	data	datum	NNS	NNS	_	21	nsubj	_	_
18	from	from	IN	IN	_	17	prep	_	_
19	multiple	multiple	JJ	JJ	_	20	amod	_	_
20	studies	study	NNS	NNS	_	18	pobj	_	_
21	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
22	that	that	IN	IN	_	25	mark	_	_
23	microglial	microglial	JJ	JJ	_	24	amod	_	_
24	responses	response	NNS	NNS	_	25	nsubj	_	_
25	are	be	VBP	VBP	_	21	ccomp	_	_
26	normally	normally	RB	RB	_	25	advmod	_	_
27	weak	weak	JJ	JJ	syn=PRD	25	acomp	_	_
28	in	in	IN	IN	sem=LOC	25	prep	_	_
29	the	the	DT	DT	_	32	det	_	_
30	mouse	mouse	NN	NN	_	32	compound	_	_
31	AD	ad	NN	NN	_	32	compound	_	_
32	models	model	NNS	NNS	_	28	pobj	_	_
33	[	[	-LRB-	-LRB-	_	34	punct	_	_
34	37	0	CD	CD	_	25	parataxis	_	_
35	–	-	SYM	SYM	_	36	punct	_	_
36	40	0	CD	CD	_	34	prep	_	_
37	]	]	-RRB-	-RRB-	_	34	punct	_	_
38	,	,	,	,	_	25	punct	_	_
39	and	and	CC	CC	_	25	cc	_	_
40	thus	thus	RB	RB	_	42	advmod	_	_
41	it	it	PRP	PRP	_	42	nsubj	_	_
42	is	be	VBZ	VBZ	_	25	conj	_	_
43	doubtful	doubtful	JJ	JJ	syn=PRD	42	acomp	_	_
44	that	that	IN	IN	_	50	mark	_	_
45	dox	dox	NN	NN	_	47	npadvmod	_	_
46	-	-	HYPH	HYPH	_	47	punct	_	_
47	mediated	mediate	VBN	VBN	_	49	amod	_	_
48	microglial	microglial	JJ	JJ	_	49	amod	_	_
49	inhibition	inhibition	NN	NN	_	50	nsubj	_	_
50	affected	affect	VBD	VBD	_	42	ccomp	_	_
51	the	the	DT	DT	_	52	det	_	_
52	outcome	outcome	NN	NN	_	50	dobj	_	_
53	of	of	IN	IN	_	52	prep	_	_
54	our	our	PRP$	PRP$	_	55	poss	_	_
55	study	study	NN	NN	_	53	pobj	_	_
56	.	.	.	.	_	21	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	persistence	persistence	NN	NN	_	11	nsubj	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	stability	stability	NN	NN	_	2	conj	_	_
5	of	of	IN	IN	_	2	prep	_	_
6	amyloid	amyloid	NN	NN	_	7	compound	_	_
7	deposits	deposit	NNS	NNS	_	5	pobj	_	_
8	in	in	IN	IN	sem=LOC	2	prep	_	_
9	our	our	PRP$	PRP$	_	10	poss	_	_
10	system	system	NN	NN	_	8	pobj	_	_
11	is	be	VBZ	VBZ	_	0	root	_	_
12	unexpected	unexpected	JJ	JJ	syn=PRD	11	acomp	_	_
13	given	give	VBN	VBN	_	11	prep	_	_
14	the	the	DT	DT	_	15	det	_	_
15	speed	speed	NN	NN	_	13	pobj	_	_
16	with	with	IN	IN	_	21	prep	_	_
17	which	which	WDT	WDT	_	16	pobj	_	15:ref
18	Aβ	aβ	NN	NN	_	19	compound	_	_
19	aggregates	aggregate	NNS	NNS	_	21	nsubjpass	_	_
20	are	be	VBP	VBP	_	21	auxpass	_	_
21	cleared	clear	VBN	VBN	_	15	relcl	_	_
22	in	in	IN	IN	sem=LOC	21	prep	_	_
23	other	other	JJ	JJ	_	25	amod	_	_
24	mouse	mouse	NN	NN	_	25	compound	_	_
25	models	model	NNS	NNS	_	22	pobj	_	_
26	of	of	IN	IN	_	25	prep	_	_
27	therapeutic	therapeutic	JJ	JJ	_	28	amod	_	_
28	intervention	intervention	NN	NN	_	26	pobj	_	_
29	.	.	.	.	_	11	punct	_	_

1	Anti-Aβ	anti-aβ	JJ	JJ	_	2	amod	_	_
2	antibodies	antibody	NNS	NNS	_	10	nsubjpass	_	_
3	injected	inject	VBN	VBN	_	2	acl	_	_
4	directly	directly	RB	RB	_	3	advmod	_	_
5	into	into	IN	IN	sem=LOC	3	prep	_	_
6	the	the	DT	DT	_	7	det	_	_
7	brain	brain	NN	NN	_	5	pobj	_	_
8	have	have	VBP	VBP	_	10	aux	_	_
9	been	be	VBN	VBN	_	10	auxpass	_	_
10	shown	show	VBN	VBN	_	0	root	_	_
11	to	to	TO	TO	_	12	aux	_	_
12	eliminate	eliminate	VB	VB	_	10	xcomp	_	_
13	amyloid	amyloid	NN	NN	_	14	compound	_	_
14	deposits	deposit	NNS	NNS	_	12	dobj	_	_
15	in	in	IN	IN	sem=TMP	12	prep	_	_
16	as	as	RB	RB	_	19	advmod	_	_
17	little	little	JJ	JJ	_	19	amod	_	_
18	as	as	IN	IN	_	19	quantmod	_	_
19	1	0	CD	CD	_	20	nummod	_	_
20	wk	wk	NN	NN	_	15	pobj	_	_
21	after	after	IN	IN	_	20	prep	_	_
22	treatment	treatment	NN	NN	_	21	pobj	_	_
23	[	[	-LRB-	-LRB-	_	24	punct	_	_
24	49	0	CD	CD	_	12	parataxis	_	_
25	–	-	SYM	SYM	_	26	punct	_	_
26	51	0	CD	CD	_	24	prep	_	_
27	]	]	-RRB-	-RRB-	_	24	punct	_	_
28	.	.	.	.	_	10	punct	_	_

1	Peripheral	peripheral	JJ	JJ	_	3	amod	_	_
2	antibody	antibody	NN	NN	_	3	compound	_	_
3	injection	injection	NN	NN	_	4	nsubj	_	_
4	decreases	decrease	VBZ	VBZ	_	0	root	_	_
5	amyloid	amyloid	NN	NN	_	6	compound	_	_
6	load	load	NN	NN	_	4	dobj	_	_
7	more	more	RBR	RBR	_	8	advmod	_	_
8	broadly	broadly	RB	RB	_	4	advmod	_	_
9	,	,	,	,	_	4	punct	_	_
10	and	and	CC	CC	_	4	cc	_	_
11	although	although	IN	IN	_	15	mark	_	_
12	it	it	PRP	PRP	_	15	nsubj	_	_
13	does	do	VBZ	VBZ	_	15	aux	_	_
14	not	not	RB	RB	_	15	neg	_	_
15	appear	appear	VB	VB	syn=ADV	26	advcl	_	_
16	to	to	TO	TO	_	17	aux	_	_
17	act	act	VB	VB	_	15	xcomp	_	_
18	as	as	RB	RB	_	19	advmod	_	_
19	quickly	quickly	RB	RB	sem=TMP	17	advmod	_	_
20	as	as	IN	IN	_	19	prep	_	_
21	local	local	JJ	JJ	_	22	amod	_	_
22	injection	injection	NN	NN	_	20	pobj	_	_
23	,	,	,	,	_	26	punct	_	_
24	can	can	MD	MD	_	26	aux	_	_
25	significantly	significantly	RB	RB	_	26	advmod	_	_
26	reduce	reduce	VB	VB	_	4	conj	_	_
27	amyloid	amyloid	NN	NN	_	28	compound	_	_
28	load	load	NN	NN	_	26	dobj	_	_
29	within	within	IN	IN	sem=TMP	26	prep	_	_
30	2	0	CD	CD	_	31	nummod	_	_
31	mo	mo	NN	NN	_	29	pobj	_	_
32	of	of	IN	IN	_	31	prep	_	_
33	initial	initial	JJ	JJ	_	34	amod	_	_
34	treatment	treatment	NN	NN	_	32	pobj	_	_
35	[	[	-LRB-	-LRB-	_	38	punct	_	_
36	52	0	CD	CD	_	38	nummod	_	_
37	,	,	,	,	_	38	punct	_	_
38	53	0	CD	CD	_	26	parataxis	_	_
39	]	]	-RRB-	-RRB-	_	38	punct	_	_
40	.	.	.	.	_	4	punct	_	_

1	More	more	RBR	RBR	_	2	advmod	_	_
2	recently	recently	RB	RB	sem=TMP	8	advmod	_	_
3	,	,	,	,	_	8	punct	_	_
4	an	an	DT	DT	_	6	det	_	_
5	alternative	alternative	JJ	JJ	_	6	amod	_	_
6	approach	approach	NN	NN	_	8	nsubj	_	_
7	has	have	VBZ	VBZ	_	8	aux	_	_
8	shown	show	VBN	VBN	_	0	root	_	_
9	that	that	IN	IN	_	16	mark	_	_
10	lentiviral	lentiviral	JJ	JJ	_	11	amod	_	_
11	transfer	transfer	NN	NN	_	16	nsubj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	neprilysin	neprilysin	NN	NN	_	12	pobj	_	_
14	can	can	MD	MD	_	16	aux	_	_
15	also	also	RB	RB	_	16	advmod	_	_
16	reduce	reduce	VB	VB	_	8	ccomp	_	_
17	the	the	DT	DT	_	18	det	_	_
18	number	number	NN	NN	_	16	dobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	aggregates	aggregate	NNS	NNS	_	19	pobj	_	_
21	in	in	IN	IN	sem=LOC	16	prep	_	_
22	the	the	DT	DT	_	23	det	_	_
23	area	area	NN	NN	_	21	pobj	_	_
24	of	of	IN	IN	_	23	prep	_	_
25	the	the	DT	DT	_	27	det	_	_
26	injection	injection	NN	NN	_	27	compound	_	_
27	site	site	NN	NN	_	24	pobj	_	_
28	[	[	-LRB-	-LRB-	_	29	punct	_	_
29	54	0	CD	CD	_	16	parataxis	_	_
30	]	]	-RRB-	-RRB-	_	29	punct	_	_
31	.	.	.	.	_	8	punct	_	_

1	Careful	careful	JJ	JJ	_	2	amod	_	_
2	study	study	NN	NN	_	15	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	the	the	DT	DT	_	5	det	_	_
5	mechanism	mechanism	NN	NN	_	3	pobj	_	_
6	behind	behind	IN	IN	_	5	prep	_	_
7	several	several	JJ	JJ	_	6	pobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	13	det	_	_
10	antibody	antibody	NN	NN	_	12	npadvmod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	mediated	mediate	VBN	VBN	_	13	amod	_	_
13	therapies	therapy	NNS	NNS	_	8	pobj	_	_
14	has	have	VBZ	VBZ	_	15	aux	_	_
15	suggested	suggest	VBN	VBN	_	0	root	_	_
16	that	that	IN	IN	_	19	mark	_	_
17	activated	activate	VBN	VBN	_	18	amod	_	_
18	microglia	microglia	NNS	NNS	_	19	nsubj	_	_
19	play	play	VBP	VBP	_	15	ccomp	_	_
20	an	an	DT	DT	_	22	det	_	_
21	important	important	JJ	JJ	_	22	amod	_	_
22	role	role	NN	NN	_	19	dobj	_	_
23	in	in	IN	IN	_	19	prep	_	_
24	the	the	DT	DT	_	25	det	_	_
25	removal	removal	NN	NN	_	23	pobj	_	_
26	of	of	IN	IN	_	25	prep	_	_
27	fibrillar	fibrillar	JJ	JJ	_	28	amod	_	_
28	plaques	plaque	NNS	NNS	_	26	pobj	_	_
29	after	after	IN	IN	sem=TMP	19	prep	_	_
30	immunization	immunization	NN	NN	_	29	pobj	_	_
31	[	[	-LRB-	-LRB-	_	36	punct	_	_
32	50	0	CD	CD	_	36	nummod	_	_
33	,	,	,	,	_	36	punct	_	_
34	52	0	CD	CD	_	36	nummod	_	_
35	,	,	,	,	_	36	punct	_	_
36	55	0	CD	CD	_	15	parataxis	_	_
37	]	]	-RRB-	-RRB-	_	36	punct	_	_
38	.	.	.	.	_	15	punct	_	_

1	However	however	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	it	it	PRP	PRP	_	6	nsubjpass	_	_
4	has	have	VBZ	VBZ	_	6	aux	_	_
5	been	be	VBN	VBN	_	6	auxpass	_	_
6	noted	note	VBN	VBN	_	0	root	_	_
7	that	that	IN	IN	_	31	mark	_	_
8	deletion	deletion	NN	NN	_	31	nsubj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	the	the	DT	DT	_	12	det	_	_
11	Fc	fc	NN	NN	_	12	compound	_	_
12	receptor	receptor	NN	NN	_	9	pobj	_	_
13	(	(	-LRB-	-LRB-	_	12	punct	_	_
14	the	the	DT	DT	_	16	det	_	_
15	primary	primary	JJ	JJ	_	16	amod	_	_
16	receptor	receptor	NN	NN	_	12	appos	_	_
17	for	for	IN	IN	_	16	prep	_	_
18	microglial	microglial	JJ	JJ	_	19	amod	_	_
19	opsinization	opsinization	NN	NN	_	17	pobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	antibody	antibody	NN	NN	_	23	compound	_	_
22	–	-	HYPH	HYPH	_	23	punct	_	_
23	antigen	antigen	NN	NN	_	24	compound	_	_
24	complexes	complex	NNS	NNS	_	20	pobj	_	_
25	)	)	-RRB-	-RRB-	_	8	punct	_	_
26	in	in	IN	IN	sem=LOC	8	prep	_	_
27	APP	app	NN	NN	_	28	npadvmod	_	_
28	transgenic	transgenic	JJ	JJ	_	30	amod	_	_
29	mouse	mouse	NN	NN	_	30	compound	_	_
30	models	model	NNS	NNS	_	26	pobj	_	_
31	has	have	VBZ	VBZ	_	6	ccomp	_	_
32	no	no	DT	DT	_	33	det	_	_
33	impact	impact	NN	NN	_	31	dobj	_	_
34	on	on	IN	IN	_	33	prep	_	_
35	the	the	DT	DT	_	36	det	_	_
36	effectiveness	effectiveness	NN	NN	_	34	pobj	_	_
37	of	of	IN	IN	_	36	prep	_	_
38	antibody	antibody	NN	NN	_	40	npadvmod	_	_
39	-	-	HYPH	HYPH	_	40	punct	_	_
40	mediated	mediate	VBN	VBN	_	41	amod	_	_
41	therapy	therapy	NN	NN	_	37	pobj	_	_
42	[	[	-LRB-	-LRB-	_	45	punct	_	_
43	56	0	CD	CD	_	45	nummod	_	_
44	,	,	,	,	_	45	punct	_	_
45	57	0	CD	CD	_	31	parataxis	_	_
46	]	]	-RRB-	-RRB-	_	45	punct	_	_
47	.	.	.	.	_	6	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	,	,	,	,	_	2	punct	_	_
4	nevertheless	nevertheless	RB	RB	_	2	advmod	_	_
5	,	,	,	,	_	2	punct	_	_
6	possible	possible	JJ	JJ	syn=PRD	2	acomp	_	_
7	that	that	IN	IN	_	12	mark	_	_
8	lack	lack	NN	NN	_	12	nsubj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	microglia	microglia	NNS	NNS	_	11	compound	_	_
11	activation	activation	NN	NN	_	9	pobj	_	_
12	is	be	VBZ	VBZ	_	2	ccomp	_	_
13	the	the	DT	DT	_	15	det	_	_
14	major	major	JJ	JJ	_	15	amod	_	_
15	difference	difference	NN	NN	syn=PRD	12	attr	_	_
16	between	between	IN	IN	_	15	prep	_	_
17	the	the	DT	DT	_	19	det	_	_
18	slow	slow	JJ	JJ	_	19	amod	_	_
19	clearance	clearance	NN	NN	_	16	pobj	_	_
20	described	describe	VBN	VBN	_	19	acl	_	_
21	here	here	RB	RB	_	20	advmod	_	_
22	,	,	,	,	_	19	punct	_	_
23	where	where	WRB	WRB	_	31	advmod	_	19:ref
24	no	no	DT	DT	_	25	det	_	_
25	perturbation	perturbation	NN	NN	_	31	nsubjpass	_	_
26	of	of	IN	IN	_	25	prep	_	_
27	the	the	DT	DT	_	29	det	_	_
28	immune	immune	JJ	JJ	_	29	amod	_	_
29	system	system	NN	NN	_	26	pobj	_	_
30	is	be	VBZ	VBZ	_	31	auxpass	_	_
31	expected	expect	VBN	VBN	_	19	relcl	_	_
32	,	,	,	,	_	19	punct	_	_
33	and	and	CC	CC	_	19	cc	_	_
34	the	the	DT	DT	_	36	det	_	_
35	rapid	rapid	JJ	JJ	_	36	amod	_	_
36	clearance	clearance	NN	NN	_	19	conj	_	_
37	described	describe	VBN	VBN	_	36	acl	_	_
38	in	in	IN	IN	_	37	prep	_	_
39	studies	study	NNS	NNS	_	38	pobj	_	_
40	involving	involve	VBG	VBG	_	39	acl	_	_
41	antibody	antibody	NN	NN	_	44	nmod	_	_
42	or	or	CC	CC	_	41	cc	_	_
43	viral	viral	JJ	JJ	_	41	conj	_	_
44	injection	injection	NN	NN	_	40	dobj	_	_
45	.	.	.	.	_	2	punct	_	_

1	In	in	IN	IN	_	15	prep	_	_
2	isolation	isolation	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	15	punct	_	_
4	mild	mild	JJ	JJ	_	5	amod	_	_
5	activation	activation	NN	NN	_	15	nsubj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	microglia	microglia	NNS	NNS	_	6	pobj	_	_
8	by	by	IN	IN	_	5	prep	_	_
9	injection	injection	NN	NN	_	10	compound	_	_
10	damage	damage	NN	NN	_	8	pobj	_	_
11	or	or	CC	CC	_	10	cc	_	_
12	opsinization	opsinization	NN	NN	_	10	conj	_	_
13	may	may	MD	MD	_	15	aux	_	_
14	not	not	RB	RB	_	15	neg	_	_
15	be	be	VB	VB	_	0	root	_	_
16	adequate	adequate	JJ	JJ	syn=PRD	15	acomp	_	_
17	to	to	TO	TO	_	18	aux	_	_
18	induce	induce	VB	VB	sem=PRP	15	advcl	_	_
19	substantial	substantial	JJ	JJ	_	20	amod	_	_
20	phagocytosis	phagocytosis	NN	NN	_	18	dobj	_	_
21	,	,	,	,	_	15	punct	_	_
22	but	but	CC	CC	_	15	cc	_	_
23	when	when	WRB	WRB	_	24	advmod	_	_
24	combined	combine	VBN	VBN	sem=TMP	44	advcl	_	_
25	with	with	IN	IN	_	24	prep	_	_
26	an	an	DT	DT	_	30	det	_	_
27	Aβ	aβ	NN	NN	_	29	npadvmod	_	_
28	-	-	HYPH	HYPH	_	29	punct	_	_
29	lowering	lower	VBG	VBG	_	30	amod	_	_
30	agent	agent	NN	NN	_	25	pobj	_	_
31	,	,	,	,	_	30	punct	_	_
32	such	such	JJ	JJ	_	33	amod	_	_
33	as	as	IN	IN	_	30	prep	_	_
34	neprilysin	neprilysin	NN	NN	_	38	npadvmod	_	_
35	or	or	CC	CC	_	34	cc	_	_
36	Aβ	aβ	NN	NN	_	34	conj	_	_
37	-	-	HYPH	HYPH	_	38	punct	_	_
38	targeted	target	VBN	VBN	_	39	amod	_	_
39	antibodies	antibody	NNS	NNS	_	33	pobj	_	_
40	,	,	,	,	_	44	punct	_	_
41	the	the	DT	DT	_	42	det	_	_
42	two	#crd#	CD	CD	_	44	nsubj	_	_
43	may	may	MD	MD	_	44	aux	_	_
44	work	work	VB	VB	_	15	conj	_	_
45	in	in	IN	IN	sem=MNR	44	prep	_	_
46	concert	concert	NN	NN	_	45	pobj	_	_
47	to	to	TO	TO	_	48	aux	_	_
48	clear	clear	VB	VB	sem=PRP	44	advcl	_	_
49	peptide	peptide	NN	NN	_	50	compound	_	_
50	deposits	deposit	NNS	NNS	_	48	dobj	_	_
51	.	.	.	.	_	44	punct	_	_

1	Consistent	consistent	JJ	JJ	syn=PRD	32	advcl	_	_
2	with	with	IN	IN	_	1	prep	_	_
3	this	this	DT	DT	_	4	det	_	_
4	hypothesis	hypothesis	NN	NN	_	2	pobj	_	_
5	,	,	,	,	_	32	punct	_	_
6	strong	strong	JJ	JJ	_	7	amod	_	_
7	activation	activation	NN	NN	_	32	nsubj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	microglia	microglia	NNS	NNS	_	8	pobj	_	_
10	through	through	IN	IN	_	7	prep	_	_
11	transgenic	transgenic	JJ	JJ	_	12	amod	_	_
12	expression	expression	NN	NN	_	10	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	TGFβ	tgfβ	NN	NN	_	13	pobj	_	_
15	[	[	-LRB-	-LRB-	_	16	punct	_	_
16	58	0	CD	CD	_	14	parataxis	_	_
17	]	]	-RRB-	-RRB-	_	16	punct	_	_
18	or	or	CC	CC	_	12	cc	_	_
19	central	central	JJ	JJ	_	20	amod	_	_
20	injection	injection	NN	NN	_	12	conj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	lipopolysaccharide	lipopolysaccharide	NN	NN	_	21	pobj	_	_
23	[	[	-LRB-	-LRB-	_	26	punct	_	_
24	59	0	CD	CD	_	26	nummod	_	_
25	,	,	,	,	_	26	punct	_	_
26	60	0	CD	CD	_	22	parataxis	_	_
27	]	]	-RRB-	-RRB-	_	26	punct	_	_
28	can	can	MD	MD	_	32	aux	_	_
29	by	by	IN	IN	sem=MNR	32	prep	_	_
30	itself	itself	PRP	PRP	_	29	pobj	_	_
31	substantially	substantially	RB	RB	_	32	advmod	_	_
32	reduce	reduce	VB	VB	_	0	root	_	_
33	plaque	plaque	NN	NN	_	34	compound	_	_
34	burden	burden	NN	NN	_	32	dobj	_	_
35	in	in	IN	IN	sem=LOC	32	prep	_	_
36	APP	app	NN	NN	_	37	npadvmod	_	_
37	transgenic	transgenic	JJ	JJ	_	38	amod	_	_
38	mice	mouse	NNS	NNS	_	35	pobj	_	_
39	.	.	.	.	_	32	punct	_	_

1	But	but	CC	CC	_	39	cc	_	_
2	in	in	IN	IN	_	39	prep	_	_
3	the	the	DT	DT	_	4	det	_	_
4	case	case	NN	NN	_	2	pobj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	acute	acute	JJ	JJ	_	15	amod	_	_
7	antibody	antibody	NN	NN	_	14	npadvmod	_	_
8	-	-	HYPH	HYPH	_	7	punct	_	_
9	and	and	CC	CC	_	7	cc	_	_
10	/	/	HYPH	HYPH	_	9	punct	_	_
11	or	or	CC	CC	_	9	cc	_	_
12	injury	injury	NN	NN	_	7	conj	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	mediated	mediate	VBN	VBN	_	15	amod	_	_
15	activation	activation	NN	NN	_	5	pobj	_	_
16	,	,	,	,	_	39	punct	_	_
17	once	once	IN	IN	_	21	mark	_	_
18	the	the	DT	DT	_	19	det	_	_
19	inflammation	inflammation	NN	NN	_	21	nsubj	_	_
20	has	have	VBZ	VBZ	_	21	aux	_	_
21	passed	pass	VBN	VBN	sem=TMP	39	advcl	_	_
22	,	,	,	,	_	21	punct	_	_
23	and	and	CC	CC	_	21	cc	_	_
24	the	the	DT	DT	_	25	det	_	_
25	antibody	antibody	NN	NN	_	31	nsubjpass	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	bound	bind	VBN	VBN	_	28	amod	_	_
28	peptide	peptide	NN	NN	_	25	conj	_	_
29	have	have	VBP	VBP	_	31	aux	_	_
30	been	be	VBN	VBN	_	31	auxpass	_	_
31	cleared	clear	VBN	VBN	_	21	conj	_	_
32	and	and	CC	CC	_	31	cc	_	_
33	degraded	degrade	VBN	VBN	_	31	conj	_	_
34	,	,	,	,	_	39	punct	_	_
35	the	the	DT	DT	_	37	det	_	_
36	remaining	remain	VBG	VBG	_	37	amod	_	_
37	Aβ	aβ	NN	NN	_	39	nsubj	_	_
38	quickly	quickly	RB	RB	sem=TMP	39	advmod	_	_
39	reaggregates	reaggregates	VBZ	VBZ	_	0	root	_	_
40	and	and	CC	CC	_	39	cc	_	_
41	amyloid	amyloid	NN	NN	_	42	compound	_	_
42	pathology	pathology	NN	NN	_	44	nsubjpass	_	_
43	is	be	VBZ	VBZ	_	44	auxpass	_	_
44	reestablished	reestablish	VBN	VBN	_	39	conj	_	_
45	[	[	-LRB-	-LRB-	_	46	punct	_	_
46	49	0	CD	CD	_	44	parataxis	_	_
47	]	]	-RRB-	-RRB-	_	46	punct	_	_
48	.	.	.	.	_	39	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	finding	finding	NN	NN	_	3	nsubj	_	_
3	reinforces	reinforce	VBZ	VBZ	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	notion	notion	NN	NN	_	3	dobj	_	_
6	that	that	IN	IN	_	17	mark	_	_
7	without	without	IN	IN	_	17	prep	_	_
8	continued	continue	VBN	VBN	_	9	amod	_	_
9	stimulation	stimulation	NN	NN	_	7	pobj	_	_
10	,	,	,	,	_	17	punct	_	_
11	microglia	microglia	NNS	NNS	_	17	nsubj	_	_
12	in	in	IN	IN	_	11	prep	_	_
13	mouse	mouse	NN	NN	_	14	compound	_	_
14	models	model	NNS	NNS	_	12	pobj	_	_
15	do	do	VBP	VBP	_	17	aux	_	_
16	not	not	RB	RB	_	17	neg	_	_
17	maintain	maintain	VB	VB	_	5	acl	_	_
18	the	the	DT	DT	_	20	det	_	_
19	same	same	JJ	JJ	_	20	amod	_	_
20	level	level	NN	NN	_	17	dobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	sustained	sustain	VBN	VBN	_	23	amod	_	_
23	activation	activation	NN	NN	_	21	pobj	_	_
24	that	that	WDT	WDT	_	26	dep	_	20:ref
25	may	may	MD	MD	_	26	aux	_	_
26	occur	occur	VB	VB	_	20	relcl	_	_
27	in	in	IN	IN	sem=LOC	26	prep	_	_
28	humans	human	NNS	NNS	_	27	pobj	_	_
29	.	.	.	.	_	3	punct	_	_

1	SantaCruz	santacruz	NNP	NNP	_	5	nsubj	_	_
2	et	et	FW	FW	_	3	advmod	_	_
3	al.	al.	FW	FW	_	1	advmod	_	_
4	recently	recently	RB	RB	sem=TMP	5	advmod	_	_
5	published	publish	VBD	VBD	_	0	root	_	_
6	a	a	DT	DT	_	7	det	_	_
7	study	study	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	mice	mouse	NNS	NNS	_	8	pobj	_	_
10	that	that	WDT	WDT	_	11	dep	_	9:ref
11	express	express	VBP	VBP	_	9	relcl	_	_
12	P301L	p0l	NN	NN	_	14	nmod	_	_
13	human	human	JJ	JJ	_	14	amod	_	_
14	tau	tau	NN	NN	_	11	dobj	_	_
15	via	via	IN	IN	_	11	prep	_	_
16	a	a	DT	DT	_	19	det	_	_
17	similar	similar	JJ	JJ	_	19	amod	_	_
18	vector	vector	NN	NN	_	19	compound	_	_
19	system	system	NN	NN	_	15	pobj	_	_
20	[	[	-LRB-	-LRB-	_	21	punct	_	_
21	61	0	CD	CD	_	5	parataxis	_	_
22	]	]	-RRB-	-RRB-	_	21	punct	_	_
23	.	.	.	.	_	5	punct	_	_

1	As	as	IN	IN	_	13	prep	_	_
2	in	in	IN	IN	sem=LOC	1	prep	_	_
3	our	our	PRP$	PRP$	_	8	poss	_	_
4	tet	tet	NN	NN	_	6	compound	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	off	off	NN	NN	_	8	compound	_	_
7	APP	app	NN	NN	_	8	compound	_	_
8	mice	mouse	NNS	NNS	_	2	pobj	_	_
9	,	,	,	,	_	13	punct	_	_
10	SantaCruz	santacruz	NNP	NNP	_	13	nsubj	_	_
11	et	et	FW	FW	_	12	advmod	_	_
12	al.	al.	FW	FW	_	10	advmod	_	_
13	found	find	VBD	VBD	_	0	root	_	_
14	that	that	IN	IN	_	25	mark	_	_
15	tau	tau	NN	NN	_	17	nmod	_	_
16	neurofibrillary	neurofibrillary	JJ	JJ	_	17	amod	_	_
17	tangles	tangle	NNS	NNS	_	25	nsubjpass	_	_
18	,	,	,	,	_	17	punct	_	_
19	like	like	IN	IN	_	17	prep	_	_
20	amyloid	amyloid	NN	NN	_	21	compound	_	_
21	plaques	plaque	NNS	NNS	_	19	pobj	_	_
22	,	,	,	,	_	25	punct	_	_
23	are	be	VBP	VBP	_	25	auxpass	_	_
24	not	not	RB	RB	_	25	neg	_	_
25	cleared	clear	VBN	VBN	_	13	ccomp	_	_
26	efficiently	efficiently	RB	RB	sem=MNR	25	advmod	_	_
27	following	follow	VBG	VBG	sem=TMP	25	prep	_	_
28	transgene	transgene	NN	NN	_	29	compound	_	_
29	suppression	suppression	NN	NN	_	27	pobj	_	_
30	.	.	.	.	_	13	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	lack	lack	NN	NN	_	11	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	clearance	clearance	NN	NN	_	3	pobj	_	_
5	in	in	IN	IN	_	2	prep	_	_
6	both	both	DT	DT	_	7	det	_	_
7	models	model	NNS	NNS	_	5	pobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	AD	ad	NN	NN	_	10	compound	_	_
10	pathology	pathology	NN	NN	_	8	pobj	_	_
11	comes	come	VBZ	VBZ	_	0	root	_	_
12	as	as	IN	IN	_	11	prep	_	_
13	a	a	DT	DT	_	15	det	_	_
14	stark	stark	JJ	JJ	_	15	amod	_	_
15	contrast	contrast	NN	NN	_	12	pobj	_	_
16	to	to	IN	IN	_	15	prep	_	_
17	the	the	DT	DT	_	19	det	_	_
18	rapid	rapid	JJ	JJ	_	19	amod	_	_
19	removal	removal	NN	NN	_	16	pobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	protein	protein	NN	NN	_	22	compound	_	_
22	aggregates	aggregate	NNS	NNS	_	20	pobj	_	_
23	found	find	VBN	VBN	_	19	acl	_	_
24	in	in	IN	IN	_	23	prep	_	_
25	similar	similar	JJ	JJ	_	30	amod	_	_
26	tet	tet	NN	NN	_	28	compound	_	_
27	-	-	HYPH	HYPH	_	28	punct	_	_
28	off	off	NN	NN	_	30	compound	_	_
29	mouse	mouse	NN	NN	_	30	compound	_	_
30	models	model	NNS	NNS	_	24	pobj	_	_
31	of	of	IN	IN	_	30	prep	_	_
32	Huntington	huntington	NNP	NNP	_	38	nmod	_	_
33	[	[	-LRB-	-LRB-	_	34	punct	_	_
34	32	0	CD	CD	_	32	parataxis	_	_
35	]	]	-RRB-	-RRB-	_	34	punct	_	_
36	and	and	CC	CC	_	32	cc	_	_
37	prion	prion	NN	NN	_	32	conj	_	_
38	disease	disease	NN	NN	_	31	pobj	_	_
39	[	[	-LRB-	-LRB-	_	40	punct	_	_
40	62	0	CD	CD	_	38	parataxis	_	_
41	]	]	-RRB-	-RRB-	_	40	punct	_	_
42	.	.	.	.	_	11	punct	_	_

1	In	in	IN	IN	_	20	prep	_	_
2	these	these	DT	DT	_	3	det	_	_
3	cases	case	NNS	NNS	_	1	pobj	_	_
4	,	,	,	,	_	20	punct	_	_
5	disrupting	disrupt	VBG	VBG	syn=NOM	20	csubj	_	_
6	the	the	DT	DT	_	7	det	_	_
7	input	input	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	new	new	JJ	JJ	_	10	amod	_	_
10	monomer	monomer	NN	NN	_	8	pobj	_	_
11	to	to	IN	IN	_	7	prep	_	_
12	the	the	DT	DT	_	13	det	_	_
13	system	system	NN	NN	_	11	pobj	_	_
14	via	via	IN	IN	sem=MNR	5	prep	_	_
15	dox	dox	NN	NN	_	17	npadvmod	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	mediated	mediate	VBN	VBN	_	19	amod	_	_
18	transgene	transgene	NN	NN	_	19	compound	_	_
19	suppression	suppression	NN	NN	_	14	pobj	_	_
20	led	lead	VBD	VBD	_	0	root	_	_
21	to	to	IN	IN	_	20	prep	_	_
22	relatively	relatively	RB	RB	_	23	advmod	_	_
23	rapid	rapid	JJ	JJ	_	24	amod	_	_
24	clearance	clearance	NN	NN	_	21	pobj	_	_
25	of	of	IN	IN	_	24	prep	_	_
26	protein	protein	NN	NN	_	27	compound	_	_
27	aggregates	aggregate	NNS	NNS	_	25	pobj	_	_
28	.	.	.	.	_	20	punct	_	_

1	By	by	IN	IN	_	12	prep	_	_
2	contrast	contrast	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	12	punct	_	_
4	our	our	PRP$	PRP$	_	5	poss	_	_
5	study	study	NN	NN	_	12	nsubj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	that	that	DT	DT	_	5	conj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	SantaCruz	santacruz	NNP	NNP	_	8	pobj	_	_
10	et	et	FW	FW	_	11	advmod	_	_
11	al.	al.	FW	FW	_	9	advmod	_	_
12	suggest	suggest	VBP	VBP	_	0	root	_	_
13	that	that	IN	IN	_	19	mark	_	_
14	protein	protein	NN	NN	_	15	compound	_	_
15	aggregates	aggregate	NNS	NNS	_	19	nsubj	_	_
16	in	in	IN	IN	sem=LOC	15	prep	_	_
17	AD	ad	NN	NN	_	16	pobj	_	_
18	may	may	MD	MD	_	19	aux	_	_
19	be	be	VB	VB	_	12	ccomp	_	_
20	more	more	RBR	RBR	_	21	advmod	_	_
21	tenacious	tenacious	JJ	JJ	syn=PRD	19	acomp	_	_
22	than	than	IN	IN	_	21	prep	_	_
23	in	in	IN	IN	sem=LOC	22	prep	_	_
24	other	other	JJ	JJ	_	26	amod	_	_
25	neurodegenerative	neurodegenerative	JJ	JJ	_	26	amod	_	_
26	disorders	disorder	NNS	NNS	_	23	pobj	_	_
27	.	.	.	.	_	12	punct	_	_

1	Perhaps	perhaps	RB	RB	_	8	advmod	_	_
2	once	once	IN	IN	_	3	mark	_	_
3	aggregated	aggregate	VBN	VBN	sem=TMP	8	advcl	_	_
4	,	,	,	,	_	8	punct	_	_
5	Aβ	aβ	NN	NN	_	8	nsubj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	tau	tau	NN	NN	_	5	conj	_	_
8	are	be	VBP	VBP	_	0	root	_	_
9	either	either	RB	RB	_	12	advmod	_	_
10	inherently	inherently	RB	RB	_	12	advmod	_	_
11	more	more	RBR	RBR	_	12	advmod	_	_
12	stable	stable	JJ	JJ	syn=PRD	8	acomp	_	_
13	than	than	IN	IN	_	12	prep	_	_
14	other	other	JJ	JJ	_	16	amod	_	_
15	protein	protein	NN	NN	_	16	compound	_	_
16	aggregates	aggregate	NNS	NNS	_	13	pobj	_	_
17	or	or	CC	CC	_	12	cc	_	_
18	more	more	RBR	RBR	_	19	advmod	_	_
19	resistant	resistant	JJ	JJ	_	12	conj	_	_
20	to	to	IN	IN	_	19	prep	_	_
21	intra	intra	AFX	AFX	_	24	advmod	_	_
22	-	-	HYPH	HYPH	_	24	punct	_	_
23	and	and	CC	CC	_	24	cc	_	_
24	extracellular	extracellular	JJ	JJ	_	26	amod	_	_
25	clearance	clearance	NN	NN	_	26	compound	_	_
26	mechanisms	mechanism	NNS	NNS	_	20	pobj	_	_
27	.	.	.	.	_	8	punct	_	_

1	One	#crd#	CD	CD	_	2	nummod	_	_
2	question	question	NN	NN	_	12	nsubj	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	were	be	VBD	VBD	_	2	advcl	_	_
5	not	not	RB	RB	_	4	neg	_	_
6	able	able	JJ	JJ	syn=PRD	4	acomp	_	_
7	to	to	TO	TO	_	8	aux	_	_
8	address	address	VB	VB	_	6	xcomp	_	_
9	in	in	IN	IN	_	8	prep	_	_
10	this	this	DT	DT	_	11	det	_	_
11	study	study	NN	NN	_	9	pobj	_	_
12	is	be	VBZ	VBZ	_	0	root	_	_
13	whether	whether	IN	IN	_	19	mark	_	_
14	abrogating	abrogate	VBG	VBG	syn=NOM	19	csubj	_	_
15	synthesis	synthesis	NN	NN	_	14	dobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	new	new	JJ	JJ	_	18	amod	_	_
18	Aβ	aβ	NN	NN	_	16	pobj	_	_
19	halts	halt	VBZ	VBZ	syn=PRD	12	ccomp	_	_
20	the	the	DT	DT	_	21	det	_	_
21	progression	progression	NN	NN	_	19	dobj	_	_
22	of	of	IN	IN	_	21	prep	_	_
23	cognitive	cognitive	JJ	JJ	_	24	amod	_	_
24	decline	decline	NN	NN	_	22	pobj	_	_
25	.	.	.	.	_	12	punct	_	_

1	Studies	study	NNS	NNS	_	9	nsubj	_	_
2	from	from	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	8	det	_	_
4	tet	tet	NN	NN	_	6	compound	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	off	off	NN	NN	_	8	compound	_	_
7	tau	tau	NN	NN	_	8	compound	_	_
8	mice	mouse	NNS	NNS	_	2	pobj	_	_
9	suggest	suggest	VBP	VBP	_	0	root	_	_
10	that	that	IN	IN	_	18	mark	_	_
11	protein	protein	NN	NN	_	12	compound	_	_
12	clearance	clearance	NN	NN	_	18	nsubjpass	_	_
13	may	may	MD	MD	_	18	aux	_	_
14	in	in	IN	IN	_	18	prep	_	_
15	fact	fact	NN	NN	_	14	pobj	_	_
16	not	not	RB	RB	_	18	neg	_	_
17	be	be	VB	VB	_	18	auxpass	_	_
18	required	require	VBN	VBN	_	9	ccomp	_	_
19	for	for	IN	IN	sem=PRP	18	prep	_	_
20	cognitive	cognitive	JJ	JJ	_	21	amod	_	_
21	improvement	improvement	NN	NN	_	19	pobj	_	_
22	following	follow	VBG	VBG	sem=TMP	18	prep	_	_
23	transgene	transgene	NN	NN	_	24	compound	_	_
24	suppression	suppression	NN	NN	_	22	pobj	_	_
25	[	[	-LRB-	-LRB-	_	26	punct	_	_
26	61	0	CD	CD	_	18	parataxis	_	_
27	]	]	-RRB-	-RRB-	_	26	punct	_	_
28	.	.	.	.	_	9	punct	_	_

1	At	at	IN	IN	sem=TMP	12	prep	_	_
2	present	present	JJ	JJ	_	1	amod	_	_
3	,	,	,	,	_	12	punct	_	_
4	because	because	IN	IN	_	12	prep	_	_
5	of	of	IN	IN	_	4	pcomp	_	_
6	unexpected	unexpected	JJ	JJ	_	9	amod	_	_
7	noncognitive	noncognitive	JJ	JJ	_	9	amod	_	_
8	behavioral	behavioral	JJ	JJ	_	9	amod	_	_
9	abnormalities	abnormality	NNS	NNS	_	4	pobj	_	_
10	,	,	,	,	_	12	punct	_	_
11	it	it	PRP	PRP	_	12	nsubj	_	_
12	is	be	VBZ	VBZ	_	0	root	_	_
13	not	not	RB	RB	_	12	neg	_	_
14	clear	clear	JJ	JJ	syn=PRD	12	acomp	_	_
15	whether	whether	IN	IN	_	24	mark	_	_
16	the	the	DT	DT	_	21	det	_	_
17	tet	tet	NN	NN	_	19	compound	_	_
18	-	-	HYPH	HYPH	_	19	punct	_	_
19	off	off	NN	NN	_	21	compound	_	_
20	APP	app	NN	NN	_	21	compound	_	_
21	mice	mouse	NNS	NNS	_	24	nsubjpass	_	_
22	can	can	MD	MD	_	24	aux	_	_
23	be	be	VB	VB	_	24	auxpass	_	_
24	used	use	VBN	VBN	_	12	ccomp	_	_
25	to	to	TO	TO	_	26	aux	_	_
26	address	address	VB	VB	sem=PRP	24	advcl	_	_
27	the	the	DT	DT	_	29	det	_	_
28	same	same	JJ	JJ	_	29	amod	_	_
29	question	question	NN	NN	_	26	dobj	_	_
30	in	in	IN	IN	_	26	prep	_	_
31	the	the	DT	DT	_	32	det	_	_
32	context	context	NN	NN	_	30	pobj	_	_
33	of	of	IN	IN	_	32	prep	_	_
34	amyloid	amyloid	NN	NN	_	35	compound	_	_
35	pathology	pathology	NN	NN	_	33	pobj	_	_
36	.	.	.	.	_	12	punct	_	_

1	Both	both	DT	DT	_	2	det	_	_
2	lines	line	NNS	NNS	_	11	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	tTA	tta	NN	NN	_	6	compound	_	_
5	/	/	HYPH	HYPH	_	6	punct	_	_
6	APP	app	NN	NN	_	7	compound	_	_
7	mice	mouse	NNS	NNS	_	3	pobj	_	_
8	we	we	PRP	PRP	_	9	nsubj	_	_
9	studied	study	VBN	VBN	_	2	advcl	_	_
10	here	here	RB	RB	sem=LOC	9	advmod	_	_
11	display	display	VBP	VBP	_	0	root	_	_
12	extreme	extreme	JJ	JJ	_	13	amod	_	_
13	hyperactivity	hyperactivity	NN	NN	_	11	dobj	_	_
14	visible	visible	JJ	JJ	_	13	amod	_	_
15	as	as	IN	IN	_	14	prep	_	_
16	cage	cage	NN	NN	_	17	compound	_	_
17	circling	circling	NN	NN	_	15	pobj	_	_
18	and	and	CC	CC	_	14	cc	_	_
19	quantified	quantify	VBN	VBN	_	14	conj	_	_
20	by	by	IN	IN	_	19	agent	_	_
21	activity	activity	NN	NN	_	22	compound	_	_
22	monitoring	monitoring	NN	NN	_	20	pobj	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	see	see	VB	VB	_	11	parataxis	_	_
25	Figure	figure	NN	NN	_	24	dobj	_	_
26	7	0	CD	CD	_	25	nummod	_	_
27	)	)	-RRB-	-RRB-	_	24	punct	_	_
28	.	.	.	.	_	11	punct	_	_

1	Many	many	JJ	JJ	_	7	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	6	det	_	_
4	double	double	JJ	JJ	_	5	amod	_	_
5	transgenic	transgenic	JJ	JJ	_	6	amod	_	_
6	mice	mouse	NNS	NNS	_	2	pobj	_	_
7	showed	show	VBD	VBD	_	0	root	_	_
8	similar	similar	JJ	JJ	_	10	amod	_	_
9	circular	circular	JJ	JJ	_	10	amod	_	_
10	patterns	pattern	NNS	NNS	_	7	dobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	swimming	swimming	NN	NN	_	11	pobj	_	_
13	near	near	IN	IN	sem=LOC	10	prep	_	_
14	the	the	DT	DT	_	15	det	_	_
15	edge	edge	NN	NN	_	13	pobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	the	the	DT	DT	_	18	det	_	_
18	tank	tank	NN	NN	_	16	pobj	_	_
19	when	when	WRB	WRB	_	20	advmod	_	_
20	tested	test	VBN	VBN	sem=TMP	7	advcl	_	_
21	in	in	IN	IN	sem=LOC	20	prep	_	_
22	the	the	DT	DT	_	25	det	_	_
23	Morris	morris	NNP	NNP	_	25	compound	_	_
24	water	water	NN	NN	_	25	compound	_	_
25	maze	maze	NN	NN	_	21	pobj	_	_
26	.	.	.	.	_	7	punct	_	_

1	Expression	expression	NN	NN	_	5	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	this	this	DT	DT	_	4	det	_	_
4	phenotype	phenotype	NN	NN	_	2	pobj	_	_
5	makes	make	VBZ	VBZ	_	0	root	_	_
6	standard	standard	JJ	JJ	_	7	amod	_	_
7	tests	test	NNS	NNS	_	12	nsubj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	learning	learning	NN	NN	_	8	pobj	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	memory	memory	NN	NN	_	9	conj	_	_
12	uninterpretable	uninterpretable	JJ	JJ	syn=PRD	5	ccomp	_	_
13	.	.	.	.	_	5	punct	_	_

1	Hyperactivity	hyperactivity	NN	NN	_	3	nsubj	_	_
2	nonspecifically	nonspecifically	RB	RB	sem=MNR	3	advmod	_	_
3	inhibits	inhibit	VBZ	VBZ	_	0	root	_	_
4	choice	choice	NN	NN	_	6	npadvmod	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	driven	drive	VBN	VBN	_	7	amod	_	_
7	changes	change	NNS	NNS	_	3	dobj	_	_
8	in	in	IN	IN	_	7	prep	_	_
9	movement	movement	NN	NN	_	8	pobj	_	_
10	,	,	,	,	_	7	punct	_	_
11	the	the	DT	DT	_	13	det	_	_
12	key	key	JJ	JJ	_	13	amod	_	_
13	element	element	NN	NN	_	7	appos	_	_
14	behind	behind	IN	IN	_	13	prep	_	_
15	all	all	DT	DT	_	18	det	_	_
16	cognitive	cognitive	JJ	JJ	_	18	amod	_	_
17	behavioral	behavioral	JJ	JJ	_	18	amod	_	_
18	paradigms	paradigm	NNS	NNS	_	14	pobj	_	_
19	.	.	.	.	_	3	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	are	be	VBP	VBP	_	4	aux	_	_
3	currently	currently	RB	RB	sem=TMP	4	advmod	_	_
4	working	work	VBG	VBG	_	0	root	_	_
5	to	to	TO	TO	_	6	aux	_	_
6	determine	determine	VB	VB	_	4	xcomp	_	_
7	whether	whether	IN	IN	_	9	mark	_	_
8	hyperactivity	hyperactivity	NN	NN	_	9	nsubj	_	_
9	correlates	correlate	VBZ	VBZ	_	6	ccomp	_	_
10	with	with	IN	IN	_	9	prep	_	_
11	expression	expression	NN	NN	_	10	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	the	the	DT	DT	_	17	det	_	_
14	APPswe	appswe	NN	NN	_	16	compound	_	_
15	/	/	HYPH	HYPH	_	16	punct	_	_
16	ind	ind	NN	NN	_	17	compound	_	_
17	holoprotein	holoprotein	NN	NN	_	12	pobj	_	_
18	or	or	CC	CC	_	11	cc	_	_
19	its	its	PRP$	PRP$	_	21	poss	_	_
20	proteolytic	proteolytic	JJ	JJ	_	21	amod	_	_
21	derivatives	derivative	NNS	NNS	_	11	conj	_	_
22	.	.	.	.	_	4	punct	_	_

1	Preliminary	preliminary	JJ	JJ	_	2	amod	_	_
2	studies	study	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	8	mark	_	_
5	hyperactivity	hyperactivity	NN	NN	_	8	nsubj	_	_
6	does	do	VBZ	VBZ	_	8	aux	_	_
7	not	not	RB	RB	_	8	neg	_	_
8	appear	appear	VB	VB	_	3	ccomp	_	_
9	quickly	quickly	RB	RB	sem=TMP	8	advmod	_	_
10	when	when	WRB	WRB	_	16	advmod	_	_
11	dox	dox	NN	NN	_	13	npadvmod	_	_
12	-	-	HYPH	HYPH	_	13	punct	_	_
13	reared	rear	VBN	VBN	_	14	amod	_	_
14	mice	mouse	NNS	NNS	_	16	nsubjpass	_	_
15	are	be	VBP	VBP	_	16	auxpass	_	_
16	shifted	shift	VBN	VBN	sem=TMP	8	advcl	_	_
17	to	to	IN	IN	_	16	prep	_	_
18	nonmedicated	nonmedicated	JJ	JJ	_	19	amod	_	_
19	diets	diet	NNS	NNS	_	17	pobj	_	_
20	(	(	-LRB-	-LRB-	_	26	punct	_	_
21	J.	j.	NNP	NNP	_	23	compound	_	_
22	L.	l.	NNP	NNP	_	23	compound	_	_
23	J.	j.	NNP	NNP	_	26	dep	_	_
24	,	,	,	,	_	26	punct	_	_
25	unpublished	unpublished	JJ	JJ	_	26	amod	_	_
26	data	datum	NNS	NNS	_	16	parataxis	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	.	.	.	.	_	3	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	4	nsubj	_	_
3	may	may	MD	MD	_	4	aux	_	_
4	indicate	indicate	VB	VB	_	0	root	_	_
5	that	that	IN	IN	_	9	mark	_	_
6	the	the	DT	DT	_	8	det	_	_
7	neuroactive	neuroactive	JJ	JJ	_	8	amod	_	_
8	culprit	culprit	NN	NN	_	9	nsubj	_	_
9	is	be	VBZ	VBZ	_	4	ccomp	_	_
10	not	not	RB	RB	_	11	neg	_	_
11	immediately	immediately	RB	RB	sem=TMP	9	advmod	_	_
12	present	present	JJ	JJ	syn=PRD	9	acomp	_	_
13	after	after	IN	IN	_	18	mark	_	_
14	transgenic	transgenic	JJ	JJ	_	16	amod	_	_
15	APP	app	NN	NN	_	16	compound	_	_
16	synthesis	synthesis	NN	NN	_	18	nsubjpass	_	_
17	is	be	VBZ	VBZ	_	18	auxpass	_	_
18	initiated	initiate	VBN	VBN	sem=TMP	9	advcl	_	_
19	,	,	,	,	_	9	punct	_	_
20	but	but	CC	CC	_	9	cc	_	_
21	requires	require	VBZ	VBZ	_	9	conj	_	_
22	additional	additional	JJ	JJ	_	23	amod	_	_
23	time	time	NN	NN	_	21	dobj	_	_
24	to	to	TO	TO	_	25	aux	_	_
25	develop	develop	VB	VB	_	23	advcl	_	_
26	.	.	.	.	_	4	punct	_	_

1	Alternatively	alternatively	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	hyperactivity	hyperactivity	NN	NN	_	6	nsubjpass	_	_
4	may	may	MD	MD	_	6	aux	_	_
5	be	be	VB	VB	_	6	auxpass	_	_
6	caused	cause	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	_	6	agent	_	_
8	neuronal	neuronal	JJ	JJ	_	9	amod	_	_
9	alterations	alteration	NNS	NNS	_	7	pobj	_	_
10	due	due	IN	IN	sem=PRP	6	prep	_	_
11	to	to	IN	IN	_	10	pcomp	_	_
12	transgene	transgene	NN	NN	_	13	compound	_	_
13	expression	expression	NN	NN	_	10	pobj	_	_
14	during	during	IN	IN	sem=TMP	13	prep	_	_
15	early	early	JJ	JJ	_	16	amod	_	_
16	postnatal	postnatal	JJ	JJ	_	17	amod	_	_
17	development	development	NN	NN	_	14	pobj	_	_
18	.	.	.	.	_	6	punct	_	_

1	Further	far	JJ	JJ	_	2	amod	_	_
2	experiments	experiment	NNS	NNS	_	4	nsubjpass	_	_
3	are	be	VBP	VBP	_	4	auxpass	_	_
4	needed	need	VBN	VBN	_	0	root	_	_
5	to	to	TO	TO	_	6	aux	_	_
6	distinguish	distinguish	VB	VB	sem=PRP	4	advcl	_	_
7	between	between	IN	IN	_	6	prep	_	_
8	these	these	DT	DT	_	9	det	_	_
9	possibilities	possibility	NNS	NNS	_	7	pobj	_	_
10	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	5	prep	_	_
2	summary	summary	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	5	punct	_	_
4	we	we	PRP	PRP	_	5	nsubj	_	_
5	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
6	that	that	IN	IN	_	10	mark	_	_
7	abrogating	abrogate	VBG	VBG	syn=NOM	10	csubj	_	_
8	Aβ	aβ	NN	NN	_	9	compound	_	_
9	production	production	NN	NN	_	7	dobj	_	_
10	halts	halt	VBZ	VBZ	_	5	ccomp	_	_
11	the	the	DT	DT	_	12	det	_	_
12	progression	progression	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	pathologic	pathologic	JJ	JJ	_	15	amod	_	_
15	changes	change	NNS	NNS	_	13	pobj	_	_
16	in	in	IN	IN	sem=LOC	12	prep	_	_
17	a	a	DT	DT	_	20	det	_	_
18	transgenic	transgenic	JJ	JJ	_	20	amod	_	_
19	mouse	mouse	NN	NN	_	20	compound	_	_
20	model	model	NN	NN	_	16	pobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	Alzheimer	alzheimer	NNP	NNP	_	24	compound	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	type	type	NN	NN	_	25	compound	_	_
25	amyloidosis	amyloidosis	NN	NN	_	21	pobj	_	_
26	.	.	.	.	_	5	punct	_	_

1	However	however	RB	RB	_	12	advmod	_	_
2	,	,	,	,	_	12	punct	_	_
3	despite	despite	IN	IN	_	12	prep	_	_
4	dramatic	dramatic	JJ	JJ	_	5	amod	_	_
5	reductions	reduction	NNS	NNS	_	3	pobj	_	_
6	in	in	IN	IN	_	5	prep	_	_
7	Aβ	aβ	NN	NN	_	8	compound	_	_
8	synthesis	synthesis	NN	NN	_	6	pobj	_	_
9	,	,	,	,	_	12	punct	_	_
10	neuritic	neuritic	JJ	JJ	_	11	amod	_	_
11	plaques	plaque	NNS	NNS	_	12	nsubj	_	_
12	are	be	VBP	VBP	_	0	root	_	_
13	stable	stable	JJ	JJ	_	14	amod	_	_
14	structures	structure	NNS	NNS	syn=PRD	12	attr	_	_
15	in	in	FW	FW	_	16	advmod	_	_
16	vivo	vivo	FW	FW	_	14	advmod	_	_
17	that	that	WDT	WDT	_	21	dep	_	14:ref
18	do	do	VBP	VBP	_	21	aux	_	_
19	not	not	RB	RB	_	21	neg	_	_
20	quickly	quickly	RB	RB	sem=TMP	21	advmod	_	_
21	disaggregate	disaggregate	VB	VB	_	14	relcl	_	_
22	.	.	.	.	_	12	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	possible	possible	JJ	JJ	syn=PRD	2	acomp	_	_
4	that	that	IN	IN	_	26	mark	_	_
5	a	a	DT	DT	_	6	det	_	_
6	combination	combination	NN	NN	_	26	nsubjpass	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	therapies	therapy	NNS	NNS	_	7	pobj	_	_
9	to	to	TO	TO	_	10	aux	_	_
10	limit	limit	VB	VB	_	8	advcl	_	_
11	Aβ	aβ	NN	NN	_	12	compound	_	_
12	production	production	NN	NN	_	10	dobj	_	_
13	,	,	,	,	_	10	punct	_	_
14	increase	increase	VB	VB	_	10	conj	_	_
15	Aβ	aβ	NN	NN	_	16	compound	_	_
16	degradation	degradation	NN	NN	_	14	dobj	_	_
17	,	,	,	,	_	14	punct	_	_
18	and	and	CC	CC	_	14	cc	_	_
19	enhance	enhance	VBP	VBP	_	14	conj	_	_
20	phagocytosis	phagocytosis	NN	NN	_	19	dobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	deposited	deposit	VBN	VBN	_	23	amod	_	_
23	amyloid	amyloid	NN	NN	_	21	pobj	_	_
24	may	may	MD	MD	_	26	aux	_	_
25	be	be	VB	VB	_	26	auxpass	_	_
26	required	require	VBN	VBN	_	2	ccomp	_	_
27	to	to	TO	TO	_	28	aux	_	_
28	reverse	reverse	VB	VB	sem=PRP	26	advcl	_	_
29	damage	damage	NN	NN	_	28	dobj	_	_
30	associated	associate	VBN	VBN	_	29	acl	_	_
31	with	with	IN	IN	_	30	prep	_	_
32	AD	ad	NN	NN	_	31	pobj	_	_
33	.	.	.	.	_	2	punct	_	_

1	However	however	RB	RB	_	17	advmod	_	_
2	,	,	,	,	_	17	punct	_	_
3	if	if	IN	IN	_	4	mark	_	_
4	started	start	VBN	VBN	syn=ADV	17	advcl	_	_
5	early	early	RB	RB	_	6	advmod	_	_
6	enough	enough	RB	RB	sem=TMP	4	advmod	_	_
7	in	in	IN	IN	_	4	prep	_	_
8	the	the	DT	DT	_	9	det	_	_
9	course	course	NN	NN	_	7	pobj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	disease	disease	NN	NN	_	10	pobj	_	_
12	,	,	,	,	_	17	punct	_	_
13	secretase	secretase	NN	NN	_	14	compound	_	_
14	inhibitors	inhibitor	NNS	NNS	_	17	nsubj	_	_
15	alone	alone	RB	RB	_	14	advmod	_	_
16	could	could	MD	MD	_	17	aux	_	_
17	provide	provide	VB	VB	_	0	root	_	_
18	substantial	substantial	JJ	JJ	_	19	amod	_	_
19	benefit	benefit	NN	NN	_	17	dobj	_	_
20	in	in	IN	IN	_	19	prep	_	_
21	slowing	slow	VBG	VBG	syn=NOM	20	pcomp	_	_
22	pathogenic	pathogenic	JJ	JJ	_	23	amod	_	_
23	processes	process	NNS	NNS	_	21	dobj	_	_
24	linked	link	VBN	VBN	_	23	acl	_	_
25	to	to	IN	IN	_	24	prep	_	_
26	amyloid	amyloid	NN	NN	_	27	compound	_	_
27	deposition	deposition	NN	NN	_	25	pobj	_	_
28	.	.	.	.	_	17	punct	_	_

1	Even	even	RB	RB	_	2	advmod	_	_
2	at	at	IN	IN	sem=TMP	21	prep	_	_
3	later	late	JJR	JJR	_	4	amod	_	_
4	stages	stage	NNS	NNS	_	2	pobj	_	_
5	in	in	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	7	det	_	_
7	disease	disease	NN	NN	_	5	pobj	_	_
8	,	,	,	,	_	21	punct	_	_
9	the	the	DT	DT	_	10	det	_	_
10	presence	presence	NN	NN	_	21	nsubj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	substantial	substantial	JJ	JJ	_	14	amod	_	_
13	microglial	microglial	JJ	JJ	_	14	amod	_	_
14	activation	activation	NN	NN	_	11	pobj	_	_
15	in	in	IN	IN	sem=LOC	10	prep	_	_
16	human	human	JJ	JJ	_	17	amod	_	_
17	AD	ad	NN	NN	_	15	pobj	_	_
18	[	[	-LRB-	-LRB-	_	19	punct	_	_
19	40	0	CD	CD	_	17	parataxis	_	_
20	]	]	-RRB-	-RRB-	_	19	punct	_	_
21	suggests	suggest	VBZ	VBZ	_	0	root	_	_
22	that	that	IN	IN	_	32	mark	_	_
23	simply	simply	RB	RB	_	24	advmod	_	_
24	slowing	slow	VBG	VBG	syn=NOM	32	csubj	_	_
25	the	the	DT	DT	_	26	det	_	_
26	formation	formation	NN	NN	_	24	dobj	_	_
27	of	of	IN	IN	_	26	prep	_	_
28	new	new	JJ	JJ	_	30	amod	_	_
29	amyloid	amyloid	NN	NN	_	30	compound	_	_
30	deposits	deposit	NNS	NNS	_	27	pobj	_	_
31	may	may	MD	MD	_	32	aux	_	_
32	allow	allow	VB	VB	_	21	ccomp	_	_
33	ongoing	ongoing	JJ	JJ	_	34	amod	_	_
34	phagocytosis	phagocytosis	NN	NN	_	36	nsubj	_	_
35	to	to	TO	TO	_	36	aux	_	_
36	diminish	diminish	VB	VB	_	32	ccomp	_	_
37	preexisting	preexisting	JJ	JJ	_	38	amod	_	_
38	lesions	lesion	NNS	NNS	_	36	dobj	_	_
39	.	.	.	.	_	21	punct	_	_

1	However	however	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	development	development	NN	NN	_	14	nsubjpass	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	safe	safe	JJ	JJ	_	10	amod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	effective	effective	JJ	JJ	_	6	conj	_	_
9	secretase	secretase	NN	NN	_	10	compound	_	_
10	inhibitors	inhibitor	NNS	NNS	_	5	pobj	_	_
11	will	will	MD	MD	_	14	aux	_	_
12	ultimately	ultimately	RB	RB	sem=TMP	14	advmod	_	_
13	be	be	VB	VB	_	14	auxpass	_	_
14	required	require	VBN	VBN	_	0	root	_	_
15	to	to	TO	TO	_	16	aux	_	_
16	determine	determine	VB	VB	sem=PRP	14	advcl	_	_
17	whether	whether	IN	IN	_	21	mark	_	_
18	the	the	DT	DT	_	20	det	_	_
19	human	human	JJ	JJ	_	20	amod	_	_
20	brain	brain	NN	NN	_	21	nsubj	_	_
21	has	have	VBZ	VBZ	_	16	ccomp	_	_
22	the	the	DT	DT	_	23	det	_	_
23	capacity	capacity	NN	NN	_	21	dobj	_	_
24	to	to	TO	TO	_	25	aux	_	_
25	repair	repair	VB	VB	_	23	acl	_	_
26	amyloid	amyloid	NN	NN	_	28	npadvmod	_	_
27	-	-	HYPH	HYPH	_	28	punct	_	_
28	associated	associate	VBN	VBN	_	29	amod	_	_
29	damage	damage	NN	NN	_	25	dobj	_	_
30	of	of	IN	IN	_	29	prep	_	_
31	AD	ad	NN	NN	_	30	pobj	_	_
32	once	once	IN	IN	_	38	mark	_	_
33	the	the	DT	DT	_	34	det	_	_
34	progression	progression	NN	NN	_	38	nsubjpass	_	_
35	of	of	IN	IN	_	34	prep	_	_
36	pathology	pathology	NN	NN	_	35	pobj	_	_
37	is	be	VBZ	VBZ	_	38	auxpass	_	_
38	arrested	arrest	VBN	VBN	sem=TMP	25	advcl	_	_
39	.	.	.	.	_	14	punct	_	_

1	Supporting	support	VBG	VBG	_	2	amod	_	_
2	Information	information	NN	NN	_	0	root	_	_

1	Figure	figure	NN	NN	_	2	compound	_	_
2	S1	s0	NN	NN	_	0	root	_	_

1	Transgenic	transgenic	JJ	JJ	_	3	amod	_	_
2	APP	app	NN	NN	_	3	compound	_	_
3	Expression	expression	NN	NN	_	0	root	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	Suppression	suppression	NN	NN	_	3	conj	_	_
6	by	by	IN	IN	_	3	prep	_	_
7	Dox	dox	NN	NN	_	6	pobj	_	_
8	in	in	IN	IN	sem=LOC	3	prep	_	_
9	the	the	DT	DT	_	16	det	_	_
10	Four	#crd#	CD	CD	_	16	nummod	_	_
11	New	new	JJ	JJ	_	16	amod	_	_
12	Tet	tet	NN	NN	_	14	compound	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	Off	off	NN	NN	_	16	compound	_	_
15	APP	app	NN	NN	_	16	compound	_	_
16	Lines	line	NNS	NNS	_	8	pobj	_	_

1	Western	western	NNP	NNP	_	2	compound	_	_
2	blotting	blotting	NN	NN	_	9	nsubj	_	_
3	with	with	IN	IN	_	2	prep	_	_
4	human	human	JJ	JJ	_	6	amod	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	specific	specific	JJ	JJ	_	8	amod	_	_
7	antibody	antibody	NN	NN	_	8	compound	_	_
8	6E10	0e0	NN	NN	_	3	pobj	_	_
9	reveals	reveal	VBZ	VBZ	_	0	root	_	_
10	transgene	transgene	NN	NN	_	12	npadvmod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	derived	derive	VBN	VBN	_	16	amod	_	_
13	full	full	JJ	JJ	_	15	amod	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	length	length	NN	NN	_	16	compound	_	_
16	APP	app	NN	NN	_	9	dobj	_	_
17	in	in	IN	IN	_	9	prep	_	_
18	cortical	cortical	JJ	JJ	_	19	amod	_	_
19	homogenates	homogenate	NNS	NNS	_	17	pobj	_	_
20	from	from	IN	IN	_	19	prep	_	_
21	untreated	untreated	JJ	JJ	_	22	amod	_	_
22	animals	animal	NNS	NNS	_	20	pobj	_	_
23	(	(	-LRB-	-LRB-	_	25	punct	_	_
24	left	left	JJ	JJ	_	25	amod	_	_
25	lanes	lane	NNS	NNS	_	9	parataxis	_	_
26	of	of	IN	IN	_	25	prep	_	_
27	each	each	DT	DT	_	28	det	_	_
28	panel	panel	NN	NN	_	26	pobj	_	_
29	)	)	-RRB-	-RRB-	_	25	punct	_	_
30	.	.	.	.	_	9	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	new	new	JJ	JJ	_	3	amod	_	_
3	lines	line	NNS	NNS	_	4	nsubj	_	_
4	produce	produce	VBP	VBP	_	25	ccomp	_	_
5	exceptionally	exceptionally	RB	RB	_	6	advmod	_	_
6	high	high	JJ	JJ	_	7	amod	_	_
7	levels	level	NNS	NNS	_	4	dobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	transgene	transgene	NN	NN	_	10	compound	_	_
10	expression	expression	NN	NN	_	8	pobj	_	_
11	;	;	:	:	_	25	punct	_	_
12	an	an	DT	DT	_	14	det	_	_
13	equal	equal	JJ	JJ	_	14	amod	_	_
14	amount	amount	NN	NN	_	25	nsubjpass	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	brain	brain	NN	NN	_	17	compound	_	_
17	homogenate	homogenate	NN	NN	_	15	pobj	_	_
18	from	from	IN	IN	_	17	prep	_	_
19	a	a	DT	DT	_	23	det	_	_
20	standard	standard	JJ	JJ	_	23	amod	_	_
21	transgenic	transgenic	JJ	JJ	_	23	amod	_	_
22	APP	app	NN	NN	_	23	compound	_	_
23	line	line	NN	NN	_	18	pobj	_	_
24	is	be	VBZ	VBZ	_	25	auxpass	_	_
25	shown	show	VBN	VBN	_	0	root	_	_
26	for	for	IN	IN	_	25	prep	_	_
27	comparison	comparison	NN	NN	_	26	pobj	_	_
28	(	(	-LRB-	-LRB-	_	43	punct	_	_
29	extreme	extreme	JJ	JJ	_	31	amod	_	_
30	left	left	JJ	JJ	_	31	amod	_	_
31	lane	lane	NN	NN	_	43	dep	_	_
32	,	,	,	,	_	43	punct	_	_
33	Standard	standard	JJ	JJ	_	36	amod	_	_
34	Tg	tg	NN	NN	_	36	compound	_	_
35	line	line	NN	NN	_	36	compound	_	_
36	C3	c0	NN	NN	_	43	dep	_	_
37	–	-	HYPH	HYPH	_	36	punct	_	_
38	3	0	CD	CD	_	36	nummod	_	_
39	;	;	:	:	_	43	punct	_	_
40	[	[	-LRB-	-LRB-	_	43	punct	_	_
41	15	0	CD	CD	_	43	nummod	_	_
42	,	,	,	,	_	43	punct	_	_
43	63	0	CD	CD	_	25	parataxis	_	_
44	]	]	-RRB-	-RRB-	_	43	punct	_	_
45	)	)	-RRB-	-RRB-	_	43	punct	_	_
46	.	.	.	.	_	25	punct	_	_

1	After	after	IN	IN	sem=TMP	20	prep	_	_
2	1	0	CD	CD	_	3	nummod	_	_
3	mo	mo	NN	NN	_	1	pobj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	dox	dox	NN	NN	_	6	compound	_	_
6	treatment	treatment	NN	NN	_	4	pobj	_	_
7	,	,	,	,	_	20	punct	_	_
8	transgenic	transgenic	JJ	JJ	_	9	amod	_	_
9	protein	protein	NN	NN	_	20	nsubjpass	_	_
10	in	in	IN	IN	_	9	prep	_	_
11	all	all	DT	DT	_	18	det	_	_
12	four	#crd#	CD	CD	_	18	nummod	_	_
13	new	new	JJ	JJ	_	18	amod	_	_
14	tet	tet	NN	NN	_	16	compound	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	off	off	NN	NN	_	18	compound	_	_
17	APP	app	NN	NN	_	18	compound	_	_
18	lines	line	NNS	NNS	_	10	pobj	_	_
19	is	be	VBZ	VBZ	_	20	auxpass	_	_
20	reduced	reduce	VBN	VBN	_	0	root	_	_
21	to	to	IN	IN	_	20	prep	_	_
22	residual	residual	JJ	JJ	_	23	amod	_	_
23	levels	level	NNS	NNS	_	21	pobj	_	_
24	(	(	-LRB-	-LRB-	_	29	punct	_	_
25	+	+	SYM	SYM	_	26	punct	_	_
26	dox	dox	NN	NN	_	29	dep	_	_
27	;	;	:	:	_	29	punct	_	_
28	right	right	JJ	JJ	_	29	amod	_	_
29	lanes	lane	NNS	NNS	_	20	parataxis	_	_
30	of	of	IN	IN	_	29	prep	_	_
31	each	each	DT	DT	_	32	det	_	_
32	panel	panel	NN	NN	_	30	pobj	_	_
33	)	)	-RRB-	-RRB-	_	29	punct	_	_
34	.	.	.	.	_	20	punct	_	_

1	(	(	-LRB-	-LRB-	_	4	punct	_	_
2	474	0	CD	CD	_	3	nummod	_	_
3	KB	kb	NN	NN	_	4	compound	_	_
4	TIF	tif	NN	NN	_	0	root	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	.	.	.	.	_	4	punct	_	_

1	Click	click	VB	VB	_	0	root	_	_
2	here	here	RB	RB	sem=LOC	1	advmod	_	_
3	for	for	IN	IN	_	1	prep	_	_
4	additional	additional	JJ	JJ	_	6	amod	_	_
5	data	datum	NNS	NNS	_	6	compound	_	_
6	file	file	NN	NN	_	3	pobj	_	_
7	.	.	.	.	_	1	punct	_	_

1	Figure	figure	NN	NN	_	2	compound	_	_
2	S2	s0	NN	NN	_	0	root	_	_

1	Transgenic	transgenic	JJ	JJ	_	3	amod	_	_
2	APP	app	NN	NN	_	3	compound	_	_
3	mRNA	mrna	NN	NN	_	4	nsubj	_	_
4	Is	be	VBZ	VBZ	_	0	root	_	_
5	Brain	brain	NN	NN	_	7	npadvmod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	Specific	specific	JJ	JJ	syn=PRD	4	acomp	_	_

1	A	a	DT	DT	_	3	det	_	_
2	slot	slot	NN	NN	_	3	compound	_	_
3	blot	blot	NN	NN	_	26	nsubjpass	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	mRNA	mrna	NN	NN	_	4	pobj	_	_
6	harvested	harvest	VBN	VBN	_	5	acl	_	_
7	from	from	IN	IN	_	6	prep	_	_
8	various	various	JJ	JJ	_	9	amod	_	_
9	tissues	tissue	NNS	NNS	_	7	pobj	_	_
10	in	in	IN	IN	sem=LOC	6	prep	_	_
11	three	#crd#	CD	CD	_	10	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	the	the	DT	DT	_	20	det	_	_
14	four	#crd#	CD	CD	_	20	nummod	_	_
15	new	new	JJ	JJ	_	20	amod	_	_
16	tet	tet	NN	NN	_	18	compound	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	off	off	NN	NN	_	20	compound	_	_
19	APP	app	NN	NN	_	20	compound	_	_
20	lines	line	NNS	NNS	_	12	pobj	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	a	a	DT	DT	_	24	det	_	_
23	nontransgenic	nontransgenic	JJ	JJ	_	24	amod	_	_
24	control	control	NN	NN	_	20	conj	_	_
25	was	be	VBD	VBD	_	26	auxpass	_	_
26	used	use	VBN	VBN	_	0	root	_	_
27	to	to	TO	TO	_	28	aux	_	_
28	examine	examine	VB	VB	sem=PRP	26	advcl	_	_
29	transgenic	transgenic	JJ	JJ	_	31	amod	_	_
30	mRNA	mrna	NN	NN	_	31	compound	_	_
31	expression	expression	NN	NN	_	28	dobj	_	_
32	.	.	.	.	_	26	punct	_	_

1	Hybridization	hybridization	NN	NN	_	3	nsubjpass	_	_
2	is	be	VBZ	VBZ	_	3	auxpass	_	_
3	seen	see	VBN	VBN	_	14	ccomp	_	_
4	only	only	RB	RB	_	5	advmod	_	_
5	in	in	IN	IN	sem=LOC	3	prep	_	_
6	the	the	DT	DT	_	7	det	_	_
7	brain	brain	NN	NN	_	5	pobj	_	_
8	;	;	:	:	_	14	punct	_	_
9	no	no	DT	DT	_	10	det	_	_
10	signal	signal	NN	NN	_	14	nsubjpass	_	_
11	above	above	IN	IN	_	10	prep	_	_
12	background	background	NN	NN	_	11	pobj	_	_
13	is	be	VBZ	VBZ	_	14	auxpass	_	_
14	seen	see	VBN	VBN	_	0	root	_	_
15	in	in	IN	IN	sem=LOC	14	prep	_	_
16	any	any	DT	DT	_	18	det	_	_
17	other	other	JJ	JJ	_	18	amod	_	_
18	tissue	tissue	NN	NN	_	15	pobj	_	_
19	.	.	.	.	_	14	punct	_	_

1	(	(	-LRB-	-LRB-	_	4	punct	_	_
2	781	0	CD	CD	_	3	nummod	_	_
3	KB	kb	NN	NN	_	4	compound	_	_
4	PSD	psd	NN	NN	_	0	root	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	.	.	.	.	_	4	punct	_	_

1	Click	click	VB	VB	_	0	root	_	_
2	here	here	RB	RB	sem=LOC	1	advmod	_	_
3	for	for	IN	IN	_	1	prep	_	_
4	additional	additional	JJ	JJ	_	6	amod	_	_
5	data	datum	NNS	NNS	_	6	compound	_	_
6	file	file	NN	NN	_	3	pobj	_	_
7	.	.	.	.	_	1	punct	_	_

1	Figure	figure	NN	NN	_	2	compound	_	_
2	S3	s0	NN	NN	_	0	root	_	_

1	Amyloid	amyloid	NN	NN	_	2	compound	_	_
2	Pathology	pathology	NN	NN	_	6	nsubj	_	_
3	in	in	IN	IN	_	2	prep	_	_
4	the	the	DT	DT	_	5	det	_	_
5	Cortex	cortex	NN	NN	_	3	pobj	_	_
6	Reiterates	reiterate	VBZ	VBZ	_	0	root	_	_
7	That	that	DT	DT	_	6	dobj	_	_
8	in	in	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	Hippocampus	hippocampus	NN	NN	_	8	pobj	_	_

1	Amyloid	amyloid	NN	NN	_	2	compound	_	_
2	histology	histology	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	performed	performed	VBN	VBN	_	0	root	_	_
5	on	on	IN	IN	_	4	prep	_	_
6	sections	section	NNS	NNS	_	5	pobj	_	_
7	from	from	IN	IN	_	6	prep	_	_
8	line	line	NN	NN	_	12	nmod	_	_
9	107	0	CD	CD	_	12	nummod	_	_
10	double	double	JJ	JJ	_	11	amod	_	_
11	transgenic	transgenic	JJ	JJ	_	12	amod	_	_
12	mice	mouse	NNS	NNS	_	7	pobj	_	_
13	by	by	IN	IN	_	4	agent	_	_
14	Hirano	hirano	NNP	NNP	_	16	compound	_	_
15	silver	silver	NN	NN	_	16	compound	_	_
16	stain	stain	NN	NN	_	13	pobj	_	_
17	(	(	-LRB-	-LRB-	_	19	punct	_	_
18	top	top	JJ	JJ	_	19	amod	_	_
19	row	row	NN	NN	_	16	parataxis	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	,	,	,	,	_	16	punct	_	_
22	thioflavin	thioflavin	NN	NN	_	24	compound	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	S	s	NN	NN	_	16	conj	_	_
25	(	(	-LRB-	-LRB-	_	27	punct	_	_
26	middle	middle	JJ	JJ	_	27	amod	_	_
27	row	row	NN	NN	_	24	parataxis	_	_
28	)	)	-RRB-	-RRB-	_	27	punct	_	_
29	,	,	,	,	_	24	punct	_	_
30	and	and	CC	CC	_	24	cc	_	_
31	Aβ	aβ	NN	NN	_	32	compound	_	_
32	immunohistochemistry	immunohistochemistry	NN	NN	_	24	conj	_	_
33	(	(	-LRB-	-LRB-	_	35	punct	_	_
34	bottom	bottom	JJ	JJ	_	35	amod	_	_
35	row	row	NN	NN	_	32	parataxis	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	to	to	TO	TO	_	38	aux	_	_
38	examine	examine	VB	VB	sem=PRP	4	advcl	_	_
39	the	the	DT	DT	_	40	det	_	_
40	persistence	persistence	NN	NN	_	38	dobj	_	_
41	of	of	IN	IN	_	40	prep	_	_
42	pathology	pathology	NN	NN	_	41	pobj	_	_
43	following	follow	VBG	VBG	sem=TMP	40	prep	_	_
44	transgene	transgene	NN	NN	_	45	compound	_	_
45	suppression	suppression	NN	NN	_	43	pobj	_	_
46	.	.	.	.	_	4	punct	_	_

1	As	as	IN	IN	_	21	prep	_	_
2	in	in	IN	IN	sem=LOC	1	prep	_	_
3	the	the	DT	DT	_	4	det	_	_
4	hippocampus	hippocampus	NN	NN	_	2	pobj	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	see	see	VB	VB	_	4	parataxis	_	_
7	Figure	figure	NN	NN	_	6	dobj	_	_
8	4	0	CD	CD	_	7	nummod	_	_
9	and	and	CC	CC	_	7	cc	_	_
10	text	text	NN	NN	_	7	conj	_	_
11	)	)	-RRB-	-RRB-	_	6	punct	_	_
12	,	,	,	,	_	21	punct	_	_
13	the	the	DT	DT	_	14	det	_	_
14	progression	progression	NN	NN	_	21	nsubj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	amyloid	amyloid	NN	NN	_	17	compound	_	_
17	pathology	pathology	NN	NN	_	15	pobj	_	_
18	in	in	IN	IN	sem=LOC	14	prep	_	_
19	the	the	DT	DT	_	20	det	_	_
20	cortex	cortex	NN	NN	_	18	pobj	_	_
21	worsens	worsen	VBZ	VBZ	_	0	root	_	_
22	substantially	substantially	RB	RB	_	21	advmod	_	_
23	between	between	IN	IN	sem=TMP	21	prep	_	_
24	6	0	CD	CD	_	27	nummod	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	9	0	CD	CD	_	24	conj	_	_
27	mo	mo	NN	NN	_	23	pobj	_	_
28	of	of	IN	IN	_	27	prep	_	_
29	age	age	NN	NN	_	28	pobj	_	_
30	in	in	IN	IN	sem=LOC	21	prep	_	_
31	untreated	untreated	JJ	JJ	_	32	amod	_	_
32	mice	mouse	NNS	NNS	_	30	pobj	_	_
33	.	.	.	.	_	21	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	progression	progression	NN	NN	_	5	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	5	auxpass	_	_
4	completely	completely	RB	RB	_	5	advmod	_	_
5	prevented	prevent	VBN	VBN	_	0	root	_	_
6	by	by	IN	IN	_	5	agent	_	_
7	suppression	suppression	NN	NN	_	6	pobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	transgene	transgene	NN	NN	_	8	pobj	_	_
11	with	with	IN	IN	_	7	prep	_	_
12	dox	dox	NN	NN	_	11	pobj	_	_
13	.	.	.	.	_	5	punct	_	_

1	For	for	IN	IN	_	7	prep	_	_
2	comparison	comparison	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	7	punct	_	_
4	normal	normal	JJ	JJ	_	5	amod	_	_
5	neurohistology	neurohistology	NN	NN	_	7	nsubjpass	_	_
6	is	be	VBZ	VBZ	_	7	auxpass	_	_
7	shown	show	VBN	VBN	_	0	root	_	_
8	in	in	IN	IN	sem=LOC	7	prep	_	_
9	an	an	DT	DT	_	19	det	_	_
10	age	age	NN	NN	_	12	npadvmod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	matched	match	VBN	VBN	_	19	amod	_	_
13	single	single	JJ	JJ	_	14	amod	_	_
14	transgenic	transgenic	JJ	JJ	_	19	amod	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	tTA	tta	NN	NN	_	14	parataxis	_	_
17	only	only	RB	RB	_	16	advmod	_	_
18	)	)	-RRB-	-RRB-	_	16	punct	_	_
19	animal	animal	NN	NN	_	8	pobj	_	_
20	.	.	.	.	_	7	punct	_	_

1	No	no	DT	DT	_	3	det	_	_
2	amyloid	amyloid	NN	NN	_	3	compound	_	_
3	pathology	pathology	NN	NN	_	6	nsubjpass	_	_
4	has	have	VBZ	VBZ	_	6	aux	_	_
5	been	be	VBN	VBN	_	6	auxpass	_	_
6	detected	detect	VBN	VBN	_	0	root	_	_
7	in	in	IN	IN	sem=LOC	6	prep	_	_
8	either	either	CC	CC	_	9	preconj	_	_
9	APP	app	NN	NN	_	14	nmod	_	_
10	or	or	CC	CC	_	9	cc	_	_
11	tTA	tta	NN	NN	_	9	conj	_	_
12	single	single	JJ	JJ	_	13	amod	_	_
13	transgenic	transgenic	JJ	JJ	_	14	amod	_	_
14	animals	animal	NNS	NNS	_	7	pobj	_	_
15	up	up	IN	IN	_	17	quantmod	_	_
16	to	to	IN	IN	_	17	quantmod	_	_
17	15	0	CD	CD	_	18	nummod	_	_
18	mo	mo	NN	NN	sem=TMP	14	npadvmod	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	age	age	NN	NN	_	19	pobj	_	_
21	.	.	.	.	_	6	punct	_	_

1	(	(	-LRB-	-LRB-	_	4	punct	_	_
2	4.8	0	CD	CD	_	3	nummod	_	_
3	MB	mb	NN	NN	_	4	compound	_	_
4	PSD	psd	NN	NN	_	0	root	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	.	.	.	.	_	4	punct	_	_

1	Click	click	VB	VB	_	0	root	_	_
2	here	here	RB	RB	_	1	advmod	_	_
3	for	for	IN	IN	_	1	prep	_	_
4	additional	additional	JJ	JJ	_	6	amod	_	_
5	data	datum	NNS	NNS	_	6	compound	_	_
6	file	file	NN	NN	_	3	pobj	_	_
7	.	.	.	.	_	1	punct	_	_

1	Figure	figure	NN	NN	_	2	compound	_	_
2	S4	s0	NN	NN	_	0	root	_	_

1	Diffuse	diffuse	NN	NN	_	2	compound	_	_
2	Deposits	deposit	NNS	NNS	_	5	nsubj	_	_
3	Do	do	VBP	VBP	_	5	aux	_	_
4	Not	not	RB	RB	_	5	neg	_	_
5	Disperse	disperse	VB	VB	_	0	root	_	_
6	During	during	IN	IN	sem=TMP	5	prep	_	_
7	Aβ	aβ	NN	NN	_	8	compound	_	_
8	Suppression	suppression	NN	NN	_	6	pobj	_	_

1	Campbell	campbell	NNP	NNP	_	3	compound	_	_
2	–	-	HYPH	HYPH	_	3	punct	_	_
3	Switzer	switzer	NNP	NNP	_	5	compound	_	_
4	silver	silver	NN	NN	_	5	compound	_	_
5	stain	stain	NN	NN	_	7	nsubjpass	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	used	use	VBN	VBN	_	0	root	_	_
8	to	to	TO	TO	_	9	aux	_	_
9	differentiate	differentiate	VB	VB	sem=PRP	7	advcl	_	_
10	cored	core	VBN	VBN	_	9	dobj	_	_
11	(	(	-LRB-	-LRB-	_	12	punct	_	_
12	brown	brown	JJ	JJ	_	10	parataxis	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	from	from	IN	IN	_	9	prep	_	_
15	diffuse	diffuse	JJ	JJ	_	19	amod	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	black	black	JJ	JJ	_	15	parataxis	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	deposits	deposit	NNS	NNS	_	14	pobj	_	_
20	in	in	IN	IN	sem=LOC	9	prep	_	_
21	line	line	NN	NN	_	26	nmod	_	_
22	107	0	CD	CD	_	21	nummod	_	_
23	tTA	tta	NN	NN	_	25	compound	_	_
24	/	/	HYPH	HYPH	_	25	punct	_	_
25	APP	app	NN	NN	_	26	compound	_	_
26	mice	mouse	NNS	NNS	_	20	pobj	_	_
27	.	.	.	.	_	7	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	stain	stain	NN	NN	_	3	nsubj	_	_
3	demonstrates	demonstrate	VBZ	VBZ	_	0	root	_	_
4	that	that	IN	IN	_	9	mark	_	_
5	both	both	DT	DT	_	6	det	_	_
6	types	type	NNS	NNS	_	9	nsubj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	deposit	deposit	NN	NN	_	7	pobj	_	_
9	persist	persist	VBP	VBP	_	3	ccomp	_	_
10	throughout	throughout	IN	IN	sem=TMP	9	prep	_	_
11	long	long	JJ	JJ	_	12	amod	_	_
12	periods	period	NNS	NNS	_	10	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	transgene	transgene	NN	NN	_	15	compound	_	_
15	suppression	suppression	NN	NN	_	13	pobj	_	_
16	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	lower	lower	JJ	JJ	_	3	amod	_	_
3	panels	panel	NNS	NNS	_	21	nsubj	_	_
4	,	,	,	,	_	3	punct	_	_
5	showing	show	VBG	VBG	_	3	acl	_	_
6	low	low	JJ	JJ	_	8	amod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	power	power	NN	NN	_	9	compound	_	_
9	images	image	NNS	NNS	_	5	dobj	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	10	0	CD	CD	_	9	parataxis	_	_
12	×	×	SYM	SYM	_	11	punct	_	_
13	)	)	-RRB-	-RRB-	_	11	punct	_	_
14	of	of	IN	IN	_	9	prep	_	_
15	frontal	frontal	JJ	JJ	_	16	amod	_	_
16	cortex	cortex	NN	NN	_	14	pobj	_	_
17	from	from	IN	IN	_	9	prep	_	_
18	each	each	DT	DT	_	19	det	_	_
19	condition	condition	NN	NN	_	17	pobj	_	_
20	,	,	,	,	_	21	punct	_	_
21	reveal	reveal	VBP	VBP	_	0	root	_	_
22	little	little	JJ	JJ	_	23	amod	_	_
23	change	change	NN	NN	_	21	dobj	_	_
24	in	in	IN	IN	_	23	prep	_	_
25	the	the	DT	DT	_	26	det	_	_
26	extent	extent	NN	NN	_	24	pobj	_	_
27	of	of	IN	IN	_	26	prep	_	_
28	diffuse	diffuse	JJ	JJ	_	29	amod	_	_
29	amyloid	amyloid	NN	NN	_	27	pobj	_	_
30	following	follow	VBG	VBG	sem=TMP	21	prep	_	_
31	up	up	IN	IN	_	33	quantmod	_	_
32	to	to	IN	IN	_	33	quantmod	_	_
33	6	0	CD	CD	_	34	nummod	_	_
34	mo	mo	NN	NN	_	30	pobj	_	_
35	of	of	IN	IN	_	34	prep	_	_
36	Aβ	aβ	NN	NN	_	37	compound	_	_
37	suppression	suppression	NN	NN	_	35	pobj	_	_
38	.	.	.	.	_	21	punct	_	_

1	High	high	JJ	JJ	_	3	amod	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	power	power	NN	NN	_	4	compound	_	_
4	images	image	NNS	NNS	_	13	nsubj	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	40	0	CD	CD	_	4	parataxis	_	_
7	×	×	SYM	SYM	_	6	punct	_	_
8	)	)	-RRB-	-RRB-	_	6	punct	_	_
9	in	in	IN	IN	_	4	prep	_	_
10	the	the	DT	DT	_	12	det	_	_
11	upper	upper	JJ	JJ	_	12	amod	_	_
12	panels	panel	NNS	NNS	_	9	pobj	_	_
13	show	show	VBP	VBP	_	0	root	_	_
14	that	that	IN	IN	_	22	mark	_	_
15	the	the	DT	DT	_	17	det	_	_
16	diffuse	diffuse	JJ	JJ	_	17	amod	_	_
17	halo	halo	NN	NN	_	22	nsubj	_	_
18	surrounding	surround	VBG	VBG	_	17	acl	_	_
19	individual	individual	JJ	JJ	_	21	amod	_	_
20	cored	core	VBN	VBN	_	21	amod	_	_
21	deposits	deposit	NNS	NNS	_	18	dobj	_	_
22	remains	remain	VBZ	VBZ	_	13	ccomp	_	_
23	relatively	relatively	RB	RB	_	24	advmod	_	_
24	unchanged	unchanged	JJ	JJ	syn=PRD	22	acomp	_	_
25	in	in	IN	IN	sem=LOC	22	prep	_	_
26	treated	treat	VBN	VBN	_	27	amod	_	_
27	mice	mouse	NNS	NNS	_	25	pobj	_	_
28	.	.	.	.	_	13	punct	_	_

1	Untreated	untreated	JJ	JJ	_	5	amod	_	_
2	tTA	tta	NN	NN	_	5	nmod	_	_
3	single	single	JJ	JJ	_	4	amod	_	_
4	transgenic	transgenic	JJ	JJ	_	5	amod	_	_
5	animals	animal	NNS	NNS	_	7	nsubjpass	_	_
6	are	be	VBP	VBP	_	7	auxpass	_	_
7	shown	show	VBN	VBN	_	0	root	_	_
8	as	as	IN	IN	_	7	prep	_	_
9	a	a	DT	DT	_	11	det	_	_
10	negative	negative	JJ	JJ	_	11	amod	_	_
11	control	control	NN	NN	_	8	pobj	_	_
12	.	.	.	.	_	7	punct	_	_

1	Protocol	protocol	NN	NN	_	12	nsubjpass	_	_
2	for	for	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	9	det	_	_
4	Campbell	campbell	NNP	NNP	_	6	nmod	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	Switzer	switzer	NNP	NNP	_	9	nmod	_	_
7	Alzheimer	alzheimer	NNP	NNP	_	9	poss	_	_
8	's	's	POS	POS	_	7	case	_	_
9	Method	method	NN	NN	_	2	pobj	_	_
10	was	be	VBD	VBD	_	12	auxpass	_	_
11	kindly	kindly	RB	RB	_	12	advmod	_	_
12	shared	share	VBN	VBN	_	0	root	_	_
13	by	by	IN	IN	_	12	agent	_	_
14	Robert	robert	NNP	NNP	_	15	compound	_	_
15	Switzer	switzer	NNP	NNP	_	13	pobj	_	_
16	,	,	,	,	_	15	punct	_	_
17	III	iii	CD	CD	_	15	nummod	_	_
18	(	(	-LRB-	-LRB-	_	20	punct	_	_
19	NeuroScience	neuroscience	NNP	NNP	_	20	compound	_	_
20	Associates	associate	NNPS	NNPS	_	15	parataxis	_	_
21	,	,	,	,	_	20	punct	_	_
22	Knoxville	knoxville	NNP	NNP	sem=LOC	20	npadvmod	_	_
23	,	,	,	,	_	20	punct	_	_
24	Tennessee	tennessee	NNP	NNP	sem=LOC	20	npadvmod	_	_
25	,	,	,	,	_	20	punct	_	_
26	United	united	NNP	NNP	_	27	compound	_	_
27	States	state	NNP	NNP	sem=LOC	20	npadvmod	_	_
28	)	)	-RRB-	-RRB-	_	20	punct	_	_
29	,	,	,	,	_	12	punct	_	_
30	and	and	CC	CC	_	12	cc	_	_
31	can	can	MD	MD	_	33	aux	_	_
32	be	be	VB	VB	_	33	auxpass	_	_
33	downloaded	download	VBN	VBN	_	12	conj	_	_
34	at	at	IN	IN	sem=LOC	33	prep	_	_
35	http://www.nsalabs.com/Documents/publications/campbell-switzer_protocol.htm	#hlink#	NN	NN	_	34	pobj	_	_
36	[	[	-LRB-	-LRB-	_	39	punct	_	_
37	64	0	CD	CD	_	39	nummod	_	_
38	,	,	,	,	_	39	punct	_	_
39	65	0	CD	CD	_	35	parataxis	_	_
40	]	]	-RRB-	-RRB-	_	39	punct	_	_
41	.	.	.	.	_	12	punct	_	_

1	(	(	-LRB-	-LRB-	_	4	punct	_	_
2	923	0	CD	CD	_	3	nummod	_	_
3	KB	kb	NN	NN	_	4	compound	_	_
4	JPG	jpg	NN	NN	_	0	root	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	.	.	.	.	_	4	punct	_	_

1	Click	click	VB	VB	_	0	root	_	_
2	here	here	RB	RB	_	1	advmod	_	_
3	for	for	IN	IN	sem=PRP	1	prep	_	_
4	additional	additional	JJ	JJ	_	6	amod	_	_
5	data	datum	NNS	NNS	_	6	compound	_	_
6	file	file	NN	NN	_	3	pobj	_	_
7	.	.	.	.	_	1	punct	_	_

1	Figure	figure	NN	NN	_	2	compound	_	_
2	S5	s0	NN	NN	_	0	root	_	_

1	Chronic	chronic	JJ	JJ	_	3	amod	_	_
2	Transgene	transgene	NN	NN	_	3	compound	_	_
3	Suppression	suppression	NN	NN	_	0	root	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	Arrest	arrest	NN	NN	_	3	conj	_	_
6	of	of	IN	IN	_	3	prep	_	_
7	Aβ	aβ	NN	NN	_	9	compound	_	_
8	Aggregate	aggregate	NN	NN	_	9	compound	_	_
9	Formation	formation	NN	NN	_	6	pobj	_	_
10	in	in	IN	IN	_	9	prep	_	_
11	an	an	DT	DT	_	13	det	_	_
12	Independent	independent	JJ	JJ	_	13	amod	_	_
13	Line	line	NN	NN	_	10	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	Tet	tet	NN	NN	_	17	compound	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	Off	off	NN	NN	_	19	compound	_	_
18	APP	app	NN	NN	_	19	compound	_	_
19	Mice	mouse	NNS	NNS	_	14	pobj	_	_
20	(	(	-LRB-	-LRB-	_	30	punct	_	_
21	CaMKIIα	camkiiα	NN	NN	_	29	nmod	_	_
22	-	-	HYPH	HYPH	_	29	punct	_	_
23	tTA	tta	NN	NN	_	29	nmod	_	_
24	×	×	SYM	SYM	_	29	punct	_	_
25	tet	tet	NN	NN	_	29	compound	_	_
26	-	-	HYPH	HYPH	_	29	punct	_	_
27	APPswe	appswe	NN	NN	_	29	compound	_	_
28	/	/	HYPH	HYPH	_	29	punct	_	_
29	ind	ind	NN	NN	_	30	compound	_	_
30	Line	line	NN	NN	_	19	parataxis	_	_
31	18	0	CD	CD	_	30	nummod	_	_
32	)	)	-RRB-	-RRB-	_	30	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	18	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	The	the	DT	DT	_	5	det	_	_
5	experiment	experiment	NN	NN	_	18	nsubjpass	_	_
6	presented	present	VBN	VBN	_	5	acl	_	_
7	in	in	IN	IN	_	6	prep	_	_
8	the	the	DT	DT	_	9	det	_	_
9	text	text	NN	NN	_	7	pobj	_	_
10	for	for	IN	IN	_	6	prep	_	_
11	line	line	NN	NN	_	16	nmod	_	_
12	107	0	CD	CD	_	11	nummod	_	_
13	tet	tet	NN	NN	_	15	compound	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	off	off	NN	NN	_	16	compound	_	_
16	APP	app	NN	NN	_	10	pobj	_	_
17	was	be	VBD	VBD	_	18	auxpass	_	_
18	repeated	repeat	VBN	VBN	_	0	root	_	_
19	with	with	IN	IN	_	18	prep	_	_
20	a	a	DT	DT	_	26	det	_	_
21	second	#ord#	JJ	JJ	_	26	amod	_	_
22	tet	tet	NN	NN	_	24	compound	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	off	off	NN	NN	_	26	compound	_	_
25	APP	app	NN	NN	_	26	compound	_	_
26	line	line	NN	NN	_	19	pobj	_	_
27	(	(	-LRB-	-LRB-	_	28	punct	_	_
28	line	line	NN	NN	_	26	parataxis	_	_
29	18	0	CD	CD	_	28	nummod	_	_
30	)	)	-RRB-	-RRB-	_	28	punct	_	_
31	to	to	TO	TO	_	32	aux	_	_
32	control	control	VB	VB	sem=PRP	18	advcl	_	_
33	for	for	IN	IN	_	32	prep	_	_
34	integration	integration	NN	NN	_	35	compound	_	_
35	site	site	NN	NN	_	36	compound	_	_
36	artifacts	artifact	NNS	NNS	_	33	pobj	_	_
37	.	.	.	.	_	18	punct	_	_

1	Cortical	cortical	JJ	JJ	_	2	amod	_	_
2	homogenates	homogenate	NNS	NNS	_	14	nsubjpass	_	_
3	from	from	IN	IN	_	2	prep	_	_
4	untreated	untreated	JJ	JJ	_	5	amod	_	_
5	control	control	NN	NN	_	12	nmod	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	dox	dox	NN	NN	_	9	npadvmod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	treated	treat	VBN	VBN	_	11	amod	_	_
10	double	double	JJ	JJ	_	11	amod	_	_
11	transgenic	transgenic	JJ	JJ	_	5	conj	_	_
12	mice	mouse	NNS	NNS	_	3	pobj	_	_
13	were	be	VBD	VBD	_	14	auxpass	_	_
14	immunoblotted	immunoblotted	VBN	VBN	_	0	root	_	_
15	for	for	IN	IN	sem=PRP	14	prep	_	_
16	full	full	JJ	JJ	_	18	amod	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	length	length	NN	NN	_	19	compound	_	_
19	APP	app	NN	NN	_	15	pobj	_	_
20	with	with	IN	IN	_	14	prep	_	_
21	the	the	DT	DT	_	26	det	_	_
22	human	human	JJ	JJ	_	24	amod	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	specific	specific	JJ	JJ	_	26	amod	_	_
25	antibody	antibody	NN	NN	_	26	compound	_	_
26	6E10	0e0	NN	NN	_	20	pobj	_	_
27	to	to	TO	TO	_	28	aux	_	_
28	confirm	confirm	VB	VB	sem=PRP	14	advcl	_	_
29	transgene	transgene	NN	NN	_	30	compound	_	_
30	suppression	suppression	NN	NN	_	28	dobj	_	_
31	at	at	IN	IN	_	28	prep	_	_
32	the	the	DT	DT	_	33	det	_	_
33	time	time	NN	NN	_	31	pobj	_	_
34	of	of	IN	IN	_	33	prep	_	_
35	harvest	harvest	NN	NN	_	34	pobj	_	_
36	.	.	.	.	_	14	punct	_	_

1	Immunostaining	immunostaining	NN	NN	_	10	nsubjpass	_	_
2	for	for	IN	IN	_	1	prep	_	_
3	endogenous	endogenous	JJ	JJ	_	5	amod	_	_
4	superoxide	superoxide	NN	NN	_	5	compound	_	_
5	dismutase	dismutase	NN	NN	_	2	pobj	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	SOD1	sod0	NN	NN	_	5	parataxis	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	was	be	VBD	VBD	_	10	auxpass	_	_
10	included	include	VBN	VBN	_	0	root	_	_
11	as	as	IN	IN	_	10	prep	_	_
12	a	a	DT	DT	_	14	det	_	_
13	loading	loading	NN	NN	_	14	compound	_	_
14	control	control	NN	NN	_	11	pobj	_	_
15	.	.	.	.	_	10	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	16	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Quantitation	quantitation	NN	NN	_	16	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	signal	signal	NN	NN	_	7	compound	_	_
7	intensity	intensity	NN	NN	_	5	pobj	_	_
8	from	from	IN	IN	_	4	prep	_	_
9	the	the	DT	DT	_	11	det	_	_
10	Western	western	NNP	NNP	_	11	compound	_	_
11	blot	blot	NN	NN	_	8	pobj	_	_
12	in	in	IN	IN	_	4	prep	_	_
13	(	(	-LRB-	-LRB-	_	12	punct	_	_
14	A	a	NN	NN	_	12	pobj	_	_
15	)	)	-RRB-	-RRB-	_	16	punct	_	_
16	shows	show	VBZ	VBZ	_	0	root	_	_
17	transgenic	transgenic	JJ	JJ	_	19	amod	_	_
18	APP	app	NN	NN	_	19	compound	_	_
19	levels	level	NNS	NNS	_	24	nsubjpass	_	_
20	in	in	IN	IN	_	19	prep	_	_
21	line	line	NN	NN	_	20	pobj	_	_
22	18	0	CD	CD	_	21	nummod	_	_
23	are	be	VBP	VBP	_	24	auxpass	_	_
24	suppressed	suppress	VBN	VBN	_	16	advcl	_	_
25	by	by	IN	IN	sem=EXT	24	prep	_	_
26	more	more	JJR	JJR	_	28	amod	_	_
27	than	than	IN	IN	_	28	quantmod	_	_
28	98	0	CD	CD	_	29	nummod	_	_
29	%	%	NN	NN	_	25	pobj	_	_
30	following	follow	VBG	VBG	sem=TMP	24	prep	_	_
31	3	0	CD	CD	_	32	nummod	_	_
32	mo	mo	NN	NN	_	30	pobj	_	_
33	of	of	IN	IN	_	32	prep	_	_
34	dox	dox	NN	NN	_	35	compound	_	_
35	treatment	treatment	NN	NN	_	33	pobj	_	_
36	(	(	-LRB-	-LRB-	_	38	punct	_	_
37	significant	significant	JJ	JJ	_	38	amod	_	_
38	effect	effect	NN	NN	_	24	parataxis	_	_
39	of	of	IN	IN	_	38	prep	_	_
40	group	group	NN	NN	_	41	compound	_	_
41	ANOVA	anova	NN	NN	_	39	pobj	_	_
42	F2	f0	NN	NN	_	46	nsubj	_	_
43	,	,	,	,	_	42	punct	_	_
44	8	0	CD	CD	_	42	nummod	_	_
45	=	=	SYM	SYM	_	46	punct	_	_
46	1559.7	0	CD	CD	_	38	ccomp	_	_
47	,	,	,	,	_	38	punct	_	_
48	p	p	NN	NN	_	50	nsubj	_	_
49	<	<	SYM	SYM	_	50	punct	_	_
50	0.001	0	CD	CD	_	38	ccomp	_	_
51	)	)	-RRB-	-RRB-	_	38	punct	_	_
52	.	.	.	.	_	16	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	level	level	NN	NN	_	5	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	suppression	suppression	NN	NN	_	3	pobj	_	_
5	was	be	VBD	VBD	_	0	root	_	_
6	equal	equal	JJ	JJ	syn=PRD	5	acomp	_	_
7	to	to	IN	IN	_	6	prep	_	_
8	or	or	CC	CC	_	6	cc	_	_
9	better	good	JJR	JJR	_	6	conj	_	_
10	than	than	IN	IN	_	9	prep	_	_
11	that	that	DT	DT	_	9	npadvmod	_	_
12	attained	attain	VBN	VBN	_	11	acl	_	_
13	in	in	IN	IN	_	12	prep	_	_
14	line	line	NN	NN	_	13	pobj	_	_
15	107	0	CD	CD	_	14	nummod	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	see	see	VB	VB	_	5	parataxis	_	_
18	Figure	figure	NN	NN	_	19	compound	_	_
19	3B	0b	NN	NN	_	17	dobj	_	_
20	)	)	-RRB-	-RRB-	_	17	punct	_	_
21	.	.	.	.	_	5	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	10	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Serial	serial	JJ	JJ	_	5	amod	_	_
5	dilution	dilution	NN	NN	_	7	compound	_	_
6	filter	filter	NN	NN	_	7	compound	_	_
7	trap	trap	NN	NN	_	8	compound	_	_
8	assay	assay	NN	NN	_	10	nsubjpass	_	_
9	was	be	VBD	VBD	_	10	auxpass	_	_
10	used	use	VBN	VBN	_	0	root	_	_
11	to	to	TO	TO	_	12	aux	_	_
12	quantify	quantify	VB	VB	sem=PRP	10	advcl	_	_
13	aggregated	aggregate	VBN	VBN	_	14	amod	_	_
14	Aβ	aβ	NN	NN	_	12	dobj	_	_
15	in	in	IN	IN	sem=LOC	12	prep	_	_
16	cortical	cortical	JJ	JJ	_	17	amod	_	_
17	homogenates	homogenate	NNS	NNS	_	15	pobj	_	_
18	.	.	.	.	_	10	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	D	d	LS	LS	_	4	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Quantitation	quantitation	NN	NN	_	0	root	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	signal	signal	NN	NN	_	7	compound	_	_
7	intensity	intensity	NN	NN	_	5	pobj	_	_
8	in	in	IN	IN	_	4	prep	_	_
9	the	the	DT	DT	_	11	det	_	_
10	linear	linear	JJ	JJ	_	11	amod	_	_
11	range	range	NN	NN	_	8	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	the	the	DT	DT	_	15	det	_	_
14	dilution	dilution	NN	NN	_	15	compound	_	_
15	series	series	NN	NN	_	12	pobj	_	_
16	shown	show	VBN	VBN	_	11	acl	_	_
17	in	in	IN	IN	_	16	prep	_	_
18	(	(	-LRB-	-LRB-	_	17	punct	_	_
19	C	c	NN	NN	_	17	pobj	_	_
20	)	)	-RRB-	-RRB-	_	4	punct	_	_
21	.	.	.	.	_	4	punct	_	_

1	Consistent	consistent	JJ	JJ	syn=PRD	13	advcl	_	_
2	with	with	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	5	det	_	_
4	amyloid	amyloid	NN	NN	_	5	compound	_	_
5	histology	histology	NN	NN	_	2	pobj	_	_
6	shown	show	VBN	VBN	_	5	acl	_	_
7	in	in	IN	IN	_	6	prep	_	_
8	Figure	figure	NN	NN	_	9	compound	_	_
9	S5	s0	NN	NN	_	7	pobj	_	_
10	,	,	,	,	_	13	punct	_	_
11	aggregate	aggregate	NN	NN	_	12	compound	_	_
12	formation	formation	NN	NN	_	13	nsubj	_	_
13	was	be	VBD	VBD	_	0	root	_	_
14	significantly	significantly	RB	RB	_	15	advmod	_	_
15	increased	increase	VBN	VBN	syn=PRD	13	acomp	_	_
16	between	between	IN	IN	sem=TMP	13	prep	_	_
17	6	0	CD	CD	_	20	nummod	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	9	0	CD	CD	_	17	conj	_	_
20	mo	mo	NN	NN	_	16	pobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	age	age	NN	NN	_	21	pobj	_	_
23	in	in	IN	IN	sem=LOC	13	prep	_	_
24	untreated	untreated	JJ	JJ	_	25	amod	_	_
25	mice	mouse	NNS	NNS	_	23	pobj	_	_
26	(	(	-LRB-	-LRB-	_	40	punct	_	_
27	significant	significant	JJ	JJ	_	28	amod	_	_
28	effect	effect	NN	NN	_	36	nsubj	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	group	group	NN	NN	_	32	compound	_	_
31	ANOVA	anova	NN	NN	_	32	compound	_	_
32	F2	f0	NN	NN	_	29	pobj	_	_
33	,	,	,	,	_	32	punct	_	_
34	18	0	CD	CD	_	32	nummod	_	_
35	=	=	SYM	SYM	_	36	punct	_	_
36	12.14	0	CD	CD	_	40	ccomp	_	_
37	,	,	,	,	_	40	punct	_	_
38	p	p	NN	NN	_	40	nsubj	_	_
39	<	<	SYM	SYM	_	40	punct	_	_
40	0.001	0	CD	CD	_	13	parataxis	_	_
41	)	)	-RRB-	-RRB-	_	40	punct	_	_
42	.	.	.	.	_	13	punct	_	_

1	Aggregate	aggregate	NN	NN	_	2	compound	_	_
2	formation	formation	NN	NN	_	5	nsubjpass	_	_
3	was	be	VBD	VBD	_	5	auxpass	_	_
4	completely	completely	RB	RB	_	5	advmod	_	_
5	arrested	arrest	VBN	VBN	_	0	root	_	_
6	by	by	IN	IN	_	5	prep	_	_
7	transgene	transgene	NN	NN	_	8	compound	_	_
8	suppression	suppression	NN	NN	_	6	pobj	_	_
9	,	,	,	,	_	5	punct	_	_
10	and	and	CC	CC	_	5	cc	_	_
11	is	be	VBZ	VBZ	_	5	conj	_	_
12	identical	identical	JJ	JJ	syn=PRD	11	acomp	_	_
13	in	in	IN	IN	sem=LOC	11	prep	_	_
14	9	0	CD	CD	_	16	nummod	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	mo	mo	NN	NN	_	18	npadvmod	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	old	old	JJ	JJ	_	19	amod	_	_
19	mice	mouse	NNS	NNS	_	13	pobj	_	_
20	treated	treat	VBN	VBN	_	19	acl	_	_
21	with	with	IN	IN	sem=MNR	20	prep	_	_
22	dox	dox	NN	NN	_	21	pobj	_	_
23	for	for	IN	IN	sem=TMP	20	prep	_	_
24	3	0	CD	CD	_	25	nummod	_	_
25	mo	mo	NN	NN	_	23	pobj	_	_
26	as	as	IN	IN	_	20	prep	_	_
27	in	in	IN	IN	sem=LOC	26	prep	_	_
28	untreated	untreated	JJ	JJ	_	29	amod	_	_
29	animals	animal	NNS	NNS	_	27	pobj	_	_
30	harvested	harvest	VBN	VBN	_	29	acl	_	_
31	when	when	WRB	WRB	_	33	advmod	_	_
32	treatment	treatment	NN	NN	_	33	nsubj	_	_
33	began	begin	VBD	VBD	sem=TMP	30	advcl	_	_
34	(	(	-LRB-	-LRB-	_	43	punct	_	_
35	p	p	NN	NN	_	37	nsubj	_	_
36	>	>	SYM	SYM	_	37	punct	_	_
37	0.5	0	CD	CD	_	43	ccomp	_	_
38	,	,	,	,	_	43	punct	_	_
39	Tukey	tukey	NNP	NNP	_	43	nmod	_	_
40	post	post	FW	FW	_	42	nmod	_	_
41	-	-	HYPH	HYPH	_	42	punct	_	_
42	hoc	hoc	FW	FW	_	43	nmod	_	_
43	test	test	NN	NN	_	33	parataxis	_	_
44	)	)	-RRB-	-RRB-	_	43	punct	_	_
45	.	.	.	.	_	5	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.05	0	CD	CD	_	17	ccomp	_	_
6	;	;	:	:	_	17	punct	_	_
7	**	**	SYM	SYM	_	11	punct	_	_
8	,	,	,	,	_	11	punct	_	_
9	p	p	NN	NN	_	11	nsubj	_	_
10	<	<	SYM	SYM	_	11	punct	_	_
11	0.005	0	CD	CD	_	17	ccomp	_	_
12	;	;	:	:	_	17	punct	_	_
13	***	**	SYM	SYM	_	17	punct	_	_
14	,	,	,	,	_	17	punct	_	_
15	p	p	NN	NN	_	17	nsubj	_	_
16	<	<	SYM	SYM	_	17	punct	_	_
17	0.001	0	CD	CD	_	0	root	_	_
18	versus	versus	CC	CC	_	17	cc	_	_
19	9	0	CD	CD	_	21	nummod	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	mo	mo	NN	NN	_	23	npadvmod	_	_
22	-	-	HYPH	HYPH	_	23	punct	_	_
23	old	old	JJ	JJ	_	25	amod	_	_
24	untreated	untreated	JJ	JJ	_	25	amod	_	_
25	mice	mouse	NNS	NNS	_	17	conj	_	_
26	,	,	,	,	_	17	punct	_	_
27	Tukey	tukey	NNP	NNP	_	31	nmod	_	_
28	post	post	FW	FW	_	30	nmod	_	_
29	-	-	HYPH	HYPH	_	30	punct	_	_
30	hoc	hoc	FW	FW	_	31	nmod	_	_
31	test	test	NN	NN	_	17	dep	_	_
32	.	.	.	.	_	17	punct	_	_

1	(	(	-LRB-	-LRB-	_	4	punct	_	_
2	962	0	CD	CD	_	3	nummod	_	_
3	KB	kb	NN	NN	_	4	compound	_	_
4	TIF	tif	NN	NN	_	0	root	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	.	.	.	.	_	4	punct	_	_

1	Click	click	VB	VB	_	0	root	_	_
2	here	here	RB	RB	_	1	advmod	_	_
3	for	for	IN	IN	_	1	prep	_	_
4	additional	additional	JJ	JJ	_	6	amod	_	_
5	data	datum	NNS	NNS	_	6	compound	_	_
6	file	file	NN	NN	_	3	pobj	_	_
7	.	.	.	.	_	1	punct	_	_

1	Figure	figure	NN	NN	_	2	compound	_	_
2	S6	s0	NN	NN	_	0	root	_	_

1	Arrest	arrest	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	Amyloid	amyloid	NN	NN	_	4	compound	_	_
4	Progression	progression	NN	NN	_	2	pobj	_	_
5	by	by	IN	IN	_	1	prep	_	_
6	Chronic	chronic	JJ	JJ	_	8	amod	_	_
7	Transgene	transgene	NN	NN	_	8	compound	_	_
8	Suppression	suppression	NN	NN	_	5	pobj	_	_
9	in	in	IN	IN	sem=LOC	1	prep	_	_
10	Line	line	NN	NN	_	16	nmod	_	_
11	18	0	CD	CD	_	10	nummod	_	_
12	Tet	tet	NN	NN	_	14	compound	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	Off	off	NN	NN	_	16	compound	_	_
15	APP	app	NN	NN	_	16	compound	_	_
16	Mice	mouse	NNS	NNS	_	9	pobj	_	_

1	Amyloid	amyloid	NN	NN	_	2	compound	_	_
2	histology	histology	NN	NN	_	26	nsubj	_	_
3	in	in	IN	IN	_	2	prep	_	_
4	cortical	cortical	JJ	JJ	_	19	amod	_	_
5	(	(	-LRB-	-LRB-	_	9	punct	_	_
6	first	#ord#	JJ	JJ	_	9	amod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	third	#ord#	JJ	JJ	_	6	conj	_	_
9	rows	row	NNS	NNS	_	4	parataxis	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	and	and	CC	CC	_	4	cc	_	_
12	hippocampal	hippocampal	JJ	JJ	_	4	conj	_	_
13	(	(	-LRB-	-LRB-	_	17	punct	_	_
14	second	#ord#	JJ	JJ	_	17	amod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	fourth	#ord#	JJ	JJ	_	14	conj	_	_
17	rows	row	NNS	NNS	_	12	parataxis	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	sections	section	NNS	NNS	_	3	pobj	_	_
20	from	from	IN	IN	_	19	prep	_	_
21	untreated	untreated	JJ	JJ	_	25	amod	_	_
22	tTA	tta	NN	NN	_	24	compound	_	_
23	/	/	HYPH	HYPH	_	24	punct	_	_
24	APP	app	NN	NN	_	25	compound	_	_
25	mice	mouse	NNS	NNS	_	20	pobj	_	_
26	shows	show	VBZ	VBZ	_	0	root	_	_
27	a	a	DT	DT	_	29	det	_	_
28	dramatic	dramatic	JJ	JJ	_	29	amod	_	_
29	progression	progression	NN	NN	_	26	dobj	_	_
30	of	of	IN	IN	_	29	prep	_	_
31	pathology	pathology	NN	NN	_	30	pobj	_	_
32	between	between	IN	IN	sem=TMP	26	prep	_	_
33	6	0	CD	CD	_	36	nummod	_	_
34	and	and	CC	CC	_	33	cc	_	_
35	9	0	CD	CD	_	33	conj	_	_
36	mo	mo	NN	NN	_	32	pobj	_	_
37	of	of	IN	IN	_	36	prep	_	_
38	age	age	NN	NN	_	37	pobj	_	_
39	.	.	.	.	_	26	punct	_	_

1	Suppression	suppression	NN	NN	_	6	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	transgenic	transgenic	JJ	JJ	_	5	amod	_	_
4	APP	app	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	2	pobj	_	_
6	arrests	arrest	VBZ	VBZ	_	0	root	_	_
7	this	this	DT	DT	_	8	det	_	_
8	progression	progression	NN	NN	_	6	dobj	_	_
9	,	,	,	,	_	6	punct	_	_
10	although	although	IN	IN	_	11	mark	_	_
11	without	without	IN	IN	syn=ADV	6	advcl	_	_
12	any	any	DT	DT	_	13	det	_	_
13	sign	sign	NN	NN	_	11	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	plaque	plaque	NN	NN	_	16	compound	_	_
16	clearance	clearance	NN	NN	_	14	pobj	_	_
17	(	(	-LRB-	-LRB-	_	23	punct	_	_
18	6	0	CD	CD	_	19	nummod	_	_
19	mo	mo	NN	NN	_	23	nmod	_	_
20	+	+	SYM	SYM	_	19	punct	_	_
21	3	0	CD	CD	_	22	nummod	_	_
22	mo	mo	NN	NN	_	19	appos	_	_
23	dox	dox	NN	NN	_	6	parataxis	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	.	.	.	.	_	6	punct	_	_

1	Hirano	hirano	NNP	NNP	_	3	compound	_	_
2	silver	silver	NN	NN	_	3	compound	_	_
3	stain	stain	NN	NN	_	0	root	_	_
4	(	(	-LRB-	-LRB-	_	6	punct	_	_
5	top	top	JJ	JJ	_	6	amod	_	_
6	panels	panel	NNS	NNS	_	3	parataxis	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	;	;	:	:	_	3	punct	_	_
9	thioflavin	thioflavin	NN	NN	_	11	compound	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	S	s	NN	NN	_	3	appos	_	_
12	(	(	-LRB-	-LRB-	_	14	punct	_	_
13	bottom	bottom	JJ	JJ	_	14	amod	_	_
14	panels	panel	NNS	NNS	_	11	parataxis	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	.	.	.	.	_	3	punct	_	_

1	(	(	-LRB-	-LRB-	_	4	punct	_	_
2	5.8	0	CD	CD	_	3	nummod	_	_
3	MB	mb	NN	NN	_	4	compound	_	_
4	PSD	psd	NN	NN	_	0	root	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	.	.	.	.	_	4	punct	_	_

1	Click	click	VB	VB	_	0	root	_	_
2	here	here	RB	RB	sem=LOC	1	advmod	_	_
3	for	for	IN	IN	_	1	prep	_	_
4	additional	additional	JJ	JJ	_	6	amod	_	_
5	data	datum	NNS	NNS	_	6	compound	_	_
6	file	file	NN	NN	_	3	pobj	_	_
7	.	.	.	.	_	1	punct	_	_

1	Patient	patient	NN	NN	_	2	compound	_	_
2	Summary	summary	NN	NN	_	0	root	_	_

1	Background	background	NN	NN	_	0	root	_	_

1	Patients	patient	NNS	NNS	_	9	nsubj	_	_
2	with	with	IN	IN	_	1	prep	_	_
3	Alzheimer	alzheimer	NNP	NNP	_	4	compound	_	_
4	disease	disease	NN	NN	_	2	pobj	_	_
5	(	(	-LRB-	-LRB-	_	4	punct	_	_
6	AD	ad	NN	NN	_	4	appos	_	_
7	)	)	-RRB-	-RRB-	_	9	punct	_	_
8	have	have	VBP	VBP	_	9	aux	_	_
9	elevated	elevate	VBN	VBN	_	0	root	_	_
10	levels	level	NNS	NNS	_	9	dobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	a	a	DT	DT	_	14	det	_	_
13	small	small	JJ	JJ	_	14	amod	_	_
14	protein	protein	NN	NN	_	11	pobj	_	_
15	called	call	VBN	VBN	_	14	acl	_	_
16	amyloid	amyloid	NN	NN	_	18	compound	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	β	β	NN	NN	_	19	compound	_	_
19	peptide	peptide	NN	NN	syn=PRD	15	oprd	_	_
20	that	that	WDT	WDT	_	21	dep	_	14:ref
21	sticks	stick	VBZ	VBZ	_	14	relcl	_	_
22	together	together	RB	RB	_	21	advmod	_	_
23	to	to	TO	TO	_	24	aux	_	_
24	form	form	VB	VB	sem=PRP	21	advcl	_	_
25	what	what	WP	WP	_	27	dep	_	_
26	are	be	VBP	VBP	_	27	auxpass	_	_
27	known	know	VBN	VBN	syn=NOM	24	ccomp	_	_
28	as	as	IN	IN	_	27	prep	_	_
29	amyloid	amyloid	NN	NN	_	30	compound	_	_
30	plaques	plaque	NNS	NNS	_	28	pobj	_	_
31	in	in	IN	IN	sem=LOC	27	prep	_	_
32	their	their	PRP$	PRP$	_	33	poss	_	_
33	brains	brain	NNS	NNS	_	31	pobj	_	_
34	.	.	.	.	_	9	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	peptide	peptide	NN	NN	_	5	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	5	auxpass	_	_
4	normally	normally	RB	RB	_	5	advmod	_	_
5	made	make	VBN	VBN	_	0	root	_	_
6	at	at	IN	IN	_	5	prep	_	_
7	low	low	JJ	JJ	_	8	amod	_	_
8	levels	level	NNS	NNS	_	6	pobj	_	_
9	in	in	IN	IN	sem=LOC	5	prep	_	_
10	healthy	healthy	JJ	JJ	_	11	amod	_	_
11	individuals	individual	NNS	NNS	_	9	pobj	_	_
12	,	,	,	,	_	5	punct	_	_
13	and	and	CC	CC	_	5	cc	_	_
14	is	be	VBZ	VBZ	_	15	auxpass	_	_
15	made	make	VBN	VBN	_	5	conj	_	_
16	when	when	WRB	WRB	_	28	advmod	_	_
17	a	a	DT	DT	_	19	det	_	_
18	larger	large	JJR	JJR	_	19	amod	_	_
19	protein	protein	NN	NN	_	28	nsubjpass	_	_
20	called	call	VBN	VBN	_	19	acl	_	_
21	amyloid	amyloid	NN	NN	_	23	compound	_	_
22	precursor	precursor	NN	NN	_	23	compound	_	_
23	protein	protein	NN	NN	syn=PRD	20	oprd	_	_
24	(	(	-LRB-	-LRB-	_	23	punct	_	_
25	APP	app	NN	NN	_	23	appos	_	_
26	)	)	-RRB-	-RRB-	_	28	punct	_	_
27	is	be	VBZ	VBZ	_	28	auxpass	_	_
28	cut	cut	VBN	VBN	sem=TMP	15	advcl	_	_
29	down	down	RP	RP	_	28	prt	_	_
30	in	in	IN	IN	_	28	prep	_	_
31	size	size	NN	NN	_	30	pobj	_	_
32	.	.	.	.	_	5	punct	_	_

1	New	new	JJ	JJ	_	2	amod	_	_
2	treatments	treatment	NNS	NNS	_	6	nsubjpass	_	_
3	are	be	VBP	VBP	_	6	aux	_	_
4	now	now	RB	RB	sem=TMP	6	advmod	_	_
5	being	be	VBG	VBG	_	6	auxpass	_	_
6	developed	develop	VBN	VBN	_	0	root	_	_
7	that	that	WDT	WDT	_	9	dep	_	_
8	will	will	MD	MD	_	9	aux	_	_
9	decrease	decrease	VB	VB	_	6	ccomp	_	_
10	the	the	DT	DT	_	11	det	_	_
11	amount	amount	NN	NN	_	9	dobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	Aβ	aβ	NN	NN	_	12	pobj	_	_
14	produced	produce	VBN	VBN	_	11	acl	_	_
15	from	from	IN	IN	_	14	prep	_	_
16	APP	app	NN	NN	_	15	pobj	_	_
17	.	.	.	.	_	6	punct	_	_

1	However	however	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	it	it	PRP	PRP	_	4	nsubj	_	_
4	is	be	VBZ	VBZ	_	0	root	_	_
5	not	not	RB	RB	_	4	neg	_	_
6	clear	clear	JJ	JJ	syn=PRD	4	acomp	_	_
7	whether	whether	IN	IN	_	14	mark	_	_
8	lowering	lower	VBG	VBG	syn=NOM	14	csubj	_	_
9	the	the	DT	DT	_	10	det	_	_
10	production	production	NN	NN	_	8	dobj	_	_
11	of	of	IN	IN	_	8	prep	_	_
12	Aβ	aβ	NN	NN	_	11	pobj	_	_
13	will	will	MD	MD	_	14	aux	_	_
14	allow	allow	VB	VB	_	4	ccomp	_	_
15	the	the	DT	DT	_	16	det	_	_
16	brain	brain	NN	NN	_	18	nsubj	_	_
17	to	to	TO	TO	_	18	aux	_	_
18	heal	heal	VB	VB	_	14	ccomp	_	_
19	itself	itself	PRP	PRP	_	18	dobj	_	_
20	by	by	IN	IN	sem=MNR	18	prep	_	_
21	clearing	clear	VBG	VBG	syn=NOM	20	pcomp	_	_
22	the	the	DT	DT	_	24	det	_	_
23	amyloid	amyloid	NN	NN	_	24	compound	_	_
24	plaques	plaque	NNS	NNS	_	21	dobj	_	_
25	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	answer	answer	NN	NN	_	7	nsubj	_	_
3	to	to	IN	IN	_	2	prep	_	_
4	this	this	DT	DT	_	5	det	_	_
5	question	question	NN	NN	_	3	pobj	_	_
6	may	may	MD	MD	_	7	aux	_	_
7	be	be	VB	VB	_	0	root	_	_
8	important	important	JJ	JJ	syn=PRD	7	acomp	_	_
9	for	for	IN	IN	_	8	prep	_	_
10	deciding	decide	VBG	VBG	syn=NOM	9	pcomp	_	_
11	when	when	WRB	WRB	_	18	advmod	_	_
12	Aβ	aβ	NN	NN	_	14	npadvmod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	lowering	lower	VBG	VBG	_	15	amod	_	_
15	drugs	drug	NNS	NNS	_	18	nsubjpass	_	_
16	should	should	MD	MD	_	18	aux	_	_
17	be	be	VB	VB	_	18	auxpass	_	_
18	started	start	VBN	VBN	sem=TMP	10	advcl	_	_
19	,	,	,	,	_	10	punct	_	_
20	and	and	CC	CC	_	10	cc	_	_
21	may	may	MD	MD	_	23	aux	_	_
22	also	also	RB	RB	_	23	advmod	_	_
23	determine	determine	VB	VB	_	10	conj	_	_
24	how	how	WRB	WRB	_	25	advmod	_	_
25	effective	effective	JJ	JJ	_	27	amod	_	_
26	they	they	PRP	PRP	_	27	nsubj	_	_
27	are	be	VBP	VBP	_	23	ccomp	_	_
28	in	in	IN	IN	_	27	prep	_	_
29	reversing	reverse	VBG	VBG	syn=NOM	28	pcomp	_	_
30	the	the	DT	DT	_	32	det	_	_
31	mental	mental	JJ	JJ	_	32	amod	_	_
32	symptoms	symptom	NNS	NNS	_	29	dobj	_	_
33	of	of	IN	IN	_	32	prep	_	_
34	AD	ad	NN	NN	_	33	pobj	_	_
35	.	.	.	.	_	7	punct	_	_

1	What	what	WP	WP	_	5	dep	_	_
2	Did	do	VBD	VBD	_	5	aux	_	_
3	the	the	DT	DT	_	4	det	_	_
4	Researchers	researcher	NNS	NNS	_	5	nsubj	_	_
5	Do	do	VB	VB	_	0	root	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	Find	find	VB	VB	_	5	conj	_	_
8	?	?	.	.	_	5	punct	_	_

1	Because	because	IN	IN	_	9	mark	_	_
2	new	new	JJ	JJ	_	3	amod	_	_
3	drugs	drug	NNS	NNS	_	9	nsubj	_	_
4	designed	design	VBN	VBN	_	3	acl	_	_
5	to	to	TO	TO	_	6	aux	_	_
6	lower	lower	VB	VB	sem=PRP	4	advcl	_	_
7	Aβ	aβ	NN	NN	_	8	compound	_	_
8	levels	level	NNS	NNS	_	6	dobj	_	_
9	are	be	VBP	VBP	sem=PRP	15	advcl	_	_
10	still	still	RB	RB	_	9	advmod	_	_
11	in	in	IN	IN	syn=PRD|sem=LOC	9	prep	_	_
12	development	development	NN	NN	_	11	pobj	_	_
13	,	,	,	,	_	15	punct	_	_
14	they	they	PRP	PRP	_	15	nsubj	_	_
15	are	be	VBP	VBP	_	0	root	_	_
16	not	not	RB	RB	_	15	neg	_	_
17	available	available	JJ	JJ	syn=PRD	15	acomp	_	_
18	for	for	IN	IN	_	17	prep	_	_
19	testing	testing	NN	NN	_	18	pobj	_	_
20	in	in	IN	IN	sem=LOC	15	prep	_	_
21	animal	animal	NN	NN	_	22	compound	_	_
22	models	model	NNS	NNS	_	20	pobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	the	the	DT	DT	_	25	det	_	_
25	disease	disease	NN	NN	_	23	pobj	_	_
26	.	.	.	.	_	15	punct	_	_

1	Instead	instead	RB	RB	_	15	advmod	_	_
2	,	,	,	,	_	15	punct	_	_
3	basic	basic	JJ	JJ	_	4	amod	_	_
4	questions	question	NNS	NNS	_	15	nsubjpass	_	_
5	about	about	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	7	det	_	_
7	effectiveness	effectiveness	NN	NN	_	5	pobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	this	this	DT	DT	_	10	det	_	_
10	type	type	NN	NN	_	8	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	treatment	treatment	NN	NN	_	11	pobj	_	_
13	must	must	MD	MD	_	15	aux	_	_
14	be	be	VB	VB	_	15	auxpass	_	_
15	answered	answer	VBN	VBN	_	0	root	_	_
16	using	use	VBG	VBG	sem=MNR	15	advcl	_	_
17	systems	system	NNS	NNS	_	16	dobj	_	_
18	that	that	WDT	WDT	_	19	dep	_	17:ref
19	mimic	mimic	VBP	VBP	_	17	relcl	_	_
20	how	how	WRB	WRB	_	23	advmod	_	_
21	the	the	DT	DT	_	22	det	_	_
22	drugs	drug	NNS	NNS	_	23	nsubj	_	_
23	work	work	VBP	VBP	syn=NOM	19	ccomp	_	_
24	.	.	.	.	_	15	punct	_	_

1	To	to	TO	TO	_	2	aux	_	_
2	do	do	VB	VB	sem=PRP	7	advcl	_	_
3	this	this	DT	DT	_	2	dobj	_	_
4	,	,	,	,	_	7	punct	_	_
5	the	the	DT	DT	_	6	det	_	_
6	authors	author	NNS	NNS	_	7	nsubj	_	_
7	created	create	VBD	VBD	_	0	root	_	_
8	mice	mouse	NNS	NNS	_	7	dobj	_	_
9	that	that	WDT	WDT	_	10	dep	_	8:ref
10	produce	produce	VBP	VBP	_	8	advcl	_	_
11	too	too	RB	RB	_	12	advmod	_	_
12	much	much	JJ	JJ	_	13	amod	_	_
13	APP	app	NN	NN	_	10	dobj	_	_
14	and	and	CC	CC	_	10	cc	_	_
15	that	that	WDT	WDT	_	16	dep	_	8:ref
16	develop	develop	VBP	VBP	_	10	conj	_	_
17	the	the	DT	DT	_	20	det	_	_
18	same	same	JJ	JJ	_	20	amod	_	_
19	amyloid	amyloid	NN	NN	_	20	compound	_	_
20	lesions	lesion	NNS	NNS	_	16	dobj	_	_
21	as	as	IN	IN	_	22	mark	_	_
22	do	do	VBP	VBP	_	20	advcl	_	_
23	human	human	JJ	JJ	_	24	amod	_	_
24	patients	patient	NNS	NNS	_	22	nsubj	_	_
25	with	with	IN	IN	_	24	prep	_	_
26	AD	ad	NN	NN	_	25	pobj	_	_
27	.	.	.	.	_	7	punct	_	_

1	Unlike	unlike	IN	IN	_	8	prep	_	_
2	normal	normal	JJ	JJ	_	3	amod	_	_
3	mice	mouse	NNS	NNS	_	1	pobj	_	_
4	,	,	,	,	_	8	punct	_	_
5	these	these	DT	DT	_	6	det	_	_
6	mice	mouse	NNS	NNS	_	8	nsubj	_	_
7	also	also	RB	RB	_	8	advmod	_	_
8	carried	carry	VBD	VBD	_	0	root	_	_
9	a	a	DT	DT	_	13	det	_	_
10	“	"	``	``	_	13	punct	_	_
11	switch	switch	NN	NN	_	13	nmod	_	_
12	”	"	''	''	_	13	punct	_	_
13	gene	gene	NN	NN	_	8	dobj	_	_
14	that	that	WDT	WDT	_	15	dep	_	13:ref
15	allowed	allow	VBD	VBD	_	13	relcl	_	_
16	the	the	DT	DT	_	17	det	_	_
17	researchers	researcher	NNS	NNS	_	19	nsubj	_	_
18	to	to	TO	TO	_	19	aux	_	_
19	turn	turn	VB	VB	_	15	ccomp	_	_
20	off	off	RP	RP	_	19	prt	_	_
21	APP	app	NN	NN	_	19	dobj	_	_
22	by	by	IN	IN	sem=MNR	19	prep	_	_
23	feeding	feed	VBG	VBG	syn=NOM	22	pcomp	_	_
24	the	the	DT	DT	_	25	det	_	_
25	mice	mouse	NNS	NNS	_	23	dative	_	_
26	special	special	JJ	JJ	_	27	amod	_	_
27	food	food	NN	NN	_	23	dobj	_	_
28	.	.	.	.	_	8	punct	_	_

1	Turning	turn	VBG	VBG	syn=NOM	7	csubj	_	_
2	off	off	RP	RP	_	1	prt	_	_
3	APP	app	NN	NN	_	1	dobj	_	_
4	in	in	IN	IN	sem=LOC	1	prep	_	_
5	these	these	DT	DT	_	6	det	_	_
6	mice	mouse	NNS	NNS	_	4	pobj	_	_
7	had	have	VBD	VBD	_	0	root	_	_
8	the	the	DT	DT	_	10	det	_	_
9	same	same	JJ	JJ	_	10	amod	_	_
10	effect	effect	NN	NN	_	7	dobj	_	_
11	as	as	IN	IN	_	10	prep	_	_
12	treating	treat	VBG	VBG	syn=NOM	11	pcomp	_	_
13	them	them	PRP	PRP	_	12	dobj	_	_
14	with	with	IN	IN	sem=MNR	12	prep	_	_
15	Aβ	aβ	NN	NN	_	17	npadvmod	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	lowering	lower	VBG	VBG	_	18	amod	_	_
18	drugs	drug	NNS	NNS	_	14	pobj	_	_
19	,	,	,	,	_	7	punct	_	_
20	and	and	CC	CC	_	7	cc	_	_
21	so	so	IN	IN	_	20	dep	_	_
22	the	the	DT	DT	_	23	det	_	_
23	researchers	researcher	NNS	NNS	_	24	nsubj	_	_
24	were	be	VBD	VBD	_	7	conj	_	_
25	able	able	JJ	JJ	syn=PRD	24	acomp	_	_
26	to	to	TO	TO	_	27	aux	_	_
27	ask	ask	VB	VB	_	25	xcomp	_	_
28	what	what	WP	WP	_	29	dep	_	_
29	happened	happened	VBD	VBD	_	27	ccomp	_	_
30	to	to	IN	IN	_	29	prep	_	_
31	the	the	DT	DT	_	33	det	_	_
32	amyloid	amyloid	NN	NN	_	33	compound	_	_
33	plaques	plaque	NNS	NNS	_	30	pobj	_	_
34	after	after	IN	IN	_	38	mark	_	_
35	Aβ	aβ	NN	NN	_	36	compound	_	_
36	production	production	NN	NN	_	38	nsubjpass	_	_
37	was	be	VBD	VBD	_	38	auxpass	_	_
38	shut	shut	VBN	VBN	sem=TMP	29	advcl	_	_
39	down	down	RP	RP	_	38	prt	_	_
40	.	.	.	.	_	24	punct	_	_

1	They	they	PRP	PRP	_	2	nsubj	_	_
2	showed	show	VBD	VBD	_	0	root	_	_
3	that	that	IN	IN	_	7	mark	_	_
4	lowering	lower	VBG	VBG	syn=NOM	7	csubj	_	_
5	Aβ	aβ	NN	NN	_	6	compound	_	_
6	production	production	NN	NN	_	4	dobj	_	_
7	prevents	prevent	VBZ	VBZ	_	2	ccomp	_	_
8	the	the	DT	DT	_	10	det	_	_
9	amyloid	amyloid	NN	NN	_	10	compound	_	_
10	lesions	lesion	NNS	NNS	_	7	dobj	_	_
11	from	from	IN	IN	_	7	prep	_	_
12	getting	get	VBG	VBG	syn=NOM	11	pcomp	_	_
13	worse	bad	JJR	JJR	syn=PRD	12	oprd	_	_
14	as	as	IN	IN	_	17	mark	_	_
15	the	the	DT	DT	_	16	det	_	_
16	disease	disease	NN	NN	_	17	nsubj	_	_
17	progresses	progress	VBZ	VBZ	sem=TMP	12	advcl	_	_
18	.	.	.	.	_	2	punct	_	_

1	This	this	DT	DT	_	2	nsubj	_	_
2	means	mean	VBZ	VBZ	_	0	root	_	_
3	that	that	IN	IN	_	11	mark	_	_
4	treatment	treatment	NN	NN	_	11	nsubj	_	_
5	with	with	IN	IN	_	4	prep	_	_
6	Aβ	aβ	NN	NN	_	8	npadvmod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	lowering	lower	VBG	VBG	_	9	amod	_	_
9	drugs	drug	NNS	NNS	_	5	pobj	_	_
10	may	may	MD	MD	_	11	aux	_	_
11	be	be	VB	VB	_	2	ccomp	_	_
12	able	able	JJ	JJ	syn=PRD	11	acomp	_	_
13	to	to	TO	TO	_	14	aux	_	_
14	stop	stop	VB	VB	_	12	xcomp	_	_
15	the	the	DT	DT	_	16	det	_	_
16	disease	disease	NN	NN	_	14	dobj	_	_
17	from	from	IN	IN	_	14	prep	_	_
18	filling	fill	VBG	VBG	syn=NOM	17	pcomp	_	_
19	the	the	DT	DT	_	20	det	_	_
20	brain	brain	NN	NN	_	18	dobj	_	_
21	with	with	IN	IN	sem=MNR	18	prep	_	_
22	plaques	plaque	NNS	NNS	_	21	pobj	_	_
23	.	.	.	.	_	2	punct	_	_

1	However	however	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	researchers	researcher	NNS	NNS	_	6	nsubj	_	_
5	also	also	RB	RB	_	6	advmod	_	_
6	found	find	VBD	VBD	_	0	root	_	_
7	that	that	IN	IN	_	18	mark	_	_
8	the	the	DT	DT	_	10	det	_	_
9	amyloid	amyloid	NN	NN	_	10	compound	_	_
10	lesions	lesion	NNS	NNS	_	18	nsubj	_	_
11	that	that	WDT	WDT	_	13	dep	_	10:ref
12	had	have	VBD	VBD	_	13	aux	_	_
13	formed	form	VBN	VBN	_	10	relcl	_	_
14	before	before	IN	IN	_	17	mark	_	_
15	treatment	treatment	NN	NN	_	17	nsubjpass	_	_
16	was	be	VBD	VBD	_	17	auxpass	_	_
17	started	start	VBN	VBN	sem=TMP	13	advcl	_	_
18	remained	remain	VBD	VBD	_	6	ccomp	_	_
19	intact	intact	JJ	JJ	syn=PRD	18	acomp	_	_
20	throughout	throughout	IN	IN	sem=TMP	18	prep	_	_
21	the	the	DT	DT	_	22	det	_	_
22	experiment	experiment	NN	NN	_	20	pobj	_	_
23	.	.	.	.	_	6	punct	_	_

1	What	what	WP	WP	_	5	dep	_	_
2	Do	do	VBP	VBP	_	5	aux	_	_
3	These	these	DT	DT	_	4	det	_	_
4	Findings	finding	NNS	NNS	_	5	nsubj	_	_
5	Mean	mean	VB	VB	_	0	root	_	_
6	?	?	.	.	_	5	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	14	mark	_	_
5	treatments	treatment	NNS	NNS	_	14	nsubj	_	_
6	designed	design	VBN	VBN	_	5	acl	_	_
7	to	to	TO	TO	_	8	aux	_	_
8	lower	lower	VB	VB	sem=PRP	6	advcl	_	_
9	the	the	DT	DT	_	10	det	_	_
10	production	production	NN	NN	_	8	dobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	Aβ	aβ	NN	NN	_	11	pobj	_	_
13	may	may	MD	MD	_	14	aux	_	_
14	be	be	VB	VB	_	3	ccomp	_	_
15	an	an	DT	DT	_	17	det	_	_
16	important	important	JJ	JJ	_	17	amod	_	_
17	part	part	NN	NN	syn=PRD	14	attr	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	future	future	JJ	JJ	_	21	amod	_	_
20	AD	ad	NN	NN	_	21	compound	_	_
21	treatment	treatment	NN	NN	_	18	pobj	_	_
22	,	,	,	,	_	14	punct	_	_
23	as	as	IN	IN	_	26	mark	_	_
24	this	this	DT	DT	_	25	det	_	_
25	approach	approach	NN	NN	_	26	nsubj	_	_
26	seems	seem	VBZ	VBZ	syn=ADV	14	advcl	_	_
27	to	to	TO	TO	_	28	aux	_	_
28	prevents	prevents	VB	VB	_	26	xcomp	_	_
29	additional	additional	JJ	JJ	_	31	amod	_	_
30	amyloid	amyloid	NN	NN	_	31	compound	_	_
31	plaques	plaque	NNS	NNS	_	28	dobj	_	_
32	from	from	IN	IN	_	28	prep	_	_
33	forming	form	VBG	VBG	syn=NOM	32	pcomp	_	_
34	in	in	IN	IN	sem=LOC	33	prep	_	_
35	the	the	DT	DT	_	37	det	_	_
36	mouse	mouse	NN	NN	_	37	compound	_	_
37	brain	brain	NN	NN	_	34	pobj	_	_
38	.	.	.	.	_	3	punct	_	_

1	However	however	RB	RB	_	10	advmod	_	_
2	,	,	,	,	_	10	punct	_	_
3	by	by	IN	IN	_	10	prep	_	_
4	itself	itself	PRP	PRP	_	3	pobj	_	_
5	,	,	,	,	_	10	punct	_	_
6	this	this	DT	DT	_	7	det	_	_
7	strategy	strategy	NN	NN	_	10	nsubj	_	_
8	may	may	MD	MD	_	10	aux	_	_
9	not	not	RB	RB	_	10	neg	_	_
10	be	be	VB	VB	_	0	root	_	_
11	able	able	JJ	JJ	syn=PRD	10	acomp	_	_
12	to	to	TO	TO	_	13	aux	_	_
13	rid	rid	VB	VB	_	11	xcomp	_	_
14	the	the	DT	DT	_	15	det	_	_
15	brain	brain	NN	NN	_	13	dobj	_	_
16	of	of	IN	IN	_	13	prep	_	_
17	plaques	plaque	NNS	NNS	_	16	pobj	_	_
18	that	that	WDT	WDT	_	21	dep	_	17:ref
19	have	have	VBP	VBP	_	21	aux	_	_
20	already	already	RB	RB	_	21	advmod	_	_
21	formed	form	VBN	VBN	_	17	relcl	_	_
22	in	in	IN	IN	sem=LOC	21	prep	_	_
23	the	the	DT	DT	_	24	det	_	_
24	brain	brain	NN	NN	_	22	pobj	_	_
25	before	before	IN	IN	_	28	mark	_	_
26	treatment	treatment	NN	NN	_	28	nsubjpass	_	_
27	is	be	VBZ	VBZ	_	28	auxpass	_	_
28	started	start	VBN	VBN	sem=TMP	21	advcl	_	_
29	.	.	.	.	_	10	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	findings	finding	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	8	mark	_	_
5	early	early	JJ	JJ	_	6	amod	_	_
6	treatment	treatment	NN	NN	_	8	nsubj	_	_
7	may	may	MD	MD	_	8	aux	_	_
8	be	be	VB	VB	_	3	ccomp	_	_
9	important	important	JJ	JJ	syn=PRD	8	acomp	_	_
10	for	for	IN	IN	_	14	mark	_	_
11	this	this	DT	DT	_	12	det	_	_
12	approach	approach	NN	NN	_	14	nsubj	_	_
13	to	to	TO	TO	_	14	aux	_	_
14	succeed	succeed	VB	VB	sem=PRP	8	advcl	_	_
15	.	.	.	.	_	3	punct	_	_

1	Where	where	WRB	WRB	_	4	advmod	_	_
2	Can	can	MD	MD	_	4	aux	_	_
3	I	I	PRP	PRP	_	4	nsubj	_	_
4	Get	get	VB	VB	_	0	root	_	_
5	More	more	JJR	JJR	_	6	amod	_	_
6	Information	information	NN	NN	_	4	dobj	_	_
7	Online	online	RB	RB	_	4	advmod	_	_
8	?	?	.	.	_	4	punct	_	_

1	MedlinePlus	medlineplus	NNP	NNP	_	2	nsubj	_	_
2	has	have	VBZ	VBZ	_	0	root	_	_
3	several	several	JJ	JJ	_	5	amod	_	_
4	Web	web	NN	NN	_	5	compound	_	_
5	pages	page	NNS	NNS	_	2	dobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	information	information	NN	NN	_	6	pobj	_	_
8	on	on	IN	IN	_	7	prep	_	_
9	Alzheimer	alzheimer	NNP	NNP	_	10	compound	_	_
10	disease	disease	NN	NN	_	8	pobj	_	_
11	:	:	:	:	_	5	punct	_	_
12	http://www.nlm.nih.gov/medlineplus/alzheimersdisease.html	#hlink#	NN	NN	_	5	appos	_	_

1	The	the	DT	DT	_	3	det	_	_
2	ADEAR	adear	NNP	NNP	_	3	compound	_	_
3	Center	center	NNP	NNP	_	14	nsubj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	the	the	DT	DT	_	7	det	_	_
6	US	us	NNP	NNP	_	7	compound	_	_
7	Government	government	NNP	NNP	_	10	poss	_	_
8	's	's	POS	POS	_	7	case	_	_
9	National	national	NNP	NNP	_	10	compound	_	_
10	Institute	institute	NNP	NNP	_	4	pobj	_	_
11	on	on	IN	IN	_	10	prep	_	_
12	Aging	aging	NNP	NNP	_	11	pobj	_	_
13	also	also	RB	RB	_	14	advmod	_	_
14	has	have	VBZ	VBZ	_	0	root	_	_
15	information	information	NN	NN	_	14	dobj	_	_
16	on	on	IN	IN	_	15	prep	_	_
17	Alzheimer	alzheimer	NNP	NNP	_	18	compound	_	_
18	disease	disease	NN	NN	_	16	pobj	_	_
19	:	:	:	:	_	15	punct	_	_
20	http://www.alzheimers.org/	#hlink#	NN	NN	_	15	appos	_	_

1	The	the	DT	DT	_	2	det	_	_
2	Alzheimer	alzheimer	NNP	NNP	_	4	poss	_	_
3	's	's	POS	POS	_	2	case	_	_
4	Association	association	NNP	NNP	_	6	compound	_	_
5	Web	web	NN	NN	_	6	compound	_	_
6	site	site	NN	NN	_	7	nsubj	_	_
7	contains	contain	VBZ	VBZ	_	0	root	_	_
8	information	information	NN	NN	_	7	dative	_	_
9	on	on	IN	IN	_	8	prep	_	_
10	both	both	CC	CC	_	11	preconj	_	_
11	caregiving	caregiving	NN	NN	_	9	pobj	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	research	research	NN	NN	_	11	conj	_	_
14	:	:	:	:	_	7	punct	_	_
15	http://www.alz.org	#hlink#	NN	NN	_	7	dobj	_	_

1	Acknowledgements	acknowledgement	NNS	NNS	_	0	root	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	thank	thank	VBP	VBP	_	0	root	_	_
3	Patrick	patrick	NNP	NNP	_	4	compound	_	_
4	Tremblay	tremblay	NNP	NNP	_	2	dobj	_	4:gap
5	for	for	IN	IN	sem=PRP	2	prep	_	5:gap
6	helpful	helpful	JJ	JJ	_	7	amod	_	_
7	advice	advice	NN	NN	_	5	pobj	_	_
8	on	on	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	11	det	_	_
10	tet	tet	NN	NN	_	11	compound	_	_
11	system	system	NN	NN	_	8	pobj	_	_
12	at	at	IN	IN	sem=TMP	7	prep	_	_
13	a	a	DT	DT	_	15	det	_	_
14	critical	critical	JJ	JJ	_	15	amod	_	_
15	time	time	NN	NN	_	12	pobj	_	_
16	in	in	IN	IN	_	15	prep	_	_
17	the	the	DT	DT	_	18	det	_	_
18	project	project	NN	NN	_	16	pobj	_	_
19	,	,	,	,	_	2	punct	_	_
20	and	and	CC	CC	_	2	cc	_	_
21	Mark	mark	NNP	NNP	_	22	compound	_	_
22	Mayford	mayford	NNP	NNP	_	2	conj	_	4:gap
23	for	for	IN	IN	sem=PRP	22	prep	_	5:gap
24	sharing	share	VBG	VBG	syn=NOM	23	pcomp	_	_
25	the	the	DT	DT	_	29	det	_	_
26	CaMKIIα	camkiiα	NN	NN	_	29	compound	_	_
27	-	-	HYPH	HYPH	_	29	punct	_	_
28	tTA	tta	NN	NN	_	29	compound	_	_
29	mice	mouse	NNS	NNS	_	24	dobj	_	_
30	through	through	IN	IN	_	24	prep	_	_
31	Jackson	jackson	NNP	NNP	_	32	compound	_	_
32	Laboratory	laboratory	NNP	NNP	_	30	pobj	_	_
33	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	thank	thank	VBP	VBP	_	0	root	_	_
4	Fraser	fraser	NNP	NNP	_	5	compound	_	_
5	Moss	moss	NNP	NNP	_	3	dobj	_	5:gap
6	for	for	IN	IN	_	3	prep	_	6:gap
7	saving	save	VBG	VBG	syn=NOM	6	pcomp	_	_
8	several	several	JJ	JJ	_	9	amod	_	_
9	immunoblots	immunoblots	NNS	NNS	_	7	dobj	_	_
10	with	with	IN	IN	_	7	prep	_	_
11	last	last	JJ	JJ	_	13	amod	_	_
12	-	-	HYPH	HYPH	_	13	punct	_	_
13	minute	minute	NN	NN	_	14	compound	_	_
14	shipments	shipment	NNS	NNS	_	10	pobj	_	_
15	,	,	,	,	_	3	punct	_	_
16	Andy	andy	NNP	NNP	_	17	compound	_	_
17	Groves	groves	NNP	NNP	_	3	conj	_	5:gap
18	for	for	IN	IN	_	17	prep	_	6:gap
19	many	many	JJ	JJ	_	21	amod	_	_
20	thoughtful	thoughtful	JJ	JJ	_	21	amod	_	_
21	discussions	discussion	NNS	NNS	_	18	pobj	_	_
22	,	,	,	,	_	17	punct	_	_
23	Neil	neil	NNP	NNP	_	24	compound	_	_
24	Segil	segil	NNP	NNP	_	17	conj	_	5:gap
25	for	for	IN	IN	_	24	prep	_	6:gap
26	generously	generously	RB	RB	sem=MNR	27	advmod	_	_
27	sharing	share	VBG	VBG	syn=NOM	25	pcomp	_	_
28	his	his	PRP$	PRP$	_	29	poss	_	_
29	laboratory	laboratory	NN	NN	_	27	dobj	_	_
30	and	and	CC	CC	_	29	cc	_	_
31	equipment	equipment	NN	NN	_	29	conj	_	_
32	,	,	,	,	_	24	punct	_	_
33	Beth	beth	NNP	NNP	_	34	compound	_	_
34	Olson	olson	NNP	NNP	_	24	conj	_	5:gap
35	,	,	,	,	_	34	punct	_	_
36	Natasha	natasha	NNP	NNP	_	37	compound	_	_
37	Bouey	bouey	NNP	NNP	_	34	conj	_	_
38	,	,	,	,	_	37	punct	_	_
39	and	and	CC	CC	_	37	cc	_	_
40	Yolanda	yolanda	NNP	NNP	_	41	compound	_	_
41	Jackson	jackson	NNP	NNP	_	37	conj	_	_
42	for	for	IN	IN	_	34	prep	_	6:gap
43	outstanding	outstanding	JJ	JJ	_	45	amod	_	_
44	animal	animal	NN	NN	_	45	compound	_	_
45	care	care	NN	NN	_	42	pobj	_	_
46	,	,	,	,	_	34	punct	_	_
47	Debbie	debbie	NNP	NNP	_	48	compound	_	_
48	Swing	swing	NNP	NNP	_	34	conj	_	5:gap
49	for	for	IN	IN	_	48	prep	_	6:gap
50	expert	expert	JJ	JJ	_	51	amod	_	_
51	microinjection	microinjection	NN	NN	_	49	pobj	_	_
52	,	,	,	,	_	48	punct	_	_
53	and	and	CC	CC	_	48	cc	_	_
54	Dave	dave	NNP	NNP	_	55	compound	_	_
55	Fromholt	fromholt	NNP	NNP	_	48	conj	_	5:gap
56	for	for	IN	IN	_	55	prep	_	6:gap
57	genotyping	genotyping	NN	NN	_	56	pobj	_	_
58	and	and	CC	CC	_	57	cc	_	_
59	dissection	dissection	NN	NN	_	57	conj	_	_
60	.	.	.	.	_	3	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	gratefully	gratefully	RB	RB	_	3	advmod	_	_
3	acknowledge	acknowledge	VBP	VBP	_	0	root	_	_
4	Takeda	takeda	NNP	NNP	_	6	compound	_	_
5	Chemical	chemical	NNP	NNP	_	6	compound	_	_
6	Industries	industry	NNPS	NNPS	_	3	dobj	_	6:gap
7	for	for	IN	IN	_	3	prep	_	7:gap
8	providing	provide	VBG	VBG	syn=NOM	7	pcomp	_	_
9	antibodies	antibody	NNS	NNS	_	10	compound	_	_
10	BAN50	ban0	NN	NN	_	8	dobj	_	_
11	,	,	,	,	_	10	punct	_	_
12	BA27	ba0	NN	NN	_	10	conj	_	_
13	,	,	,	,	_	12	punct	_	_
14	and	and	CC	CC	_	12	cc	_	_
15	BC05	bc0	NN	NN	_	12	conj	_	_
16	,	,	,	,	_	3	punct	_	_
17	Konrad	konrad	NNP	NNP	_	18	compound	_	_
18	Beyreuther	beyreuther	NNP	NNP	_	3	conj	_	6:gap
19	and	and	CC	CC	_	18	cc	_	_
20	Andreas	andreas	NNP	NNP	_	21	compound	_	_
21	Weidemann	weidemann	NNP	NNP	_	18	conj	_	_
22	for	for	IN	IN	_	18	prep	_	7:gap
23	providing	provide	VBG	VBG	syn=NOM	22	pcomp	_	_
24	22C11	0c0	NN	NN	_	25	compound	_	_
25	antibody	antibody	NN	NN	_	23	dobj	_	_
26	,	,	,	,	_	18	punct	_	_
27	and	and	CC	CC	_	18	cc	_	_
28	Ed	ed	NNP	NNP	_	29	compound	_	_
29	Koo	koo	NNP	NNP	_	18	conj	_	6:gap
30	for	for	IN	IN	_	29	prep	_	7:gap
31	sharing	share	VBG	VBG	syn=NOM	30	pcomp	_	_
32	CT15	ct0	NN	NN	_	33	compound	_	_
33	antibody	antibody	NN	NN	_	31	dobj	_	_
34	.	.	.	.	_	3	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	work	work	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	supported	support	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	_	4	agent	_	_
6	grants	grant	NNS	NNS	_	5	pobj	_	_
7	from	from	IN	IN	_	6	prep	_	_
8	the	the	DT	DT	_	15	det	_	_
9	Johns	johns	NNP	NNP	_	10	nmod	_	_
10	Hopkins	hopkins	NNP	NNP	_	15	nmod	_	_
11	Alzheimer	alzheimer	NNP	NNP	_	13	poss	_	_
12	's	's	POS	POS	_	11	case	_	_
13	Disease	disease	NNP	NNP	_	15	compound	_	_
14	Research	research	NNP	NNP	_	15	compound	_	_
15	Center	center	NNP	NNP	_	7	pobj	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	JLJ	jlj	NNP	NNP	_	15	parataxis	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	,	,	,	,	_	6	punct	_	_
20	the	the	DT	DT	_	22	det	_	_
21	National	national	NNP	NNP	_	22	compound	_	_
22	Alliance	alliance	NNP	NNP	_	6	conj	_	_
23	for	for	IN	IN	_	22	prep	_	_
24	Research	research	NNP	NNP	_	23	pobj	_	_
25	on	on	IN	IN	_	24	prep	_	_
26	Schizophrenia	schizophrenia	NNP	NNP	_	25	pobj	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	Depression	depression	NNP	NNP	_	26	conj	_	_
29	(	(	-LRB-	-LRB-	_	34	punct	_	_
30	Young	young	NNP	NNP	_	32	compound	_	_
31	Investigator	investigator	NNP	NNP	_	32	compound	_	_
32	Award	award	NNP	NNP	_	34	dep	_	_
33	[	[	-LRB-	-LRB-	_	34	punct	_	_
34	JLJ	jlj	NNP	NNP	_	22	parataxis	_	_
35	]	]	-RRB-	-RRB-	_	34	punct	_	_
36	)	)	-RRB-	-RRB-	_	34	punct	_	_
37	,	,	,	,	_	22	punct	_	_
38	the	the	DT	DT	_	41	det	_	_
39	Rose	rose	NNP	NNP	_	41	compound	_	_
40	Hills	hills	NNP	NNP	_	41	compound	_	_
41	Foundation	foundation	NNP	NNP	_	22	conj	_	_
42	(	(	-LRB-	-LRB-	_	43	punct	_	_
43	JLJ	jlj	NNP	NNP	_	41	parataxis	_	_
44	)	)	-RRB-	-RRB-	_	43	punct	_	_
45	,	,	,	,	_	41	punct	_	_
46	the	the	DT	DT	_	47	det	_	_
47	Alzheimer	alzheimer	NNP	NNP	_	49	poss	_	_
48	's	's	POS	POS	_	47	case	_	_
49	Association	association	NNP	NNP	_	41	conj	_	_
50	(	(	-LRB-	-LRB-	_	54	punct	_	_
51	Zenith	zenith	NNP	NNP	_	52	compound	_	_
52	Award	award	NNP	NNP	_	54	dep	_	_
53	[	[	-LRB-	-LRB-	_	54	punct	_	_
54	DRB	drb	NN	NN	_	49	parataxis	_	_
55	]	]	-RRB-	-RRB-	_	54	punct	_	_
56	)	)	-RRB-	-RRB-	_	54	punct	_	_
57	,	,	,	,	_	49	punct	_	_
58	the	the	DT	DT	_	60	det	_	_
59	National	national	NNP	NNP	_	60	compound	_	_
60	Institute	institute	NNP	NNP	_	49	conj	_	_
61	of	of	IN	IN	_	60	prep	_	_
62	Aging	aging	NNP	NNP	_	61	pobj	_	_
63	(	(	-LRB-	-LRB-	_	69	punct	_	_
64	K01	k0	NN	NN	_	65	compound	_	_
65	AG26144	ag0	NN	NN	_	69	dep	_	_
66	–	-	HYPH	HYPH	_	65	punct	_	_
67	01	0	CD	CD	_	65	nummod	_	_
68	[	[	-LRB-	-LRB-	_	69	punct	_	_
69	JLJ	jlj	NNP	NNP	_	62	parataxis	_	_
70	]	]	-RRB-	-RRB-	_	69	punct	_	_
71	,	,	,	,	_	69	punct	_	_
72	P50	p0	NN	NN	_	73	compound	_	_
73	AGO5146	ago0	NN	NN	_	77	dep	_	_
74	–	-	HYPH	HYPH	_	73	punct	_	_
75	20	0	CD	CD	_	73	nummod	_	_
76	[	[	-LRB-	-LRB-	_	77	punct	_	_
77	DRB	drb	NN	NN	_	69	conj	_	_
78	]	]	-RRB-	-RRB-	_	77	punct	_	_
79	,	,	,	,	_	77	punct	_	_
80	R01	r0	NN	NN	_	81	compound	_	_
81	AG006656	ag0	NN	NN	_	85	dep	_	_
82	–	-	HYPH	HYPH	_	81	punct	_	_
83	16	0	CD	CD	_	81	nummod	_	_
84	[	[	-LRB-	-LRB-	_	85	punct	_	_
85	SGY	sgy	NN	NN	_	77	conj	_	_
86	]	]	-RRB-	-RRB-	_	85	punct	_	_
87	,	,	,	,	_	85	punct	_	_
88	and	and	CC	CC	_	85	cc	_	_
89	P01	p0	NN	NN	_	90	compound	_	_
90	AG015453	ag0	NN	NN	_	92	dep	_	_
91	[	[	-LRB-	-LRB-	_	92	punct	_	_
92	SGY	sgy	NNP	NNP	_	85	conj	_	_
93	]	]	-RRB-	-RRB-	_	92	punct	_	_
94	)	)	-RRB-	-RRB-	_	92	punct	_	_
95	,	,	,	,	_	60	punct	_	_
96	the	the	DT	DT	_	98	det	_	_
97	National	national	NNP	NNP	_	98	compound	_	_
98	Institute	institute	NNP	NNP	_	60	conj	_	_
99	of	of	IN	IN	_	98	prep	_	_
100	Neurologic	neurologic	JJ	JJ	_	101	amod	_	_
101	Disease	disease	NN	NN	_	99	pobj	_	_
102	and	and	CC	CC	_	101	cc	_	_
103	Stoke	stoke	NN	NN	_	101	conj	_	_
104	(	(	-LRB-	-LRB-	_	109	punct	_	_
105	R01	r0	NN	NN	_	106	compound	_	_
106	NS	ns	NN	NN	_	109	dep	_	_
107	047225	0	CD	CD	_	106	nummod	_	_
108	[	[	-LRB-	-LRB-	_	109	punct	_	_
109	DRB	drb	NNP	NNP	_	103	parataxis	_	_
110	]	]	-RRB-	-RRB-	_	109	punct	_	_
111	)	)	-RRB-	-RRB-	_	109	punct	_	_
112	,	,	,	,	_	98	punct	_	_
113	and	and	CC	CC	_	98	cc	_	_
114	the	the	DT	DT	_	117	det	_	_
115	National	national	NNP	NNP	_	117	compound	_	_
116	Cancer	cancer	NNP	NNP	_	117	compound	_	_
117	Institute	institute	NNP	NNP	_	98	conj	_	_
118	(	(	-LRB-	-LRB-	_	119	punct	_	_
119	NAJ	naj	NNP	NNP	_	117	parataxis	_	_
120	and	and	CC	CC	_	119	cc	_	_
121	NGC	ngc	NNP	NNP	_	119	conj	_	_
122	)	)	-RRB-	-RRB-	_	119	punct	_	_
123	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	funding	funding	NN	NN	_	3	compound	_	_
3	agencies	agency	NNS	NNS	_	5	nsubj	_	_
4	generously	generously	RB	RB	_	5	advmod	_	_
5	provided	provided	VBN	VBN	_	22	ccomp	_	_
6	for	for	IN	IN	_	5	prep	_	_
7	research	research	NN	NN	_	8	compound	_	_
8	supplies	supply	NNS	NNS	_	6	pobj	_	_
9	,	,	,	,	_	8	punct	_	_
10	animal	animal	NN	NN	_	11	compound	_	_
11	care	care	NN	NN	_	8	conj	_	_
12	,	,	,	,	_	11	punct	_	_
13	and	and	CC	CC	_	11	cc	_	_
14	salary	salary	NN	NN	_	15	compound	_	_
15	support	support	NN	NN	_	11	conj	_	_
16	;	;	:	:	_	22	punct	_	_
17	the	the	DT	DT	_	18	det	_	_
18	funders	funder	NNS	NNS	_	22	nsubj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	this	this	DT	DT	_	21	det	_	_
21	work	work	NN	NN	_	19	pobj	_	_
22	had	have	VBD	VBD	_	0	root	_	_
23	no	no	DT	DT	_	24	det	_	_
24	role	role	NN	NN	_	22	dobj	_	_
25	in	in	IN	IN	_	24	prep	_	_
26	study	study	NN	NN	_	27	compound	_	_
27	design	design	NN	NN	_	25	pobj	_	_
28	,	,	,	,	_	27	punct	_	_
29	data	datum	NNS	NNS	_	30	compound	_	_
30	collection	collection	NN	NN	_	27	conj	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	analysis	analysis	NN	NN	_	30	conj	_	_
33	,	,	,	,	_	30	punct	_	_
34	decision	decision	NN	NN	_	30	conj	_	_
35	to	to	TO	TO	_	36	aux	_	_
36	publish	publish	VB	VB	_	34	acl	_	_
37	,	,	,	,	_	34	punct	_	_
38	or	or	CC	CC	_	34	cc	_	_
39	preparation	preparation	NN	NN	_	34	conj	_	_
40	of	of	IN	IN	_	39	prep	_	_
41	the	the	DT	DT	_	42	det	_	_
42	manuscript	manuscript	NN	NN	_	40	pobj	_	_
43	.	.	.	.	_	22	punct	_	_

1	Abbreviations	abbreviation	NNS	NNS	_	0	root	_	_

1	Aβ	aβ	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	amyloid	amyloid	NN	NN	_	5	compound	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	β	β	NN	NN	_	1	appos	_	_

1	AD	ad	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	Alzheimer	alzheimer	NNP	NNP	_	4	compound	_	_
4	disease	disease	NN	NN	_	1	appos	_	_

1	APLP	aplp	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	amyloid	amyloid	NN	NN	_	5	nmod	_	_
4	precursor–like	precursor–like	JJ	JJ	_	5	amod	_	_
5	protein	protein	NN	NN	_	1	appos	_	_

1	APP	app	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	amyloid	amyloid	NN	NN	_	5	compound	_	_
4	precursor	precursor	NN	NN	_	5	compound	_	_
5	protein	protein	NN	NN	_	1	appos	_	_

1	CaMKIIα	camkiiα	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	calcium	calcium	NN	NN	_	5	compound	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	calmodulin	calmodulin	NN	NN	_	7	compound	_	_
6	kinase	kinase	NN	NN	_	7	compound	_	_
7	IIα	iiα	NN	NN	_	1	appos	_	_

1	dox	dox	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	doxycycline	doxycycline	NN	NN	_	1	appos	_	_

1	FA	fa	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	formic	formic	JJ	JJ	_	4	amod	_	_
4	acid	acid	NN	NN	_	1	appos	_	_

1	GFAP	gfap	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	glial	glial	JJ	JJ	_	6	amod	_	_
4	fibrillary	fibrillary	JJ	JJ	_	6	amod	_	_
5	acidic	acidic	JJ	JJ	_	6	amod	_	_
6	protein	protein	NN	NN	_	1	appos	_	_

1	mo	mo	NN	NN	_	3	compound	_	_
2	/	/	HYPH	HYPH	_	3	punct	_	_
3	huAPP695	huapp0	NN	NN	_	0	root	_	_
4	-	-	:	:	_	3	punct	_	_
5	mouse	mouse	NN	NN	_	6	compound	_	_
6	APP	app	NN	NN	_	3	appos	_	_
7	with	with	IN	IN	_	6	prep	_	_
8	a	a	DT	DT	_	11	det	_	_
9	humanized	humanize	VBN	VBN	_	11	amod	_	_
10	Aβ	aβ	NN	NN	_	11	compound	_	_
11	domain	domain	NN	NN	_	7	pobj	_	_

1	PBS	pbs	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	phosphate	phosphate	NN	NN	_	5	npadvmod	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	buffered	buffer	VBN	VBN	_	6	amod	_	_
6	saline	saline	NN	NN	_	1	appos	_	_

1	SDS	sds	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	sodium	sodium	NN	NN	_	5	compound	_	_
4	dodecyl	dodecyl	NN	NN	_	5	compound	_	_
5	sulfate	sulfate	NN	NN	_	1	appos	_	_

1	swe	swe	NN	NN	_	3	compound	_	_
2	/	/	HYPH	HYPH	_	3	punct	_	_
3	ind	ind	NN	NN	_	0	root	_	_
4	-	-	:	:	_	3	punct	_	_
5	Swedish	swedish	JJ	JJ	_	7	amod	_	_
6	/	/	HYPH	HYPH	_	7	punct	_	_
7	Indiana	indiana	NNP	NNP	_	3	appos	_	_

1	tTA	tta	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	tetracycline	tetracycline	NN	NN	_	4	compound	_	_
4	transactivator	transactivator	NN	NN	_	1	appos	_	_

1	Figures	figure	NNS	NNS	_	0	root	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	Tables	table	NNS	NNS	_	1	conj	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	1	0	CD	CD	_	1	nummod	_	_

1	Control	control	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	Transgenic	transgenic	JJ	JJ	_	5	amod	_	_
4	APP	app	NN	NN	_	5	compound	_	_
5	Expression	expression	NN	NN	_	2	pobj	_	_
6	by	by	IN	IN	_	1	prep	_	_
7	Dox	dox	NN	NN	_	6	pobj	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	16	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Western	western	NNP	NNP	_	5	compound	_	_
5	blotting	blotting	NN	NN	_	16	nsubj	_	_
6	for	for	IN	IN	_	5	prep	_	_
7	transgenic	transgenic	JJ	JJ	_	8	amod	_	_
8	APP	app	NN	NN	_	6	pobj	_	_
9	using	use	VBG	VBG	_	5	acl	_	_
10	the	the	DT	DT	_	15	det	_	_
11	human	human	JJ	JJ	_	13	amod	_	_
12	-	-	HYPH	HYPH	_	13	punct	_	_
13	specific	specific	JJ	JJ	_	15	amod	_	_
14	6E10	0e0	NN	NN	_	15	compound	_	_
15	antibody	antibody	NN	NN	_	9	dobj	_	_
16	shows	show	VBZ	VBZ	_	0	root	_	_
17	expression	expression	NN	NN	_	16	dobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	full	full	JJ	JJ	_	21	amod	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	length	length	NN	NN	_	22	compound	_	_
22	protein	protein	NN	NN	_	18	pobj	_	_
23	in	in	IN	IN	sem=LOC	17	prep	_	_
24	forebrain	forebrain	NN	NN	_	25	compound	_	_
25	tissue	tissue	NN	NN	_	23	pobj	_	_
26	from	from	IN	IN	_	25	prep	_	_
27	young	young	JJ	JJ	_	31	amod	_	_
28	predeposit	predeposit	JJ	JJ	_	31	amod	_	_
29	double	double	JJ	JJ	_	30	amod	_	_
30	transgenic	transgenic	JJ	JJ	_	31	amod	_	_
31	animals	animal	NNS	NNS	_	26	pobj	_	_
32	(	(	-LRB-	-LRB-	_	33	punct	_	_
33	line	line	NN	NN	_	31	parataxis	_	_
34	107	0	CD	CD	_	33	nummod	_	_
35	)	)	-RRB-	-RRB-	_	33	punct	_	_
36	and	and	CC	CC	_	31	cc	_	_
37	its	its	PRP$	PRP$	_	38	poss	_	_
38	suppression	suppression	NN	NN	_	31	conj	_	_
39	following	follow	VBG	VBG	sem=TMP	38	prep	_	_
40	dox	dox	NN	NN	_	41	compound	_	_
41	treatment	treatment	NN	NN	_	39	pobj	_	_
42	.	.	.	.	_	16	punct	_	_

1	Untreated	untreated	JJ	JJ	_	2	amod	_	_
2	animals	animal	NNS	NNS	_	3	nsubj	_	_
3	show	show	VBP	VBP	_	12	ccomp	_	_
4	high	high	JJ	JJ	_	5	amod	_	_
5	levels	level	NNS	NNS	_	3	dobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	transgene	transgene	NN	NN	_	8	compound	_	_
8	expression	expression	NN	NN	_	6	pobj	_	_
9	;	;	:	:	_	12	punct	_	_
10	protein	protein	NN	NN	_	11	compound	_	_
11	levels	level	NNS	NNS	_	12	nsubj	_	_
12	drop	drop	VBP	VBP	_	0	root	_	_
13	dramatically	dramatically	RB	RB	_	12	advmod	_	_
14	in	in	IN	IN	sem=LOC	12	prep	_	_
15	animals	animal	NNS	NNS	_	14	pobj	_	_
16	acutely	acutely	RB	RB	_	17	advmod	_	_
17	treated	treat	VBN	VBN	_	15	acl	_	_
18	with	with	IN	IN	sem=MNR	17	prep	_	_
19	dox	dox	NN	NN	_	18	pobj	_	_
20	for	for	IN	IN	sem=TMP	17	prep	_	_
21	2	0	CD	CD	_	22	nummod	_	_
22	wk	wk	NN	NN	_	20	pobj	_	_
23	.	.	.	.	_	12	punct	_	_

1	A	a	DT	DT	_	6	det	_	_
2	faint	faint	NN	NN	_	5	npadvmod	_	_
3	,	,	,	,	_	5	punct	_	_
4	but	but	CC	CC	_	5	cc	_	_
5	detectable	detectable	JJ	JJ	_	6	amod	_	_
6	band	band	NN	NN	_	12	nsubj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	full	full	JJ	JJ	_	10	amod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	length	length	NN	NN	_	11	compound	_	_
11	protein	protein	NN	NN	_	7	pobj	_	_
12	remains	remain	VBZ	VBZ	_	0	root	_	_
13	in	in	IN	IN	syn=PRD|sem=LOC	12	prep	_	_
14	acutely	acutely	RB	RB	_	16	advmod	_	_
15	treated	treat	VBN	VBN	_	16	amod	_	_
16	animals	animal	NNS	NNS	_	13	pobj	_	_
17	that	that	WDT	WDT	_	20	dep	_	16:ref
18	can	can	MD	MD	_	20	aux	_	_
19	be	be	VB	VB	_	20	auxpass	_	_
20	eliminated	eliminate	VBN	VBN	_	16	relcl	_	_
21	in	in	IN	IN	sem=LOC	20	prep	_	_
22	mice	mouse	NNS	NNS	_	21	pobj	_	_
23	born	bear	VBN	VBN	_	22	acl	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	raised	raise	VBN	VBN	_	23	conj	_	_
26	on	on	IN	IN	_	25	prep	_	_
27	dox	dox	NN	NN	_	26	pobj	_	_
28	.	.	.	.	_	12	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	19	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Immunoblotting	immunoblotting	NN	NN	_	19	nsubj	_	_
5	with	with	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	10	det	_	_
7	N	n	NN	NN	_	9	npadvmod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	terminal	terminal	JJ	JJ	_	10	amod	_	_
10	antibody	antibody	NN	NN	_	5	pobj	_	_
11	22C11	0c0	NN	NN	_	10	appos	_	_
12	to	to	TO	TO	_	13	aux	_	_
13	detect	detect	VB	VB	_	4	advcl	_	_
14	both	both	CC	CC	_	18	preconj	_	_
15	transgenic	transgenic	JJ	JJ	_	18	amod	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	endogenous	endogenous	JJ	JJ	_	15	conj	_	_
18	protein	protein	NN	NN	_	13	dobj	_	_
19	shows	show	VBZ	VBZ	_	0	root	_	_
20	that	that	IN	IN	_	23	mark	_	_
21	dox	dox	NN	NN	_	22	compound	_	_
22	treatment	treatment	NN	NN	_	23	nsubj	_	_
23	reduces	reduce	VBZ	VBZ	_	19	ccomp	_	_
24	APP	app	NN	NN	_	26	compound	_	_
25	/	/	HYPH	HYPH	_	26	punct	_	_
26	APLP	aplp	NN	NN	_	23	dobj	_	_
27	to	to	IN	IN	_	23	prep	_	_
28	levels	level	NNS	NNS	_	27	pobj	_	_
29	found	find	VBN	VBN	_	28	acl	_	_
30	in	in	IN	IN	sem=LOC	29	prep	_	_
31	nontransgenic	nontransgenic	JJ	JJ	_	32	amod	_	_
32	mice	mouse	NNS	NNS	_	30	pobj	_	_
33	.	.	.	.	_	19	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	16	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Measurement	measurement	NN	NN	_	16	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	signal	signal	NN	NN	_	7	compound	_	_
7	intensity	intensity	NN	NN	_	5	pobj	_	_
8	from	from	IN	IN	_	4	prep	_	_
9	the	the	DT	DT	_	11	det	_	_
10	Western	western	NNP	NNP	_	11	compound	_	_
11	blot	blot	NN	NN	_	8	pobj	_	_
12	in	in	IN	IN	_	4	prep	_	_
13	(	(	-LRB-	-LRB-	_	12	punct	_	_
14	A	a	NN	NN	_	12	pobj	_	_
15	)	)	-RRB-	-RRB-	_	16	punct	_	_
16	shows	show	VBZ	VBZ	_	0	root	_	_
17	transgenic	transgenic	JJ	JJ	_	19	amod	_	_
18	APP	app	NN	NN	_	19	compound	_	_
19	levels	level	NNS	NNS	_	21	nsubjpass	_	_
20	are	be	VBP	VBP	_	21	auxpass	_	_
21	decreased	decrease	VBN	VBN	_	16	advcl	_	_
22	more	more	JJR	JJR	_	24	amod	_	_
23	than	than	IN	IN	_	24	quantmod	_	_
24	95	0	CD	CD	_	25	nummod	_	_
25	%	%	NN	NN	sem=EXT	21	npadvmod	_	_
26	by	by	IN	IN	sem=MNR	21	prep	_	_
27	dox	dox	NN	NN	_	26	pobj	_	_
28	in	in	IN	IN	sem=LOC	21	prep	_	_
29	both	both	CC	CC	_	30	preconj	_	_
30	acutely	acutely	RB	RB	_	33	advmod	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	chronically	chronically	RB	RB	_	30	conj	_	_
33	treated	treat	VBN	VBN	_	34	amod	_	_
34	animals	animal	NNS	NNS	_	28	pobj	_	_
35	(	(	-LRB-	-LRB-	_	37	punct	_	_
36	97.2	0	CD	CD	_	37	nummod	_	_
37	%	%	NN	NN	_	21	parataxis	_	_
38	for	for	IN	IN	_	37	prep	_	_
39	4	0	CD	CD	_	40	nummod	_	_
40	wk	wk	NN	NN	_	44	nmod	_	_
41	+	+	SYM	SYM	_	40	punct	_	_
42	2	0	CD	CD	_	43	nummod	_	_
43	wk	wk	NN	NN	_	40	appos	_	_
44	dox	dox	NN	NN	_	38	pobj	_	_
45	,	,	,	,	_	37	punct	_	_
46	98.0	0	CD	CD	_	47	nummod	_	_
47	%	%	NN	NN	_	37	appos	_	_
48	for	for	IN	IN	_	47	prep	_	_
49	reared	rear	VBN	VBN	_	48	pobj	_	_
50	on	on	IN	IN	_	49	prep	_	_
51	dox	dox	NN	NN	_	50	pobj	_	_
52	versus	versus	CC	CC	_	49	cc	_	_
53	4	0	CD	CD	_	54	nummod	_	_
54	wk	wk	NN	NN	_	55	npadvmod	_	_
55	untreated	untreated	JJ	JJ	_	49	conj	_	_
56	;	;	:	:	_	37	punct	_	_
57	ANOVA	anova	NN	NN	_	58	compound	_	_
58	effect	effect	NN	NN	_	66	nsubj	_	_
59	of	of	IN	IN	_	58	prep	_	_
60	treatment	treatment	NN	NN	_	62	compound	_	_
61	group	group	NN	NN	_	62	compound	_	_
62	F4	f0	NN	NN	_	59	pobj	_	_
63	,	,	,	,	_	62	punct	_	_
64	15	0	CD	CD	_	62	nummod	_	_
65	=	=	SYM	SYM	_	66	punct	_	_
66	85.55	0	CD	CD	_	37	ccomp	_	_
67	,	,	,	,	_	37	punct	_	_
68	p	p	NN	NN	_	70	nsubj	_	_
69	<	<	SYM	SYM	_	70	punct	_	_
70	0.001	0	CD	CD	_	37	ccomp	_	_
71	)	)	-RRB-	-RRB-	_	37	punct	_	_
72	.	.	.	.	_	16	punct	_	_

1	APP	app	NN	NN	_	2	compound	_	_
2	levels	level	NNS	NNS	_	20	nsubj	_	_
3	in	in	IN	IN	sem=LOC	2	prep	_	_
4	4	0	CD	CD	_	5	nummod	_	_
5	wk	wk	NN	NN	_	9	nmod	_	_
6	+	+	SYM	SYM	_	5	punct	_	_
7	2	0	CD	CD	_	8	nummod	_	_
8	wk	wk	NN	NN	_	5	appos	_	_
9	dox	dox	NN	NN	_	3	pobj	_	_
10	,	,	,	,	_	9	punct	_	_
11	reared	rear	VBN	VBN	_	9	acl	_	_
12	on	on	IN	IN	_	11	prep	_	_
13	dox	dox	NN	NN	_	12	pobj	_	_
14	,	,	,	,	_	9	punct	_	_
15	and	and	CC	CC	_	9	cc	_	_
16	nontransgenic	nontransgenic	JJ	JJ	_	9	conj	_	_
17	(	(	-LRB-	-LRB-	_	16	punct	_	_
18	NTg	ntg	NN	NN	_	16	appos	_	_
19	)	)	-RRB-	-RRB-	_	2	punct	_	_
20	were	be	VBD	VBD	_	0	root	_	_
21	not	not	RB	RB	_	20	neg	_	_
22	significantly	significantly	RB	RB	_	23	advmod	_	_
23	different	different	JJ	JJ	syn=PRD	20	acomp	_	_
24	(	(	-LRB-	-LRB-	_	33	punct	_	_
25	p	p	NN	NN	_	27	nsubj	_	_
26	>	>	SYM	SYM	_	27	punct	_	_
27	0.9	0	CD	CD	_	33	ccomp	_	_
28	,	,	,	,	_	33	punct	_	_
29	Tukey	tukey	NNP	NNP	_	33	nmod	_	_
30	post	post	FW	FW	_	32	nmod	_	_
31	-	-	HYPH	HYPH	_	32	punct	_	_
32	hoc	hoc	FW	FW	_	33	nmod	_	_
33	test	test	NN	NN	_	23	parataxis	_	_
34	)	)	-RRB-	-RRB-	_	33	punct	_	_
35	.	.	.	.	_	20	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	D	d	LS	LS	_	16	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Measurement	measurement	NN	NN	_	16	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	signal	signal	NN	NN	_	7	compound	_	_
7	intensity	intensity	NN	NN	_	5	pobj	_	_
8	from	from	IN	IN	_	4	prep	_	_
9	the	the	DT	DT	_	11	det	_	_
10	Western	western	NNP	NNP	_	11	compound	_	_
11	blot	blot	NN	NN	_	8	pobj	_	_
12	in	in	IN	IN	_	11	prep	_	_
13	(	(	-LRB-	-LRB-	_	12	punct	_	_
14	B	b	NN	NN	_	12	pobj	_	_
15	)	)	-RRB-	-RRB-	_	16	punct	_	_
16	shows	show	VBZ	VBZ	_	0	root	_	_
17	total	total	JJ	JJ	_	21	amod	_	_
18	APP	app	NN	NN	_	20	compound	_	_
19	/	/	HYPH	HYPH	_	20	punct	_	_
20	APLP	aplp	NN	NN	_	21	compound	_	_
21	levels	level	NNS	NNS	_	30	nsubj	_	_
22	in	in	IN	IN	_	21	prep	_	_
23	dox	dox	NN	NN	_	25	npadvmod	_	_
24	-	-	HYPH	HYPH	_	25	punct	_	_
25	treated	treat	VBN	VBN	_	29	amod	_	_
26	tTA	tta	NN	NN	_	28	compound	_	_
27	/	/	HYPH	HYPH	_	28	punct	_	_
28	APP	app	NN	NN	_	29	compound	_	_
29	mice	mouse	NNS	NNS	_	22	pobj	_	_
30	are	be	VBP	VBP	_	16	advcl	_	_
31	significantly	significantly	RB	RB	_	32	advmod	_	_
32	lower	low	JJR	JJR	syn=PRD	30	acomp	_	_
33	than	than	IN	IN	_	32	prep	_	_
34	in	in	IN	IN	sem=LOC	33	prep	_	_
35	4	0	CD	CD	_	37	nummod	_	_
36	-	-	HYPH	HYPH	_	37	punct	_	_
37	wk	wk	NN	NN	_	39	npadvmod	_	_
38	-	-	HYPH	HYPH	_	39	punct	_	_
39	old	old	JJ	JJ	_	41	amod	_	_
40	untreated	untreated	JJ	JJ	_	41	amod	_	_
41	mice	mouse	NNS	NNS	_	34	pobj	_	_
42	(	(	-LRB-	-LRB-	_	56	punct	_	_
43	ANOVA	anova	NN	NN	_	44	compound	_	_
44	effect	effect	NN	NN	_	52	nsubj	_	_
45	of	of	IN	IN	_	44	prep	_	_
46	treatment	treatment	NN	NN	_	48	compound	_	_
47	group	group	NN	NN	_	48	compound	_	_
48	F4	f0	NN	NN	_	45	pobj	_	_
49	,	,	,	,	_	48	punct	_	_
50	15	0	CD	CD	_	48	nummod	_	_
51	=	=	SYM	SYM	_	52	punct	_	_
52	84.41	0	CD	CD	_	56	ccomp	_	_
53	,	,	,	,	_	56	punct	_	_
54	p	p	NN	NN	_	56	nsubj	_	_
55	<	<	SYM	SYM	_	56	punct	_	_
56	0.001	0	CD	CD	_	41	parataxis	_	_
57	)	)	-RRB-	-RRB-	_	56	punct	_	_
58	and	and	CC	CC	_	32	cc	_	_
59	indistinguishable	indistinguishable	JJ	JJ	_	32	conj	_	_
60	from	from	IN	IN	_	59	prep	_	_
61	those	those	DT	DT	_	60	pobj	_	_
62	of	of	IN	IN	_	61	prep	_	_
63	nontransgenic	nontransgenic	JJ	JJ	_	64	amod	_	_
64	animals	animal	NNS	NNS	_	62	pobj	_	_
65	(	(	-LRB-	-LRB-	_	74	punct	_	_
66	p	p	NN	NN	_	68	nsubj	_	_
67	>	>	SYM	SYM	_	68	punct	_	_
68	0.9	0	CD	CD	_	74	ccomp	_	_
69	,	,	,	,	_	74	punct	_	_
70	Tukey	tukey	NNP	NNP	_	74	nmod	_	_
71	post	post	FW	FW	_	73	nmod	_	_
72	-	-	HYPH	HYPH	_	73	punct	_	_
73	hoc	hoc	FW	FW	_	74	nmod	_	_
74	test	test	NN	NN	_	64	parataxis	_	_
75	)	)	-RRB-	-RRB-	_	74	punct	_	_
76	.	.	.	.	_	16	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.001	0	CD	CD	_	0	root	_	_
6	versus	versus	IN	IN	_	5	prep	_	_
7	untreated	untreated	JJ	JJ	_	13	amod	_	_
8	4	0	CD	CD	_	10	nummod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	wk	wk	NN	NN	_	12	npadvmod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	old	old	JJ	JJ	_	13	amod	_	_
13	mice	mouse	NNS	NNS	_	6	pobj	_	_
14	,	,	,	,	_	5	punct	_	_
15	Tukey	tukey	NNP	NNP	_	19	nmod	_	_
16	post	post	FW	FW	_	18	nmod	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	hoc	hoc	FW	FW	_	19	nmod	_	_
19	test	test	NN	NN	syn=ADV	5	npadvmod	_	_
20	applied	apply	VBN	VBN	_	19	acl	_	_
21	to	to	IN	IN	_	20	prep	_	_
22	significant	significant	JJ	JJ	_	23	amod	_	_
23	effect	effect	NN	NN	_	21	pobj	_	_
24	of	of	IN	IN	_	23	prep	_	_
25	group	group	NN	NN	_	26	compound	_	_
26	ANOVA	anova	NN	NN	_	24	pobj	_	_
27	.	.	.	.	_	5	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	2	0	CD	CD	_	1	nummod	_	_

1	Aβ	aβ	NN	NN	_	2	compound	_	_
2	Levels	level	NNS	NNS	_	5	nsubjpass	_	_
3	Are	be	VBP	VBP	_	5	auxpass	_	_
4	Dramatically	dramatically	RB	RB	_	5	advmod	_	_
5	Reduced	reduce	VBN	VBN	_	0	root	_	_
6	by	by	IN	IN	_	5	agent	_	_
7	Transgene	transgene	NN	NN	_	8	compound	_	_
8	Suppression	suppression	NN	NN	_	6	pobj	_	_

1	Cortical	cortical	JJ	JJ	_	2	amod	_	_
2	homogenates	homogenate	NNS	NNS	_	23	nsubjpass	_	_
3	from	from	IN	IN	_	2	prep	_	_
4	young	young	JJ	JJ	_	10	amod	_	_
5	,	,	,	,	_	10	punct	_	_
6	predeposit	predeposit	JJ	JJ	_	10	amod	_	_
7	tTA	tta	NN	NN	_	9	compound	_	_
8	/	/	HYPH	HYPH	_	9	punct	_	_
9	APP	app	NN	NN	_	10	compound	_	_
10	mice	mouse	NNS	NNS	_	3	pobj	_	_
11	used	use	VBN	VBN	_	10	acl	_	_
12	for	for	IN	IN	_	11	prep	_	_
13	Western	western	NNP	NNP	_	14	compound	_	_
14	blot	blot	NN	NN	_	12	pobj	_	_
15	in	in	IN	IN	_	11	prep	_	_
16	Figure	figure	NN	NN	_	15	pobj	_	_
17	1	0	CD	CD	_	16	nummod	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	line	line	NN	NN	_	11	parataxis	_	_
20	107	0	CD	CD	_	19	nummod	_	_
21	)	)	-RRB-	-RRB-	_	19	punct	_	_
22	were	be	VBD	VBD	_	23	auxpass	_	_
23	fractionated	fractionate	VBN	VBN	_	0	root	_	_
24	by	by	IN	IN	sem=MNR	23	prep	_	_
25	sequential	sequential	JJ	JJ	_	27	amod	_	_
26	multi-step	multi-step	JJ	JJ	_	27	amod	_	_
27	extraction	extraction	NN	NN	_	24	pobj	_	_
28	with	with	IN	IN	_	27	prep	_	_
29	PBS	pbs	NN	NN	_	28	pobj	_	_
30	,	,	,	,	_	29	punct	_	_
31	2	0	CD	CD	_	32	nummod	_	_
32	%	%	NN	NN	_	33	compound	_	_
33	SDS	sds	NN	NN	_	29	conj	_	_
34	,	,	,	,	_	33	punct	_	_
35	and	and	CC	CC	_	33	cc	_	_
36	70	0	CD	CD	_	37	nummod	_	_
37	%	%	NN	NN	_	38	compound	_	_
38	FA	fa	NN	NN	_	33	conj	_	_
39	followed	followed	VBN	VBN	_	27	acl	_	_
40	by	by	IN	IN	_	39	agent	_	_
41	human	human	JJ	JJ	_	43	amod	_	_
42	-	-	HYPH	HYPH	_	43	punct	_	_
43	specific	specific	JJ	JJ	_	45	amod	_	_
44	Aβ	aβ	NN	NN	_	45	compound	_	_
45	ELISA	elisa	NN	NN	_	40	pobj	_	_
46	to	to	TO	TO	_	47	aux	_	_
47	measure	measure	VB	VB	sem=PRP	39	advcl	_	_
48	transgene	transgene	NN	NN	_	50	npadvmod	_	_
49	-	-	HYPH	HYPH	_	50	punct	_	_
50	derived	derive	VBN	VBN	_	51	amod	_	_
51	peptide	peptide	NN	NN	_	47	dobj	_	_
52	in	in	IN	IN	_	47	prep	_	_
53	each	each	DT	DT	_	54	det	_	_
54	fraction	fraction	NN	NN	_	52	pobj	_	_
55	.	.	.	.	_	23	punct	_	_

1	Aβ40	aβ0	NN	NN	_	3	nsubjpass	_	1:gap
2	is	be	VBZ	VBZ	_	3	auxpass	_	_
3	shown	show	VBN	VBN	_	7	ccomp	_	_
4	in	in	IN	IN	_	3	prep	_	4:gap
5	white	white	JJ	JJ	_	4	pobj	_	_
6	,	,	,	,	_	7	punct	_	_
7	Aβ42	aβ0	NN	NN	_	0	root	_	1:gap
8	in	in	IN	IN	_	7	prep	_	4:gap
9	black	black	JJ	JJ	_	8	pobj	_	_
10	.	.	.	.	_	7	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	11	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	PBS	pbs	NN	NN	_	6	npadvmod	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	soluble	soluble	JJ	JJ	_	8	amod	_	_
7	Aβ	aβ	NN	NN	_	8	compound	_	_
8	levels	level	NNS	NNS	_	11	nsubjpass	_	_
9	are	be	VBP	VBP	_	11	auxpass	_	_
10	substantially	substantially	RB	RB	_	11	advmod	_	_
11	reduced	reduce	VBN	VBN	_	0	root	_	_
12	by	by	IN	IN	_	11	agent	_	_
13	both	both	CC	CC	_	18	preconj	_	_
14	acute	acute	JJ	JJ	_	18	amod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	chronic	chronic	JJ	JJ	_	14	conj	_	_
17	dox	dox	NN	NN	_	18	compound	_	_
18	treatment	treatment	NN	NN	_	12	pobj	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	ANOVA	anova	NN	NN	_	11	parataxis	_	_
21	,	,	,	,	_	20	punct	_	_
22	effect	effect	NN	NN	_	30	nsubj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	treatment	treatment	NN	NN	_	25	compound	_	_
25	group	group	NN	NN	_	26	compound	_	_
26	F4	f0	NN	NN	_	23	pobj	_	_
27	,	,	,	,	_	26	punct	_	_
28	24	0	CD	CD	_	26	nummod	_	_
29	=	=	SYM	SYM	_	30	punct	_	_
30	137.10	0	CD	CD	_	36	ccomp	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	386.01	0	CD	CD	_	30	conj	_	_
33	,	,	,	,	_	36	punct	_	_
34	p	p	NN	NN	_	36	nsubj	_	_
35	<	<	SYM	SYM	_	36	punct	_	_
36	0.001	0	CD	CD	_	20	ccomp	_	_
37	,	,	,	,	_	36	punct	_	_
38	for	for	IN	IN	_	36	prep	_	_
39	Aβ40	aβ0	NN	NN	_	38	pobj	_	_
40	and	and	CC	CC	_	39	cc	_	_
41	Aβ42	aβ0	NN	NN	_	39	conj	_	_
42	,	,	,	,	_	36	punct	_	_
43	respectively	respectively	RB	RB	_	36	advmod	_	_
44	)	)	-RRB-	-RRB-	_	20	punct	_	_
45	.	.	.	.	_	11	punct	_	_

1	Aβ	aβ	NN	NN	_	2	compound	_	_
2	levels	level	NNS	NNS	_	6	nsubj	_	_
3	in	in	IN	IN	_	2	prep	_	_
4	treated	treat	VBN	VBN	_	5	amod	_	_
5	animals	animal	NNS	NNS	_	3	pobj	_	_
6	are	be	VBP	VBP	_	0	root	_	_
7	indistinguishable	indistinguishable	JJ	JJ	syn=PRD	6	acomp	_	_
8	from	from	IN	IN	_	7	prep	_	_
9	nontransgenic	nontransgenic	JJ	JJ	_	13	amod	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	NTg	ntg	NN	NN	_	9	parataxis	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	animals	animal	NNS	NNS	_	8	pobj	_	_
14	(	(	-LRB-	-LRB-	_	23	punct	_	_
15	p	p	NN	NN	_	17	nsubj	_	_
16	>	>	SYM	SYM	_	17	punct	_	_
17	0.3	0	CD	CD	_	23	ccomp	_	_
18	,	,	,	,	_	23	punct	_	_
19	Tukey	tukey	NNP	NNP	_	23	nmod	_	_
20	post	post	FW	FW	_	22	nmod	_	_
21	-	-	HYPH	HYPH	_	22	punct	_	_
22	hoc	hoc	FW	FW	_	23	nmod	_	_
23	test	test	NN	NN	_	6	parataxis	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	.	.	.	.	_	6	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	22	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	In	in	IN	IN	sem=LOC	22	prep	_	_
5	the	the	DT	DT	_	7	det	_	_
6	young	young	JJ	JJ	_	7	amod	_	_
7	animals	animal	NNS	NNS	_	4	pobj	_	_
8	tested	test	VBN	VBN	_	7	acl	_	_
9	here	here	RB	RB	_	8	advmod	_	_
10	prior	prior	JJ	JJ	_	11	amod	_	_
11	to	to	IN	IN	sem=TMP	8	prep	_	_
12	the	the	DT	DT	_	13	det	_	_
13	formation	formation	NN	NN	_	11	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	visible	visible	JJ	JJ	_	17	amod	_	_
16	amyloid	amyloid	NN	NN	_	17	compound	_	_
17	deposits	deposit	NNS	NNS	_	14	pobj	_	_
18	,	,	,	,	_	22	punct	_	_
19	most	most	JJS	JJS	_	20	amod	_	_
20	Aβ	aβ	NN	NN	_	22	nsubjpass	_	_
21	is	be	VBZ	VBZ	_	22	auxpass	_	_
22	extracted	extract	VBN	VBN	_	0	root	_	_
23	into	into	IN	IN	_	22	prep	_	_
24	the	the	DT	DT	_	26	det	_	_
25	SDS	sds	NN	NN	_	26	compound	_	_
26	fraction	fraction	NN	NN	_	23	pobj	_	_
27	(	(	-LRB-	-LRB-	_	29	punct	_	_
28	84	0	CD	CD	_	29	nummod	_	_
29	%	%	NN	NN	_	22	parataxis	_	_
30	and	and	CC	CC	_	29	cc	_	_
31	76	0	CD	CD	_	32	nummod	_	_
32	%	%	NN	NN	_	29	conj	_	_
33	of	of	IN	IN	_	29	prep	_	_
34	all	all	DT	DT	_	38	det	_	_
35	transgene	transgene	JJ	JJ	_	37	amod	_	_
36	-	-	HYPH	HYPH	_	37	punct	_	_
37	derived	derive	VBN	VBN	_	38	amod	_	_
38	Aβ40	aβ0	NN	NN	_	33	pobj	_	_
39	and	and	CC	CC	_	38	cc	_	_
40	Aβ42	aβ0	NN	NN	_	38	conj	_	_
41	,	,	,	,	_	29	punct	_	_
42	respectively	respectively	RB	RB	_	29	advmod	_	_
43	)	)	-RRB-	-RRB-	_	29	punct	_	_
44	.	.	.	.	_	22	punct	_	_

1	As	as	IN	IN	_	17	prep	_	_
2	in	in	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	7	det	_	_
4	PBS	pbs	NN	NN	_	6	npadvmod	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	soluble	soluble	JJ	JJ	_	7	amod	_	_
7	fraction	fraction	NN	NN	_	2	pobj	_	_
8	,	,	,	,	_	17	punct	_	_
9	Aβ	aβ	NN	NN	_	10	compound	_	_
10	levels	level	NNS	NNS	_	17	nsubjpass	_	_
11	in	in	IN	IN	_	10	prep	_	_
12	the	the	DT	DT	_	14	det	_	_
13	SDS	sds	NN	NN	_	14	compound	_	_
14	fraction	fraction	NN	NN	_	11	pobj	_	_
15	are	be	VBP	VBP	_	17	auxpass	_	_
16	significantly	significantly	RB	RB	_	17	advmod	_	_
17	lowered	lower	VBN	VBN	_	0	root	_	_
18	by	by	IN	IN	_	17	agent	_	_
19	dox	dox	NN	NN	_	20	compound	_	_
20	treatment	treatment	NN	NN	_	18	pobj	_	_
21	compared	compare	VBN	VBN	_	17	prep	_	_
22	to	to	IN	IN	_	21	prep	_	_
23	untreated	untreated	JJ	JJ	_	24	amod	_	_
24	animals	animal	NNS	NNS	_	22	pobj	_	_
25	(	(	-LRB-	-LRB-	_	40	punct	_	_
26	ANOVA	anova	NN	NN	_	27	compound	_	_
27	effect	effect	NN	NN	_	34	nsubj	_	_
28	of	of	IN	IN	_	27	prep	_	_
29	group	group	NN	NN	_	30	compound	_	_
30	F4	f0	NN	NN	_	28	pobj	_	_
31	,	,	,	,	_	30	punct	_	_
32	24	0	CD	CD	_	30	nummod	_	_
33	=	=	SYM	SYM	_	34	punct	_	_
34	197.57	0	CD	CD	_	40	ccomp	_	_
35	and	and	CC	CC	_	34	cc	_	_
36	163.48	0	CD	CD	_	34	conj	_	_
37	,	,	,	,	_	40	punct	_	_
38	p	p	NN	NN	_	40	nsubj	_	_
39	<	<	SYM	SYM	_	40	punct	_	_
40	0.001	0	CD	CD	_	24	parataxis	_	_
41	,	,	,	,	_	40	punct	_	_
42	for	for	IN	IN	_	40	prep	_	_
43	Aβ40	aβ0	NN	NN	_	42	pobj	_	_
44	and	and	CC	CC	_	43	cc	_	_
45	Aβ42	aβ0	NN	NN	_	43	conj	_	_
46	,	,	,	,	_	40	punct	_	_
47	respectively	respectively	RB	RB	_	40	advmod	_	_
48	)	)	-RRB-	-RRB-	_	40	punct	_	_
49	.	.	.	.	_	17	punct	_	_

1	Acutely	acutely	RB	RB	_	2	advmod	_	_
2	treated	treat	VBN	VBN	_	3	amod	_	_
3	animals	animal	NNS	NNS	_	4	nsubj	_	_
4	retained	retain	VBD	VBD	_	0	root	_	_
5	a	a	DT	DT	_	11	det	_	_
6	small	small	JJ	JJ	_	11	amod	_	_
7	(	(	-LRB-	-LRB-	_	9	punct	_	_
8	although	although	IN	IN	_	9	mark	_	_
9	significant	significant	JJ	JJ	_	6	parataxis	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	amount	amount	NN	NN	_	4	dobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	residual	residual	JJ	JJ	_	14	amod	_	_
14	peptide	peptide	NN	NN	_	12	pobj	_	_
15	(	(	-LRB-	-LRB-	_	27	punct	_	_
16	p	p	NN	NN	_	18	nsubj	_	_
17	<	<	SYM	SYM	_	18	punct	_	_
18	0.001	0	CD	CD	_	27	ccomp	_	_
19	compared	compare	VBN	VBN	_	18	prep	_	_
20	to	to	IN	IN	_	19	prep	_	_
21	nontransgeinc	nontransgeinc	JJ	JJ	_	20	amod	_	_
22	,	,	,	,	_	27	punct	_	_
23	Tukey	tukey	NNP	NNP	_	27	nmod	_	_
24	post	post	FW	FW	_	26	nmod	_	_
25	-	-	HYPH	HYPH	_	26	punct	_	_
26	hoc	hoc	FW	FW	_	27	nmod	_	_
27	test	test	NN	NN	_	4	parataxis	_	_
28	)	)	-RRB-	-RRB-	_	27	punct	_	_
29	,	,	,	,	_	4	punct	_	_
30	whereas	whereas	IN	IN	_	41	mark	_	_
31	Aβ	aβ	NN	NN	_	32	compound	_	_
32	levels	level	NNS	NNS	_	41	nsubjpass	_	_
33	in	in	IN	IN	sem=LOC	32	prep	_	_
34	mice	mouse	NNS	NNS	_	33	pobj	_	_
35	born	bear	VBN	VBN	_	34	acl	_	_
36	and	and	CC	CC	_	35	cc	_	_
37	raised	raise	VBN	VBN	_	35	conj	_	_
38	on	on	IN	IN	_	37	prep	_	_
39	dox	dox	NN	NN	_	38	pobj	_	_
40	were	be	VBD	VBD	_	41	auxpass	_	_
41	reduced	reduce	VBN	VBN	syn=ADV	4	advcl	_	_
42	to	to	IN	IN	_	41	prep	_	_
43	levels	level	NNS	NNS	_	42	pobj	_	_
44	indistinguishable	indistinguishable	JJ	JJ	_	43	amod	_	_
45	from	from	IN	IN	_	44	prep	_	_
46	nontransgenic	nontransgenic	JJ	JJ	_	45	amod	_	_
47	(	(	-LRB-	-LRB-	_	56	punct	_	_
48	p	p	NN	NN	_	50	nsubj	_	_
49	>	>	SYM	SYM	_	50	punct	_	_
50	0.8	0	CD	CD	_	56	ccomp	_	_
51	,	,	,	,	_	56	punct	_	_
52	Tukey	tukey	NNP	NNP	_	56	nmod	_	_
53	post	post	FW	FW	_	55	nmod	_	_
54	-	-	HYPH	HYPH	_	55	punct	_	_
55	hoc	hoc	FW	FW	_	56	nmod	_	_
56	test	test	NN	NN	_	41	parataxis	_	_
57	)	)	-RRB-	-RRB-	_	56	punct	_	_
58	.	.	.	.	_	4	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	10	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	The	the	DT	DT	_	8	det	_	_
5	FA	fa	NN	NN	_	7	npadvmod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	soluble	soluble	JJ	JJ	_	8	amod	_	_
8	fraction	fraction	NN	NN	_	10	nsubj	_	_
9	already	already	RB	RB	_	10	advmod	_	_
10	contains	contain	VBZ	VBZ	_	0	root	_	_
11	a	a	DT	DT	_	15	det	_	_
12	small	small	JJ	JJ	_	15	amod	_	_
13	but	but	CC	CC	_	12	cc	_	_
14	significant	significant	JJ	JJ	_	12	conj	_	_
15	pool	pool	NN	NN	_	10	dobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	aggregated	aggregate	VBN	VBN	_	18	amod	_	_
18	Aβ42	aβ0	NN	NN	_	16	pobj	_	_
19	in	in	IN	IN	sem=LOC	10	prep	_	_
20	untreated	untreated	JJ	JJ	_	21	amod	_	_
21	animals	animal	NNS	NNS	_	19	pobj	_	_
22	by	by	IN	IN	sem=TMP	10	prep	_	_
23	4	0	CD	CD	_	24	nummod	_	_
24	wk	wk	NN	NN	_	22	pobj	_	_
25	of	of	IN	IN	_	24	prep	_	_
26	age	age	NN	NN	_	25	pobj	_	_
27	(	(	-LRB-	-LRB-	_	54	punct	_	_
28	p	p	NN	NN	_	30	nsubj	_	_
29	<	<	SYM	SYM	_	30	punct	_	_
30	0.05	0	CD	CD	_	54	ccomp	_	_
31	versus	versus	IN	IN	_	30	prep	_	_
32	nontransgenic	nontransgenic	JJ	JJ	_	31	pobj	_	_
33	;	;	:	:	_	54	punct	_	_
34	Tukey	tukey	NNP	NNP	_	38	nmod	_	_
35	post	post	FW	FW	_	37	nmod	_	_
36	-	-	HYPH	HYPH	_	37	punct	_	_
37	hoc	hoc	FW	FW	_	38	nmod	_	_
38	test	test	NN	NN	_	50	nsubj	_	_
39	applied	apply	VBN	VBN	_	38	acl	_	_
40	to	to	IN	IN	_	39	prep	_	_
41	significant	significant	JJ	JJ	_	42	amod	_	_
42	effect	effect	NN	NN	_	40	pobj	_	_
43	of	of	IN	IN	_	42	prep	_	_
44	group	group	NN	NN	_	46	compound	_	_
45	ANOVA	anova	NN	NN	_	46	compound	_	_
46	F4	f0	NN	NN	_	43	pobj	_	_
47	,	,	,	,	_	46	punct	_	_
48	24	0	CD	CD	_	46	nummod	_	_
49	=	=	SYM	SYM	_	50	punct	_	_
50	17.11	0	CD	CD	_	54	ccomp	_	_
51	,	,	,	,	_	54	punct	_	_
52	p	p	NN	NN	_	54	nsubj	_	_
53	<	<	SYM	SYM	_	54	punct	_	_
54	0.001	0	CD	CD	_	10	parataxis	_	_
55	)	)	-RRB-	-RRB-	_	54	punct	_	_
56	.	.	.	.	_	10	punct	_	_

1	By	by	IN	IN	sem=TMP	16	prep	_	_
2	6	0	CD	CD	_	3	nummod	_	_
3	wk	wk	NN	NN	_	1	pobj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	age	age	NN	NN	_	4	pobj	_	_
6	,	,	,	,	_	16	punct	_	_
7	the	the	DT	DT	_	8	det	_	_
8	amount	amount	NN	NN	_	16	nsubjpass	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	Aβ	aβ	NN	NN	_	9	pobj	_	_
11	in	in	IN	IN	sem=LOC	8	prep	_	_
12	the	the	DT	DT	_	14	det	_	_
13	FA	fa	NN	NN	_	14	compound	_	_
14	fraction	fraction	NN	NN	_	11	pobj	_	_
15	is	be	VBZ	VBZ	_	16	auxpass	_	_
16	increased	increase	VBN	VBN	_	0	root	_	_
17	significantly	significantly	RB	RB	_	16	advmod	_	_
18	preceding	precede	VBG	VBG	sem=TMP	16	advcl	_	_
19	the	the	DT	DT	_	20	det	_	_
20	appearance	appearance	NN	NN	_	18	dobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	visible	visible	JJ	JJ	_	23	amod	_	_
23	deposits	deposit	NNS	NNS	_	21	pobj	_	_
24	2	0	CD	CD	_	25	nummod	_	_
25	wk	wk	NN	NN	_	26	npadvmod	_	_
26	later	later	RB	RB	sem=TMP	18	advmod	_	_
27	.	.	.	.	_	16	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	FA	fa	NN	NN	_	3	compound	_	_
3	pool	pool	NN	NN	_	4	nsubj	_	_
4	is	be	VBZ	VBZ	_	0	root	_	_
5	the	the	DT	DT	_	8	det	_	_
6	only	only	JJ	JJ	_	8	amod	_	_
7	peptide	peptide	NN	NN	_	8	compound	_	_
8	fraction	fraction	NN	NN	syn=PRD	4	attr	_	_
9	not	not	RB	RB	_	10	neg	_	_
10	lowered	lower	VBN	VBN	_	8	acl	_	_
11	by	by	IN	IN	_	10	agent	_	_
12	acute	acute	JJ	JJ	_	14	amod	_	_
13	dox	dox	NN	NN	_	14	compound	_	_
14	treatment	treatment	NN	NN	_	11	pobj	_	_
15	(	(	-LRB-	-LRB-	_	29	punct	_	_
16	4	0	CD	CD	_	17	nummod	_	_
17	wk	wk	NN	NN	_	25	nsubj	_	_
18	untreated	untreated	JJ	JJ	_	17	amod	_	_
19	=	=	SYM	SYM	_	25	punct	_	_
20	4	0	CD	CD	_	21	nummod	_	_
21	wk	wk	NN	NN	_	25	nmod	_	_
22	+	+	SYM	SYM	_	21	punct	_	_
23	2	0	CD	CD	_	24	nummod	_	_
24	wk	wk	NN	NN	_	21	appos	_	_
25	dox	dox	NN	NN	_	29	ccomp	_	_
26	,	,	,	,	_	29	punct	_	_
27	p	p	NN	NN	_	29	nsubj	_	_
28	>	>	SYM	SYM	_	29	punct	_	_
29	0.9	0	CD	CD	_	14	parataxis	_	_
30	,	,	,	,	_	29	punct	_	_
31	Tukey	tukey	NNP	NNP	_	35	nmod	_	_
32	post	post	FW	FW	_	34	advmod	_	_
33	-	-	HYPH	HYPH	_	34	punct	_	_
34	hoc	hoc	FW	FW	_	35	amod	_	_
35	test	test	NN	NN	syn=ADV	29	npadvmod	_	_
36	)	)	-RRB-	-RRB-	_	29	punct	_	_
37	,	,	,	,	_	4	punct	_	_
38	consistent	consistent	JJ	JJ	syn=PRD	4	advcl	_	_
39	with	with	IN	IN	_	38	prep	_	_
40	poor	poor	JJ	JJ	_	41	amod	_	_
41	turnover	turnover	NN	NN	_	39	pobj	_	_
42	of	of	IN	IN	_	41	prep	_	_
43	aggregated	aggregate	VBN	VBN	_	45	amod	_	_
44	Aβ	aβ	NN	NN	_	45	compound	_	_
45	species	species	NNS	NNS	_	42	pobj	_	_
46	.	.	.	.	_	4	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	D	d	LS	LS	_	18	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Measurements	measurement	NNS	NNS	_	18	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	total	total	JJ	JJ	_	7	amod	_	_
7	Aβ	aβ	NN	NN	_	5	pobj	_	_
8	,	,	,	,	_	4	punct	_	_
9	including	include	VBG	VBG	_	4	prep	_	_
10	both	both	CC	CC	_	11	preconj	_	_
11	endogenous	endogenous	JJ	JJ	_	16	amod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	transgene	transgene	NN	NN	_	15	npadvmod	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	derived	derive	VBN	VBN	_	11	conj	_	_
16	peptides	peptide	NNS	NNS	_	9	pobj	_	_
17	,	,	,	,	_	18	punct	_	_
18	show	show	VBP	VBP	_	0	root	_	_
19	that	that	IN	IN	_	26	mark	_	_
20	animals	animal	NNS	NNS	_	26	nsubj	_	_
21	born	bear	VBN	VBN	_	20	acl	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	raised	raise	VBN	VBN	_	21	conj	_	_
24	on	on	IN	IN	_	23	prep	_	_
25	dox	dox	NN	NN	_	24	pobj	_	_
26	harbor	harbor	VBP	VBP	_	18	ccomp	_	_
27	Aβ	aβ	NN	NN	_	28	compound	_	_
28	levels	level	NNS	NNS	_	26	dobj	_	_
29	identical	identical	JJ	JJ	_	28	amod	_	_
30	to	to	IN	IN	_	29	prep	_	_
31	nontransgenic	nontransgenic	JJ	JJ	_	32	amod	_	_
32	animals	animal	NNS	NNS	_	30	pobj	_	_
33	(	(	-LRB-	-LRB-	_	58	punct	_	_
34	p	p	NN	NN	_	36	nsubj	_	_
35	>	>	SYM	SYM	_	36	punct	_	_
36	0.9	0	CD	CD	_	58	ccomp	_	_
37	,	,	,	,	_	36	punct	_	_
38	Tukey	tukey	NNP	NNP	_	42	nmod	_	_
39	post	post	FW	FW	_	41	advmod	_	_
40	-	-	HYPH	HYPH	_	41	punct	_	_
41	hoc	hoc	FW	FW	_	42	amod	_	_
42	test	test	NN	NN	syn=ADV	36	npadvmod	_	_
43	,	,	,	,	_	36	punct	_	_
44	effect	effect	NN	NN	_	52	nsubj	_	_
45	of	of	IN	IN	_	44	prep	_	_
46	group	group	NN	NN	_	48	compound	_	_
47	ANOVA	anova	NN	NN	_	48	compound	_	_
48	F4	f0	NN	NN	_	45	pobj	_	_
49	,	,	,	,	_	48	punct	_	_
50	24	0	CD	CD	_	48	nummod	_	_
51	=	=	SYM	SYM	_	52	punct	_	_
52	39.13	0	CD	CD	_	58	ccomp	_	_
53	and	and	CC	CC	_	52	cc	_	_
54	35.29	0	CD	CD	_	52	conj	_	_
55	,	,	,	,	_	58	punct	_	_
56	p	p	NN	NN	_	58	nsubj	_	_
57	<	<	SYM	SYM	_	58	punct	_	_
58	0.001	0	CD	CD	_	26	parataxis	_	_
59	,	,	,	,	_	58	punct	_	_
60	for	for	IN	IN	_	58	prep	_	_
61	Aβ40	aβ0	NN	NN	_	60	pobj	_	_
62	and	and	CC	CC	_	61	cc	_	_
63	Aβ42	aβ0	NN	NN	_	61	conj	_	_
64	,	,	,	,	_	58	punct	_	_
65	respectively	respectively	RB	RB	_	58	advmod	_	_
66	)	)	-RRB-	-RRB-	_	58	punct	_	_
67	.	.	.	.	_	18	punct	_	_

1	Whereas	whereas	IN	IN	_	6	mark	_	_
2	chronic	chronic	JJ	JJ	_	4	amod	_	_
3	transgene	transgene	NN	NN	_	4	compound	_	_
4	suppression	suppression	NN	NN	_	6	nsubj	_	_
5	fully	fully	RB	RB	_	6	advmod	_	_
6	prevents	prevent	VBZ	VBZ	syn=ADV	16	advcl	_	_
7	synthesis	synthesis	NN	NN	_	6	dobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	both	both	DT	DT	_	10	det	_	_
10	peptides	peptide	NNS	NNS	_	8	pobj	_	_
11	,	,	,	,	_	16	punct	_	_
12	acute	acute	JJ	JJ	_	14	amod	_	_
13	dox	dox	NN	NN	_	14	compound	_	_
14	treatment	treatment	NN	NN	_	16	nsubj	_	_
15	fully	fully	RB	RB	_	16	advmod	_	_
16	suppresses	suppress	VBZ	VBZ	_	0	root	_	_
17	Aβ40	aβ0	NN	NN	_	18	compound	_	_
18	levels	level	NNS	NNS	_	16	dobj	_	_
19	(	(	-LRB-	-LRB-	_	28	punct	_	_
20	p	p	NN	NN	_	22	nsubj	_	_
21	>	>	SYM	SYM	_	22	punct	_	_
22	0.8	0	CD	CD	_	28	ccomp	_	_
23	,	,	,	,	_	28	punct	_	_
24	Tukey	tukey	NNP	NNP	_	28	nmod	_	_
25	post	post	FW	FW	_	27	advmod	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	hoc	hoc	FW	FW	_	28	amod	_	_
28	test	test	NN	NN	_	16	parataxis	_	_
29	)	)	-RRB-	-RRB-	_	28	punct	_	_
30	,	,	,	,	_	16	punct	_	_
31	but	but	CC	CC	_	16	cc	_	_
32	leaves	leave	VBZ	VBZ	_	16	conj	_	_
33	a	a	DT	DT	_	35	det	_	_
34	small	small	JJ	JJ	_	35	amod	_	_
35	amount	amount	NN	NN	_	32	dobj	_	_
36	of	of	IN	IN	_	35	prep	_	_
37	nonsuppressed	nonsuppressed	JJ	JJ	_	38	amod	_	_
38	Aβ42	aβ0	NN	NN	_	36	pobj	_	_
39	.	.	.	.	_	16	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	residual	residual	JJ	JJ	_	3	amod	_	_
3	Aβ42	aβ0	NN	NN	_	10	nsubj	_	_
4	observed	observe	VBN	VBN	_	3	acl	_	_
5	in	in	IN	IN	sem=LOC	4	prep	_	_
6	acutely	acutely	RB	RB	_	7	advmod	_	_
7	treated	treat	VBN	VBN	_	9	amod	_	_
8	young	young	JJ	JJ	_	9	amod	_	_
9	animals	animal	NNS	NNS	_	5	pobj	_	_
10	derives	derive	VBZ	VBZ	_	0	root	_	_
11	from	from	IN	IN	_	10	prep	_	_
12	uncleared	uncleared	JJ	JJ	_	13	amod	_	_
13	aggregates	aggregate	NNS	NNS	_	11	pobj	_	_
14	extracted	extract	VBN	VBN	_	13	amod	_	_
15	in	in	IN	IN	sem=LOC	10	prep	_	_
16	the	the	DT	DT	_	20	det	_	_
17	SDS	sds	NN	NN	_	20	nmod	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	FA	fa	NN	NN	_	17	conj	_	_
20	fractions	fraction	NNS	NNS	_	15	pobj	_	_
21	.	.	.	.	_	10	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.05	0	CD	CD	_	17	ccomp	_	_
6	;	;	:	:	_	17	punct	_	_
7	**	**	SYM	SYM	_	11	punct	_	_
8	,	,	,	,	_	11	punct	_	_
9	p	p	NN	NN	_	11	nsubj	_	_
10	<	<	SYM	SYM	_	11	punct	_	_
11	0.005	0	CD	CD	_	17	ccomp	_	_
12	;	;	:	:	_	17	punct	_	_
13	***	**	SYM	SYM	_	17	punct	_	_
14	,	,	,	,	_	17	punct	_	_
15	p	p	NN	NN	_	17	nsubj	_	_
16	<	<	SYM	SYM	_	17	punct	_	_
17	0.001	0	CD	CD	_	0	root	_	_
18	versus	versus	IN	IN	_	17	prep	_	_
19	4	0	CD	CD	_	21	nummod	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	wk	wk	NN	NN	_	23	npadvmod	_	_
22	-	-	HYPH	HYPH	_	23	punct	_	_
23	old	old	JJ	JJ	_	25	amod	_	_
24	untreated	untreated	JJ	JJ	_	25	amod	_	_
25	mice	mouse	NNS	NNS	_	18	pobj	_	_
26	,	,	,	,	_	17	punct	_	_
27	Tukey	tukey	NNP	NNP	syn=ADV	17	npadvmod	_	_
28	post	post	FW	FW	_	27	nmod	_	_
29	-	-	HYPH	HYPH	_	27	punct	_	_
30	hoc	hoc	FW	FW	_	27	nmod	_	_
31	applied	apply	VBN	VBN	_	27	acl	_	_
32	to	to	IN	IN	_	31	prep	_	_
33	significant	significant	JJ	JJ	_	34	amod	_	_
34	effect	effect	NN	NN	_	32	pobj	_	_
35	of	of	IN	IN	_	34	prep	_	_
36	group	group	NN	NN	_	37	compound	_	_
37	ANOVA	anova	NN	NN	_	35	pobj	_	_
38	.	.	.	.	_	17	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	3	0	CD	CD	_	1	nummod	_	_

1	Robust	robust	JJ	JJ	_	3	amod	_	_
2	Transgene	transgene	NN	NN	_	3	compound	_	_
3	Suppression	suppression	NN	NN	_	0	root	_	_
4	in	in	IN	IN	sem=LOC	3	prep	_	_
5	Older	older	JJ	JJ	_	6	amod	_	_
6	Mice	mouse	NNS	NNS	_	4	pobj	_	_
7	with	with	IN	IN	_	6	prep	_	_
8	Preexisting	preexist	VBG	VBG	_	10	amod	_	_
9	Amyloid	amyloid	NN	NN	_	10	compound	_	_
10	Pathology	pathology	NN	NN	_	7	pobj	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	27	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Cortical	cortical	JJ	JJ	_	5	amod	_	_
5	homogenates	homogenate	NNS	NNS	_	27	nsubjpass	_	_
6	from	from	IN	IN	_	5	prep	_	_
7	6	0	CD	CD	_	10	quantmod	_	_
8	-	-	HYPH	HYPH	_	10	punct	_	_
9	to	to	IN	IN	_	10	quantmod	_	_
10	12	0	CD	CD	_	12	nummod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	mo	mo	NN	NN	_	14	npadvmod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	old	old	JJ	JJ	_	15	amod	_	_
15	animals	animal	NNS	NNS	_	6	pobj	_	_
16	used	use	VBN	VBN	_	15	acl	_	_
17	for	for	IN	IN	_	16	prep	_	_
18	pathology	pathology	NN	NN	_	19	compound	_	_
19	studies	study	NNS	NNS	_	17	pobj	_	_
20	described	describe	VBN	VBN	_	19	acl	_	_
21	below	below	RB	RB	_	20	advmod	_	_
22	(	(	-LRB-	-LRB-	_	23	punct	_	_
23	line	line	NN	NN	_	20	parataxis	_	_
24	107	0	CD	CD	_	23	nummod	_	_
25	)	)	-RRB-	-RRB-	_	23	punct	_	_
26	were	be	VBD	VBD	_	27	auxpass	_	_
27	immunoblotted	immunoblotted	VBN	VBN	_	0	root	_	_
28	with	with	IN	IN	sem=MNR	27	prep	_	_
29	human	human	JJ	JJ	_	31	amod	_	_
30	-	-	HYPH	HYPH	_	31	punct	_	_
31	specific	specific	JJ	JJ	_	33	amod	_	_
32	antibody	antibody	NN	NN	_	33	compound	_	_
33	6E10	0e0	NN	NN	_	28	pobj	_	_
34	to	to	TO	TO	_	35	aux	_	_
35	examine	examine	VB	VB	sem=PRP	27	advcl	_	_
36	transgene	transgene	NN	NN	_	37	compound	_	_
37	suppression	suppression	NN	NN	_	35	dobj	_	_
38	following	follow	VBG	VBG	_	35	prep	_	_
39	3	0	CD	CD	_	42	nummod	_	_
40	or	or	CC	CC	_	39	cc	_	_
41	6	0	CD	CD	_	39	conj	_	_
42	mo	mo	NN	NN	_	38	pobj	_	_
43	of	of	IN	IN	_	42	prep	_	_
44	dox	dox	NN	NN	_	45	compound	_	_
45	treatment	treatment	NN	NN	_	43	pobj	_	_
46	.	.	.	.	_	27	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	blot	blot	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	co-immunostained	co-immunostained	VBN	VBN	_	0	root	_	_
5	for	for	IN	IN	_	4	prep	_	_
6	endogenous	endogenous	JJ	JJ	_	8	amod	_	_
7	superoxide	superoxide	NN	NN	_	8	compound	_	_
8	dismutase	dismutase	NN	NN	_	5	pobj	_	_
9	1	0	CD	CD	_	8	nummod	_	_
10	(	(	-LRB-	-LRB-	_	8	punct	_	_
11	SOD1	sod0	NN	NN	_	8	appos	_	_
12	)	)	-RRB-	-RRB-	_	4	punct	_	_
13	as	as	IN	IN	_	4	prep	_	_
14	a	a	DT	DT	_	15	det	_	_
15	control	control	NN	NN	_	13	pobj	_	_
16	for	for	IN	IN	_	15	prep	_	_
17	loading	loading	NN	NN	_	16	pobj	_	_
18	.	.	.	.	_	4	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	4	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Quantitation	quantitation	NN	NN	_	0	root	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	signal	signal	NN	NN	_	7	compound	_	_
7	intensity	intensity	NN	NN	_	5	pobj	_	_
8	from	from	IN	IN	_	4	prep	_	_
9	the	the	DT	DT	_	11	det	_	_
10	Western	western	NNP	NNP	_	11	compound	_	_
11	blot	blot	NN	NN	_	8	pobj	_	_
12	shown	show	VBN	VBN	_	11	acl	_	_
13	in	in	IN	IN	_	12	prep	_	_
14	(	(	-LRB-	-LRB-	_	13	punct	_	_
15	A	a	NN	NN	_	13	pobj	_	_
16	)	)	-RRB-	-RRB-	_	4	punct	_	_
17	.	.	.	.	_	4	punct	_	_

1	Transgenic	transgenic	JJ	JJ	_	3	amod	_	_
2	APP	app	NN	NN	_	3	compound	_	_
3	levels	level	NNS	NNS	_	6	nsubjpass	_	_
4	are	be	VBP	VBP	_	6	auxpass	_	_
5	significantly	significantly	RB	RB	_	6	advmod	_	_
6	suppressed	suppress	VBN	VBN	_	0	root	_	_
7	following	follow	VBG	VBG	sem=TMP	6	prep	_	_
8	3	0	CD	CD	_	11	nummod	_	_
9	or	or	CC	CC	_	8	cc	_	_
10	6	0	CD	CD	_	8	conj	_	_
11	mo	mo	NN	NN	_	7	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	dox	dox	NN	NN	_	14	compound	_	_
14	treatment	treatment	NN	NN	_	12	pobj	_	_
15	(	(	-LRB-	-LRB-	_	17	punct	_	_
16	96.9	0	CD	CD	_	17	nummod	_	_
17	%	%	NN	NN	_	6	parataxis	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	97.6	0	CD	CD	_	20	nummod	_	_
20	%	%	NN	NN	_	17	conj	_	_
21	,	,	,	,	_	17	punct	_	_
22	respectively	respectively	RB	RB	_	17	advmod	_	_
23	)	)	-RRB-	-RRB-	_	17	punct	_	_
24	.	.	.	.	_	6	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.001	0	CD	CD	_	36	ccomp	_	_
6	compared	compare	VBN	VBN	_	5	prep	_	_
7	to	to	IN	IN	_	6	prep	_	_
8	6	0	CD	CD	_	10	nummod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	mo	mo	NN	NN	_	12	npadvmod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	old	old	JJ	JJ	_	14	amod	_	_
13	untreated	untreated	JJ	JJ	_	14	amod	_	_
14	animals	animal	NNS	NNS	_	7	pobj	_	_
15	,	,	,	,	_	36	punct	_	_
16	Tukey	tukey	NNP	NNP	_	20	nmod	_	_
17	post	post	FW	FW	_	19	advmod	_	_
18	-	-	HYPH	HYPH	_	19	punct	_	_
19	hoc	hoc	FW	FW	_	20	amod	_	_
20	test	test	NN	NN	_	32	nsubj	_	_
21	applied	apply	VBN	VBN	_	20	acl	_	_
22	to	to	IN	IN	_	21	prep	_	_
23	significant	significant	JJ	JJ	_	24	amod	_	_
24	effect	effect	NN	NN	_	22	pobj	_	_
25	of	of	IN	IN	_	24	prep	_	_
26	group	group	NN	NN	_	28	compound	_	_
27	ANOVA	anova	NN	NN	_	28	compound	_	_
28	F3	f0	NN	NN	_	25	pobj	_	_
29	,	,	,	,	_	28	punct	_	_
30	12	0	CD	CD	_	28	nummod	_	_
31	=	=	SYM	SYM	_	32	punct	_	_
32	107.22	0	CD	CD	_	36	ccomp	_	_
33	,	,	,	,	_	36	punct	_	_
34	p	p	NN	NN	_	36	nsubj	_	_
35	<	<	SYM	SYM	_	36	punct	_	_
36	0.001	0	CD	CD	_	0	root	_	_
37	.	.	.	.	_	36	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	9	mark	_	_
5	strong	strong	JJ	JJ	_	7	amod	_	_
6	transgene	transgene	NN	NN	_	7	compound	_	_
7	suppression	suppression	NN	NN	_	9	nsubjpass	_	_
8	is	be	VBZ	VBZ	_	9	auxpass	_	_
9	attained	attain	VBN	VBN	_	3	ccomp	_	_
10	both	both	CC	CC	_	11	preconj	_	_
11	before	before	IN	IN	sem=TMP	9	prep	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	after	after	IN	IN	_	11	conj	_	_
14	the	the	DT	DT	_	15	det	_	_
15	onset	onset	NN	NN	_	13	pobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	amyloid	amyloid	NN	NN	_	18	compound	_	_
18	pathology	pathology	NN	NN	_	16	pobj	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	see	see	VB	VB	_	9	parataxis	_	_
21	Figure	figure	NN	NN	_	20	dobj	_	_
22	1	0	CD	CD	_	21	nummod	_	_
23	for	for	IN	IN	_	20	prep	_	_
24	predeposit	predeposit	JJ	JJ	_	25	amod	_	_
25	experiments	experiment	NNS	NNS	_	23	pobj	_	_
26	)	)	-RRB-	-RRB-	_	20	punct	_	_
27	.	.	.	.	_	3	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	5	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Experimental	experimental	JJ	JJ	_	5	amod	_	_
5	design	design	NN	NN	_	0	root	_	_
6	.	.	.	.	_	5	punct	_	_

1	To	to	TO	TO	_	2	aux	_	_
2	examine	examine	VB	VB	sem=PRP	19	advcl	_	_
3	the	the	DT	DT	_	4	det	_	_
4	effects	effect	NNS	NNS	_	2	dobj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	chronic	chronic	JJ	JJ	_	8	amod	_	_
7	Aβ	aβ	NN	NN	_	8	compound	_	_
8	suppression	suppression	NN	NN	_	5	pobj	_	_
9	on	on	IN	IN	_	4	prep	_	_
10	amyloid	amyloid	NN	NN	_	11	compound	_	_
11	pathology	pathology	NN	NN	_	9	pobj	_	_
12	after	after	IN	IN	sem=TMP	2	prep	_	_
13	the	the	DT	DT	_	14	det	_	_
14	onset	onset	NN	NN	_	12	pobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	deposition	deposition	NN	NN	_	15	pobj	_	_
17	,	,	,	,	_	19	punct	_	_
18	we	we	PRP	PRP	_	19	nsubj	_	_
19	compared	compare	VBD	VBD	_	0	root	_	_
20	untreated	untreated	JJ	JJ	_	21	amod	_	_
21	controls	control	NNS	NNS	_	19	dobj	_	_
22	harvested	harvest	VBN	VBN	_	21	acl	_	_
23	at	at	IN	IN	sem=TMP	22	prep	_	_
24	6	0	CD	CD	_	27	nummod	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	9	0	CD	CD	_	24	conj	_	_
27	mo	mo	NN	NN	_	23	pobj	_	_
28	of	of	IN	IN	_	27	prep	_	_
29	age	age	NN	NN	_	28	pobj	_	_
30	to	to	IN	IN	_	22	prep	_	_
31	animals	animal	NNS	NNS	_	30	pobj	_	_
32	placed	place	VBN	VBN	_	31	acl	_	_
33	on	on	IN	IN	_	32	prep	_	_
34	dox	dox	NN	NN	_	33	pobj	_	_
35	at	at	IN	IN	sem=TMP	32	prep	_	_
36	6	0	CD	CD	_	37	nummod	_	_
37	mo	mo	NN	NN	_	35	pobj	_	_
38	of	of	IN	IN	_	37	prep	_	_
39	age	age	NN	NN	_	38	pobj	_	_
40	and	and	CC	CC	_	32	cc	_	_
41	harvested	harvest	VBN	VBN	_	32	conj	_	_
42	after	after	IN	IN	sem=TMP	41	prep	_	_
43	3	0	CD	CD	_	46	nummod	_	_
44	or	or	CC	CC	_	43	cc	_	_
45	6	0	CD	CD	_	43	conj	_	_
46	mo	mo	NN	NN	_	42	pobj	_	_
47	of	of	IN	IN	_	46	prep	_	_
48	treatment	treatment	NN	NN	_	47	pobj	_	_
49	.	.	.	.	_	19	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	D	d	LS	LS	_	6	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Dox	dox	NN	NN	_	5	compound	_	_
5	treatment	treatment	NN	NN	_	6	nsubj	_	_
6	leads	lead	VBZ	VBZ	_	0	root	_	_
7	to	to	IN	IN	_	6	prep	_	_
8	rapid	rapid	JJ	JJ	_	10	amod	_	_
9	transgene	transgene	NN	NN	_	10	compound	_	_
10	suppression	suppression	NN	NN	_	7	pobj	_	_
11	even	even	RB	RB	_	12	advmod	_	_
12	in	in	IN	IN	sem=LOC	6	prep	_	_
13	6	0	CD	CD	_	15	nummod	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	mo	mo	NN	NN	_	17	npadvmod	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	old	old	JJ	JJ	_	21	amod	_	_
18	tTA	tta	NN	NN	_	20	compound	_	_
19	/	/	HYPH	HYPH	_	20	punct	_	_
20	APP	app	NN	NN	_	21	compound	_	_
21	mice	mouse	NNS	NNS	_	12	pobj	_	_
22	.	.	.	.	_	6	punct	_	_

1	Immunostaining	immunostaining	NN	NN	_	11	nsubjpass	_	_
2	with	with	IN	IN	_	1	prep	_	_
3	6E10	0e0	NN	NN	_	2	pobj	_	_
4	shows	show	VBZ	VBZ	_	1	acl	_	_
5	APPswe	appswe	NN	NN	_	7	compound	_	_
6	/	/	HYPH	HYPH	_	7	punct	_	_
7	ind	ind	NN	NN	_	8	compound	_	_
8	levels	level	NNS	NNS	_	4	dobj	_	_
9	are	be	VBP	VBP	_	11	auxpass	_	_
10	dramatically	dramatically	RB	RB	_	11	advmod	_	_
11	reduced	reduce	VBN	VBN	_	0	root	_	_
12	in	in	IN	IN	sem=LOC	11	prep	_	_
13	6	0	CD	CD	_	15	nummod	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	mo	mo	NN	NN	_	17	npadvmod	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	old	old	JJ	JJ	_	18	amod	_	_
18	mice	mouse	NNS	NNS	_	12	pobj	_	_
19	treated	treat	VBN	VBN	_	18	acl	_	_
20	for	for	IN	IN	sem=EXT	19	prep	_	_
21	1	0	CD	CD	_	22	nummod	_	_
22	wk	wk	NN	NN	_	20	pobj	_	_
23	with	with	IN	IN	sem=MNR	19	prep	_	_
24	dox	dox	NN	NN	_	23	pobj	_	_
25	(	(	-LRB-	-LRB-	_	27	punct	_	_
26	upper	upper	JJ	JJ	_	27	amod	_	_
27	panel	panel	NN	NN	_	19	parataxis	_	_
28	)	)	-RRB-	-RRB-	_	27	punct	_	_
29	.	.	.	.	_	11	punct	_	_

1	A	a	DT	DT	_	3	det	_	_
2	separate	separate	JJ	JJ	_	3	amod	_	_
3	blot	blot	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	immunostained	immunostained	VBN	VBN	_	0	root	_	_
6	for	for	IN	IN	_	5	prep	_	_
7	APP	app	NN	NN	_	8	compound	_	_
8	C	c	NN	NN	_	10	npadvmod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	terminal	terminal	JJ	JJ	_	11	amod	_	_
11	fragments	fragment	NNS	NNS	_	6	pobj	_	_
12	with	with	IN	IN	sem=MNR	5	prep	_	_
13	CT15	ct0	NN	NN	_	14	compound	_	_
14	antibody	antibody	NN	NN	_	12	pobj	_	_
15	to	to	TO	TO	_	16	aux	_	_
16	show	show	VB	VB	sem=PRP	5	advcl	_	_
17	that	that	IN	IN	_	24	mark	_	_
18	the	the	DT	DT	_	19	det	_	_
19	precursors	precursor	NNS	NNS	_	24	nsubjpass	_	_
20	to	to	IN	IN	_	19	prep	_	_
21	Aβ	aβ	NN	NN	_	22	compound	_	_
22	cleavage	cleavage	NN	NN	_	20	pobj	_	_
23	are	be	VBP	VBP	_	24	auxpass	_	_
24	decreased	decrease	VBN	VBN	_	16	ccomp	_	_
25	in	in	IN	IN	_	24	prep	_	_
26	parallel	parallel	NN	NN	_	25	pobj	_	_
27	with	with	IN	IN	_	26	prep	_	_
28	the	the	DT	DT	_	32	det	_	_
29	full	full	JJ	JJ	_	31	amod	_	_
30	-	-	HYPH	HYPH	_	31	punct	_	_
31	length	length	NN	NN	_	32	compound	_	_
32	protein	protein	NN	NN	_	27	pobj	_	_
33	(	(	-LRB-	-LRB-	_	35	punct	_	_
34	middle	middle	JJ	JJ	_	35	amod	_	_
35	panel	panel	NN	NN	_	5	parataxis	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	.	.	.	.	_	5	punct	_	_

1	Costaining	costaining	NN	NN	_	7	nsubjpass	_	_
2	for	for	IN	IN	_	1	prep	_	_
3	superoxide	superoxide	NN	NN	_	4	compound	_	_
4	dismutase	dismutase	NN	NN	_	2	pobj	_	_
5	1	0	CD	CD	_	4	nummod	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	used	use	VBN	VBN	_	0	root	_	_
8	as	as	IN	IN	_	7	prep	_	_
9	an	an	DT	DT	_	11	det	_	_
10	internal	internal	JJ	JJ	_	11	amod	_	_
11	control	control	NN	NN	_	8	pobj	_	_
12	for	for	IN	IN	_	11	prep	_	_
13	loading	loading	NN	NN	_	12	pobj	_	_
14	(	(	-LRB-	-LRB-	_	16	punct	_	_
15	lower	lower	JJ	JJ	_	16	amod	_	_
16	panel	panel	NN	NN	_	7	parataxis	_	_
17	,	,	,	,	_	16	punct	_	_
18	taken	take	VBN	VBN	_	16	acl	_	_
19	from	from	IN	IN	_	18	prep	_	_
20	bottom	bottom	JJ	JJ	_	21	amod	_	_
21	half	half	NN	NN	_	19	pobj	_	_
22	of	of	IN	IN	_	21	prep	_	_
23	6E10	0e0	NN	NN	_	24	compound	_	_
24	blot	blot	NN	NN	_	22	pobj	_	_
25	)	)	-RRB-	-RRB-	_	16	punct	_	_
26	.	.	.	.	_	7	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	4	0	CD	CD	_	1	nummod	_	_

1	Suppression	suppression	NN	NN	_	5	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	Transgenic	transgenic	JJ	JJ	_	4	amod	_	_
4	APP	app	NN	NN	_	2	pobj	_	_
5	Arrests	arrest	VBZ	VBZ	_	0	root	_	_
6	Progression	progression	NN	NN	_	5	dobj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	Amyloid	amyloid	NN	NN	_	9	compound	_	_
9	Pathology	pathology	NN	NN	_	7	pobj	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	7	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Aggregated	aggregate	VBN	VBN	_	5	amod	_	_
5	Aβ	aβ	NN	NN	_	7	nsubjpass	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	quantified	quantify	VBN	VBN	_	0	root	_	_
8	in	in	IN	IN	sem=LOC	7	prep	_	_
9	cortical	cortical	JJ	JJ	_	10	amod	_	_
10	tissue	tissue	NN	NN	_	8	pobj	_	_
11	from	from	IN	IN	_	10	prep	_	_
12	dox	dox	NN	NN	_	14	npadvmod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	treated	treat	VBN	VBN	_	20	amod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	control	control	NN	NN	_	14	conj	_	_
17	tTA	tta	NN	NN	_	19	compound	_	_
18	/	/	HYPH	HYPH	_	19	punct	_	_
19	APP	app	NN	NN	_	20	compound	_	_
20	mice	mouse	NNS	NNS	_	11	pobj	_	_
21	(	(	-LRB-	-LRB-	_	22	punct	_	_
22	line	line	NN	NN	_	20	parataxis	_	_
23	107	0	CD	CD	_	22	nummod	_	_
24	)	)	-RRB-	-RRB-	_	22	punct	_	_
25	using	use	VBG	VBG	sem=MNR	7	advcl	_	_
26	a	a	DT	DT	_	29	det	_	_
27	filter	filter	NN	NN	_	29	compound	_	_
28	trap	trap	NN	NN	_	29	compound	_	_
29	assay	assay	NN	NN	_	25	dobj	_	_
30	.	.	.	.	_	7	punct	_	_

1	Serial	serial	JJ	JJ	_	2	amod	_	_
2	dilutions	dilution	NNS	NNS	_	7	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	protein	protein	NN	NN	_	5	compound	_	_
5	homogenate	homogenate	NN	NN	_	3	pobj	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	passed	pass	VBN	VBN	_	22	ccomp	_	_
8	through	through	IN	IN	_	7	prep	_	_
9	a	a	DT	DT	_	12	det	_	_
10	cellulose	cellulose	NN	NN	_	12	compound	_	_
11	acetate	acetate	NN	NN	_	12	compound	_	_
12	filter	filter	NN	NN	_	8	pobj	_	_
13	;	;	:	:	_	22	punct	_	_
14	protein	protein	NN	NN	_	15	compound	_	_
15	aggregates	aggregate	NNS	NNS	_	22	nsubjpass	_	_
16	larger	large	JJR	JJR	_	15	amod	_	_
17	than	than	IN	IN	_	16	prep	_	_
18	the	the	DT	DT	_	20	det	_	_
19	pore	pore	NN	NN	_	20	compound	_	_
20	size	size	NN	NN	_	17	pobj	_	_
21	were	be	VBD	VBD	_	22	auxpass	_	_
22	trapped	trap	VBN	VBN	_	0	root	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	immunostained	immunostained	VBN	VBN	_	22	conj	_	_
25	for	for	IN	IN	_	24	prep	_	_
26	Aβ	aβ	NN	NN	_	25	pobj	_	_
27	.	.	.	.	_	22	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	26	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Quantitation	quantitation	NN	NN	_	26	nsubjpass	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	signal	signal	NN	NN	_	7	compound	_	_
7	intensity	intensity	NN	NN	_	5	pobj	_	_
8	in	in	IN	IN	sem=LOC	4	prep	_	_
9	the	the	DT	DT	_	11	det	_	_
10	linear	linear	JJ	JJ	_	11	amod	_	_
11	range	range	NN	NN	_	8	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	each	each	DT	DT	_	17	det	_	_
14	filter	filter	NN	NN	_	15	compound	_	_
15	trap	trap	NN	NN	_	17	compound	_	_
16	dilution	dilution	NN	NN	_	17	compound	_	_
17	series	series	NNS	NNS	_	12	pobj	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	arrow	arrow	NN	NN	_	17	parataxis	_	_
20	in	in	IN	IN	_	19	prep	_	_
21	[	[	-LRB-	-LRB-	_	20	punct	_	_
22	A	a	NN	NN	_	20	pobj	_	_
23	]	]	-RRB-	-RRB-	_	19	punct	_	_
24	)	)	-RRB-	-RRB-	_	19	punct	_	_
25	was	be	VBD	VBD	_	26	auxpass	_	_
26	used	use	VBN	VBN	_	0	root	_	_
27	to	to	TO	TO	_	28	aux	_	_
28	compare	compare	VB	VB	sem=PRP	26	advcl	_	_
29	aggregate	aggregate	JJ	JJ	_	30	amod	_	_
30	load	load	NN	NN	_	28	dobj	_	_
31	across	across	IN	IN	_	28	prep	_	_
32	treatment	treatment	NN	NN	_	33	compound	_	_
33	groups	group	NNS	NNS	_	31	pobj	_	_
34	.	.	.	.	_	26	punct	_	_

1	Aggregated	aggregate	VBN	VBN	_	2	amod	_	_
2	Aβ	aβ	NN	NN	_	3	nsubj	_	_
3	increased	increase	VBD	VBD	_	0	root	_	_
4	significantly	significantly	RB	RB	sem=EXT	3	advmod	_	_
5	between	between	IN	IN	sem=TMP	3	prep	_	_
6	6	0	CD	CD	_	9	nummod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	9	0	CD	CD	_	6	conj	_	_
9	mo	mo	NN	NN	_	5	pobj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	age	age	NN	NN	_	10	pobj	_	_
12	in	in	IN	IN	sem=LOC	3	prep	_	_
13	untreated	untreated	JJ	JJ	_	14	amod	_	_
14	mice	mouse	NNS	NNS	_	12	pobj	_	_
15	(	(	-LRB-	-LRB-	_	29	punct	_	_
16	significant	significant	JJ	JJ	_	17	amod	_	_
17	effect	effect	NN	NN	_	25	nsubj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	group	group	NN	NN	_	21	compound	_	_
20	ANOVA	anova	NN	NN	_	21	compound	_	_
21	F3	f0	NN	NN	_	18	pobj	_	_
22	,	,	,	,	_	21	punct	_	_
23	18	0	CD	CD	_	21	nummod	_	_
24	=	=	SYM	SYM	_	25	punct	_	_
25	7.85	0	CD	CD	_	29	ccomp	_	_
26	,	,	,	,	_	29	punct	_	_
27	p	p	NN	NN	_	29	nsubj	_	_
28	<	<	SYM	SYM	_	29	punct	_	_
29	0.002	0	CD	CD	_	3	parataxis	_	_
30	)	)	-RRB-	-RRB-	_	29	punct	_	_
31	.	.	.	.	_	3	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	progression	progression	NN	NN	_	7	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	pathology	pathology	NN	NN	_	3	pobj	_	_
5	was	be	VBD	VBD	_	7	auxpass	_	_
6	completely	completely	RB	RB	_	7	advmod	_	_
7	prevented	prevent	VBN	VBN	_	0	root	_	_
8	by	by	IN	IN	_	7	agent	_	_
9	transgene	transgene	NN	NN	_	10	compound	_	_
10	suppression	suppression	NN	NN	_	8	pobj	_	_
11	.	.	.	.	_	7	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	amount	amount	NN	NN	_	6	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	aggregated	aggregate	VBN	VBN	_	5	amod	_	_
5	Aβ	aβ	NN	NN	_	3	pobj	_	_
6	was	be	VBD	VBD	_	0	root	_	_
7	identical	identical	JJ	JJ	syn=PRD	6	acomp	_	_
8	in	in	IN	IN	sem=LOC	6	prep	_	_
9	untreated	untreated	JJ	JJ	_	10	amod	_	_
10	mice	mouse	NNS	NNS	_	8	pobj	_	_
11	at	at	IN	IN	sem=TMP	6	prep	_	_
12	6	0	CD	CD	_	13	nummod	_	_
13	mo	mo	NN	NN	_	11	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	age	age	NN	NN	_	14	pobj	_	_
16	to	to	IN	IN	_	6	prep	_	_
17	that	that	DT	DT	_	16	pobj	_	_
18	in	in	IN	IN	sem=LOC	17	prep	_	_
19	9	0	CD	CD	_	24	nummod	_	_
20	-	-	HYPH	HYPH	_	19	punct	_	_
21	or	or	CC	CC	_	19	cc	_	_
22	12	0	CD	CD	_	19	conj	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	mo	mo	NN	NN	_	26	npadvmod	_	_
25	-	-	HYPH	HYPH	_	26	punct	_	_
26	old	old	JJ	JJ	_	27	amod	_	_
27	animals	animal	NNS	NNS	_	18	pobj	_	_
28	treated	treat	VBN	VBN	_	27	acl	_	_
29	with	with	IN	IN	sem=MNR	28	prep	_	_
30	dox	dox	NN	NN	_	29	pobj	_	_
31	(	(	-LRB-	-LRB-	_	40	punct	_	_
32	p	p	NN	NN	_	34	nsubj	_	_
33	>	>	SYM	SYM	_	34	punct	_	_
34	0.9	0	CD	CD	_	40	ccomp	_	_
35	,	,	,	,	_	40	punct	_	_
36	Tukey	tukey	NNP	NNP	_	40	nmod	_	_
37	post	post	FW	FW	_	39	advmod	_	_
38	-	-	HYPH	HYPH	_	39	punct	_	_
39	hoc	hoc	FW	FW	_	40	amod	_	_
40	test	test	NN	NN	_	28	parataxis	_	_
41	)	)	-RRB-	-RRB-	_	40	punct	_	_
42	.	.	.	.	_	6	punct	_	_

1	Single	single	JJ	JJ	_	2	amod	_	_
2	transgenic	transgenic	JJ	JJ	_	4	amod	_	_
3	tTA	tta	NN	NN	_	4	compound	_	_
4	samples	sample	NNS	NNS	_	6	nsubjpass	_	_
5	were	be	VBD	VBD	_	6	auxpass	_	_
6	included	include	VBN	VBN	_	0	root	_	_
7	as	as	IN	IN	_	6	prep	_	_
8	negative	negative	JJ	JJ	_	9	amod	_	_
9	controls	control	NNS	NNS	_	7	pobj	_	_
10	and	and	CC	CC	_	6	cc	_	_
11	showed	show	VBD	VBD	_	6	conj	_	_
12	no	no	DT	DT	_	13	det	_	_
13	signal	signal	NN	NN	_	11	dobj	_	_
14	above	above	IN	IN	_	13	prep	_	_
15	background	background	NN	NN	_	14	pobj	_	_
16	.	.	.	.	_	6	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.01	0	CD	CD	_	31	ccomp	_	_
6	;	;	:	:	_	31	punct	_	_
7	**	**	SYM	SYM	_	11	punct	_	_
8	,	,	,	,	_	11	punct	_	_
9	p	p	NN	NN	_	11	nsubj	_	_
10	<	<	SYM	SYM	_	11	punct	_	_
11	0.005	0	CD	CD	_	31	ccomp	_	_
12	versus	versus	IN	IN	_	11	prep	_	_
13	9	0	CD	CD	_	15	nummod	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	mo	mo	NN	NN	_	17	npadvmod	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	old	old	JJ	JJ	_	19	amod	_	_
18	untreated	untreated	JJ	JJ	_	19	amod	_	_
19	mice	mouse	NNS	NNS	_	12	pobj	_	_
20	,	,	,	,	_	11	punct	_	_
21	Tukey	tukey	NNP	NNP	_	25	nmod	_	_
22	post	post	FW	FW	_	24	advmod	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	hoc	hoc	FW	FW	_	25	amod	_	_
25	test	test	NN	NN	syn=ADV	11	npadvmod	_	_
26	;	;	:	:	_	31	punct	_	_
27	***	**	SYM	SYM	_	31	punct	_	_
28	,	,	,	,	_	31	punct	_	_
29	p	p	NN	NN	_	31	nsubj	_	_
30	<	<	SYM	SYM	_	31	punct	_	_
31	0.001	0	CD	CD	_	0	root	_	_
32	versus	versus	IN	IN	_	31	prep	_	_
33	9	0	CD	CD	_	35	nummod	_	_
34	-	-	HYPH	HYPH	_	35	punct	_	_
35	mo	mo	NN	NN	_	37	npadvmod	_	_
36	-	-	HYPH	HYPH	_	37	punct	_	_
37	old	old	JJ	JJ	_	39	amod	_	_
38	untreated	untreated	JJ	JJ	_	39	amod	_	_
39	mice	mouse	NNS	NNS	_	32	pobj	_	_
40	,	,	,	,	_	31	punct	_	_
41	Student	student	NNP	NNP	_	45	poss	_	_
42	's	's	POS	POS	_	41	case	_	_
43	t	t	NN	NN	_	45	compound	_	_
44	-	-	HYPH	HYPH	_	45	punct	_	_
45	test	test	NN	NN	syn=ADV	31	npadvmod	_	_
46	.	.	.	.	_	31	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	5	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Amyloid	amyloid	NN	NN	_	5	compound	_	_
5	pathology	pathology	NN	NN	_	0	root	_	_
6	in	in	IN	IN	_	5	prep	_	_
7	the	the	DT	DT	_	8	det	_	_
8	hippocampus	hippocampus	NN	NN	_	6	pobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	representative	representative	JJ	JJ	_	11	amod	_	_
11	mice	mouse	NNS	NNS	_	9	pobj	_	_
12	from	from	IN	IN	_	11	prep	_	_
13	each	each	DT	DT	_	15	det	_	_
14	treatment	treatment	NN	NN	_	15	compound	_	_
15	group	group	NN	NN	_	12	pobj	_	_
16	:	:	:	:	_	15	punct	_	_
17	Hirano	hirano	NNP	NNP	_	19	compound	_	_
18	silver	silver	NN	NN	_	19	compound	_	_
19	stain	stain	NN	NN	_	15	appos	_	_
20	(	(	-LRB-	-LRB-	_	22	punct	_	_
21	top	top	JJ	JJ	_	22	amod	_	_
22	row	row	NN	NN	_	19	parataxis	_	_
23	)	)	-RRB-	-RRB-	_	22	punct	_	_
24	,	,	,	,	_	19	punct	_	_
25	thioflavin	thioflavin	NN	NN	_	27	compound	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	S	s	NN	NN	_	19	conj	_	_
28	(	(	-LRB-	-LRB-	_	30	punct	_	_
29	middle	middle	JJ	JJ	_	30	amod	_	_
30	row	row	NN	NN	_	27	parataxis	_	_
31	)	)	-RRB-	-RRB-	_	30	punct	_	_
32	,	,	,	,	_	27	punct	_	_
33	and	and	CC	CC	_	27	cc	_	_
34	Aβ	aβ	NN	NN	_	35	compound	_	_
35	immunohistochemistry	immunohistochemistry	NN	NN	_	27	conj	_	_
36	(	(	-LRB-	-LRB-	_	38	punct	_	_
37	bottom	bottom	JJ	JJ	_	38	amod	_	_
38	row	row	NN	NN	_	35	parataxis	_	_
39	)	)	-RRB-	-RRB-	_	38	punct	_	_
40	.	.	.	.	_	5	punct	_	_

1	Amyloid	amyloid	NN	NN	_	2	compound	_	_
2	burden	burden	NN	NN	_	3	nsubj	_	_
3	increases	increase	VBZ	VBZ	_	0	root	_	_
4	dramatically	dramatically	RB	RB	_	3	advmod	_	_
5	between	between	IN	IN	_	3	prep	_	_
6	6	0	CD	CD	_	9	nummod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	9	0	CD	CD	_	6	conj	_	_
9	mo	mo	NN	NN	_	5	pobj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	age	age	NN	NN	_	10	pobj	_	_
12	in	in	IN	IN	sem=LOC	3	prep	_	_
13	untreated	untreated	JJ	JJ	_	14	amod	_	_
14	animals	animal	NNS	NNS	_	12	pobj	_	_
15	,	,	,	,	_	3	punct	_	_
16	but	but	CC	CC	_	3	cc	_	_
17	remains	remain	VBZ	VBZ	_	3	conj	_	_
18	stable	stable	JJ	JJ	syn=PRD	17	acomp	_	_
19	in	in	IN	IN	sem=LOC	17	prep	_	_
20	transgene	transgene	NN	NN	_	22	npadvmod	_	_
21	-	-	HYPH	HYPH	_	22	punct	_	_
22	suppressed	suppress	VBN	VBN	_	23	amod	_	_
23	mice	mouse	NNS	NNS	_	19	pobj	_	_
24	over	over	IN	IN	sem=TMP	17	prep	_	_
25	the	the	DT	DT	_	27	det	_	_
26	same	same	JJ	JJ	_	27	amod	_	_
27	period	period	NN	NN	_	24	pobj	_	_
28	(	(	-LRB-	-LRB-	_	34	punct	_	_
29	6	0	CD	CD	_	30	nummod	_	_
30	mo	mo	NN	NN	_	34	nmod	_	_
31	+	+	SYM	SYM	_	30	punct	_	_
32	3	0	CD	CD	_	33	nummod	_	_
33	mo	mo	NN	NN	_	30	appos	_	_
34	dox	dox	NN	NN	_	17	parataxis	_	_
35	and	and	CC	CC	_	34	cc	_	_
36	6	0	CD	CD	_	37	nummod	_	_
37	mo	mo	NN	NN	_	41	nmod	_	_
38	+	+	SYM	SYM	_	37	punct	_	_
39	6	0	CD	CD	_	40	nummod	_	_
40	mo	mo	NN	NN	_	37	appos	_	_
41	dox	dox	NN	NN	_	34	conj	_	_
42	)	)	-RRB-	-RRB-	_	34	punct	_	_
43	.	.	.	.	_	3	punct	_	_

1	Single	single	JJ	JJ	_	2	amod	_	_
2	transgenic	transgenic	JJ	JJ	_	3	amod	_	_
3	animals	animal	NNS	NNS	_	10	nsubj	_	_
4	(	(	-LRB-	-LRB-	_	7	punct	_	_
5	tTA	tta	NN	NN	_	7	nsubj	_	_
6	only	only	RB	RB	_	7	advmod	_	_
7	shown	show	VBN	VBN	_	3	parataxis	_	_
8	here	here	RB	RB	_	7	advmod	_	_
9	)	)	-RRB-	-RRB-	_	7	punct	_	_
10	show	show	VBP	VBP	_	0	root	_	_
11	no	no	DT	DT	_	12	det	_	_
12	sign	sign	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	amyloid	amyloid	NN	NN	_	15	compound	_	_
15	pathology	pathology	NN	NN	_	13	pobj	_	_
16	at	at	IN	IN	sem=TMP	10	prep	_	_
17	any	any	DT	DT	_	18	det	_	_
18	age	age	NN	NN	_	16	pobj	_	_
19	tested	test	VBN	VBN	_	18	acl	_	_
20	.	.	.	.	_	10	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	5	0	CD	CD	_	1	nummod	_	_

1	Aβ	aβ	NN	NN	_	2	compound	_	_
2	ELISA	elisa	NN	NN	_	3	nsubj	_	_
3	Confirms	confirm	VBZ	VBZ	_	0	root	_	_
4	Arrest	arrest	NN	NN	_	3	dobj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	Progression	progression	NN	NN	_	5	pobj	_	_
7	without	without	IN	IN	_	3	prep	_	_
8	Clearance	clearance	NN	NN	_	7	pobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	Peptide	peptide	NN	NN	_	9	pobj	_	_
11	in	in	IN	IN	sem=LOC	3	prep	_	_
12	Mice	mouse	NNS	NNS	_	11	pobj	_	_
13	with	with	IN	IN	_	12	prep	_	_
14	Preexisting	preexist	VBG	VBG	_	15	amod	_	_
15	Aggregates	aggregate	NNS	NNS	_	13	pobj	_	_

1	Aβ	aβ	NN	NN	_	2	compound	_	_
2	levels	level	NNS	NNS	_	26	nsubjpass	_	_
3	in	in	IN	IN	sem=LOC	2	prep	_	_
4	untreated	untreated	JJ	JJ	_	18	amod	_	_
5	6	0	CD	CD	_	10	nummod	_	_
6	-	-	HYPH	HYPH	_	5	punct	_	_
7	and	and	CC	CC	_	5	cc	_	_
8	9	0	CD	CD	_	5	conj	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	mo	mo	NN	NN	_	12	npadvmod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	old	old	JJ	JJ	_	18	amod	_	_
13	tTA	tta	NN	NN	_	15	nmod	_	_
14	/	/	HYPH	HYPH	_	15	punct	_	_
15	APP	app	NN	NN	_	18	nmod	_	_
16	line	line	NN	NN	_	18	nmod	_	_
17	107	0	CD	CD	_	16	nummod	_	_
18	mice	mouse	NNS	NNS	_	3	pobj	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	shown	show	VBN	VBN	_	18	parataxis	_	_
21	in	in	IN	IN	_	20	prep	_	_
22	Figure	figure	NN	NN	_	21	pobj	_	_
23	4	0	CD	CD	_	22	nummod	_	_
24	)	)	-RRB-	-RRB-	_	20	punct	_	_
25	were	be	VBD	VBD	_	26	auxpass	_	_
26	compared	compare	VBN	VBN	_	0	root	_	_
27	to	to	IN	IN	_	26	prep	_	_
28	those	those	DT	DT	_	27	pobj	_	_
29	in	in	IN	IN	sem=LOC	28	prep	_	_
30	9	0	CD	CD	_	35	nummod	_	_
31	-	-	HYPH	HYPH	_	30	punct	_	_
32	and	and	CC	CC	_	30	cc	_	_
33	12	0	CD	CD	_	30	conj	_	_
34	-	-	HYPH	HYPH	_	35	punct	_	_
35	mo	mo	NN	NN	_	37	npadvmod	_	_
36	-	-	HYPH	HYPH	_	37	punct	_	_
37	old	old	JJ	JJ	_	38	amod	_	_
38	animals	animal	NNS	NNS	_	29	pobj	_	_
39	treated	treat	VBN	VBN	_	38	acl	_	_
40	with	with	IN	IN	sem=MNR	39	prep	_	_
41	dox	dox	NN	NN	_	40	pobj	_	_
42	from	from	IN	IN	sem=TMP	39	prep	_	_
43	the	the	DT	DT	_	44	det	_	_
44	age	age	NN	NN	_	42	pobj	_	_
45	of	of	IN	IN	_	44	prep	_	_
46	6	0	CD	CD	_	47	nummod	_	_
47	mo	mo	NN	NN	_	45	pobj	_	_
48	.	.	.	.	_	26	punct	_	_

1	Single	single	JJ	JJ	_	2	amod	_	_
2	transgenic	transgenic	JJ	JJ	_	4	amod	_	_
3	APP	app	NN	NN	_	4	compound	_	_
4	samples	sample	NNS	NNS	_	6	nsubjpass	_	_
5	were	be	VBD	VBD	_	6	auxpass	_	_
6	included	include	VBN	VBN	_	0	root	_	_
7	as	as	IN	IN	_	6	prep	_	_
8	negative	negative	JJ	JJ	_	9	amod	_	_
9	controls	control	NNS	NNS	_	7	pobj	_	_
10	.	.	.	.	_	6	punct	_	_

1	Cortical	cortical	JJ	JJ	_	2	amod	_	_
2	homogenates	homogenate	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	fractionated	fractionate	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	sem=MNR	4	prep	_	_
6	sequential	sequential	JJ	JJ	_	8	amod	_	_
7	multi-step	multi-step	JJ	JJ	_	8	amod	_	_
8	extraction	extraction	NN	NN	_	5	pobj	_	_
9	with	with	IN	IN	sem=MNR	4	prep	_	_
10	PBS	pbs	NN	NN	_	9	pobj	_	_
11	,	,	,	,	_	10	punct	_	_
12	2	0	CD	CD	_	13	nummod	_	_
13	%	%	NN	NN	_	14	compound	_	_
14	SDS	sds	NN	NN	_	10	conj	_	_
15	,	,	,	,	_	14	punct	_	_
16	and	and	CC	CC	_	14	cc	_	_
17	70	0	CD	CD	_	18	nummod	_	_
18	%	%	NN	NN	_	19	compound	_	_
19	FA	fa	NN	NN	_	14	conj	_	_
20	followed	followed	VBN	VBN	_	10	acl	_	_
21	by	by	IN	IN	_	20	agent	_	_
22	human	human	JJ	JJ	_	24	amod	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	specific	specific	JJ	JJ	_	26	amod	_	_
25	Aβ	aβ	NN	NN	_	26	compound	_	_
26	ELISA	elisa	NN	NN	_	21	pobj	_	_
27	to	to	TO	TO	_	28	aux	_	_
28	measure	measure	VB	VB	sem=PRP	4	advcl	_	_
29	transgene	transgene	NN	NN	_	31	npadvmod	_	_
30	-	-	HYPH	HYPH	_	31	punct	_	_
31	derived	derive	VBN	VBN	_	32	amod	_	_
32	peptide	peptide	NN	NN	_	28	dobj	_	_
33	in	in	IN	IN	_	28	prep	_	_
34	each	each	DT	DT	_	35	det	_	_
35	fraction	fraction	NN	NN	_	33	pobj	_	_
36	.	.	.	.	_	4	punct	_	_

1	Aβ40	aβ0	NN	NN	_	3	nsubjpass	_	1:gap
2	is	be	VBZ	VBZ	_	3	auxpass	_	_
3	shown	show	VBN	VBN	_	7	ccomp	_	_
4	in	in	IN	IN	_	3	prep	_	4:gap
5	white	white	JJ	JJ	_	4	pobj	_	_
6	,	,	,	,	_	7	punct	_	_
7	Aβ42	aβ0	NN	NN	_	0	root	_	1:gap
8	in	in	IN	IN	_	7	prep	_	4:gap
9	black	black	JJ	JJ	_	8	pobj	_	_
10	.	.	.	.	_	7	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	17	meta	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	B	b	LS	LS	_	2	conj	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	Most	most	JJS	JJS	_	7	amod	_	_
7	Aβ	aβ	NN	NN	_	17	nsubjpass	_	_
8	in	in	IN	IN	sem=LOC	7	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	brains	brain	NNS	NNS	_	8	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	plaque	plaque	NN	NN	_	14	npadvmod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	bearing	bear	VBG	VBG	_	15	amod	_	_
15	mice	mouse	NNS	NNS	_	11	pobj	_	_
16	is	be	VBZ	VBZ	_	17	auxpass	_	_
17	extracted	extract	VBN	VBN	_	0	root	_	_
18	into	into	IN	IN	_	17	prep	_	_
19	the	the	DT	DT	_	23	det	_	_
20	FA	fa	NN	NN	_	23	nmod	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	SDS	sds	NN	NN	_	20	conj	_	_
23	fractions	fraction	NNS	NNS	_	18	pobj	_	_
24	.	.	.	.	_	17	punct	_	_

1	Consistent	consistent	JJ	JJ	syn=PRD	29	advcl	_	_
2	with	with	IN	IN	_	1	prep	_	_
3	amyloid	amyloid	NN	NN	_	4	compound	_	_
4	burden	burden	NN	NN	_	2	pobj	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	Figures	figure	NNS	NNS	_	4	parataxis	_	_
7	4	0	CD	CD	_	6	nummod	_	_
8	and	and	CC	CC	_	6	cc	_	_
9	Figure	figure	NN	NN	_	10	compound	_	_
10	S3	s0	NN	NN	_	6	conj	_	_
11	)	)	-RRB-	-RRB-	_	6	punct	_	_
12	,	,	,	,	_	29	punct	_	_
13	SDS	sds	NN	NN	_	18	npadvmod	_	_
14	-	-	HYPH	HYPH	_	13	punct	_	_
15	and	and	CC	CC	_	13	cc	_	_
16	FA	fa	NN	NN	_	13	conj	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	extracted	extract	VBN	VBN	_	20	amod	_	_
19	Aβ	aβ	NN	NN	_	20	compound	_	_
20	levels	level	NNS	NNS	_	29	nsubj	_	_
21	in	in	IN	IN	sem=LOC	20	prep	_	_
22	untreated	untreated	JJ	JJ	_	28	amod	_	_
23	9	0	CD	CD	_	25	nummod	_	_
24	-	-	HYPH	HYPH	_	25	punct	_	_
25	mo	mo	NN	NN	_	27	npadvmod	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	old	old	JJ	JJ	_	28	amod	_	_
28	mice	mouse	NNS	NNS	_	21	pobj	_	_
29	were	be	VBD	VBD	_	0	root	_	_
30	significantly	significantly	RB	RB	_	31	advmod	_	_
31	higher	high	JJR	JJR	syn=PRD	29	acomp	_	_
32	than	than	IN	IN	_	31	prep	_	_
33	in	in	IN	IN	sem=LOC	32	prep	_	_
34	untreated	untreated	JJ	JJ	_	40	amod	_	_
35	6	0	CD	CD	_	37	nummod	_	_
36	-	-	HYPH	HYPH	_	37	punct	_	_
37	mo	mo	NN	NN	_	39	npadvmod	_	_
38	-	-	HYPH	HYPH	_	39	punct	_	_
39	old	old	JJ	JJ	_	40	amod	_	_
40	mice	mouse	NNS	NNS	_	33	pobj	_	_
41	(	(	-LRB-	-LRB-	_	46	punct	_	_
42	Tukey	tukey	NNP	NNP	_	46	nmod	_	_
43	post	post	FW	FW	_	45	advmod	_	_
44	-	-	HYPH	HYPH	_	45	punct	_	_
45	hoc	hoc	FW	FW	_	46	amod	_	_
46	test	test	NN	NN	_	29	parataxis	_	_
47	applied	apply	VBN	VBN	_	46	acl	_	_
48	to	to	IN	IN	_	47	prep	_	_
49	significant	significant	JJ	JJ	_	50	amod	_	_
50	effect	effect	NN	NN	_	48	pobj	_	_
51	of	of	IN	IN	_	50	prep	_	_
52	group	group	NN	NN	_	53	compound	_	_
53	ANOVA	anova	NN	NN	_	51	pobj	_	_
54	for	for	IN	IN	_	50	prep	_	_
55	SDS	sds	NN	NN	_	58	nmod	_	_
56	and	and	CC	CC	_	55	cc	_	_
57	FA	fa	NN	NN	_	55	conj	_	_
58	fractions	fraction	NNS	NNS	_	54	pobj	_	_
59	F3	f0	NN	NN	_	65	nsubj	_	_
60	,	,	,	,	_	59	punct	_	_
61	18	0	CD	CD	_	59	nummod	_	_
62	=	=	SYM	SYM	_	65	punct	_	_
63	4.72	0	CD	CD	_	65	quantmod	_	_
64	–	-	SYM	SYM	_	65	punct	_	_
65	12.92	0	CD	CD	_	46	ccomp	_	_
66	,	,	,	,	_	46	punct	_	_
67	p	p	NN	NN	_	69	nsubj	_	_
68	<	<	SYM	SYM	_	69	punct	_	_
69	0.02	0	CD	CD	_	46	ccomp	_	_
70	)	)	-RRB-	-RRB-	_	46	punct	_	_
71	.	.	.	.	_	29	punct	_	_

1	In	in	IN	IN	_	11	prep	_	_
2	contrast	contrast	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	11	punct	_	_
4	3	0	CD	CD	_	7	nummod	_	_
5	or	or	CC	CC	_	4	cc	_	_
6	6	0	CD	CD	_	4	conj	_	_
7	mo	mo	NN	NN	_	11	nsubj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	transgene	transgene	NN	NN	_	10	compound	_	_
10	suppression	suppression	NN	NN	_	8	pobj	_	_
11	held	hold	VBD	VBD	_	0	root	_	_
12	Aβ	aβ	NN	NN	_	11	dobj	_	_
13	at	at	IN	IN	_	11	prep	_	_
14	levels	level	NNS	NNS	_	13	pobj	_	_
15	equivalent	equivalent	JJ	JJ	_	14	amod	_	_
16	to	to	IN	IN	_	15	prep	_	_
17	those	those	DT	DT	_	16	pobj	_	_
18	harbored	harbor	VBN	VBN	_	17	acl	_	_
19	when	when	WRB	WRB	_	22	advmod	_	_
20	treatment	treatment	NN	NN	_	22	nsubjpass	_	_
21	was	be	VBD	VBD	_	22	auxpass	_	_
22	started	start	VBN	VBN	sem=TMP	18	advcl	_	_
23	(	(	-LRB-	-LRB-	_	26	punct	_	_
24	p	p	NN	NN	_	26	nsubj	_	_
25	>	>	SYM	SYM	_	26	punct	_	_
26	0.2	0	CD	CD	_	11	parataxis	_	_
27	compared	compare	VBN	VBN	_	26	prep	_	_
28	to	to	IN	IN	_	27	prep	_	_
29	6	0	CD	CD	_	30	nummod	_	_
30	mo	mo	NN	NN	_	32	nmod	_	_
31	untreated	untreated	JJ	JJ	_	32	amod	_	_
32	mice	mouse	NNS	NNS	_	28	pobj	_	_
33	,	,	,	,	_	26	punct	_	_
34	Tukey	tukey	NNP	NNP	_	38	nmod	_	_
35	post	post	FW	FW	_	37	advmod	_	_
36	-	-	HYPH	HYPH	_	37	punct	_	_
37	hoc	hoc	FW	FW	_	38	amod	_	_
38	test	test	NN	NN	syn=ADV	26	npadvmod	_	_
39	)	)	-RRB-	-RRB-	_	26	punct	_	_
40	.	.	.	.	_	11	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.05	0	CD	CD	_	17	ccomp	_	_
6	;	;	:	:	_	17	punct	_	_
7	**	**	SYM	SYM	_	11	punct	_	_
8	,	,	,	,	_	11	punct	_	_
9	p	p	NN	NN	_	11	nsubj	_	_
10	<	<	SYM	SYM	_	11	punct	_	_
11	0.005	0	CD	CD	_	17	ccomp	_	_
12	;	;	:	:	_	17	punct	_	_
13	***	**	SYM	SYM	_	17	punct	_	_
14	,	,	,	,	_	17	punct	_	_
15	p	p	NN	NN	_	17	nsubj	_	_
16	<	<	SYM	SYM	_	17	punct	_	_
17	0.001	0	CD	CD	_	0	root	_	_
18	versus	versus	IN	IN	_	17	prep	_	_
19	9	0	CD	CD	_	21	nummod	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	mo	mo	NN	NN	_	23	npadvmod	_	_
22	-	-	HYPH	HYPH	_	23	punct	_	_
23	old	old	JJ	JJ	_	25	amod	_	_
24	untreated	untreated	JJ	JJ	_	25	amod	_	_
25	mice	mouse	NNS	NNS	_	18	pobj	_	_
26	,	,	,	,	_	17	punct	_	_
27	Tukey	tukey	NNP	NNP	_	31	nmod	_	_
28	post	post	FW	FW	_	30	advmod	_	_
29	-	-	HYPH	HYPH	_	30	punct	_	_
30	hoc	hoc	FW	FW	_	31	amod	_	_
31	test	test	NN	NN	syn=ADV	17	npadvmod	_	_
32	.	.	.	.	_	17	punct	_	_

1	Significance	significance	NN	NN	_	13	nsubjpass	_	_
2	for	for	IN	IN	_	1	prep	_	_
3	APP	app	NN	NN	_	2	pobj	_	_
4	versus	versus	CC	CC	_	3	cc	_	_
5	9	0	CD	CD	_	7	nummod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	mo	mo	NN	NN	_	9	npadvmod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	old	old	JJ	JJ	_	11	amod	_	_
10	untreated	untreated	JJ	JJ	_	11	amod	_	_
11	mice	mouse	NNS	NNS	_	3	conj	_	_
12	is	be	VBZ	VBZ	_	13	auxpass	_	_
13	based	base	VBN	VBN	_	0	root	_	_
14	on	on	IN	IN	_	13	prep	_	_
15	Student	student	NNP	NNP	_	19	poss	_	_
16	's	's	POS	POS	_	15	case	_	_
17	t	t	NN	NN	_	19	compound	_	_
18	-	-	HYPH	HYPH	_	19	punct	_	_
19	test	test	NN	NN	_	14	pobj	_	_
20	.	.	.	.	_	13	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	7	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	The	the	DT	DT	_	6	det	_	_
5	PBS	pbs	NN	NN	_	6	compound	_	_
6	fraction	fraction	NN	NN	_	7	nsubj	_	_
7	represents	represent	VBZ	VBZ	_	0	root	_	_
8	less	less	JJR	JJR	_	10	amod	_	_
9	than	than	IN	IN	_	10	quantmod	_	_
10	0.1	0	CD	CD	_	11	nummod	_	_
11	%	%	NN	NN	_	7	dobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	total	total	JJ	JJ	_	14	amod	_	_
14	Aβ	aβ	NN	NN	_	12	pobj	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	note	note	VB	VB	_	14	parataxis	_	_
17	the	the	DT	DT	_	18	det	_	_
18	change	change	NN	NN	_	16	dobj	_	_
19	in	in	IN	IN	_	16	prep	_	_
20	y	y	NN	NN	_	22	compound	_	_
21	-	-	HYPH	HYPH	_	22	punct	_	_
22	axis	axis	NN	NN	_	19	pobj	_	_
23	from	from	IN	IN	_	16	prep	_	_
24	[	[	-LRB-	-LRB-	_	23	punct	_	_
25	A	a	NN	NN	_	23	pobj	_	_
26	]	]	-RRB-	-RRB-	_	25	punct	_	_
27	and	and	CC	CC	_	25	cc	_	_
28	[	[	-LRB-	-LRB-	_	29	punct	_	_
29	B	b	NN	NN	_	25	conj	_	_
30	]	]	-RRB-	-RRB-	_	16	punct	_	_
31	)	)	-RRB-	-RRB-	_	16	punct	_	_
32	,	,	,	,	_	7	punct	_	_
33	but	but	CC	CC	_	7	cc	_	_
34	only	only	RB	RB	_	35	advmod	_	_
35	here	here	RB	RB	_	45	advmod	_	_
36	do	do	VB	VB	_	45	aux	_	_
37	Aβ	aβ	NN	NN	_	38	compound	_	_
38	levels	level	NNS	NNS	_	45	nsubj	_	_
39	in	in	IN	IN	sem=LOC	38	prep	_	_
40	the	the	DT	DT	_	44	det	_	_
41	dox	dox	NN	NN	_	43	npadvmod	_	_
42	-	-	HYPH	HYPH	_	43	punct	_	_
43	treated	treat	VBN	VBN	_	44	amod	_	_
44	mice	mouse	NNS	NNS	_	39	pobj	_	_
45	differ	differ	VBP	VBP	_	7	conj	_	_
46	from	from	IN	IN	_	45	prep	_	_
47	those	those	DT	DT	_	46	pobj	_	_
48	in	in	IN	IN	sem=LOC	45	prep	_	_
49	younger	young	JJR	JJR	_	51	amod	_	_
50	untreated	untreated	JJ	JJ	_	51	amod	_	_
51	mice	mouse	NNS	NNS	_	48	pobj	_	_
52	.	.	.	.	_	45	punct	_	_

1	Although	although	IN	IN	_	4	mark	_	_
2	both	both	DT	DT	_	3	det	_	_
3	peptides	peptide	NNS	NNS	_	4	nsubj	_	_
4	appear	appear	VBP	VBP	syn=ADV	23	advcl	_	_
5	elevated	elevated	JJ	JJ	syn=PRD	4	oprd	_	_
6	in	in	IN	IN	_	4	prep	_	_
7	the	the	DT	DT	_	9	det	_	_
8	treated	treat	VBN	VBN	_	9	amod	_	_
9	groups	group	NNS	NNS	_	6	pobj	_	_
10	compared	compare	VBN	VBN	_	4	prep	_	_
11	to	to	IN	IN	_	10	prep	_	_
12	the	the	DT	DT	_	19	det	_	_
13	untreated	untreated	JJ	JJ	_	19	amod	_	_
14	6	0	CD	CD	_	16	nummod	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	mo	mo	NN	NN	_	18	npadvmod	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	old	old	JJ	JJ	_	19	amod	_	_
19	mice	mouse	NNS	NNS	_	11	pobj	_	_
20	,	,	,	,	_	23	punct	_	_
21	only	only	RB	RB	_	22	advmod	_	_
22	Aβ40	aβ0	NN	NN	_	23	nsubj	_	_
23	reaches	reach	VBZ	VBZ	_	0	root	_	_
24	statistical	statistical	JJ	JJ	_	25	amod	_	_
25	significance	significance	NN	NN	_	23	dobj	_	_
26	(	(	-LRB-	-LRB-	_	35	punct	_	_
27	p	p	NN	NN	_	29	nsubj	_	_
28	<	<	SYM	SYM	_	29	punct	_	_
29	0.05	0	CD	CD	_	35	ccomp	_	_
30	,	,	,	,	_	35	punct	_	_
31	Tukey	tukey	NNP	NNP	_	35	nmod	_	_
32	post	post	FW	FW	_	34	advmod	_	_
33	-	-	HYPH	HYPH	_	34	punct	_	_
34	hoc	hoc	FW	FW	_	35	amod	_	_
35	test	test	NN	NN	_	23	parataxis	_	_
36	applied	apply	VBN	VBN	_	35	acl	_	_
37	to	to	IN	IN	_	36	prep	_	_
38	significant	significant	JJ	JJ	_	39	amod	_	_
39	effect	effect	NN	NN	_	37	pobj	_	_
40	of	of	IN	IN	_	39	prep	_	_
41	group	group	NN	NN	_	42	compound	_	_
42	ANOVA	anova	NN	NN	_	40	pobj	_	_
43	for	for	IN	IN	_	39	prep	_	_
44	Aβ40	aβ0	NN	NN	_	43	pobj	_	_
45	F3	f0	NN	NN	_	49	nsubj	_	_
46	,	,	,	,	_	45	punct	_	_
47	18	0	CD	CD	_	45	nummod	_	_
48	=	=	SYM	SYM	_	49	punct	_	_
49	4.60	0	CD	CD	_	35	ccomp	_	_
50	,	,	,	,	_	35	punct	_	_
51	p	p	NN	NN	_	53	nsubj	_	_
52	<	<	SYM	SYM	_	53	punct	_	_
53	0.02	0	CD	CD	_	35	ccomp	_	_
54	)	)	-RRB-	-RRB-	_	35	punct	_	_
55	.	.	.	.	_	23	punct	_	_

1	A	a	DT	DT	_	3	det	_	_
2	similar	similar	JJ	JJ	_	3	amod	_	_
3	trend	trend	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	seen	see	VBN	VBN	_	36	ccomp	_	_
6	for	for	IN	IN	_	5	prep	_	_
7	Aβ42	aβ0	NN	NN	_	6	pobj	_	_
8	,	,	,	,	_	5	punct	_	_
9	where	where	WRB	WRB	_	11	advmod	_	_
10	ANOVA	anova	NN	NN	_	11	nsubj	_	_
11	yielded	yield	VBD	VBD	syn=ADV	5	advcl	_	_
12	a	a	DT	DT	_	14	det	_	_
13	significant	significant	JJ	JJ	_	14	amod	_	_
14	effect	effect	NN	NN	_	11	dobj	_	_
15	of	of	IN	IN	_	11	prep	_	_
16	group	group	NN	NN	_	15	pobj	_	_
17	for	for	IN	IN	_	11	prep	_	_
18	PBS	pbs	NN	NN	_	20	npadvmod	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	soluble	soluble	JJ	JJ	_	21	amod	_	_
21	Aβ42	aβ0	NN	NN	_	17	pobj	_	_
22	(	(	-LRB-	-LRB-	_	31	punct	_	_
23	F3	f0	NN	NN	_	27	nsubj	_	_
24	,	,	,	,	_	23	punct	_	_
25	18	0	CD	CD	_	23	nummod	_	_
26	=	=	SYM	SYM	_	27	punct	_	_
27	3.75	0	CD	CD	_	31	ccomp	_	_
28	,	,	,	,	_	31	punct	_	_
29	p	p	NN	NN	_	31	nsubj	_	_
30	<	<	SYM	SYM	_	31	punct	_	_
31	0.03	0	CD	CD	_	11	parataxis	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	,	,	,	,	_	36	punct	_	_
34	however	however	RB	RB	_	36	advmod	_	_
35	this	this	DT	DT	_	36	nsubj	_	_
36	was	be	VBD	VBD	_	0	root	_	_
37	due	due	IN	IN	syn=PRD	36	prep	_	_
38	only	only	RB	RB	_	37	advmod	_	_
39	to	to	IN	IN	_	37	pcomp	_	_
40	differences	difference	NNS	NNS	_	37	pobj	_	_
41	between	between	IN	IN	_	40	prep	_	_
42	the	the	DT	DT	_	52	det	_	_
43	untreated	untreated	JJ	JJ	_	52	amod	_	_
44	6	0	CD	CD	_	49	nummod	_	_
45	-	-	HYPH	HYPH	_	44	punct	_	_
46	and	and	CC	CC	_	44	cc	_	_
47	9	0	CD	CD	_	44	conj	_	_
48	-	-	HYPH	HYPH	_	49	punct	_	_
49	mo	mo	NN	NN	_	51	npadvmod	_	_
50	-	-	HYPH	HYPH	_	51	punct	_	_
51	old	old	JJ	JJ	_	52	amod	_	_
52	groups	group	NNS	NNS	_	41	pobj	_	_
53	.	.	.	.	_	36	punct	_	_

1	•	-	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.05	0	CD	CD	_	25	ccomp	_	_
6	versus	versus	IN	IN	_	5	prep	_	_
7	6	0	CD	CD	_	9	nummod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	mo	mo	NN	NN	_	11	npadvmod	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	old	old	JJ	JJ	_	13	amod	_	_
12	untreated	untreated	JJ	JJ	_	13	amod	_	_
13	mice	mouse	NNS	NNS	_	6	pobj	_	_
14	,	,	,	,	_	5	punct	_	_
15	Tukey	tukey	NNP	NNP	_	19	nmod	_	_
16	post	post	FW	FW	_	18	advmod	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	hoc	hoc	FW	FW	_	19	amod	_	_
19	test	test	NN	NN	syn=ADV	5	npadvmod	_	_
20	;	;	:	:	_	25	punct	_	_
21	•••	•••	SYM	SYM	_	25	punct	_	_
22	,	,	,	,	_	25	punct	_	_
23	p	p	NN	NN	_	25	nsubj	_	_
24	<	<	SYM	SYM	_	25	punct	_	_
25	0.001	0	CD	CD	_	0	root	_	_
26	versus	versus	IN	IN	_	25	prep	_	_
27	6	0	CD	CD	_	29	nummod	_	_
28	-	-	HYPH	HYPH	_	29	punct	_	_
29	mo	mo	NN	NN	_	31	npadvmod	_	_
30	-	-	HYPH	HYPH	_	31	punct	_	_
31	old	old	JJ	JJ	_	33	amod	_	_
32	untreated	untreated	JJ	JJ	_	33	amod	_	_
33	mice	mouse	NNS	NNS	_	26	pobj	_	_
34	,	,	,	,	_	25	punct	_	_
35	Student	student	NNP	NNP	_	39	poss	_	_
36	's	's	POS	POS	_	35	case	_	_
37	t	t	NN	NN	_	39	compound	_	_
38	-	-	HYPH	HYPH	_	39	punct	_	_
39	test	test	NN	NN	syn=ADV	25	npadvmod	_	_
40	.	.	.	.	_	25	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	6	0	CD	CD	_	1	nummod	_	_

1	Neuritic	neuritic	JJ	JJ	_	4	amod	_	_
2	and	and	CC	CC	_	4	cc	_	_
3	Glial	glial	JJ	JJ	_	4	amod	_	_
4	Pathology	pathology	NN	NN	_	5	nsubj	_	_
5	Are	be	VBP	VBP	_	0	root	_	_
6	Unchanged	unchanged	JJ	JJ	syn=PRD	5	acomp	_	_
7	following	follow	VBG	VBG	sem=TMP	5	prep	_	_
8	Transgene	transgene	NN	NN	_	9	compound	_	_
9	Suppression	suppression	NN	NN	_	7	pobj	_	_

1	Dystrophic	dystrophic	JJ	JJ	_	2	amod	_	_
2	neurites	neurites	NNS	NNS	_	6	nsubj	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	activated	activate	VBN	VBN	_	5	amod	_	_
5	astrocytes	astrocyte	NNS	NNS	_	2	conj	_	_
6	surround	surround	VBP	VBP	_	0	root	_	_
7	most	most	JJS	JJS	_	9	amod	_	_
8	compact	compact	JJ	JJ	_	9	amod	_	_
9	plaques	plaque	NNS	NNS	_	6	dobj	_	_
10	in	in	IN	IN	sem=LOC	6	prep	_	_
11	tet	tet	NN	NN	_	13	compound	_	_
12	-	-	HYPH	HYPH	_	13	punct	_	_
13	off	off	NN	NN	_	15	compound	_	_
14	APP	app	NN	NN	_	15	compound	_	_
15	mice	mouse	NNS	NNS	_	10	pobj	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	line	line	NN	NN	_	6	parataxis	_	_
18	107	0	CD	CD	_	17	nummod	_	_
19	)	)	-RRB-	-RRB-	_	17	punct	_	_
20	.	.	.	.	_	6	punct	_	_

1	Dark	dark	NN	NN	_	3	npadvmod	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	stained	stain	VBN	VBN	_	8	amod	_	_
4	,	,	,	,	_	8	punct	_	_
5	ubiquitin	ubiquitin	NN	NN	_	7	npadvmod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	filled	fill	VBN	VBN	_	8	amod	_	_
8	neurites	neurites	NNS	NNS	_	12	nsubj	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	reactive	reactive	JJ	JJ	_	11	amod	_	_
11	astrocytes	astrocyte	NNS	NNS	_	8	conj	_	_
12	form	form	VBP	VBP	_	0	root	_	_
13	a	a	DT	DT	_	14	det	_	_
14	halo	halo	NN	NN	_	12	dobj	_	_
15	around	around	IN	IN	sem=LOC	12	prep	_	_
16	cored	core	VBN	VBN	_	19	amod	_	_
17	,	,	,	,	_	19	punct	_	_
18	fibrillar	fibrillar	JJ	JJ	_	19	amod	_	_
19	deposits	deposit	NNS	NNS	_	15	pobj	_	_
20	by	by	IN	IN	sem=TMP	12	prep	_	_
21	6	0	CD	CD	_	22	nummod	_	_
22	mo	mo	NN	NN	_	20	pobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	age	age	NN	NN	_	23	pobj	_	_
25	that	that	WDT	WDT	_	26	dep	_	_
26	worsens	worsen	VBZ	VBZ	_	12	ccomp	_	_
27	with	with	IN	IN	_	26	prep	_	_
28	time	time	NN	NN	_	27	pobj	_	_
29	in	in	IN	IN	sem=LOC	12	prep	_	_
30	untreated	untreated	JJ	JJ	_	31	amod	_	_
31	mice	mouse	NNS	NNS	_	29	pobj	_	_
32	.	.	.	.	_	12	punct	_	_

1	Both	both	DT	DT	_	5	det	_	_
2	plaque	plaque	NN	NN	_	4	npadvmod	_	_
3	-	-	HYPH	HYPH	_	4	punct	_	_
4	associated	associate	VBN	VBN	_	5	amod	_	_
5	pathologies	pathology	NNS	NNS	_	7	nsubjpass	_	_
6	are	be	VBP	VBP	_	7	auxpass	_	_
7	arrested	arrest	VBN	VBN	_	0	root	_	_
8	,	,	,	,	_	7	punct	_	_
9	although	although	IN	IN	_	11	mark	_	_
10	not	not	RB	RB	_	11	neg	_	_
11	reversed	reverse	VBN	VBN	syn=ADV	7	advcl	_	_
12	,	,	,	,	_	7	punct	_	_
13	by	by	IN	IN	_	7	agent	_	_
14	transgene	transgene	NN	NN	_	15	compound	_	_
15	suppression	suppression	NN	NN	_	13	pobj	_	_
16	.	.	.	.	_	7	punct	_	_

1	Hirano	hirano	NNP	NNP	_	3	compound	_	_
2	silver	silver	NN	NN	_	3	compound	_	_
3	stain	stain	NN	NN	_	0	root	_	_
4	(	(	-LRB-	-LRB-	_	6	punct	_	_
5	top	top	JJ	JJ	_	6	amod	_	_
6	row	row	NN	NN	_	3	parataxis	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	;	;	:	:	_	3	punct	_	_
9	GFAP	gfap	NN	NN	_	10	compound	_	_
10	immunohistochemistry	immunohistochemistry	NN	NN	_	3	appos	_	_
11	(	(	-LRB-	-LRB-	_	13	punct	_	_
12	middle	middle	JJ	JJ	_	13	amod	_	_
13	row	row	NN	NN	_	10	parataxis	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	;	;	:	:	_	3	punct	_	_
16	ubiquitin	ubiquitin	NN	NN	_	17	compound	_	_
17	immunohistochemistry	immunohistochemistry	NN	NN	_	3	appos	_	_
18	(	(	-LRB-	-LRB-	_	20	punct	_	_
19	bottom	bottom	JJ	JJ	_	20	amod	_	_
20	row	row	NN	NN	_	17	parataxis	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	.	.	.	.	_	3	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	7	0	CD	CD	_	1	nummod	_	_

1	Transgene	transgene	NN	NN	_	2	compound	_	_
2	Suppression	suppression	NN	NN	_	3	nsubj	_	_
3	Attenuates	attenuate	VBZ	VBZ	_	0	root	_	_
4	Hyperactivity	hyperactivity	NN	NN	_	3	dobj	_	_
5	in	in	IN	IN	sem=LOC	3	prep	_	_
6	tTA	tta	NN	NN	_	8	compound	_	_
7	/	/	HYPH	HYPH	_	8	punct	_	_
8	APP	app	NN	NN	_	9	compound	_	_
9	Mice	mouse	NNS	NNS	_	5	pobj	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	11	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	A	a	DT	DT	_	8	det	_	_
5	48	0	CD	CD	_	7	nummod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	h	h	NN	NN	_	8	compound	_	_
8	measure	measure	NN	NN	_	11	nsubj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	ambulation	ambulation	NN	NN	_	9	pobj	_	_
11	records	record	VBZ	VBZ	_	0	root	_	_
12	extreme	extreme	JJ	JJ	_	13	amod	_	_
13	hyperactivity	hyperactivity	NN	NN	_	11	dobj	_	_
14	in	in	IN	IN	sem=LOC	11	prep	_	_
15	untreated	untreated	JJ	JJ	_	18	amod	_	_
16	double	double	JJ	JJ	_	17	amod	_	_
17	transgenic	transgenic	JJ	JJ	_	18	amod	_	_
18	mice	mouse	NNS	NNS	_	14	pobj	_	_
19	compared	compare	VBN	VBN	_	11	prep	_	_
20	to	to	IN	IN	_	19	prep	_	_
21	single	single	JJ	JJ	_	22	amod	_	_
22	transgenic	transgenic	JJ	JJ	_	25	amod	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	nontransgenic	nontransgenic	JJ	JJ	_	22	conj	_	_
25	controls	control	NNS	NNS	_	20	pobj	_	_
26	(	(	-LRB-	-LRB-	_	27	punct	_	_
27	line	line	NN	NN	_	11	parataxis	_	_
28	107	0	CD	CD	_	27	nummod	_	_
29	)	)	-RRB-	-RRB-	_	27	punct	_	_
30	.	.	.	.	_	11	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	phenotype	phenotype	NN	NN	_	5	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	5	auxpass	_	_
4	completely	completely	RB	RB	_	5	advmod	_	_
5	eliminated	eliminate	VBN	VBN	_	0	root	_	_
6	by	by	IN	IN	_	5	agent	_	_
7	rearing	rear	VBG	VBG	syn=NOM	6	pcomp	_	_
8	the	the	DT	DT	_	11	det	_	_
9	double	double	JJ	JJ	_	10	amod	_	_
10	transgenic	transgenic	JJ	JJ	_	11	amod	_	_
11	mice	mouse	NNS	NNS	_	7	dobj	_	_
12	on	on	IN	IN	_	7	prep	_	_
13	dox	dox	NN	NN	_	12	pobj	_	_
14	.	.	.	.	_	5	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	13	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	The	the	DT	DT	_	6	det	_	_
5	same	same	JJ	JJ	_	6	amod	_	_
6	data	datum	NNS	NNS	_	13	nsubjpass	_	_
7	shown	show	VBN	VBN	_	6	acl	_	_
8	in	in	IN	IN	_	7	prep	_	_
9	(	(	-LRB-	-LRB-	_	8	punct	_	_
10	A	a	NN	NN	_	8	pobj	_	_
11	)	)	-RRB-	-RRB-	_	13	punct	_	_
12	are	be	VBP	VBP	_	13	auxpass	_	_
13	replotted	replotted	VBN	VBN	_	0	root	_	_
14	to	to	TO	TO	_	15	aux	_	_
15	magnify	magnify	VB	VB	sem=PRP	13	advcl	_	_
16	data	datum	NNS	NNS	_	15	dobj	_	_
17	from	from	IN	IN	_	16	prep	_	_
18	untreated	untreated	JJ	JJ	_	19	amod	_	_
19	control	control	NN	NN	_	24	nmod	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	dox	dox	NN	NN	_	23	npadvmod	_	_
22	-	-	HYPH	HYPH	_	23	punct	_	_
23	treated	treat	VBN	VBN	_	19	conj	_	_
24	groups	group	NNS	NNS	_	17	pobj	_	_
25	.	.	.	.	_	13	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	23	meta	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	D	d	LS	LS	_	2	conj	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	Activity	activity	NN	NN	_	7	compound	_	_
7	levels	level	NNS	NNS	_	23	nsubjpass	_	_
8	in	in	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	12	det	_	_
10	combined	combine	VBN	VBN	_	12	amod	_	_
11	control	control	NN	NN	_	12	compound	_	_
12	groups	group	NNS	NNS	_	8	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	(	(	-LRB-	-LRB-	_	13	punct	_	_
15	A	a	NN	NN	_	13	pobj	_	_
16	)	)	-RRB-	-RRB-	_	15	punct	_	_
17	and	and	CC	CC	_	15	cc	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	B	b	NN	NN	_	15	conj	_	_
20	)	)	-RRB-	-RRB-	_	23	punct	_	_
21	are	be	VBP	VBP	_	23	auxpass	_	_
22	here	here	RB	RB	sem=LOC	23	advmod	_	_
23	separated	separate	VBN	VBN	_	0	root	_	_
24	by	by	IN	IN	_	23	prep	_	_
25	genotype	genotype	NN	NN	_	24	pobj	_	_
26	.	.	.	.	_	23	punct	_	_

1	None	none	NN	NN	_	10	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	9	det	_	_
4	single	single	JJ	JJ	_	5	amod	_	_
5	transgenic	transgenic	JJ	JJ	_	9	amod	_	_
6	or	or	CC	CC	_	5	cc	_	_
7	nontransgenic	nontransgenic	JJ	JJ	_	8	amod	_	_
8	control	control	NN	NN	_	5	conj	_	_
9	groups	group	NNS	NNS	_	2	pobj	_	_
10	display	display	VBP	VBP	_	0	root	_	_
11	the	the	DT	DT	_	12	det	_	_
12	hyperactivity	hyperactivity	NN	NN	_	10	dobj	_	_
13	present	present	JJ	JJ	_	12	amod	_	_
14	in	in	IN	IN	sem=LOC	10	prep	_	_
15	untreated	untreated	JJ	JJ	_	19	amod	_	_
16	tTA	tta	NN	NN	_	18	compound	_	_
17	/	/	HYPH	HYPH	_	18	punct	_	_
18	APP	app	NN	NN	_	19	compound	_	_
19	animals	animal	NNS	NNS	_	14	pobj	_	_
20	.	.	.	.	_	10	punct	_	_

1	Again	again	RB	RB	_	3	advmod	_	_
2	,	,	,	,	_	3	punct	_	_
3	note	note	VBP	VBP	_	0	root	_	_
4	the	the	DT	DT	_	7	det	_	_
5	y	y	NN	NN	_	7	compound	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	axes	ax	NNS	NNS	_	10	nsubjpass	_	_
8	have	have	VBP	VBP	_	10	aux	_	_
9	been	be	VBN	VBN	_	10	auxpass	_	_
10	enlarged	enlarge	VBN	VBN	_	3	advcl	_	_
11	for	for	IN	IN	_	10	prep	_	_
12	detail	detail	NN	NN	_	11	pobj	_	_
13	compared	compare	VBN	VBN	_	10	prep	_	_
14	to	to	IN	IN	_	13	prep	_	_
15	(	(	-LRB-	-LRB-	_	14	punct	_	_
16	A	a	NN	NN	_	14	pobj	_	_
17	)	)	-RRB-	-RRB-	_	3	punct	_	_
18	.	.	.	.	_	3	punct	_	_

1	Footnotes	footnote	NNS	NNS	_	0	root	_	_

1	Citation	citation	NN	NN	_	24	dep	_	_
2	:	:	:	:	_	24	punct	_	_
3	Jankowsky	jankowsky	NNP	NNP	_	24	meta	_	_
4	JL	jl	NNP	NNP	_	3	nmod	_	_
5	,	,	,	,	_	3	punct	_	_
6	Slunt	slunt	NNP	NNP	_	3	nmod	_	_
7	HH	hh	NNP	NNP	_	3	nmod	_	_
8	,	,	,	,	_	3	punct	_	_
9	Gonzales	gonzales	NNP	NNP	_	3	nmod	_	_
10	V	v	NNP	NNP	_	3	nmod	_	_
11	,	,	,	,	_	3	punct	_	_
12	Savonenko	savonenko	NNP	NNP	_	3	nmod	_	_
13	AV	av	NNP	NNP	_	3	nmod	_	_
14	,	,	,	,	_	3	punct	_	_
15	Wen	wen	NNP	NNP	_	3	nmod	_	_
16	JC	jc	NNP	NNP	_	3	nmod	_	_
17	,	,	,	,	_	3	punct	_	_
18	et	et	FW	FW	_	3	nmod	_	_
19	al.	al.	FW	FW	_	3	nmod	_	_
20	(	(	-LRB-	-LRB-	_	3	punct	_	_
21	2005	0	CD	CD	_	3	nummod	_	_
22	)	)	-RRB-	-RRB-	_	3	punct	_	_
23	Persistent	persistent	JJ	JJ	_	24	amod	_	_
24	amyloidosis	amyloidosis	NN	NN	_	0	root	_	_
25	following	follow	VBG	VBG	sem=TMP	24	prep	_	_
26	suppression	suppression	NN	NN	_	25	pobj	_	_
27	of	of	IN	IN	_	26	prep	_	_
28	Aβ	aβ	NN	NN	_	29	compound	_	_
29	production	production	NN	NN	_	27	pobj	_	_
30	in	in	IN	IN	_	24	prep	_	_
31	a	a	DT	DT	_	33	det	_	_
32	transgenic	transgenic	JJ	JJ	_	33	amod	_	_
33	model	model	NN	NN	_	30	pobj	_	_
34	of	of	IN	IN	_	33	prep	_	_
35	Alzheimer	alzheimer	NNP	NNP	_	36	compound	_	_
36	disease	disease	NN	NN	_	34	pobj	_	_
37	.	.	.	.	_	24	punct	_	_

1	PLoS	plos	NNP	NNP	_	0	root	_	_
2	Med	med	NNP	NNP	_	1	nmod	_	_
3	2	0	CD	CD	_	1	nummod	_	_
4	(	(	-LRB-	-LRB-	_	1	punct	_	_
5	12	0	CD	CD	_	1	nummod	_	_
6	)	)	-RRB-	-RRB-	_	1	punct	_	_
7	:	:	:	:	_	1	punct	_	_
8	e355	e0	NN	NN	_	1	nmod	_	_
9	.	.	.	.	_	1	punct	_	_

